<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML+RDFa 1.0//EN" "http://www.w3.org/MarkUp/DTD/xhtml-rdfa-1.dtd">
<!--[if lt IE 7]> <html class="no-mqs lt-ie9 lt-ie8 lt-ie7" lang="en" xml:lang="en" dir="ltr" > <![endif]-->
<!--[if IE 7]>    <html class="no-mqs lt-ie9 lt-ie8" lang="en" xml:lang="en" dir="ltr" > <![endif]-->
<!--[if IE 8]>    <html class="no-mqs lt-ie9" lang="en" xml:lang="en" dir="ltr" > <![endif]-->
<!--[if gt IE 8]><!-->
<html class="modernizr-js modernizr-no-touch modernizr-localstorage modernizr-svg modernizr-inlinesvg modernizr-svgclippaths js js flexbox canvas canvastext webgl no-touch geolocation postmessage no-websqldatabase indexeddb hashchange history draganddrop websockets rgba hsla multiplebgs backgroundsize borderimage borderradius boxshadow textshadow opacity cssanimations csscolumns cssgradients no-cssreflections csstransforms csstransforms3d csstransitions fontface generatedcontent video audio localstorage sessionstorage webworkers applicationcache svg inlinesvg smil svgclippaths" style="" xml:lang="en" dir="ltr" lang="en"><!--<![endif]--><!--[if IE 9]>    <html class="no-mqs" lang="en" xml:lang="en" dir="ltr" > <![endif]--><!-- <html lang="" dir=""> --><head profile="http://www.w3.org/1999/xhtml/vocab"><script async="" src="CONSORT%202010%20Explanation%20and%20Elaboration_%20updated%20guidelines%20for%20reporting%20parallel%20group%20randomised%20trials%20%7C%20The%20BMJ_files/cbgapi_002.js"></script><script async="" src="CONSORT%202010%20Explanation%20and%20Elaboration_%20updated%20guidelines%20for%20reporting%20parallel%20group%20randomised%20trials%20%7C%20The%20BMJ_files/cbgapi.js"></script><script type="text/javascript" async="" src="CONSORT%202010%20Explanation%20and%20Elaboration_%20updated%20guidelines%20for%20reporting%20parallel%20group%20randomised%20trials%20%7C%20The%20BMJ_files/4896.js"></script>
  <meta charset="utf-8">
  <meta name="viewport" content="width=device-width, initial-scale=1.0">
  <link rel="”apple-touch-icon-precomposed”" href="http://www.bmj.com/content/340/%E2%80%9D/sites/default/themes/bmj/the_bmj/img/icon.png%E2%80%9D/">
  <meta http-equiv="X-UA-Compatible" content="IE=edge">
  <meta http-equiv="Content-Type" content="text/html; charset=UTF-8">
<link rel="shortcut icon" href="http://static.www.bmj.com/sites/default/themes/bmj/the_bmj/favicon.ico" type="image/vnd.microsoft.icon">
<!--[if (gte IE 6)&(lte IE 9)]><script src="/sites/default/themes/bmj/the_bmj/js/respond.min.js" />
</script><![endif]--><link href="CONSORT%202010%20Explanation%20and%20Elaboration_%20updated%20guidelines%20for%20reporting%20parallel%20group%20randomised%20trials%20%7C%20The%20BMJ_files/font-awesome.css" rel="stylesheet" media="all" type="text/css">
<meta http-equiv="x-dns-prefetch-control" content="on">
<link rel="dns-prefetch" href="http://static.www.bmj.com/">
<meta name="HW.identifier" content="/bmj/340/bmj.c869.atom">
<meta name="HW.pisa" content="bmj;340/mar23_1/c869">
<meta name="DC.Format" content="text/html">
<meta name="DC.Language" content="en">
<meta name="DC.Title" content="CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials">
<meta name="DC.Identifier" content="10.1136/bmj.c869">
<meta name="DC.Date" content="2010-03-24">
<meta name="DC.Publisher" content="BMJ Publishing Group Ltd">
<meta name="DC.Rights" content="© Moher et al 2010. This is an open-access article distributed under the terms of the Creative Commons Attribution Non-commercial License, which permits use, distribution, and reproduction in any medium, provided the original work is properly cited, the use is non commercial and is otherwise in compliance with the license. See: http://creativecommons.org/licenses/by-nc/2.0/  and  http://creativecommons.org/licenses/by-nc/2.0/legalcode.">
<meta name="DC.Relation" content="10.1136/bmj.321.7266.931">
<meta name="DC.Relation" content="10.1136/bmj.317.7155.362">
<meta name="DC.Relation" content="10.1136/bmj.321.7257.329">
<meta name="DC.Relation" content="10.1136/bmj.a2299">
<meta name="DC.Relation" content="10.1136/bmj.b4074">
<meta name="DC.Relation" content="10.1136/bmj.a2390">
<meta name="DC.Relation" content="10.1136/bmj.326.7400.1167">
<meta name="DC.Relation" content="10.1136/bmj.295.6599.654">
<meta name="DC.Relation" content="10.1136/bmj.311.7013.1145">
<meta name="DC.Relation" content="10.1136/bmj.308.6924.283">
<meta name="DC.Relation" content="10.1136/bmj.c723">
<meta name="DC.Relation" content="10.1136/bmj.321.7252.20">
<meta name="DC.Relation" content="10.1136/bmj.b1732">
<meta name="DC.Relation" content="10.1136/bmj.2.1037.769">
<meta name="DC.Relation" content="10.1136/bmj.302.6791.1481">
<meta name="DC.Relation" content="10.1136/bmj.317.7168.1309">
<meta name="DC.Relation" content="10.1136/bmj.313.7069.1390">
<meta name="DC.Relation" content="10.1136/bmj.319.7211.703">
<meta name="DC.Relation" content="10.1136/bmj.313.7052.275">
<meta name="DC.Relation" content="10.1136/bmj.315.7109.635">
<meta name="DC.Relation" content="10.1136/bmj.310.6977.452">
<meta name="DC.Relation" content="10.1136/bmj.c6325">
<meta name="DC.Relation" content="10.1136/bmj.317.7167.1181">
<meta name="DC.Relation" content="10.1136/bmj.321.7259.504">
<meta name="DC.Relation" content="10.1136/bmj.317.7167.1191">
<meta name="DC.Relation" content="10.1136/bmj.38414.422650.8F">
<meta name="DC.Relation" content="10.1136/bmj.38414.422650.8F">
<meta name="DC.Relation" content="10.1136/bmj.325.7358.249">
<meta name="DC.Relation" content="10.1136/bmj.328.7441.702">
<meta name="DC.Relation" content="10.1136/bmj.b2684">
<meta name="DC.Relation" content="10.1136/bmj.308.6921.72">
<meta name="DC.Relation" content="10.1136/bmj.319.7223.1492">
<meta name="DC.Relation" content="10.1136/bmj.1.108.85">
<meta name="DC.Relation" content="10.1136/bmj.312.7033.742">
<meta name="DC.Relation" content="10.1136/bmj.314.7098.1874">
<meta name="DC.Relation" content="10.1136/bmj.38895.410451.79">
<meta name="DC.Relation" content="10.1136/bmj.38895.410451.79">
<meta name="DC.Relation" content="10.1136/bmj.326.7400.1171">
<meta name="DC.Relation" content="10.1136/bmj.313.7060.808">
<meta name="DC.Relation" content="10.1136/bmj.319.7211.670">
<meta name="DC.Relation" content="10.1136/bmj.d2090">
<meta name="DC.Relation" content="10.1136/bmj.d6131">
<meta name="DC.Relation" content="10.1136/bmj.d6783">
<meta name="DC.Relation" content="10.1136/bmj.d8141">
<meta name="DC.Relation" content="10.1136/bmj.e686">
<meta name="DC.Relation" content="10.1136/bmj.e2809">
<meta name="DC.Relation" content="10.1136/bmj.e2758">
<meta name="DC.Relation" content="10.1136/bmj.e4178">
<meta name="DC.Relation" content="10.1136/bmj.e4547">
<meta name="DC.Relation" content="10.1136/bmj.e5155">
<meta name="DC.Relation" content="10.1136/bmj.e5661">
<meta name="DC.Relation" content="10.1136/bmj.e5840">
<meta name="DC.Relation" content="10.1136/bmj.e7837">
<meta name="DC.Relation" content="10.1136/bmj.e8668">
<meta name="DC.Relation" content="10.1136/bmj.e7586">
<meta name="DC.Relation" content="10.1136/bmj.f5334">
<meta name="DC.Relation" content="10.1136/bmj.f6104">
<meta name="DC.Relation" content="10.1136/bmj.f6782">
<meta name="DC.Relation" content="10.1136/bmj.g3804">
<meta name="DC.Relation" content="10.1136/bmj.g4145">
<meta name="DC.Relation" content="10.1136/bmj.314.7098.1907">
<meta name="DC.Relation" content="10.1136/bmj.328.7448.1136">
<meta name="DC.Relation" content="10.1136/bmj.313.7057.628">
<meta name="DC.Relation" content="10.1136/bmj.h796">
<meta name="DC.Description" content="#### Abstract

Overwhelming evidence shows the quality of reporting of randomised controlled trials (RCTs) is not optimal. Without transparent reporting, readers cannot judge the reliability and validity of trial findings nor extract information for systematic reviews. Recent methodological analyses indicate that inadequate reporting and design are associated with biased estimates of treatment effects. Such systematic error is seriously damaging to RCTs, which are considered the gold standard for evaluating interventions because of their ability to minimise or avoid bias.

A group of scientists and editors developed the CONSORT (Consolidated Standards of Reporting Trials) statement to improve the quality of reporting of RCTs. It was first published in 1996 and updated in 2001. The statement consists of a checklist and flow diagram that authors can use for reporting an RCT. Many leading medical journals and major international editorial groups have endorsed the CONSORT statement. The statement facilitates critical appraisal and interpretation of RCTs.

During the 2001 CONSORT revision, it became clear that explanation and elaboration of the principles underlying the CONSORT statement would help investigators and others to write or appraise trial reports. A CONSORT explanation and elaboration article was published in 2001 alongside the 2001 version of the CONSORT statement.

After an expert meeting in January 2007, the CONSORT statement has been further revised and is published as the CONSORT 2010 Statement. This update improves the wording and clarity of the previous checklist and incorporates recommendations related to topics that have only recently received recognition, such as selective outcome reporting bias.

This explanatory and elaboration document—intended to enhance the use, understanding, and dissemination of the CONSORT statement—has also been extensively revised. It presents the meaning and rationale for each new and updated checklist item providing examples of good reporting and, where possible, references to relevant empirical studies. Several examples of flow diagrams …">
<meta name="DC.Contributor" content="David Moher ">
<meta name="DC.Contributor" content="Sally Hopewell ">
<meta name="DC.Contributor" content="Kenneth F Schulz ">
<meta name="DC.Contributor" content="Victor Montori ">
<meta name="DC.Contributor" content="Peter C Gøtzsche ">
<meta name="DC.Contributor" content="P J Devereaux ">
<meta name="DC.Contributor" content="Diana Elbourne ">
<meta name="DC.Contributor" content="Matthias Egger ">
<meta name="DC.Contributor" content="Douglas G Altman ">
<meta name="og:title" content="CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials">
<meta name="og:url" content="http://www.bmj.com/content/340/bmj.c869">
<meta name="og:site_name" content="The BMJ">
<meta name="og:type" content="article">
<meta name="article:published_time" content="2010-03-24">
<meta name="article:section" content="Research Methods &amp;amp; Reporting">
<meta name="citation_journal_title" content="BMJ">
<meta name="citation_publisher" content="BMJ Publishing Group Ltd">
<meta name="citation_title" content="CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials">
<meta name="citation_publication_date" content="2010/03/24">
<meta name="citation_mjid" content="bmj;340/mar23_1/c869">
<meta name="citation_id" content="340/mar23_1/c869">
<meta name="citation_public_url" content="http://www.bmj.com/content/340/bmj.c869">
<meta name="citation_abstract_html_url" content="http://www.bmj.com/content/340/bmj.c869.abstract">
<meta name="citation_full_html_url" content="http://www.bmj.com/content/340/bmj.c869.full">
<meta name="citation_pdf_url" content="http://www.bmj.com/content/bmj/340/bmj.c869.full.pdf">
<meta name="citation_issn" content="0959-8138">
<meta name="citation_issn" content="1468-5833">
<meta name="citation_doi" content="10.1136/bmj.c869">
<meta name="citation_pmid" content="20332511">
<meta name="citation_volume" content="340">
<meta name="citation_section" content="Research Methods &amp;amp; Reporting">
<meta name="citation_firstpage" content="c869">
<meta name="citation_access" content="all">
<meta name="citation_author" content="David Moher">
<meta name="citation_author" content="Sally Hopewell">
<meta name="citation_author" content="Kenneth F Schulz">
<meta name="citation_author" content="Victor Montori">
<meta name="citation_author" content="Peter C Gøtzsche">
<meta name="citation_author" content="P J Devereaux">
<meta name="citation_author" content="Diana Elbourne">
<meta name="citation_author" content="Matthias Egger">
<meta name="citation_author" content="Douglas G Altman">
<meta name="citation_reference" content="citation_journal_title=JAMA;citation_journal_abbrev=JAMA;citation_title=CONSORT Revised--Improving the Reporting of Randomized Trials;citation_pages=2006-2007;citation_volume=285;citation_year=2001;citation_issue=15;citation_issn=0002-9955;citation_pmid=11308440;citation_doi=10.1001/jama.285.15.2006">
<meta name="citation_reference" content="citation_journal_title=JAMA;citation_journal_abbrev=JAMA;citation_title=Empirical Evidence of Bias: Dimensions of Methodological Quality Associated With Estimates of Treatment Effects in Controlled Trials;citation_pages=408-412;citation_volume=273;citation_year=1995;citation_issue=5;citation_issn=0002-9955;citation_pmid=7823387;citation_doi=10.1001/jama.1995.03520290060030">
<meta name="citation_reference" content="citation_journal_title=JAMA;citation_journal_abbrev=JAMA;citation_title=CONSORT: An Evolving Tool to Help Improve the Quality of Reports of Randomized Controlled Trials;citation_pages=1489-1491;citation_volume=279;citation_year=1998;citation_issue=18;citation_issn=0002-9955;citation_pmid=9600488;citation_doi=10.1001/jama.279.18.1489">
<meta name="citation_reference" content="citation_journal_title=BMJ;citation_journal_abbrev=BMJ;citation_title=Systematic reviews in health care: Assessing the quality of controlled clinical trials;citation_pages=42-46;citation_volume=323;citation_year=2001;citation_issue=7303;citation_issn=0007-1447;citation_pmid=11440947;citation_doi=10.1136/bmj.323.7303.42">
<meta name="citation_reference" content="citation_journal_title=The American journal of gastroenterology;citation_journal_abbrev=Am J Gastroenterol;citation_title=Drug treatment of functional dyspepsia: a systematic analysis of trial methodology with recommendations for design of future trials.;citation_pages=660-673;citation_volume=91;citation_year=1996;citation_issue=4;citation_pmid=8677926">
<meta name="citation_reference" content="citation_journal_title=The American journal of gastroenterology;citation_journal_abbrev=Am J Gastroenterol;citation_title=Psychological treatments for irritable bowel syndrome: a critique of controlled treatment trials.;citation_pages=277-283;citation_volume=91;citation_year=1996;citation_issue=2;citation_pmid=8607493">
<meta name="citation_reference" content="citation_journal_title=Archives of Dermatology;citation_journal_abbrev=Arch Dermatol;citation_title=How Well Are Randomized Controlled Trials Reported in the Dermatology Literature?;citation_pages=381-385;citation_volume=136;citation_year=2000;citation_issue=3;citation_issn=0003-987X;citation_pmid=10724201;citation_doi=10.1001/archderm.136.3.381">
<meta name="citation_reference" content="citation_journal_title=Hepatology (Baltimore, Md.);citation_journal_abbrev=Hepatology;citation_title=Randomized clinical trials in HEPATOLOGY: predictors of quality.;citation_pages=1134-1138;citation_volume=30;citation_year=1999;citation_issue=5;citation_pmid=10534332;citation_doi=10.1002/hep.510300510">
<meta name="citation_reference" content="citation_journal_title=JAMA;citation_journal_abbrev=JAMA;citation_title=Statistical Evaluation of Medical Journal Manuscripts;citation_pages=1123-1128;citation_volume=195;citation_year=1966;citation_issue=13;citation_issn=0002-9955;citation_pmid=5952081;citation_doi=10.1001/jama.1966.03100130097026">
<meta name="citation_reference" content="citation_journal_title=BMJ;citation_journal_abbrev=BMJ;citation_title=Misuse of statistical methods: critical assessment of articles in BMJ from January to March 1976.;citation_pages=85-87;citation_volume=1;citation_year=1977;citation_issue=6053;citation_issn=0007-1447;citation_pmid=832023;citation_doi=10.1136/bmj.1.6053.85">
<meta name="citation_reference" content="citation_journal_title=The Australian and New Zealand journal of surgery;citation_journal_abbrev=Aust N Z J Surg;citation_title=Misuse of statistical methods in the Australasian surgical literature.;citation_pages=541-543;citation_volume=52;citation_year=1982;citation_issue=5;citation_pmid=6959608;citation_doi=10.1111/j.1445-2197.1982.tb06050.x">
<meta name="citation_reference" content="citation_journal_title=Statistics in medicine;citation_journal_abbrev=Stat Med;citation_title=Statistics in medical journals.;citation_pages=59-71;citation_volume=1;citation_year=1982;citation_issue=1;citation_pmid=7187083;citation_doi=10.1002/sim.4780010109">
<meta name="citation_reference" content="citation_journal_title=New England Journal of Medicine;citation_journal_abbrev=NEJM;citation_title=Statistical problems in the reporting of clinical trials. A survey of three medical journals;citation_pages=426-432;citation_volume=317;citation_year=1987;citation_issue=7;citation_issn=0028-4793;citation_pmid=3614286;citation_doi=10.1056/NEJM198708133170706">
<meta name="citation_reference" content="citation_journal_title=BMJ;citation_journal_abbrev=BMJ;citation_title=The scandal of poor medical research;citation_pages=283-284;citation_volume=308;citation_year=1994;citation_issue=6924;citation_issn=0007-1447;citation_pmid=8124111;citation_doi=10.1136/bmj.308.6924.283">
<meta name="citation_reference" content="citation_journal_title=Lancet;citation_journal_abbrev=Lancet;citation_title=Epidemiology and reporting of randomised trials published in PubMed journals.;citation_pages=1159-1162;citation_volume=365;citation_year=2005;citation_issue=9465;citation_pmid=15794971;citation_doi=10.1016/S0140-6736(05)71879-1">
<meta name="citation_reference" content="citation_journal_title=BMJ;citation_volume=340;citation_year=2010;citation_pmid=20332510;citation_doi=10.1136/bmj.c723">
<meta name="citation_reference" content="citation_journal_title=BMJ;citation_journal_abbrev=BMJ;citation_title=What is meant by intention to treat analysis? Survey of published randomised controlled trials;citation_pages=670-674;citation_volume=319;citation_year=1999;citation_issue=7211;citation_issn=0007-1447;citation_pmid=10480822;citation_doi=10.1136/bmj.319.7211.670">
<meta name="citation_reference" content="citation_journal_title=Ophthalmic epidemiology;citation_journal_abbrev=Ophthalmic Epidemiol;citation_title=Quality of reporting of key methodological items of randomized controlled trials in clinical ophthalmic journals.;citation_pages=390-398;citation_volume=14;citation_year=2007;citation_issue=6;citation_pmid=18161613;citation_doi=10.1080/09286580701344399">
<meta name="citation_reference" content="citation_journal_title=Lancet;citation_journal_abbrev=Lancet;citation_title=Completeness of reporting of trials published in languages other than English: implications for conduct and reporting of systematic reviews.;citation_pages=363-366;citation_volume=347;citation_year=1996;citation_issue=8998;citation_pmid=8598702;citation_doi=10.1016/S0140-6736(96)90538-3">
<meta name="citation_reference" content="citation_journal_title=JAMA;citation_journal_abbrev=JAMA;citation_title=Adherence to Published Standards of Reporting: A Comparison of Placebo-Controlled Trials Published in English or German;citation_pages=247-249;citation_volume=280;citation_year=1998;citation_issue=3;citation_issn=0002-9955;citation_pmid=9676671;citation_doi=10.1001/jama.280.3.247">
<meta name="citation_reference" content="citation_journal_title=BMJ;citation_journal_abbrev=BMJ;citation_title=Randomisation.;citation_pages=1481-1482;citation_volume=302;citation_year=1991;citation_issue=6791;citation_issn=0007-1447;citation_pmid=1855013;citation_doi=10.1136/bmj.302.6791.1481">
<meta name="citation_reference" content="citation_journal_title=JAMA;citation_journal_abbrev=JAMA;citation_title=Assessing the Quality of Randomization From Reports of Controlled Trials Published in Obstetrics and Gynecology Journals;citation_pages=125-128;citation_volume=272;citation_year=1994;citation_issue=2;citation_issn=0002-9955;citation_pmid=8015122;citation_doi=10.1001/jama.1994.03520020051014">
<meta name="citation_reference" content="citation_journal_title=BMJ;citation_journal_abbrev=BMJ;citation_title=Streptomycin Treatment of Pulmonary Tuberculosis: A Medical Research Council Investigation;citation_pages=769-782;citation_volume=2;citation_year=1948;citation_issue=4582;citation_issn=0007-1447;citation_pmid=18890300;citation_doi=10.1136/bmj.2.4582.769">
<meta name="citation_reference" content="citation_journal_title=Clinical obstetrics and gynecology;citation_journal_abbrev=Clin Obstet Gynecol;citation_title=Randomized controlled trials.;citation_pages=245-256;citation_volume=41;citation_year=1998;citation_issue=2;citation_pmid=9646957;citation_doi=10.1097/00003081-199806000-00005">
<meta name="citation_reference" content="citation_journal_title=Epidemiology (Cambridge, Mass.);citation_journal_abbrev=Epidemiology;citation_title=Randomization, statistics, and causal inference.;citation_pages=421-429;citation_volume=1;citation_year=1990;citation_issue=6;citation_pmid=2090279;citation_doi=10.1097/00001648-199011000-00003">
<meta name="citation_reference" content="citation_journal_title=Statistics in medicine;citation_journal_abbrev=Stat Med;citation_title=The role of randomization in clinical trials.;citation_pages=345-352;citation_volume=1;citation_year=1982;citation_issue=4;citation_pmid=7187102;citation_doi=10.1002/sim.4780010412">
<meta name="citation_reference" content="citation_title=Non-random reflections on health services research;citation_year=1997">
<meta name="citation_reference" content="citation_journal_title=Journal of the Royal Society of Medicine;citation_journal_abbrev=J R Soc Med;citation_title=Assembling Comparison Groups to Assess the Effects of Health Care;citation_pages=379-386;citation_volume=90;citation_year=1997;citation_issue=7;citation_issn=0141-0768;citation_pmid=9290419;citation_doi=10.1177/014107689709000706">
<meta name="citation_reference" content="citation_journal_title=JAMA;citation_journal_abbrev=JAMA;citation_title=Quality, Evolution, and Clinical Implications of Randomized, Controlled Trials on the Treatment of Lung Cancer: A Lost Opportunity for Meta-analysis;citation_pages=2101-2107;citation_volume=262;citation_year=1989;citation_issue=15;citation_issn=0002-9955;citation_pmid=2677423;citation_doi=10.1001/jama.1989.03430150069028">
<meta name="citation_reference" content="citation_journal_title=The Journal of laryngology and otology;citation_journal_abbrev=J Laryngol Otol;citation_title=A qualitative assessment of randomized controlled trials in otolaryngology.;citation_pages=460-463;citation_volume=112;citation_year=1998;citation_issue=5;citation_pmid=9747475">
<meta name="citation_reference" content="citation_journal_title=Lancet;citation_journal_abbrev=Lancet;citation_title=Randomisation and baseline comparisons in clinical trials.;citation_pages=149-153;citation_volume=335;citation_year=1990;citation_issue=8682;citation_pmid=1967441;citation_doi=10.1016/0140-6736(90)90014-V">
<meta name="citation_reference" content="citation_journal_title=BMJ;citation_journal_abbrev=BMJ;citation_title=Content and quality of 2000&nbsp;controlled trials in schizophrenia over 50&nbsp;years;citation_pages=1181-1184;citation_volume=317;citation_year=1998;citation_issue=7167;citation_issn=0007-1447;citation_pmid=9794850;citation_doi=10.1136/bmj.317.7167.1181">
<meta name="citation_reference" content="citation_journal_title=New England Journal of Medicine;citation_journal_abbrev=NEJM;citation_title=Reporting on methods in clinical trials;citation_pages=1332-1337;citation_volume=306;citation_year=1982;citation_issue=22;citation_issn=0028-4793;citation_pmid=7070458;citation_doi=10.1056/NEJM198206033062204">
<meta name="citation_reference" content="citation_journal_title=JAMA;citation_journal_abbrev=JAMA;citation_title=A Proposal for Structured Reporting of Randomized Controlled Trials;citation_pages=1926-1931;citation_volume=272;citation_year=1994;citation_issue=24;citation_issn=0002-9955;citation_pmid=7990245;citation_doi=10.1001/jama.1994.03520240054041">
<meta name="citation_reference" content="citation_journal_title=Annals of Internal Medicine;citation_journal_abbrev=ANN INTERN MED;citation_title=Call for Comments on a Proposal To Improve Reporting of Clinical Trials in the Biomedical Literature;citation_pages=894-895;citation_volume=121;citation_year=1994;citation_issue=11;citation_issn=0003-4819;citation_pmid=7978706">
<meta name="citation_reference" content="citation_journal_title=JAMA;citation_journal_abbrev=JAMA;citation_title=Reporting Randomized Controlled Trials: An Experiment and a Call for Responses From Readers;citation_pages=1054-1055;citation_volume=273;citation_year=1995;citation_issue=13;citation_issn=0002-9955;citation_pmid=7897791;citation_doi=10.1001/jama.1995.03520370096044">
<meta name="citation_reference" content="citation_journal_title=JAMA;citation_journal_abbrev=JAMA;citation_title=Improving the Quality of Reporting of Randomized Controlled Trials: The CONSORT Statement;citation_pages=637-639;citation_volume=276;citation_year=1996;citation_issue=8;citation_issn=0002-9955;citation_pmid=8773637;citation_doi=10.1001/jama.1996.03540080059030">
<meta name="citation_reference" content="citation_journal_title=JAMA;citation_journal_abbrev=JAMA;citation_title=Reporting of Noninferiority and Equivalence Randomized Trials: An Extension of the CONSORT Statement;citation_pages=1152-1160;citation_volume=295;citation_year=2006;citation_issue=10;citation_issn=0002-9955;citation_pmid=16522836;citation_doi=10.1001/jama.295.10.1152">
<meta name="citation_reference" content="citation_journal_title=BMJ;citation_journal_abbrev=BMJ;citation_title=CONSORT statement: extension to cluster randomised trials;citation_pages=702-708;citation_volume=328;citation_year=2004;citation_issue=7441;citation_issn=0007-1447;citation_pmid=15031246;citation_doi=10.1136/bmj.328.7441.702">
<meta name="citation_reference" content="citation_journal_title=BMJ;citation_journal_abbrev=BMJ;citation_title=Improving the reporting of pragmatic trials: an extension of the CONSORT statement;citation_pages=a2390-a2390;citation_volume=337;citation_year=2008;citation_issue=nov11_2;citation_issn=0007-1447;citation_pmid=19001484;citation_doi=10.1136/bmj.a2390">
<meta name="citation_reference" content="citation_journal_title=Annals of Internal Medicine;citation_journal_abbrev=ANN INTERN MED;citation_title=Better Reporting of Harms in Randomized Trials: An Extension of the CONSORT Statement;citation_pages=781-788;citation_volume=141;citation_year=2004;citation_issue=10;citation_issn=0003-4819;citation_pmid=15545678;citation_doi=10.7326/0003-4819-141-10-200411160-00009">
<meta name="citation_reference" content="citation_journal_title=Annals of Internal Medicine;citation_journal_abbrev=ANN INTERN MED;citation_title=Extending the CONSORT Statement to Randomized Trials of Nonpharmacologic Treatment: Explanation and Elaboration;citation_pages=295-309;citation_volume=148;citation_year=2008;citation_issue=4;citation_issn=0003-4819;citation_pmid=18283207;citation_doi=10.7326/0003-4819-148-4-200802190-00008">
<meta name="citation_reference" content="citation_journal_title=Annals of Internal Medicine;citation_journal_abbrev=ANN INTERN MED;citation_title=Reporting randomized, controlled trials of herbal interventions: an elaborated CONSORT statement.;citation_pages=364-367;citation_volume=144;citation_year=2006;citation_issue=5;citation_issn=0003-4819;citation_pmid=16520478;citation_doi=10.7326/0003-4819-144-5-200603070-00013">
<meta name="citation_reference" content="citation_journal_abbrev=PLoS Med;citation_title=CONSORT for reporting randomized controlled trials in journal and conference abstracts: explanation and elaboration.;citation_pages=e20-e20;citation_volume=5;citation_year=2008;citation_issue=1;citation_pmid=18215107;citation_doi=10.1371/journal.pmed.0050020">
<meta name="citation_reference" content="citation_journal_title=JAMA;citation_journal_abbrev=JAMA;citation_title=Recommendations for Reporting Cost-effectiveness Analyses;citation_pages=1339-1341;citation_volume=276;citation_year=1996;citation_issue=16;citation_issn=0002-9955;citation_pmid=8861994;citation_doi=10.1001/jama.1996.03540160061034">
<meta name="citation_reference" content="citation_journal_title=BMJ;citation_journal_abbrev=BMJ;citation_title=Guidelines for authors and peer reviewers of economic submissions to the BMJ;citation_pages=275-283;citation_volume=313;citation_year=1996;citation_issue=7052;citation_issn=0007-1447;citation_pmid=8704542;citation_doi=10.1136/bmj.313.7052.275">
<meta name="citation_reference" content="citation_title=How to report statistics in medicine. Annotated guidelines for authors, editors, and reviewers;citation_year=1997">
<meta name="citation_reference" content="citation_journal_title=Annals of Internal Medicine;citation_journal_abbrev=ANN INTERN MED;citation_title=News from the International Committee of Medical Journal Editors;citation_pages=229-231;citation_volume=133;citation_year=2000;citation_issue=3;citation_issn=0003-4819;citation_pmid=10906840;citation_doi=10.7326/0003-4819-133-3-200008010-00017">
<meta name="citation_reference" content="citation_journal_title=Medical Journal of Australia;citation_journal_abbrev=Medical Journal of Australia;citation_title=Does the CONSORT checklist improve the quality of reports of randomised controlled trials? A systematic review.;citation_pages=263-267;citation_volume=185;citation_year=2006;citation_issue=5;citation_pmid=16948622">
<meta name="citation_reference" content="citation_journal_title=JAMA;citation_journal_abbrev=JAMA;citation_title=Value of Flow Diagrams in Reports of Randomized Controlled Trials;citation_pages=1996-1999;citation_volume=285;citation_year=2001;citation_issue=15;citation_issn=0002-9955;citation_pmid=11308437;citation_doi=10.1001/jama.285.15.1996">
<meta name="citation_reference" content="citation_journal_title=Annals of Internal Medicine;citation_journal_abbrev=ANN INTERN MED;citation_title=The CONSORT Statement: Revised Recommendations for Improving the Quality of Reports of Parallel-Group Randomized Trials;citation_pages=657-662;citation_volume=134;citation_year=2001;citation_issue=8;citation_issn=0003-4819;citation_pmid=11304106;citation_doi=10.7326/0003-4819-134-8-200104170-00011">
<meta name="citation_reference" content="citation_journal_title=JAMA;citation_journal_abbrev=JAMA;citation_title=The CONSORT Statement: Revised Recommendations for Improving the Quality of Reports of Parallel-Group Randomized Trials;citation_pages=1987-1991;citation_volume=285;citation_year=2001;citation_issue=15;citation_issn=0002-9955;citation_pmid=11308435;citation_doi=10.1001/jama.285.15.1987">
<meta name="citation_reference" content="citation_journal_title=Lancet;citation_journal_abbrev=Lancet;citation_title=The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials.;citation_pages=1191-1194;citation_volume=357;citation_year=2001;citation_issue=9263;citation_pmid=11323066;citation_doi=10.1016/S0140-6736(00)04337-3">
<meta name="citation_reference" content="citation_journal_title=JAMA;citation_journal_abbrev=JAMA;citation_title=Empirical Evidence for Selective Reporting of Outcomes in Randomized Trials: Comparison of Protocols to Published Articles;citation_pages=2457-2465;citation_volume=291;citation_year=2004;citation_issue=20;citation_issn=0002-9955;citation_pmid=15161896;citation_doi=10.1001/jama.291.20.2457">
<meta name="citation_reference" content="citation_journal_title=Lancet;citation_journal_abbrev=Lancet;citation_title=Selective reporting in clinical trials: analysis of trial protocols accepted by The Lancet.;citation_pages=201-201;citation_volume=372;citation_year=2008;citation_issue=9634;citation_pmid=18640445">
<meta name="citation_reference" content="citation_journal_abbrev=PLoS ONE;citation_title=Systematic review of the empirical evidence of study publication bias and outcome reporting bias.;citation_pages=e3081-e3081;citation_volume=3;citation_year=2008;citation_issue=8;citation_pmid=18769481;citation_doi=10.1371/journal.pone.0003081">
<meta name="citation_reference" content="citation_journal_title=Annals of Internal Medicine;citation_journal_abbrev=ANN INTERN MED;citation_title=The Revised CONSORT Statement for Reporting Randomized Trials: Explanation and Elaboration;citation_pages=663-694;citation_volume=134;citation_year=2001;citation_issue=8;citation_issn=0003-4819;citation_pmid=11304107;citation_doi=10.7326/0003-4819-134-8-200104170-00012">
<meta name="citation_reference" content="citation_journal_title=BMJ;citation_volume=340;citation_year=2010;citation_pmid=20332509;citation_doi=10.1136/bmj.c332">
<meta name="citation_reference" content="citation_title=Clinical trials: a practical approach;citation_year=1983">
<meta name="citation_reference" content="citation_title=Clinical trials: design, conduct and analysis;citation_year=1986">
<meta name="citation_reference" content="citation_title=Fundamentals of clinical trials;citation_year=1998">
<meta name="citation_reference" content="citation_journal_title=BMJ;citation_journal_abbrev=BMJ;citation_title=Smoking reduction with oral nicotine inhalers: double blind, randomised clinical trial of efficacy and safety;citation_pages=329-333;citation_volume=321;citation_year=2000;citation_issue=7257;citation_issn=0007-1447;citation_pmid=10926587;citation_doi=10.1136/bmj.321.7257.329">
<meta name="citation_reference" content="citation_journal_title=Evaluation &amp; the Health Professions;citation_journal_abbrev=Eval Health Prof;citation_title=Development of the Cochrane Collaboration's Central Register of Controlled Clinical Trials;citation_pages=38-64;citation_volume=25;citation_year=2002;citation_issue=1;citation_issn=0163-2787;citation_pmid=11868444;citation_doi=10.1177/016327870202500104">
<meta name="citation_reference" content="citation_journal_title=Lancet;citation_journal_abbrev=Lancet;citation_title=CONSORT for reporting randomised trials in journal and conference abstracts.;citation_pages=281-283;citation_volume=371;citation_year=2008;citation_issue=9609;citation_pmid=18221781;citation_doi=10.1016/S0140-6736(07)61835-2">
<meta name="citation_reference" content="citation_journal_abbrev=PLoS Med;citation_title=The impact of open access upon public health.;citation_pages=e252-e252;citation_volume=3;citation_year=2006;citation_issue=5;citation_pmid=16719556;citation_doi=10.1371/journal.pmed.0030252">
<meta name="citation_reference" content="citation_journal_title=Bulletin of the Medical Library Association;citation_journal_abbrev=Bull Med Libr Assoc;citation_title=Structured abstracts in MEDLINE, 1989-1991.;citation_pages=190-195;citation_volume=83;citation_year=1995;citation_issue=2;citation_pmid=7599584">
<meta name="citation_reference" content="citation_journal_title=The Journal of psychology;citation_journal_abbrev=J Psychol;citation_title=The accuracy of abstracts in psychology journals.;citation_pages=141-148;citation_volume=136;citation_year=2002;citation_issue=2;citation_pmid=12081089">
<meta name="citation_reference" content="citation_journal_title=JAMA;citation_journal_abbrev=JAMA;citation_title=Accuracy of Data in Abstracts of Published Research Articles;citation_pages=1110-1111;citation_volume=281;citation_year=1999;citation_issue=12;citation_issn=0002-9955;citation_pmid=10188662;citation_doi=10.1001/jama.281.12.1110">
<meta name="citation_reference" content="citation_journal_title=Ann Pharmacother;citation_volume=38;citation_year=2004;citation_pmid=15150375;citation_doi=10.1345/aph.1D416">
<meta name="citation_reference" content="citation_journal_title=BMJ;citation_volume=333;citation_year=2006;citation_pmid=16854948;citation_doi=10.1136/bmj.38895.410451.79">
<meta name="citation_reference" content="citation_journal_title=JAMA;citation_journal_abbrev=JAMA;citation_title=Completeness of Safety Reporting in Randomized Trials: An Evaluation of 7 Medical Areas;citation_pages=437-443;citation_volume=285;citation_year=2001;citation_issue=4;citation_issn=0002-9955;citation_pmid=11242428;citation_doi=10.1001/jama.285.4.437">
<meta name="citation_reference" content="citation_journal_title=Annals of Internal Medicine;citation_journal_abbrev=ANN INTERN MED;citation_title=More Informative Abstracts Revisited;citation_pages=69-76;citation_volume=113;citation_year=1990;citation_issue=1;citation_issn=0003-4819;citation_pmid=2190518;citation_doi=10.7326/0003-4819-113-1-69">
<meta name="citation_reference" content="citation_journal_title=Canadian Medical Association Journal;citation_journal_abbrev=CMAJ;citation_title=Quality of nonstructured and structured abstracts of original research articles in the British Medical Journal, the Canadian Medical Association Journal and the Journal of the American Medical Association;citation_pages=1611-1615;citation_volume=150;citation_year=1994;citation_issue=10;citation_issn=0008-4409;citation_pmid=8174031">
<meta name="citation_reference" content="citation_title=Cochrane Database Syst Rev;citation_year=2008">
<meta name="citation_reference" content="citation_journal_title=J Inform Sci;citation_pages=349;citation_volume=22;citation_year=1996;citation_doi=10.1177/016555159602200503">
<meta name="citation_reference" content="citation_journal_title=Lancet;citation_journal_abbrev=Lancet;citation_title=Preoperative chemotherapy in patients with resectable non-small cell lung cancer: results of the MRC LU22/NVALT 2/EORTC 08012 multicentre randomised trial and update of systematic review.;citation_pages=1929-1937;citation_volume=369;citation_year=2007;citation_issue=9577;citation_pmid=17544497;citation_doi=10.1016/S0140-6736(07)60714-4">
<meta name="citation_reference" content="citation_journal_title=New England Journal of Medicine;citation_journal_abbrev=NEJM;citation_title=Lack of Benefit of a Single Dose of Synthetic Human Secretin in the Treatment of Autism and Pervasive Developmental Disorder;citation_pages=1801-1806;citation_volume=341;citation_year=1999;citation_issue=24;citation_issn=0028-4793;citation_pmid=10588965;citation_doi=10.1056/NEJM199912093412404">
<meta name="citation_reference" content="citation_journal_title=New England Journal of Medicine;citation_journal_abbrev=NEJM;citation_title=Cumulative meta-analysis of therapeutic trials for myocardial infarction;citation_pages=248-254;citation_volume=327;citation_year=1992;citation_issue=4;citation_issn=0028-4793;citation_pmid=1614465;citation_doi=10.1056/NEJM199207233270406">
<meta name="citation_reference" content="citation_journal_title=Clinical Trials;citation_journal_abbrev=Clin Trials;citation_title=Randomized controlled trials of aprotinin in cardiac surgery: could clinical equipoise have stopped the bleeding?;citation_pages=218-232;citation_volume=2;citation_year=2005;citation_issue=3;citation_issn=1740-7745;citation_pmid=16279145;citation_doi=10.1191/1740774505cn085oa">
<meta name="citation_reference" content="citation_journal_title=BMJ;citation_journal_abbrev=BMJ;citation_title=Are research ethics committees behaving unethically? Some suggestions for improving performance and accountability;citation_pages=1390-1393;citation_volume=313;citation_year=1996;citation_issue=7069;citation_issn=0007-1447;citation_pmid=8956711">
<meta name="citation_reference" content="citation_journal_title=BJOG :  an international journal of obstetrics and gynaecology;citation_journal_abbrev=BJOG;citation_title=A randomised controlled trial and meta-analysis of active management of labour.;citation_pages=909-915;citation_volume=107;citation_year=2000;citation_issue=7;citation_pmid=10901564;citation_doi=10.1111/j.1471-0528.2000.tb11091.x">
<meta name="citation_reference" content="citation_journal_title=Stroke;citation_journal_abbrev=Stroke;citation_title=Quality of Full and Final Publications Reporting Acute Stroke Trials : A Systematic Review;citation_pages=2203-2210;citation_volume=29;citation_year=1998;citation_issue=10;citation_issn=0039-2499;citation_pmid=9756604;citation_doi=10.1161/01.STR.29.10.2203">
<meta name="citation_reference" content="citation_journal_title=Pediatrics;citation_journal_abbrev=Pediatrics;citation_title=Controlled Clinical Trial of Zolpidem for the Treatment of Insomnia Associated With Attention-Deficit/ Hyperactivity Disorder in Children 6 to 17 Years of Age;citation_pages=e770-e776;citation_volume=123;citation_year=2009;citation_issue=5;citation_issn=0031-4005;citation_pmid=19403468;citation_doi=10.1542/peds.2008-2945">
<meta name="citation_reference" content="citation_journal_title=Lancet;citation_journal_abbrev=Lancet;citation_title=Otamixaban for the treatment of patients with non-ST-elevation acute coronary syndromes (SEPIA-ACS1 TIMI 42): a randomised, double-blind, active-controlled, phase 2 trial.;citation_pages=787-795;citation_volume=374;citation_year=2009;citation_issue=9692;citation_pmid=19717184;citation_doi=10.1016/S0140-6736(09)61454-9">
<meta name="citation_reference" content="citation_journal_abbrev=dummy;citation_title=The effectiveness of the Heidelberg Retina Tomograph and laser diagnostic glaucoma scanning system (GDx) in detecting and monitoring glaucoma.;citation_pages=1- iii;citation_volume=9;citation_year=2005;citation_issue=46;citation_pmid=16303099">
<meta name="citation_reference" content="citation_journal_title=Drug Information Journal;citation_pages=421;citation_volume=40;citation_year=2006;citation_issn=0092-8615">
<meta name="citation_reference" content="citation_journal_title=Annual review of public health;citation_journal_abbrev=Annu Rev Public Health;citation_title=Adaptive designs for randomized trials in public health.;citation_pages=1-25;citation_volume=30;citation_year=2009;citation_issn=0163-7525;citation_pmid=19296774;citation_doi=10.1146/annurev.publhealth.031308.100223">
<meta name="citation_reference" content="citation_journal_title=Journal of biopharmaceutical statistics;citation_journal_abbrev=J Biopharm Stat;citation_title=A practical comparison of group-sequential and adaptive designs.;citation_pages=719-738;citation_volume=15;citation_year=2005;citation_issue=4;citation_pmid=16022175;citation_doi=10.1081/BIP-200062859">
<meta name="citation_reference" content="citation_journal_title=BMJ;citation_volume=330;citation_year=2005;citation_pmid=15817527;citation_doi=10.1136/bmj.38414.422650.8F">
<meta name="citation_reference" content="citation_journal_title=BMJ;citation_journal_abbrev=BMJ;citation_title=Discrepancies in sample size calculations and data analyses reported in randomised trials: comparison of publications with protocols;citation_pages=a2299-a2299;citation_volume=337;citation_year=2008;citation_issue=dec04_1;citation_issn=0007-1447;citation_pmid=19056791;citation_doi=10.1136/bmj.a2299">
<meta name="citation_reference" content="citation_journal_title=BMJ;citation_pages=1867;citation_volume=338;citation_year=2009;citation_issn=0007-1447;citation_doi=10.1136/bmj.b1867">
<meta name="citation_reference" content="citation_journal_title=Lancet;citation_journal_abbrev=Lancet;citation_title=External validity of randomised controlled trials: &quot;to whom do the results of this trial apply?&quot;.;citation_pages=82-93;citation_volume=365;citation_year=2005;citation_issue=9453;citation_pmid=15639683;citation_doi=10.1016/S0140-6736(04)17670-8">
<meta name="citation_reference" content="citation_journal_title=Journal of clinical epidemiology;citation_journal_abbrev=J Clin Epidemiol;citation_title=A study in contrasts: eligibility criteria in a twenty-year sample of NSABP and POG clinical trials. National Surgical Adjuvant Breast and Bowel Program. Pediatric Oncology Group.;citation_pages=69-79;citation_volume=51;citation_year=1998;citation_issue=2;citation_pmid=9474067;citation_doi=10.1016/S0895-4356(97)00240-0">
<meta name="citation_reference" content="citation_journal_title=Journal of clinical epidemiology;citation_journal_abbrev=J Clin Epidemiol;citation_title=Reporting the study populations of clinical trials. Clear transmission or static on the line?;citation_pages=973-979;citation_volume=53;citation_year=2000;citation_issue=10;citation_pmid=11027928;citation_doi=10.1016/S0895-4356(00)00227-4">
<meta name="citation_reference" content="citation_journal_title=AIDS (London, England);citation_journal_abbrev=AIDS;citation_title=Eligibility criteria for HIV clinical trials and generalizability of results: the gap between published reports and study protocols.;citation_pages=1885-1896;citation_volume=19;citation_year=2005;citation_issue=16;citation_pmid=16227797;citation_doi=10.1097/01.aids.0000189866.67182.f7">
<meta name="citation_reference" content="citation_journal_title=Surgery;citation_journal_abbrev=Surgery;citation_title=Methodologic standards in surgical trials.;citation_pages=466-472;citation_volume=119;citation_year=1996;citation_issue=4;citation_pmid=8644014;citation_doi=10.1016/S0039-6060(96)80149-8">
<meta name="citation_reference" content="citation_journal_title=Archives of Internal Medicine;citation_journal_abbrev=Arch Intern Med;citation_title=Generalizability of the Results of Randomized Trials;citation_pages=133-135;citation_volume=168;citation_year=2008;citation_issue=2;citation_issn=0003-9926;citation_pmid=18227357;citation_doi=10.1001/archinternmed.2007.30">
<meta name="citation_reference" content="citation_journal_title=Lancet;citation_journal_abbrev=Lancet;citation_title=Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial.;citation_pages=1839-1847;citation_volume=371;citation_year=2008;citation_issue=9627;citation_pmid=18479744;citation_doi=10.1016/S0140-6736(08)60601-7">
<meta name="citation_reference" content="citation_journal_title=Annals of Internal Medicine;citation_journal_abbrev=ANN INTERN MED;citation_title=Splint for Base-of-Thumb Osteoarthritis: A Randomized Trial;citation_pages=661-669;citation_volume=150;citation_year=2009;citation_issue=10;citation_issn=0003-4819;citation_pmid=19451573;citation_doi=10.7326/0003-4819-150-10-200905190-00003">
<meta name="citation_reference" content="citation_journal_title=BMJ;citation_journal_abbrev=BMJ;citation_title=What is missing from descriptions of treatment in trials and reviews?;citation_pages=1472-1474;citation_volume=336;citation_year=2008;citation_issue=7659;citation_issn=0007-1447;citation_pmid=18583680;citation_doi=10.1136/bmj.39590.732037.47">
<meta name="citation_reference" content="citation_journal_title=Lancet;citation_journal_abbrev=Lancet;citation_title=Etanercept in the treatment of psoriatic arthritis and psoriasis: a randomised trial.;citation_pages=385-390;citation_volume=356;citation_year=2000;citation_issue=9227;citation_pmid=10972371;citation_doi=10.1016/S0140-6736(00)02530-7">
<meta name="citation_reference" content="citation_journal_abbrev=Trials;citation_title=Standardising outcomes for clinical trials and systematic reviews.;citation_pages=39-39;citation_volume=8;citation_year=2007;citation_pmid=18039365;citation_doi=10.1186/1745-6215-8-39">
<meta name="citation_reference" content="citation_journal_title=BMJ;citation_journal_abbrev=BMJ;citation_title=Reporting on quality of life in randomised controlled trials: bibliographic study;citation_pages=1191-1194;citation_volume=317;citation_year=1998;citation_issue=7167;citation_issn=0007-1447;citation_pmid=9794853;citation_doi=10.1136/bmj.317.7167.1191">
<meta name="citation_reference" content="citation_journal_title=Controlled clinical trials;citation_journal_abbrev=Control Clin Trials;citation_title=Methodology and overt and hidden bias in reports of 196 double-blind trials of nonsteroidal antiinflammatory drugs in rheumatoid arthritis.;citation_pages=31-56;citation_volume=10;citation_year=1989;citation_issue=1;citation_pmid=2702836;citation_doi=10.1016/0197-2456(89)90017-2">
<meta name="citation_reference" content="citation_journal_title=The British Journal of Psychiatry;citation_journal_abbrev=Br. J. Psychiatry;citation_title=Unpublished rating scales: a major source of bias in randomised controlled trials of treatments for schizophrenia;citation_pages=249-252;citation_volume=176;citation_year=2000;citation_issue=3;citation_issn=0007-1250;citation_pmid=10755072;citation_doi=10.1192/bjp.176.3.249">
<meta name="citation_reference" content="citation_journal_title=Lancet;citation_journal_abbrev=Lancet;citation_title=Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial.;citation_pages=1385-1390;citation_volume=357;citation_year=2001;citation_issue=9266;citation_pmid=11356434;citation_doi=10.1016/S0140-6736(00)04560-8">
<meta name="citation_reference" content="citation_journal_title=Canadian Medical Association Journal;citation_journal_abbrev=CMAJ;citation_title=Outcome reporting bias in randomized trials funded by the Canadian Institutes of Health Research;citation_pages=735-740;citation_volume=171;citation_year=2004;citation_issue=7;citation_issn=0008-4409;citation_pmid=15451835;citation_doi=10.1503/cmaj.1041086">
<meta name="citation_reference" content="citation_journal_abbrev=Trials;citation_title=Intravenous fluid restriction after major abdominal surgery: a randomized blinded clinical trial.;citation_pages=50-50;citation_volume=10;citation_year=2009;citation_pmid=19583868;citation_doi=10.1186/1745-6215-10-50">
<meta name="citation_reference" content="citation_journal_title=Lancet;citation_journal_abbrev=Lancet;citation_title=Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial.;citation_pages=807-816;citation_volume=372;citation_year=2008;citation_issue=9641;citation_pmid=18757088;citation_doi=10.1016/S0140-6736(08)61170-8">
<meta name="citation_reference" content="citation_journal_title=BMJ;citation_journal_abbrev=BMJ;citation_title=Estimating sample sizes for binary, ordered categorical, and continuous outcomes in two group comparisons;citation_pages=1145-1148;citation_volume=311;citation_year=1995;citation_issue=7013;citation_issn=0007-1447;citation_pmid=7580713">
<meta name="citation_reference" content="citation_journal_abbrev=PLoS Med;citation_title=In the era of systematic reviews, does the size of an individual trial still matter.;citation_pages=e4-e4;citation_volume=5;citation_year=2008;citation_issue=1;citation_pmid=18177203;citation_doi=10.1371/journal.pmed.0050004">
<meta name="citation_reference" content="citation_journal_title=Lancet;citation_journal_abbrev=Lancet;citation_title=Sample size calculations in randomised trials: mandatory and mystical.;citation_pages=1348-1353;citation_volume=365;citation_year=2005;citation_issue=9467;citation_pmid=15823387;citation_doi=10.1016/S0140-6736(05)61034-3">
<meta name="citation_reference" content="citation_journal_title=JAMA;citation_journal_abbrev=JAMA;citation_title=The Continuing Unethical Conduct of Underpowered Clinical Trials;citation_pages=358-362;citation_volume=288;citation_year=2002;citation_issue=3;citation_issn=0002-9955;citation_pmid=12117401;citation_doi=10.1001/jama.288.3.358">
<meta name="citation_reference" content="citation_journal_title=BMJ;citation_journal_abbrev=BMJ;citation_title=Statistics notes: Absence of evidence is not evidence of absence;citation_pages=485-485;citation_volume=311;citation_year=1995;citation_issue=7003;citation_issn=0007-1447;citation_pmid=7647644;citation_doi=10.1136/bmj.311.7003.485">
<meta name="citation_reference" content="citation_journal_title=JAMA;citation_journal_abbrev=JAMA;citation_title=Statistical Power, Sample Size, and Their Reporting in Randomized Controlled Trials;citation_pages=122-124;citation_volume=272;citation_year=1994;citation_issue=2;citation_issn=0002-9955;citation_pmid=8015121;citation_doi=10.1001/jama.1994.03520020048013">
<meta name="citation_reference" content="citation_journal_title=New England Journal of Medicine;citation_journal_abbrev=NEJM;citation_title=The importance of beta, the type II error and sample size in the design and interpretation of the randomized control trial. Survey of 71 " negative"="" trials;citation_pages="690-694;citation_volume=299;citation_year=1978;citation_issue=13;citation_issn=0028-4793;citation_pmid=355881;citation_doi=10.1056/NEJM197809282991304&quot;">
<meta name="citation_reference" content="citation_journal_title=BMJ;citation_volume=338;citation_year=2009;citation_pmid=19435763;citation_doi=10.1136/bmj.b1732">
<meta name="citation_reference" content="citation_journal_title=Statistics in medicine;citation_journal_abbrev=Stat Med;citation_title=Why do we need some large, simple randomized trials?;citation_pages=409-422;citation_volume=3;citation_year=1984;citation_issue=4;citation_pmid=6528136;citation_doi=10.1002/sim.4780030421">
<meta name="citation_reference" content="citation_journal_title=Annals of Internal Medicine;citation_journal_abbrev=ANN INTERN MED;citation_title=The Use of Predicted Confidence Intervals When Planning Experiments and the Misuse of Power When Interpreting Results;citation_pages=200-206;citation_volume=121;citation_year=1994;citation_issue=3;citation_issn=0003-4819;citation_pmid=8017747;citation_doi=10.7326/0003-4819-121-3-199408010-00008">
<meta name="citation_reference" content="citation_journal_title=Annals of Internal Medicine;citation_journal_abbrev=ANN INTERN MED;citation_title=Comparison of Oral Fluconazole and Itraconazole for Progressive, Nonmeningeal Coccidioidomycosis: A Randomized, Double-Blind Trial;citation_pages=676-686;citation_volume=133;citation_year=2000;citation_issue=9;citation_issn=0003-4819;citation_pmid=11074900;citation_doi=10.7326/0003-4819-133-9-200011070-00009">
<meta name="citation_reference" content="citation_journal_title=N Engl J Med;citation_volume=360;citation_year=2009;citation_pmid=19336502;citation_doi=10.1056/NEJMoa0901301">
<meta name="citation_reference" content="citation_journal_title=Biometrics;citation_pages=213;citation_volume=43;citation_year=1987;citation_pmid=3567306;citation_doi=10.2307/2531962">
<meta name="citation_reference" content="citation_journal_title=Statistics in medicine;citation_journal_abbrev=Stat Med;citation_title=Interim analyses in clinical trials: classical vs. Bayesian approaches.;citation_pages=521-526;citation_volume=4;citation_year=1985;citation_issue=4;citation_pmid=4089353;citation_doi=10.1002/sim.4780040412">
<meta name="citation_reference" content="citation_journal_title=BMJ;citation_journal_abbrev=BMJ;citation_title=When to stop a clinical trial.;citation_pages=235-240;citation_volume=305;citation_year=1992;citation_issue=6847;citation_issn=0007-1447;citation_pmid=1392832;citation_doi=10.1136/bmj.305.6847.235">
<meta name="citation_reference" content="citation_journal_title=Lancet;citation_journal_abbrev=Lancet;citation_title=The agonising negative trend in monitoring of clinical trials.;citation_pages=1983-1988;citation_volume=354;citation_year=1999;citation_issue=9194;citation_pmid=10622312;citation_doi=10.1016/S0140-6736(99)03464-9">
<meta name="citation_reference" content="citation_journal_title=Statistics in medicine;citation_journal_abbrev=Stat Med;citation_title=Interim analyses, stopping rules and data monitoring in clinical trials in Europe.;citation_pages=509-520;citation_volume=12;citation_year=1993;citation_issue=5-6;citation_pmid=8493429">
<meta name="citation_reference" content="citation_journal_title=Clinical Trials;citation_journal_abbrev=Clin Trials;citation_title=Reported use of data monitoring committees in the main published reports of randomized controlled trials: a cross-sectional study;citation_pages=48-59;citation_volume=1;citation_year=2004;citation_issue=1;citation_issn=1740-7745;citation_pmid=16281462;citation_doi=10.1191/1740774504cn003oa">
<meta name="citation_reference" content="citation_journal_title=JAMA;citation_journal_abbrev=JAMA;citation_title=Randomized Trials Stopped Early for Benefit: A Systematic Review;citation_pages=2203-2209;citation_volume=294;citation_year=2005;citation_issue=17;citation_issn=0002-9955;citation_pmid=16264162;citation_doi=10.1001/jama.294.17.2203">
<meta name="citation_reference" content="citation_journal_title=Obstetrics &amp; Gynecology;citation_journal_abbrev=Obstet Gynecol;citation_title=Uterine exteriorization compared with in situ repair at cesarean delivery: a randomized controlled trial.;citation_pages=639-647;citation_volume=111;citation_year=2008;citation_issue=3;citation_issn=0029-7844;citation_pmid=18310366;citation_doi=10.1097/AOG.0b013e31816521e2">
<meta name="citation_reference" content="citation_title=Systematic reviews in health care: meta-analysis in context;citation_year=2001">
<meta name="citation_reference" content="citation_journal_title=Obstetrics &amp; Gynecology;citation_journal_abbrev=Obstet Gynecol;citation_title=Multicenter comparison of the contraceptive ring and patch: a randomized controlled trial.;citation_pages=267-277;citation_volume=111;citation_year=2008;citation_issue=2 Pt 1;citation_issn=0029-7844;citation_pmid=18238962;citation_doi=10.1097/01.AOG.0000298338.58511.d1">
<meta name="citation_reference" content="citation_journal_title=JAMA;citation_journal_abbrev=JAMA;citation_title=Effects of Internet Behavioral Counseling on Weight Loss in Adults at Risk for Type 2 Diabetes: A Randomized Trial;citation_pages=1833-1836;citation_volume=289;citation_year=2003;citation_issue=14;citation_issn=0002-9955;citation_pmid=12684363;citation_doi=10.1001/jama.289.14.1833">
<meta name="citation_reference" content="citation_journal_title=Controlled clinical trials;citation_journal_abbrev=Control Clin Trials;citation_title=Properties of simple randomization in clinical trials.;citation_pages=312-326;citation_volume=9;citation_year=1988;citation_issue=4;citation_pmid=3203523;citation_doi=10.1016/0197-2456(88)90046-3">
<meta name="citation_reference" content="citation_journal_title=British Journal of Cancer;citation_journal_abbrev=British Journal of Cancer;citation_title=Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design.;citation_pages=585-612;citation_volume=34;citation_year=1976;citation_issue=6;citation_pmid=795448;citation_doi=10.1038/bjc.1976.220">
<meta name="citation_reference" content="citation_title=The Lancet handbook of essential concepts in clinical research;citation_year=2006">
<meta name="citation_reference" content="citation_journal_title=BMJ;citation_journal_abbrev=BMJ;citation_title=Statistics notes: How to randomise;citation_pages=703-704;citation_volume=319;citation_year=1999;citation_issue=7211;citation_issn=0007-1447;citation_pmid=10480833">
<meta name="citation_reference" content="citation_journal_title=JAMA;citation_journal_abbrev=JAMA;citation_title=Subverting Randomization in Controlled Trials;citation_pages=1456-1458;citation_volume=274;citation_year=1995;citation_issue=18;citation_issn=0002-9955;citation_pmid=7474192;citation_doi=10.1001/jama.1995.03530180050029">
<meta name="citation_reference" content="citation_journal_title=Drug Information Journal;citation_journal_abbrev=Drug Information Journal;citation_title=Baseline Comparability in Clinical Trials: Prevention of " poststudy="" anxiety";citation_pages="541-548;citation_volume=24;citation_year=1990;citation_issue=3;citation_issn=0092-8615;citation_doi=10.1177/009286159002400312&quot;">
<meta name="citation_reference" content="citation_journal_title=BMJ;citation_journal_abbrev=BMJ;citation_title=Minimisation: the platinum standard for trials?;citation_pages=362-363;citation_volume=317;citation_year=1998;citation_issue=7155;citation_issn=0007-1447;citation_pmid=9694748;citation_doi=10.1136/bmj.317.7155.362">
<meta name="citation_reference" content="citation_journal_title=British journal of obstetrics and gynaecology;citation_journal_abbrev=Br J Obstet Gynaecol;citation_title=Preventing IUCD-related pelvic infection: the efficacy of prophylactic doxycycline at insertion.;citation_pages=412-419;citation_volume=97;citation_year=1990;citation_issue=5;citation_pmid=2196934">
<meta name="citation_reference" content="citation_journal_title=BMC musculoskeletal disorders [electronic resource];citation_journal_abbrev=BMC Musculoskelet Disord;citation_title=Effectiveness of low-Dye taping for the short-term treatment of plantar heel pain: a randomised trial.;citation_pages=64-64;citation_volume=7;citation_year=2006;citation_pmid=16895612;citation_doi=10.1186/1471-2474-7-64">
<meta name="citation_reference" content="citation_journal_title=Statistics in medicine;citation_journal_abbrev=Stat Med;citation_title=Meta-analysis of clinical trials as a scientific discipline. I: Control of bias and comparison with large co-operative trials.;citation_pages=315-328;citation_volume=6;citation_year=1987;citation_issue=3;citation_pmid=2887023">
<meta name="citation_reference" content="citation_journal_title=Statistician;citation_pages=1;citation_volume=31;citation_year=1982;citation_doi=10.2307/2988097">
<meta name="citation_reference" content="citation_journal_title=Drug Information Journal;citation_pages=11;citation_volume=32;citation_year=1998;citation_issn=0092-8615">
<meta name="citation_reference" content="citation_journal_title=BMC medical research methodology [electronic resource];citation_journal_abbrev=BMC Med Res Methodol;citation_title=The reporting of methods for reducing and detecting bias: an example from the WHO Misoprostol Third Stage of Labour equivalence randomised controlled trial.;citation_pages=19-19;citation_volume=3;citation_year=2003;citation_pmid=14525622;citation_doi=10.1186/1471-2288-3-19">
<meta name="citation_reference" content="citation_journal_title=Int J Epidemiol;citation_volume=36;citation_year=2007;citation_pmid=17517809;citation_doi=10.1093/ije/dym087">
<meta name="citation_reference" content="citation_journal_title=BMJ;citation_volume=336;citation_year=2008;citation_pmid=18316340;citation_doi=10.1136/bmj.39465.451748.AD">
<meta name="citation_reference" content="citation_journal_title=British journal of obstetrics and gynaecology;citation_journal_abbrev=Br J Obstet Gynaecol;citation_title=A randomised controlled trial of care of the perineum during second stage of normal labour.;citation_pages=1262-1272;citation_volume=105;citation_year=1998;citation_issue=12;citation_pmid=9883917">
<meta name="citation_reference" content="citation_journal_title=BMJ;citation_journal_abbrev=BMJ;citation_title=Routine care of peripheral intravenous catheters versus clinically indicated replacement: randomised controlled trial;citation_pages=a339-a339;citation_volume=337;citation_year=2008;citation_issue=jul08_1;citation_issn=0007-1447;citation_pmid=18614482;citation_doi=10.1136/bmj.a339">
<meta name="citation_reference" content="citation_journal_title=Mayo Clinic Proceedings;citation_journal_abbrev=Mayo Clin Proc.;citation_title=Chronic Care Model and Shared Care in Diabetes: Randomized Trial of an Electronic Decision Support System;citation_pages=747-757;citation_volume=83;citation_year=2008;citation_issue=7;citation_issn=0025-6196;citation_pmid=18613991;citation_doi=10.4065/83.7.747">
<meta name="citation_reference" content="citation_journal_title=New England Journal of Medicine;citation_journal_abbrev=NEJM;citation_title=Comparison of weight-loss diets with different compositions of fat, protein, and carbohydrates.;citation_pages=859-873;citation_volume=360;citation_year=2009;citation_issue=9;citation_issn=0028-4793;citation_pmid=19246357;citation_doi=10.1056/NEJMoa0804748">
<meta name="citation_reference" content="citation_journal_title=Bulletin of the History of Medicine;citation_journal_abbrev=Bulletin of the History of Medicine;citation_title=Intentional ignorance: a history of blind assessment and placebo controls in medicine.;citation_pages=389-433;citation_volume=72;citation_year=1998;citation_issue=3;citation_issn=0007-5140;citation_pmid=9780448;citation_doi=10.1353/bhm.1998.0159">
<meta name="citation_reference" content="citation_journal_title=Thorax;citation_journal_abbrev=Thorax;citation_title=Effect of encouragement on walking test performance.;citation_pages=818-822;citation_volume=39;citation_year=1984;citation_issue=11;citation_issn=0040-6376;citation_pmid=6505988;citation_doi=10.1136/thx.39.11.818">
<meta name="citation_reference" content="citation_journal_title=Controlled clinical trials;citation_journal_abbrev=Control Clin Trials;citation_title=Blinding during data analysis and writing of manuscripts.;citation_pages=285-290;citation_volume=17;citation_year=1996;citation_issue=4;citation_pmid=8889343;citation_doi=10.1016/0197-2456(95)00263-4">
<meta name="citation_reference" content="citation_journal_title=JAMA;citation_journal_abbrev=JAMA;citation_title=Ascorbic Acid for the Common Cold: A Prophylactic and Therapeutic Trial;citation_pages=1038-1042;citation_volume=231;citation_year=1975;citation_issue=10;citation_issn=0002-9955;citation_pmid=163386;citation_doi=10.1001/jama.1975.03240220018013">
<meta name="citation_reference" content="citation_journal_title=Neurology;citation_journal_abbrev=Neurology;citation_title=The impact of blinding on the results of a randomized, placebo-controlled multiple sclerosis clinical trial;citation_pages=16-16;citation_volume=44;citation_year=1994;citation_issue=1;citation_issn=0028-3878;citation_pmid=8290055;citation_doi=10.1212/WNL.44.1.16">
<meta name="citation_reference" content="citation_journal_title=BMJ;citation_journal_abbrev=BMJ;citation_title=An open prospective randomised trial to reduce the pain of blood glucose testing: ear versus thumb;citation_pages=20-20;citation_volume=321;citation_year=2000;citation_issue=7252;citation_issn=0007-1447;citation_pmid=10875827;citation_doi=10.1136/bmj.321.7252.20">
<meta name="citation_reference" content="citation_journal_title=Annals of Internal Medicine;citation_journal_abbrev=ANN INTERN MED;citation_title=The Landscape and Lexicon of Blinding in Randomized Trials;citation_pages=254-259;citation_volume=136;citation_year=2002;citation_issue=3;citation_issn=0003-4819;citation_pmid=11827510;citation_doi=10.7326/0003-4819-136-3-200202050-00022">
<meta name="citation_reference" content="citation_journal_title=BMJ;citation_journal_abbrev=BMJ;citation_title=Statistics Notes: Blinding in clinical trials and other studies;citation_pages=504-504;citation_volume=321;citation_year=2000;citation_issue=7259;citation_issn=0007-1447;citation_pmid=10948038;citation_doi=10.1136/bmj.321.7259.504">
<meta name="citation_reference" content="citation_journal_title=Journal of clinical epidemiology;citation_journal_abbrev=J Clin Epidemiol;citation_title=In the dark: the reporting of blinding status in randomized controlled trials.;citation_pages=787-790;citation_volume=55;citation_year=2002;citation_issue=8;citation_pmid=12384193;citation_doi=10.1016/S0895-4356(02)00446-8">
<meta name="citation_reference" content="citation_journal_title=Pediatric pulmonology;citation_journal_abbrev=Pediatr Pulmonol;citation_title=Randomized controlled trials in cystic fibrosis (1966-1997) categorized by time, design, and intervention.;citation_pages=1-7;citation_volume=29;citation_year=2000;citation_issue=1;citation_pmid=10613779;citation_doi=10.1002/(SICI)1099-0496(200001)29:1&lt;1::AID-PPUL1&gt;3.0.CO;2-1">
<meta name="citation_reference" content="citation_journal_title=Med Gen Med;citation_pages=25E;citation_volume=2;citation_year=2000">
<meta name="citation_reference" content="citation_journal_title=JAMA;citation_journal_abbrev=JAMA;citation_title=Physician Interpretations and Textbook Definitions of Blinding Terminology in Randomized Controlled Trials;citation_pages=2000-2003;citation_volume=285;citation_year=2001;citation_issue=15;citation_issn=0002-9955;citation_pmid=11308438;citation_doi=10.1001/jama.285.15.2000">
<meta name="citation_reference" content="citation_journal_title=Clinical Trials;citation_journal_abbrev=Clin Trials;citation_title=Who is blinded in randomized clinical trials? A study of 200 trials and a         survey of authors;citation_pages=360-365;citation_volume=3;citation_year=2006;citation_issue=4;citation_issn=1740-7745;citation_pmid=17060210;citation_doi=10.1177/1740774506069153">
<meta name="citation_reference" content="citation_journal_title=New England Journal of Medicine;citation_journal_abbrev=NEJM;citation_title=Masked Monitoring in Clinical Trials -- Blind Stupidity?;citation_pages=1381-1382;citation_volume=338;citation_year=1998;citation_issue=19;citation_issn=0028-4793;citation_pmid=9571262;citation_doi=10.1056/NEJM199805073381911">
<meta name="citation_reference" content="citation_journal_title=BMC clinical pharmacology [electronic resource];citation_journal_abbrev=BMC Clin Pharmacol;citation_title=The safety of over-the-counter niacin. A randomized placebo-controlled trial [ISRCTN18054903].;citation_pages=4-4;citation_volume=3;citation_year=2003;citation_pmid=14614780;citation_doi=10.1186/1472-6904-3-4">
<meta name="citation_reference" content="citation_journal_title=BMJ;citation_journal_abbrev=BMJ;citation_title=Blinding and exclusions after allocation in randomised controlled trials: survey of published parallel group trials in obstetrics and gynaecology;citation_pages=742-744;citation_volume=312;citation_year=1996;citation_issue=7033;citation_issn=0007-1447;citation_pmid=8605459;citation_doi=10.1136/bmj.312.7033.742">
<meta name="citation_reference" content="citation_journal_title=BMJ;citation_volume=328;citation_year=2004;citation_pmid=14761905;citation_doi=10.1136/bmj.37952.631667.EE">
<meta name="citation_reference" content="citation_journal_title=BMJ;citation_journal_abbrev=BMJ;citation_title=Turning a blind eye: Why we don't test for blindness at the end of our trials;citation_pages=1136-1136;citation_volume=328;citation_year=2004;citation_issue=7448;citation_issn=0007-1447;citation_pmid=15130997">
<meta name="citation_reference" content="citation_journal_title=Lancet;citation_journal_abbrev=Lancet;citation_title=Effects of liraglutide in the treatment of obesity: a randomised, double-blind, placebo-controlled study.;citation_pages=1606-1616;citation_volume=374;citation_year=2009;citation_issue=9701;citation_pmid=19853906;citation_doi=10.1016/S0140-6736(09)61375-1">
<meta name="citation_reference" content="citation_title=Statistics with confidence: confidence intervals and statistical guidelines;citation_year=2000">
<meta name="citation_reference" content="citation_journal_title=BMJ;citation_journal_abbrev=BMJ;citation_title=Statistics Notes: Units of analysis;citation_pages=1874-1874;citation_volume=314;citation_year=1997;citation_issue=7098;citation_issn=0007-1447;citation_pmid=9224131;citation_doi=10.1136/bmj.314.7098.1874">
<meta name="citation_reference" content="citation_journal_title=The Journal of Clinical Pharmacology;citation_journal_abbrev=J Clin Pharmacol;citation_title=Independence and statistical inference in clinical trial designs: a tutorial review;citation_pages=408-412;citation_volume=38;citation_year=1998;citation_issue=5;citation_issn=0021-9754;citation_pmid=9602951">
<meta name="citation_reference" content="citation_journal_title=International Journal of Epidemiology;citation_journal_abbrev=Int J Epidemiol;citation_title=Principles of multilevel modelling;citation_pages=158-167;citation_volume=29;citation_year=2000;citation_issue=1;citation_issn=0300-5771;citation_pmid=10750618;citation_doi=10.1093/ije/29.1.158">
<meta name="citation_reference" content="citation_journal_title=JAMA;citation_journal_abbrev=JAMA;citation_title=Effect of Folic Acid and B Vitamins on Risk of Cardiovascular Events and Total Mortality Among Women at High Risk for Cardiovascular Disease: A Randomized Trial;citation_pages=2027-2036;citation_volume=299;citation_year=2008;citation_issue=17;citation_issn=0002-9955;citation_pmid=18460663;citation_doi=10.1001/jama.299.17.2027">
<meta name="citation_reference" content="citation_journal_title=BMJ;citation_journal_abbrev=BMJ;citation_title=Statistics notes: Interaction 3: How to examine heterogeneity;citation_pages=862-862;citation_volume=313;citation_year=1996;citation_issue=7061;citation_issn=0007-1447;citation_pmid=8870577;citation_doi=10.1136/bmj.313.7061.862">
<meta name="citation_reference" content="citation_journal_title=Lancet;citation_journal_abbrev=Lancet;citation_title=Subgroup analysis and other (mis)uses of baseline data in clinical trials.;citation_pages=1064-1069;citation_volume=355;citation_year=2000;citation_issue=9209;citation_pmid=10744093;citation_doi=10.1016/S0140-6736(00)02039-0">
<meta name="citation_reference" content="citation_journal_title=BMJ;citation_journal_abbrev=BMJ;citation_title=Statistics Notes: Interaction 2: compare effect sizes not P values;citation_pages=808-808;citation_volume=313;citation_year=1996;citation_issue=7060;citation_issn=0007-1447;citation_pmid=8842080;citation_doi=10.1136/bmj.313.7060.808">
<meta name="citation_reference" content="citation_journal_title=Annals of Internal Medicine;citation_journal_abbrev=ANN INTERN MED;citation_title=A Consumer's Guide to Subgroup Analyses;citation_pages=78-84;citation_volume=116;citation_year=1992;citation_issue=1;citation_issn=0003-4819;citation_pmid=1530753;citation_doi=10.7326/0003-4819-116-1-78">
<meta name="citation_reference" content="citation_journal_title=American heart journal;citation_journal_abbrev=Am Heart J;citation_title=Clinical trials in acute myocardial infarction: should we adjust for baseline characteristics?;citation_pages=745-751;citation_volume=139;citation_year=2000;citation_issue=5;citation_pmid=10783203;citation_doi=10.1016/S0002-8703(00)90001-2">
<meta name="citation_reference" content="citation_title=Encyclopedia of biostatistics;citation_year=1998">
<meta name="citation_reference" content="citation_journal_title=Annals of Internal Medicine;citation_journal_abbrev=ANN INTERN MED;citation_title=Reporting on Statistical Methods To Adjust for Confounding: A Cross-Sectional Survey;citation_pages=122-126;citation_volume=136;citation_year=2002;citation_issue=2;citation_issn=0003-4819;citation_pmid=11790063">
<meta name="citation_reference" content="citation_journal_title=Annals of Internal Medicine;citation_journal_abbrev=ANN INTERN MED;citation_title=The Risk of Determining Risk with Multivariable Models;citation_pages=201-210;citation_volume=118;citation_year=1993;citation_issue=3;citation_issn=0003-4819;citation_pmid=8417638;citation_doi=10.7326/0003-4819-118-3-199302010-00009">
<meta name="citation_reference" content="citation_journal_title=BMJ;citation_journal_abbrev=BMJ;citation_title=Logistic regression models used in medical research are poorly presented;citation_pages=628-628;citation_volume=313;citation_year=1996;citation_issue=7057;citation_issn=0007-1447;citation_pmid=8845725;citation_doi=10.1136/bmj.313.7057.628">
<meta name="citation_reference" content="citation_journal_title=Obstetrics &amp; Gynecology;citation_journal_abbrev=Obstet Gynecol;citation_title=Logistic regression models in obstetrics and gynecology literature.;citation_pages=1014-1020;citation_volume=93;citation_year=1999;citation_issue=6;citation_issn=0029-7844;citation_pmid=10362173;citation_doi=10.1016/S0029-7844(98)00537-7">
<meta name="citation_reference" content="citation_journal_title=New England Journal of Medicine;citation_journal_abbrev=NEJM;citation_title=Controversy in counting and attributing events in clinical trials;citation_pages=1410-1412;citation_volume=301;citation_year=1979;citation_issue=26;citation_issn=0028-4793;citation_pmid=514321;citation_doi=10.1056/NEJM197912273012602">
<meta name="citation_reference" content="citation_journal_title=Circulation;citation_journal_abbrev=Circulation;citation_title=The randomized clinical trial: bias in analysis;citation_pages=669-673;citation_volume=64;citation_year=1981;citation_issue=4;citation_issn=0009-7322;citation_pmid=7023743">
<meta name="citation_reference" content="citation_journal_title=New England Journal of Medicine;citation_journal_abbrev=NEJM;citation_title=More on Zidovudine in Asymptomatic HIV Infection;citation_pages=1758-1759;citation_volume=330;citation_year=1994;citation_issue=24;citation_issn=0028-4793;citation_pmid=8190146;citation_doi=10.1056/NEJM199406163302415">
<meta name="citation_reference" content="citation_journal_title=JAMA;citation_journal_abbrev=JAMA;citation_title=Beyond CONSORT: Need for Improved Reporting Standards for Clinical Trials;citation_pages=1487-1489;citation_volume=279;citation_year=1998;citation_issue=18;citation_issn=0002-9955;citation_pmid=9600487;citation_doi=10.1001/jama.279.18.1487">
<meta name="citation_reference" content="citation_journal_title=BMJ;citation_journal_abbrev=BMJ;citation_title=Minimal access surgery compared with medical management for chronic gastro-oesophageal reflux disease: UK collaborative randomised trial;citation_pages=a2664-a2664;citation_volume=337;citation_year=2008;citation_issue=dec15_2;citation_issn=0007-1447;citation_pmid=19074946;citation_doi=10.1136/bmj.a2664">
<meta name="citation_reference" content="citation_journal_title=Lancet;citation_journal_abbrev=Lancet;citation_title=Randomised controlled trial of magnetic-resonance pelvimetry in breech presentation at term.;citation_pages=1799-1804;citation_volume=350;citation_year=1997;citation_issue=9094;citation_pmid=9428250;citation_doi=10.1016/S0140-6736(97)05431-7">
<meta name="citation_reference" content="citation_journal_title=Lancet;citation_journal_abbrev=Lancet;citation_title=Morbidity and mortality in patients randomised to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment (INSIGHT).;citation_pages=366-372;citation_volume=356;citation_year=2000;citation_issue=9227;citation_pmid=10972368;citation_doi=10.1016/S0140-6736(00)02527-7">
<meta name="citation_reference" content="citation_journal_title=Annals of Internal Medicine;citation_journal_abbrev=ANN INTERN MED;citation_title=Low-Dose Hydrochlorothiazide and Preservation of Bone Mineral Density in Older Adults: A Randomized, Double-Blind, Placebo-Controlled Trial;citation_pages=516-526;citation_volume=133;citation_year=2000;citation_issue=7;citation_issn=0003-4819;citation_pmid=11015164;citation_doi=10.7326/0003-4819-133-7-200010030-00010">
<meta name="citation_reference" content="citation_journal_title=Journal of Clinical Oncology;citation_journal_abbrev=JCO;citation_title=Median follow-up in clinical trials;citation_pages=191-192;citation_volume=9;citation_year=1991;citation_issue=1;citation_issn=0732-183X;citation_pmid=1985169">
<meta name="citation_reference" content="citation_journal_title=British Journal of Cancer;citation_journal_abbrev=British Journal of Cancer;citation_title=Review of survival analyses published in cancer journals.;citation_pages=511-518;citation_volume=72;citation_year=1995;citation_issue=2;citation_pmid=7640241;citation_doi=10.1038/bjc.1995.364">
<meta name="citation_reference" content="citation_journal_abbrev=PLoS Med;citation_title=Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: the ANRS 1265 Trial.;citation_pages=e298-e298;citation_volume=2;citation_year=2005;citation_issue=11;citation_pmid=16231970;citation_doi=10.1371/journal.pmed.0020298">
<meta name="citation_reference" content="citation_journal_title=BMJ;citation_journal_abbrev=BMJ;citation_title=Effect of needle length on incidence of local reactions to routine immunisation in infants aged 4 months: randomised controlled trial;citation_pages=931-933;citation_volume=321;citation_year=2000;citation_issue=7266;citation_issn=0007-1447;citation_pmid=11030682;citation_doi=10.1136/bmj.321.7266.931">
<meta name="citation_reference" content="citation_journal_title=Lancet;citation_journal_abbrev=Lancet;citation_title=Trials stopped early: too good to be true?;citation_pages=943-944;citation_volume=353;citation_year=1999;citation_issue=9157;citation_pmid=10459899;citation_doi=10.1016/S0140-6736(98)00379-1">
<meta name="citation_reference" content="citation_journal_title=Statistics in medicine;citation_journal_abbrev=Stat Med;citation_title=Stopping rules and estimation problems in clinical trials.;citation_pages=1231-1242;citation_volume=7;citation_year=1988;citation_issue=12;citation_pmid=3231947;citation_doi=10.1002/sim.4780071204">
<meta name="citation_reference" content="citation_journal_title=Clinical Trials;citation_journal_abbrev=Clin Trials;citation_title=Treatment effects monitoring committees and early stopping in large clinical trials;citation_pages=40-47;citation_volume=1;citation_year=2004;citation_issue=1;citation_issn=1740-7745;citation_pmid=16281461;citation_doi=10.1191/1740774504cn014oa">
<meta name="citation_reference" content="citation_journal_title=JAMA;citation_journal_abbrev=JAMA;citation_title=Stopping Medical Research to Save Money: A Broken Pact With Researchers and Patients;citation_pages=2128-2131;citation_volume=289;citation_year=2003;citation_issue=16;citation_issn=0002-9955;citation_pmid=12709471;citation_doi=10.1001/jama.289.16.2128">
<meta name="citation_reference" content="citation_journal_title=Statistics in medicine;citation_journal_abbrev=Stat Med;citation_title=FDA perspective on trials with interim efficacy evaluations.;citation_pages=3245-3249;citation_volume=25;citation_year=2006;citation_issue=19;citation_pmid=16847824;citation_doi=10.1002/sim.2631">
<meta name="citation_reference" content="citation_journal_title=Lancet;citation_journal_abbrev=Lancet;citation_title=Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial.;citation_pages=1174-1183;citation_volume=372;citation_year=2008;citation_issue=9644;citation_pmid=18757085;citation_doi=10.1016/S0140-6736(08)61242-8">
<meta name="citation_reference" content="citation_journal_title=Clin Res Regulatory Affairs;citation_pages=171;citation_volume=12;citation_year=1995;citation_doi=10.3109/10601339509019426">
<meta name="citation_reference" content="citation_journal_title=Statistician;citation_pages=125;citation_volume=34;citation_year=1985;citation_doi=10.2307/2987510">
<meta name="citation_reference" content="citation_journal_title=Annals of Internal Medicine;citation_journal_abbrev=ANN INTERN MED;citation_title=Ardeparin Sodium for Extended Out-of-Hospital Prophylaxis against Venous Thromboembolism after Total Hip or Knee Replacement: A Randomized, Double-Blind, Placebo-Controlled Trial;citation_pages=853-861;citation_volume=132;citation_year=2000;citation_issue=11;citation_issn=0003-4819;citation_pmid=10836911">
<meta name="citation_reference" content="citation_journal_title=Gastroenterology;citation_pages=639;citation_volume=119;citation_year=2000;citation_pmid=10982756;citation_doi=10.1053/gast.2000.16518">
<meta name="citation_reference" content="citation_journal_title=JAMA;citation_journal_abbrev=JAMA;citation_title=Joint Study of Extracranial Arterial Occlusion: V. Progress Report of Prognosis Following Surgery or Nonsurgical Treatment for Transient Cerebral Ischemic Attacks and Cervical Carotid Artery Lesions;citation_pages=1993-2003;citation_volume=211;citation_year=1970;citation_issue=12;citation_issn=0002-9955;citation_pmid=5467158;citation_doi=10.1001/jama.1970.03170120039008">
<meta name="citation_reference" content="citation_journal_title=Statistics in medicine;citation_journal_abbrev=Stat Med;citation_title=Analysis of clinical trials by treatment actually received: is it really an option?;citation_pages=1595-1605;citation_volume=10;citation_year=1991;citation_issue=10;citation_pmid=1947515;citation_doi=10.1002/sim.4780101011">
<meta name="citation_reference" content="citation_journal_title=British Journal of Cancer;citation_journal_abbrev=British Journal of Cancer;citation_title=Intention to treat--who should use ITT?;citation_pages=647-650;citation_volume=68;citation_year=1993;citation_issue=4;citation_pmid=8398686;citation_doi=10.1038/bjc.1993.402">
<meta name="citation_reference" content="citation_journal_title=Controlled clinical trials;citation_journal_abbrev=Control Clin Trials;citation_title=Statistical considerations in the intent-to-treat principle;citation_pages=526-526;citation_volume=21;citation_year=2000;citation_issue=5;citation_pmid=11018568;citation_doi=10.1016/S0197-2456(00)00092-1">
<meta name="citation_reference" content="citation_journal_title=Clinical pharmacology and therapeutics;citation_journal_abbrev=Clin Pharmacol Ther;citation_title=Intention-to-treat analysis and the goals of clinical trials.;citation_pages=6-15;citation_volume=57;citation_year=1995;citation_issue=1;citation_pmid=7828382;citation_doi=10.1016/0009-9236(95)90260-0">
<meta name="citation_reference" content="citation_journal_title=Statistics in medicine;citation_journal_abbrev=Stat Med;citation_title=Estimating treatment effects in randomized clinical trials in the presence of non-compliance.;citation_pages=1849-1864;citation_volume=19;citation_year=2000;citation_issue=14;citation_pmid=10867675;citation_doi=10.1002/1097-0258(20000730)19:14&lt;1849::AID-SIM506&gt;3.0.CO;2-1">
<meta name="citation_reference" content="citation_journal_title=BMJ;citation_journal_abbrev=BMJ;citation_title=Evidence b(i)ased medicine--selective reporting from studies sponsored by pharmaceutical industry: review of studies in new drug applications;citation_pages=1171-1173;citation_volume=326;citation_year=2003;citation_issue=7400;citation_issn=0007-1447;citation_pmid=12775615;citation_doi=10.1136/bmj.326.7400.1171">
<meta name="citation_reference" content="citation_journal_title=Clinical Trials;citation_journal_abbrev=Clin Trials;citation_title=The intention-to-treat approach in randomized controlled trials: Are authors saying what they do and doing what they say?;citation_pages=350-356;citation_volume=4;citation_year=2007;citation_issue=4;citation_issn=1740-7745;citation_pmid=17848496;citation_doi=10.1177/1740774507081223">
<meta name="citation_reference" content="citation_journal_title=The Journal of family practice;citation_journal_abbrev=J Fam Pract;citation_title=Intention-to-treat analysis: who is in? Who is out?;citation_pages=969-971;citation_volume=51;citation_year=2002;citation_issue=11;citation_pmid=12485553">
<meta name="citation_reference" content="citation_journal_title=The Journal of Bone and Joint Surgery;citation_journal_abbrev=JBJS;citation_title=Intention-to-Treat Analysis and Accounting for Missing Data in Orthopaedic Randomized Clinical Trials;citation_pages=2137-2143;citation_volume=91;citation_year=2009;citation_issue=9;citation_issn=0021-9355;citation_pmid=19723990;citation_doi=10.2106/JBJS.H.01481">
<meta name="citation_reference" content="citation_journal_title=BMJ;citation_journal_abbrev=BMJ;citation_title=Intention to treat analysis is related to methodological quality;citation_pages=1007-1007;citation_volume=320;citation_year=2000;citation_issue=7240;citation_issn=0007-1447;citation_pmid=10809554;citation_doi=10.1136/bmj.320.7240.1007">
<meta name="citation_reference" content="citation_journal_title=Open Med;citation_pages=e21;citation_volume=3;citation_year=2009">
<meta name="citation_reference" content="citation_journal_title=Clinical Trials;citation_journal_abbrev=Clin Trials;citation_title=Are missing outcome data adequately handled? A review of published randomized controlled trials in major medical journals;citation_pages=368-376;citation_volume=1;citation_year=2004;citation_issue=4;citation_issn=1740-7745;citation_pmid=16279275;citation_doi=10.1191/1740774504cn032oa">
<meta name="citation_reference" content="citation_journal_title=Evidence-Based Mental Health;citation_journal_abbrev=Evid. Based Ment. Health;citation_title=A different look;citation_pages=3-3;citation_volume=11;citation_year=2008;citation_issue=1;citation_issn=1362-0347;citation_pmid=18223040;citation_doi=10.1136/ebmh.11.1.3">
<meta name="citation_reference" content="citation_journal_title=Canadian Medical Association Journal;citation_journal_abbrev=CMAJ;citation_title=Does analysis using " last="" observation="" carried="" forward"="" introduce="" bias="" in="" dementia="" research?;citation_pages="751-753;citation_volume=179;citation_year=2008;citation_issue=8;citation_issn=0008-4409;citation_pmid=18838445;citation_doi=10.1503/cmaj.080820&quot;">
<meta name="citation_reference" content="citation_journal_title=New England Journal of Medicine;citation_journal_abbrev=NEJM;citation_title=Interpreting Incomplete Data in Studies of Diet and Weight Loss;citation_pages=2136-2137;citation_volume=348;citation_year=2003;citation_issue=21;citation_issn=0028-4793;citation_pmid=12761370;citation_doi=10.1056/NEJMe030054">
<meta name="citation_reference" content="citation_journal_title=Canadian journal of psychiatry.  Revue canadienne de psychiatrie;citation_journal_abbrev=Can J Psychiatry;citation_title=The case of the missing data: methods of dealing with dropouts and other research vagaries.;citation_pages=68-75;citation_volume=47;citation_year=2002;citation_issue=1;citation_pmid=11873711">
<meta name="citation_reference" content="citation_journal_abbrev=Pharm Stat;citation_title=Handling drop-out in longitudinal clinical trials: a comparison of the LOCF and MMRM approaches.;citation_pages=93-106;citation_volume=7;citation_year=2008;citation_issue=2;citation_pmid=17351897;citation_doi=10.1002/pst.267">
<meta name="citation_reference" content="citation_title=Statistics with confidence;citation_year=2000">
<meta name="citation_reference" content="citation_journal_title=BMJ;citation_volume=339;citation_year=2009;citation_pmid=19843565;citation_doi=10.1136/bmj.b4074">
<meta name="citation_reference" content="citation_title=Statistics with confidence;citation_year=2000">
<meta name="citation_reference" content="citation_journal_title=Annals of Internal Medicine;citation_journal_abbrev=ANN INTERN MED;citation_title=Uniform Requirements for Manuscripts Submitted to Biomedical Journals;citation_pages=36-47;citation_volume=126;citation_year=1997;citation_issue=1;citation_issn=0003-4819;citation_pmid=8992922;citation_doi=10.7326/0003-4819-126-1-199701010-00006">
<meta name="citation_reference" content="citation_journal_title=BMJ;citation_journal_abbrev=BMJ;citation_title=Confidence intervals rather than P values: estimation rather than hypothesis testing.;citation_pages=746-750;citation_volume=292;citation_year=1986;citation_issue=6522;citation_issn=0007-1447;citation_pmid=3082422;citation_doi=10.1136/bmj.292.6522.746">
<meta name="citation_reference" content="citation_journal_title=Annals of Internal Medicine;citation_journal_abbrev=ANN INTERN MED;citation_title=Guidelines for Statistical Reporting in Articles for Medical Journals: Amplifications and Explanations;citation_pages=266-273;citation_volume=108;citation_year=1988;citation_issue=2;citation_issn=0003-4819;citation_pmid=3341656">
<meta name="citation_reference" content="citation_journal_title=BMJ;citation_journal_abbrev=BMJ;citation_title=Treatment for haemophilia by calendar in Hungary;citation_pages=1907-1907;citation_volume=314;citation_year=1997;citation_issue=7098;citation_issn=0007-1447;citation_pmid=9224155;citation_doi=10.1136/bmj.314.7098.1907">
<meta name="citation_reference" content="citation_journal_title=BMJ;citation_journal_abbrev=BMJ;citation_title=The number needed to treat: a clinically useful measure of treatment effect;citation_pages=452-454;citation_volume=310;citation_year=1995;citation_issue=6977;citation_issn=0007-1447;citation_pmid=7873954;citation_doi=10.1136/bmj.310.6977.452">
<meta name="citation_reference" content="citation_journal_title=BMJ;citation_journal_abbrev=BMJ;citation_title=Calculating the number needed to treat for trials where the outcome is time to an event;citation_pages=1492-1495;citation_volume=319;citation_year=1999;citation_issue=7223;citation_issn=0007-1447;citation_pmid=10582940;citation_doi=10.1136/bmj.319.7223.1492">
<meta name="citation_reference" content="citation_journal_title=Lancet;citation_journal_abbrev=Lancet;citation_title=Early versus delayed neonatal administration of a synthetic surfactant--the judgment of OSIRIS. The OSIRIS Collaborative Group (open study of infants at high risk of or with respiratory insufficiency--the role of surfactant.;citation_pages=1363-1369;citation_volume=340;citation_year=1992;citation_issue=8832;citation_pmid=1360087;citation_doi=10.1016/0140-6736(92)92557-V">
<meta name="citation_reference" content="citation_journal_title=BMC medical informatics and decision making [electronic resource];citation_journal_abbrev=BMC Med Inform Decis Mak;citation_title=Laypersons' understanding of relative risk reductions: randomised cross-sectional study.;citation_pages=31-31;citation_volume=8;citation_year=2008;citation_pmid=18631406;citation_doi=10.1186/1472-6947-8-31">
<meta name="citation_reference" content="citation_journal_title=Lancet;citation_journal_abbrev=Lancet;citation_title=Completeness of reporting trial results: effect on physicians' willingness to prescribe.;citation_pages=1209-1211;citation_volume=343;citation_year=1994;citation_issue=8907;citation_pmid=7909875;citation_doi=10.1016/S0140-6736(94)92407-4">
<meta name="citation_reference" content="citation_journal_title=Annals of Internal Medicine;citation_journal_abbrev=ANN INTERN MED;citation_title=Measured Enthusiasm: Does the Method of Reporting Trial Results Alter Perceptions of Therapeutic Effectiveness?;citation_pages=916-921;citation_volume=117;citation_year=1992;citation_issue=11;citation_issn=0003-4819;citation_pmid=1443954;citation_doi=10.7326/0003-4819-117-11-916">
<meta name="citation_reference" content="citation_journal_title=Science;citation_journal_abbrev=Science;citation_title=Some thoughts on clinical trials, especially problems of multiplicity;citation_pages=679-684;citation_volume=198;citation_year=1977;citation_issue=4318;citation_issn=0036-8075;citation_pmid=333584;citation_doi=10.1126/science.333584">
<meta name="citation_reference" content="citation_journal_title=JAMA;citation_journal_abbrev=JAMA;citation_title=Analysis and Interpretation of Treatment Effects in Subgroups of Patients in Randomized Clinical Trials;citation_pages=93-98;citation_volume=266;citation_year=1991;citation_issue=1;citation_issn=0002-9955;citation_pmid=2046134;citation_doi=10.1001/jama.1991.03470010097038">
<meta name="citation_reference" content="citation_journal_title=Statistics in medicine;citation_journal_abbrev=Stat Med;citation_title=Assessing the potential for bias in meta-analysis due to selective reporting of subgroup analyses within studies.;citation_pages=3325-3336;citation_volume=19;citation_year=2000;citation_issue=24;citation_pmid=11122498;citation_doi=10.1002/1097-0258(20001230)19:24&lt;3325::AID-SIM827&gt;3.0.CO;2-D">
<meta name="citation_reference" content="citation_journal_title=Clinical orthopaedics and related research;citation_journal_abbrev=Clin Orthop;citation_title=Misuse of baseline comparison tests and subgroup analyses in surgical trials.;citation_pages=247-251;citation_volume=447;citation_year=2006;citation_pmid=16672904;citation_doi=10.1097/01.blo.0000218736.23506.fe">
<meta name="citation_reference" content="citation_journal_title=Lancet;citation_journal_abbrev=Lancet;citation_title=Recombinant bactericidal/permeability-increasing protein (rBPI21) as adjunctive treatment for children with severe meningococcal sepsis: a randomised trial. rBPI21 Meningococcal Sepsis Study Group.;citation_pages=961-967;citation_volume=356;citation_year=2000;citation_issue=9234;citation_pmid=11041396;citation_doi=10.1016/S0140-6736(00)02712-4">
<meta name="citation_reference" content="citation_journal_title=Journal of Clinical Oncology;citation_journal_abbrev=JCO;citation_title=Adverse Event Reporting in Publications Compared With Sponsor Database for Cancer Clinical Trials;citation_pages=3933-3938;citation_volume=24;citation_year=2006;citation_issue=24;citation_issn=0732-183X;citation_pmid=16921045;citation_doi=10.1200/JCO.2005.05.3959">
<meta name="citation_reference" content="citation_journal_title=Archives of Internal Medicine;citation_journal_abbrev=Arch Intern Med;citation_title=Reporting of Safety Results in Published Reports of Randomized Controlled Trials;citation_pages=1756-1761;citation_volume=169;citation_year=2009;citation_issue=19;citation_issn=0003-9926;citation_pmid=19858432;citation_doi=10.1001/archinternmed.2009.306">
<meta name="citation_reference" content="citation_journal_title=New England Journal of Medicine;citation_journal_abbrev=NEJM;citation_title=Optimal medical therapy with or without PCI for stable coronary disease.;citation_pages=1503-1516;citation_volume=356;citation_year=2007;citation_issue=15;citation_issn=0028-4793;citation_pmid=17387127;citation_doi=10.1056/NEJMoa070829">
<meta name="citation_reference" content="citation_journal_title=BMJ;citation_journal_abbrev=BMJ;citation_title=The rhetoric of research;citation_pages=985-987;citation_volume=310;citation_year=1995;citation_issue=6985;citation_issn=0007-1447;citation_pmid=7728037">
<meta name="citation_reference" content="citation_journal_title=BMJ;citation_journal_abbrev=BMJ;citation_title=The case for structuring the discussion of scientific papers;citation_pages=1224-1225;citation_volume=318;citation_year=1999;citation_issue=7193;citation_issn=0007-1447;citation_pmid=10231230;citation_doi=10.1136/bmj.318.7193.1224">
<meta name="citation_reference" content="citation_journal_title=JAMA;citation_journal_abbrev=JAMA;citation_title=Changes to Manuscripts During the Editorial Process: Characterizing the Evolution of a Clinical Paper;citation_pages=227-228;citation_volume=280;citation_year=1998;citation_issue=3;citation_issn=0002-9955;citation_pmid=9676663;citation_doi=10.1001/jama.280.3.227">
<meta name="citation_reference" content="citation_journal_title=Journal of clinical epidemiology;citation_journal_abbrev=J Clin Epidemiol;citation_title=Limitations are not properly acknowledged in the scientific literature.;citation_pages=324-329;citation_volume=60;citation_year=2007;citation_issue=4;citation_pmid=17346604;citation_doi=10.1016/j.jclinepi.2006.09.011">
<meta name="citation_reference" content="citation_journal_title=Lancet;citation_journal_abbrev=Lancet;citation_title=Randomised trial of laparoscopic versus open cholecystectomy for acute and gangrenous cholecystitis.;citation_pages=321-325;citation_volume=351;citation_year=1998;citation_issue=9099;citation_pmid=9652612;citation_doi=10.1016/S0140-6736(97)08447-X">
<meta name="citation_reference" content="citation_journal_title=BMJ;citation_volume=339;citation_year=2009;citation_pmid=19589822;citation_doi=10.1136/bmj.b2684">
<meta name="citation_reference" content="citation_journal_title=JAMA;citation_journal_abbrev=JAMA;citation_title=Prevention of depression in at-risk adolescents: a randomized controlled trial.;citation_pages=2215-2224;citation_volume=301;citation_year=2009;citation_issue=21;citation_issn=0002-9955;citation_pmid=19491183;citation_doi=10.1001/jama.2009.788">
<meta name="citation_reference" content="citation_journal_title=Psychological bulletin;citation_journal_abbrev=Psychol Bull;citation_title=Factors relevant to the validity of experiments in social settings.;citation_pages=297-312;citation_volume=54;citation_year=1957;citation_issue=4;citation_pmid=13465924;citation_doi=10.1037/h0040950">
<meta name="citation_reference" content="citation_journal_abbrev=PLoS Clin Trials;citation_title=Factors that can affect the external validity of randomised controlled trials.;citation_pages=e9-e9;citation_volume=1;citation_year=2006;citation_issue=1;citation_pmid=16871331;citation_doi=10.1371/journal.pctr.0010009">
<meta name="citation_reference" content="citation_journal_abbrev=dummy;citation_title=The effectiveness of the Heidelberg Retina Tomograph and laser diagnostic glaucoma scanning system (GDx) in detecting and monitoring glaucoma.;citation_pages=1- iii;citation_volume=9;citation_year=2005;citation_issue=46;citation_pmid=16303099">
<meta name="citation_reference" content="citation_journal_title=Lancet;citation_journal_abbrev=Lancet;citation_title=The uncertainty principle and industry-sponsored research.;citation_pages=635-638;citation_volume=356;citation_year=2000;citation_issue=9230;citation_pmid=10968436;citation_doi=10.1016/S0140-6736(00)02605-2">
<meta name="citation_reference" content="citation_journal_title=JAMA;citation_journal_abbrev=JAMA;citation_title=Users' Guides to the Medical Literature: XIV. How to Decide on the Applicability of Clinical Trial Results to Your Patient;citation_pages=545-549;citation_volume=279;citation_year=1998;citation_issue=7;citation_issn=0002-9955;citation_pmid=9480367;citation_doi=10.1001/jama.279.7.545">
<meta name="citation_reference" content="citation_journal_title=BMJ;citation_journal_abbrev=BMJ;citation_title=Who benefits from medical interventions?;citation_pages=72-4;citation_volume=308;citation_year=1994;citation_issue=6921;citation_issn=0007-1447;citation_pmid=8298415">
<meta name="citation_reference" content="citation_title=Systematic reviews in health care: meta-analysis in context;citation_year=2001">
<meta name="citation_reference" content="citation_journal_title=Health technology assessment (Winchester, England);citation_journal_abbrev=Health Technol Assess;citation_title=Randomised evaluation of alternative electrosurgical modalities to treat bladder outflow obstruction in men with benign prostatic hyperplasia.;citation_pages=iii-iii-iv,30;citation_volume=9;citation_year=2005;citation_issue=4;citation_pmid=15698525">
<meta name="citation_reference" content="citation_journal_title=BMJ;citation_journal_abbrev=BMJ;citation_title=Assessment of generalisability in trials of health interventions: suggested framework and systematic review;citation_pages=346-349;citation_volume=333;citation_year=2006;citation_issue=7563;citation_issn=0007-1447;citation_pmid=16902217;citation_doi=10.1136/bmj.333.7563.346">
<meta name="citation_reference" content="citation_journal_title=BMC medical research methodology [electronic resource];citation_journal_abbrev=BMC Med Res Methodol;citation_title=Checklist for the qualitative evaluation of clinical studies with particular focus on external validity and model validity.;citation_pages=56-56;citation_volume=6;citation_year=2006;citation_pmid=17156475;citation_doi=10.1186/1471-2288-6-56">
<meta name="citation_reference" content="citation_journal_title=New England Journal of Medicine;citation_journal_abbrev=NEJM;citation_title=An assessment of clinically useful measures of the consequences of treatment;citation_pages=1728-1733;citation_volume=318;citation_year=1988;citation_issue=26;citation_issn=0028-4793;citation_pmid=3374545;citation_doi=10.1056/NEJM198806303182605">
<meta name="citation_reference" content="citation_journal_title=BMJ;citation_journal_abbrev=BMJ;citation_title=Confidence intervals for the number needed to treat;citation_pages=1309-1312;citation_volume=317;citation_year=1998;citation_issue=7168;citation_issn=0007-1447;citation_pmid=9804726;citation_doi=10.1136/bmj.317.7168.1309">
<meta name="citation_reference" content="citation_journal_title=New England Journal of Medicine;citation_journal_abbrev=NEJM;citation_title=A Controlled Trial of Intravenous Immune Globulin to Reduce Nosocomial Infections in Very-Low-Birth-Weight Infants;citation_pages=1107-1113;citation_volume=330;citation_year=1994;citation_issue=16;citation_issn=0028-4793;citation_pmid=8133853;citation_doi=10.1056/NEJM199404213301602">
<meta name="citation_reference" content="citation_journal_title=Lancet;citation_journal_abbrev=Lancet;citation_title=Randomised trial of intravenous atenolol among 16 027 cases of suspected acute myocardial infarction: ISIS-1. First International Study of Infarct Survival Collaborative Group.;citation_pages=57-66;citation_volume=2;citation_year=1986;citation_issue=8498;citation_pmid=2873379;citation_doi=10.1016/S0140-6736(02)92899-0">
<meta name="citation_reference" content="citation_journal_title=BMJ;citation_journal_abbrev=BMJ;citation_title=Somatostatin v placebo in bleeding oesophageal varices: randomised trial and meta-analysis;citation_pages=1495-1498;citation_volume=310;citation_year=1995;citation_issue=6993;citation_issn=0007-1447;citation_pmid=7787594">
<meta name="citation_reference" content="citation_journal_title=Journal of the Royal Society of Medicine;citation_journal_abbrev=J R Soc Med;citation_title=Reports of clinical trials should begin and end with up-to-datesystematic reviews of other relevant evidence: a status report;citation_pages=187-190;citation_volume=100;citation_year=2007;citation_issue=4;citation_issn=0141-0768;citation_pmid=17404342;citation_doi=10.1258/jrsm.100.4.187">
<meta name="citation_reference" content="citation_journal_title=Annals of Internal Medicine;citation_journal_abbrev=ANN INTERN MED;citation_title=Toward Evidence-Based Medical Statistics. 1: The P Value Fallacy;citation_pages=995-1004;citation_volume=130;citation_year=1999;citation_issue=12;citation_issn=0003-4819;citation_pmid=10383371;citation_doi=10.7326/0003-4819-130-12-199906150-00008">
<meta name="citation_reference" content="citation_journal_title=BMJ;citation_journal_abbrev=BMJ;citation_title=Reference bias in reports of drug trials.;citation_pages=654-656;citation_volume=295;citation_year=1987;citation_issue=6599;citation_issn=0007-1447;citation_pmid=3117277;citation_doi=10.1136/bmj.295.6599.654">
<meta name="citation_reference" content="citation_journal_title=Lancet;citation_journal_abbrev=Lancet;citation_title=Efficacy of ISA247 in plaque psoriasis: a randomised, multicentre, double-blind, placebo-controlled phase III study.;citation_pages=1337-1342;citation_volume=371;citation_year=2008;citation_issue=9621;citation_pmid=18424323;citation_doi=10.1016/S0140-6736(08)60593-0">
<meta name="citation_reference" content="citation_journal_title=AIDS education and prevention :  official publication of the International Society for AIDS Education;citation_journal_abbrev=AIDS Educ Prev;citation_title=How important is publication bias? A synthesis of available data.;citation_pages=15-21;citation_volume=9;citation_year=1997;citation_issue=1 Suppl;citation_pmid=9083596">
<meta name="citation_reference" content="citation_journal_title=Health technology assessment (Winchester, England);citation_journal_abbrev=Health Technol Assess;citation_title=Community provision of hearing aids and related audiology services.;citation_pages=1-120;citation_volume=4;citation_year=2000;citation_issue=4;citation_pmid=10858636">
<meta name="citation_reference" content="citation_journal_title=Statistics in medicine;citation_journal_abbrev=Stat Med;citation_title=Identification and impact of outcome selection bias in meta-analysis.;citation_pages=1547-1561;citation_volume=24;citation_year=2005;citation_issue=10;citation_pmid=15580591;citation_doi=10.1002/sim.2025">
<meta name="citation_reference" content="citation_journal_title=BMJ;citation_journal_abbrev=BMJ;citation_title=Impact of covert duplicate publication on meta-analysis: a case study;citation_pages=635-640;citation_volume=315;citation_year=1997;citation_issue=7109;citation_issn=0007-1447;citation_pmid=9310564;citation_doi=10.1136/bmj.315.7109.635">
<meta name="citation_reference" content="citation_journal_title=Journal of Clinical Oncology;citation_journal_abbrev=JCO;citation_title=Publication bias: the case for an international registry of clinical trials;citation_pages=1529-1541;citation_volume=4;citation_year=1986;citation_issue=10;citation_issn=0732-183X;citation_pmid=3760920">
<meta name="citation_reference" content="citation_journal_title=Journal of the Royal Society of Medicine;citation_journal_abbrev=J R Soc Med;citation_title=From optimism to disillusion about commitment to transparency in themedico-industrial complex;citation_pages=337-341;citation_volume=99;citation_year=2006;citation_issue=7;citation_issn=0141-0768;citation_pmid=16816262;citation_doi=10.1258/jrsm.99.7.337">
<meta name="citation_reference" content="citation_journal_title=BMJ;citation_journal_abbrev=BMJ;citation_title=A clinical trials register for Europe;citation_pages=1314-1315;citation_volume=325;citation_year=2002;citation_issue=7376;citation_issn=0007-1447;citation_pmid=12468459;citation_doi=10.1136/bmj.325.7376.1314">
<meta name="citation_reference" content="citation_journal_title=JAMA;citation_journal_abbrev=JAMA;citation_title=Registering Clinical Trials;citation_pages=516-523;citation_volume=290;citation_year=2003;citation_issue=4;citation_issn=0002-9955;citation_pmid=12876095;citation_doi=10.1001/jama.290.4.516">
<meta name="citation_reference" content="citation_journal_title=Lancet;citation_journal_abbrev=Lancet;citation_title=Selective serotonin reuptake inhibitors in childhood depression: systematic review of published versus unpublished data.;citation_pages=1341-1345;citation_volume=363;citation_year=2004;citation_issue=9418;citation_pmid=15110490;citation_doi=10.1016/S0140-6736(04)16043-1">
<meta name="citation_reference" content="citation_journal_title=Lancet;citation_journal_abbrev=Lancet;citation_title=Is this clinical trial fully registered? A statement from the International Committee of Medical Journal Editors.;citation_pages=1827-1829;citation_volume=365;citation_year=2005;citation_issue=9474;citation_pmid=15924965;citation_doi=10.1016/S0140-6736(05)66588-9">
<meta name="citation_reference" content="citation_journal_title=JAMA;citation_journal_abbrev=JAMA;citation_title=Issues in the Registration of Clinical Trials;citation_pages=2112-2120;citation_volume=297;citation_year=2007;citation_issue=19;citation_issn=0002-9955;citation_pmid=17507347;citation_doi=10.1001/jama.297.19.2112">
<meta name="citation_reference" content="citation_journal_abbrev=Trials;citation_title=Endorsement of the CONSORT Statement by high impact factor medical journals: a survey of journal editors and journal 'Instructions to Authors'.;citation_pages=20-20;citation_volume=9;citation_year=2008;citation_pmid=18423021;citation_doi=10.1186/1745-6215-9-20">
<meta name="citation_reference" content="citation_journal_title=New England Journal of Medicine;citation_journal_abbrev=NEJM;citation_title=Vasopressin versus Norepinephrine Infusion in Patients with Septic Shock;citation_pages=877-887;citation_volume=358;citation_year=2008;citation_issue=9;citation_issn=0028-4793;citation_pmid=18305265;citation_doi=10.1056/NEJMoa067373">
<meta name="citation_reference" content="citation_journal_title=Zeitschrift fur Evidenz, Fortbildung und Qualitat im Gesundheitswesen;citation_pages=27;citation_volume=102;citation_year=2008">
<meta name="citation_reference" content="citation_journal_abbrev=PLoS Med;citation_title=Impact and process evaluation of integrated community and clinic-based HIV-1 control: a cluster-randomised trial in eastern Zimbabwe.;citation_pages=e102-e102;citation_volume=4;citation_year=2007;citation_issue=3;citation_pmid=17388666;citation_doi=10.1371/journal.pmed.0040102">
<meta name="citation_reference" content="citation_journal_title=JAMA;citation_journal_abbrev=JAMA;citation_title=Carvedilol for Children and Adolescents With Heart Failure: A Randomized Controlled Trial;citation_pages=1171-1179;citation_volume=298;citation_year=2007;citation_issue=10;citation_issn=0002-9955;citation_pmid=17848651;citation_doi=10.1001/jama.298.10.1171">
<meta name="citation_reference" content="citation_journal_title=BMJ;citation_journal_abbrev=BMJ;citation_title=Pharmaceutical industry sponsorship and research outcome and quality: systematic review;citation_pages=1167-1170;citation_volume=326;citation_year=2003;citation_issue=7400;citation_issn=0007-1447;citation_pmid=12775614;citation_doi=10.1136/bmj.326.7400.1167">
<meta name="citation_reference" content="citation_journal_title=BMJ;citation_journal_abbrev=BMJ;citation_title=Association between competing interests and authors' conclusions: epidemiological study of randomised clinical trials published in the BMJ;citation_pages=249-249;citation_volume=325;citation_year=2002;citation_issue=7358;citation_issn=0007-1447;citation_pmid=12153921;citation_doi=10.1136/bmj.325.7358.249">
<meta name="citation_reference" content="citation_journal_abbrev=PLoS Med;citation_title=Factors associated with findings of published trials of drug-drug comparisons: why some statins appear more efficacious than others.;citation_pages=e184-e184;citation_volume=4;citation_year=2007;citation_issue=6;citation_pmid=17550302;citation_doi=10.1371/journal.pmed.0040184">
<meta name="citation_reference" content="citation_journal_abbrev=Contemp Clin Trials;citation_title=Pharmaceutical company funding and its consequences: a qualitative systematic review.;citation_pages=109-113;citation_volume=29;citation_year=2008;citation_issue=2;citation_pmid=17919992;citation_doi=10.1016/j.cct.2007.08.001">
<meta name="citation_reference" content="citation_journal_title=JAMA;citation_journal_abbrev=JAMA;citation_title=Association of Funding and Conclusions in Randomized Drug Trials: A Reflection of Treatment Effect or Adverse Events?;citation_pages=921-928;citation_volume=290;citation_year=2003;citation_issue=7;citation_issn=0002-9955;citation_pmid=12928469;citation_doi=10.1001/jama.290.7.921">
<meta name="citation_reference" content="citation_journal_title=JAMA;citation_journal_abbrev=JAMA;citation_title=Guest Authorship and Ghostwriting in Publications Related to Rofecoxib: A Case Study of Industry Documents From Rofecoxib Litigation;citation_pages=1800-1812;citation_volume=299;citation_year=2008;citation_issue=15;citation_issn=0002-9955;citation_pmid=18413874;citation_doi=10.1001/jama.299.15.1800">
<meta name="citation_reference" content="citation_journal_title=JAMA;citation_journal_abbrev=JAMA;citation_title=Analysis and Reporting of Factorial Trials: A Systematic Review;citation_pages=2545-2553;citation_volume=289;citation_year=2003;citation_issue=19;citation_issn=0002-9955;citation_pmid=12759326;citation_doi=10.1001/jama.289.19.2545">
<meta name="citation_reference" content="citation_title=Crossover trials in clinical research.;citation_year=2002">
<meta name="citation_reference" content="citation_journal_title=Health technology assessment (Winchester, England);citation_journal_abbrev=Health Technol Assess;citation_title=A review of the clinical effectiveness and cost-effectiveness of routine anti-D prophylaxis for pregnant women who are rhesus-negative.;citation_pages=iii-i62;citation_volume=7;citation_year=2003;citation_issue=4;citation_pmid=12633527">
<meta name="citation_reference" content="citation_title=Cochrane Database Syst Rev;citation_year=2007">
<meta name="citation_reference" content="citation_journal_title=Lancet;citation_journal_abbrev=Lancet;citation_title=Reliable assessment of the effects of treatment on mortality and major morbidity, I: clinical trials.;citation_pages=373-380;citation_volume=357;citation_year=2001;citation_issue=9253;citation_pmid=11211013;citation_doi=10.1016/S0140-6736(00)03651-5">
<meta name="citation_reference" content="citation_journal_title=Lancet;citation_journal_abbrev=Lancet;citation_title=Randomised trials, human nature, and reporting guidelines.;citation_pages=596-598;citation_volume=348;citation_year=1996;citation_issue=9027;citation_pmid=8774577;citation_doi=10.1016/S0140-6736(96)01201-9">
<meta name="citation_reference" content="citation_journal_title=Statistical Methods in Medical Research;citation_journal_abbrev=Stat Methods Med Res;citation_title=Promoting good research practice;citation_pages=17-24;citation_volume=9;citation_year=2000;citation_issue=1;citation_issn=0962-2802;citation_pmid=10826155;citation_doi=10.1177/096228020000900103">
<meta name="citation_reference" content="citation_journal_title=Journal of alternative and complementary medicine (New York, N.Y.);citation_journal_abbrev=J Altern Complement Med;citation_title=Evidence-based approaches for the Ayurvedic traditional herbal formulations: toward an Ayurvedic CONSORT model.;citation_pages=769-776;citation_volume=14;citation_year=2008;citation_issue=6;citation_pmid=18684081;citation_doi=10.1089/acm.2007.0818">
<meta name="citation_reference" content="citation_journal_title=Annals of Internal Medicine;citation_journal_abbrev=ANN INTERN MED;citation_title=Towards Complete and Accurate Reporting of Studies of Diagnostic Accuracy: The STARD Initiative;citation_pages=40-44;citation_volume=138;citation_year=2003;citation_issue=1;citation_issn=0003-4819;citation_pmid=12513043;citation_doi=10.7326/0003-4819-138-1-200301070-00010">
<meta name="citation_reference" content="citation_journal_title=Annals of Internal Medicine;citation_journal_abbrev=ANN INTERN MED;citation_title=The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for Reporting Observational Studies;citation_pages=573-577;citation_volume=147;citation_year=2007;citation_issue=8;citation_issn=0003-4819;citation_pmid=17938396;citation_doi=10.7326/0003-4819-147-8-200710160-00010">
<meta name="citation_reference" content="citation_journal_title=New England Journal of Medicine;citation_journal_abbrev=NEJM;citation_title=Fractional Flow Reserve versus Angiography for Guiding Percutaneous Coronary Intervention;citation_pages=213-224;citation_volume=360;citation_year=2009;citation_issue=3;citation_issn=0028-4793;citation_pmid=19144937;citation_doi=10.1056/NEJMoa0807611">
<meta name="citation_fulltext_world_readable" content="">
<meta name="generator" content="Drupal 7 (http://drupal.org)">
<link rel="canonical" href="http://www.bmj.com/content/340/bmj.c869">
<link rel="shortlink" href="http://www.bmj.com/node/195507">
<meta name="dcterms.title" content="CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials">
<meta name="dcterms.creator" content="hwadmin">
<meta name="dcterms.date" content="2010-03-24T00:06+00:00">
<meta name="dcterms.modified" content="2015-02-26T15:18+00:00">
<meta name="dcterms.type" content="Text">
<meta name="dcterms.format" content="text/html">
<meta name="dcterms.identifier" content="http://www.bmj.com/content/340/bmj.c869">
<meta name="dcterms.language" content="und">
  <title>CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials | The BMJ</title>

  <!--[if lte IE 9]>
    <link href="/sites/default/themes/bmj/the_bmj/css/ie.css" rel="stylesheet" media="all" type="text/css">
    <link href="/sites/default/themes/bmj/the_bmj/css/ie_2.css" rel="stylesheet" media="all" type="text/css">
    <link href="/sites/default/themes/bmj/the_bmj/css/ie_3.css" rel="stylesheet" media="all" type="text/css">
    <link href="/sites/default/themes/bmj/the_bmj/css/bootstrap-ie7.css" rel="stylesheet” media="all" type="text/css">
  <![endif]-->
  <!--[if IEMobile]>
      <link href="/sites/default/themes/bmj/the_bmj/css/screen.css" rel="stylesheet" media="all" type="text/css">
      <link href="/sites/default/themes/bmj/the_bmj/css/screen_2.css" rel="stylesheet" media="all" type="text/css">
      <link href="/sites/default/themes/bmj/the_bmj/css/screen_3.css" rel="stylesheet" media="all" type="text/css">     
  <![endif]-->
  <link type="text/css" rel="stylesheet" href="CONSORT%202010%20Explanation%20and%20Elaboration_%20updated%20guidelines%20for%20reporting%20parallel%20group%20randomised%20trials%20%7C%20The%20BMJ_files/css_nZpqy9LysFSwGKJ7v4z11U9YB9kpVSWL_JhlIW3O5FI.css" media="all">
<link type="text/css" rel="stylesheet" href="CONSORT%202010%20Explanation%20and%20Elaboration_%20updated%20guidelines%20for%20reporting%20parallel%20group%20randomised%20trials%20%7C%20The%20BMJ_files/css_LCvCQQenOZftP9DGmJQ1AC-c57eFSh7UXDLv8OVdeZg.css" media="all">
<link type="text/css" rel="stylesheet" href="CONSORT%202010%20Explanation%20and%20Elaboration_%20updated%20guidelines%20for%20reporting%20parallel%20group%20randomised%20trials%20%7C%20The%20BMJ_files/css_rwxGLXozf0RbWpDtSzZchXTORokyCqgnw0PJXiTTUOY.css" media="all">
<link type="text/css" rel="stylesheet" href="CONSORT%202010%20Explanation%20and%20Elaboration_%20updated%20guidelines%20for%20reporting%20parallel%20group%20randomised%20trials%20%7C%20The%20BMJ_files/css_kuG1RatMg6PpBDzh6D4s0qtY7zxW5dDydlTFlPPKccs.css" media="all">
<link type="text/css" rel="stylesheet" href="CONSORT%202010%20Explanation%20and%20Elaboration_%20updated%20guidelines%20for%20reporting%20parallel%20group%20randomised%20trials%20%7C%20The%20BMJ_files/css_RDcMSV7IP1zyN3I_Sg8JaeIiRE_2rv_M1tLiaESUnf4_highwire.css" media="all">
<link type="text/css" rel="stylesheet" href="CONSORT%202010%20Explanation%20and%20Elaboration_%20updated%20guidelines%20for%20reporting%20parallel%20group%20randomised%20trials%20%7C%20The%20BMJ_files/css_A_rA2ozng3OC6r4ciqDjv2caQn9C_d-R_x7EdQIZSNE.css" media="all">
<link type="text/css" rel="stylesheet" href="CONSORT%202010%20Explanation%20and%20Elaboration_%20updated%20guidelines%20for%20reporting%20parallel%20group%20randomised%20trials%20%7C%20The%20BMJ_files/css_VXn5JR586SULWVDL67jN01tt5YpX724gC2Q9rYfH9wg.css" media="print">
<link type="text/css" rel="stylesheet" href="CONSORT%202010%20Explanation%20and%20Elaboration_%20updated%20guidelines%20for%20reporting%20parallel%20group%20randomised%20trials%20%7C%20The%20BMJ_files/css_GmB3cCWgpK2q5ihUSSCapsAyFPHt-j4AyUGHyqXhLe0.css" media="screen">
<link type="text/css" rel="stylesheet" href="CONSORT%202010%20Explanation%20and%20Elaboration_%20updated%20guidelines%20for%20reporting%20parallel%20group%20randomised%20trials%20%7C%20The%20BMJ_files/css_v6zFA1BmHOCB2wWOVU75wPPiCDfArDrqdYt_PmLxD0A.css" media="all">
  <link href="CONSORT%202010%20Explanation%20and%20Elaboration_%20updated%20guidelines%20for%20reporting%20parallel%20group%20randomised%20trials%20%7C%20The%20BMJ_files/fonts.css" rel="stylesheet" media="all" type="text/css">
 
  <script src="CONSORT%202010%20Explanation%20and%20Elaboration_%20updated%20guidelines%20for%20reporting%20parallel%20group%20randomised%20trials%20%7C%20The%20BMJ_files/analytics.js" async=""></script><script src="CONSORT%202010%20Explanation%20and%20Elaboration_%20updated%20guidelines%20for%20reporting%20parallel%20group%20randomised%20trials%20%7C%20The%20BMJ_files/modernizr.js"></script>
<script src="CONSORT%202010%20Explanation%20and%20Elaboration_%20updated%20guidelines%20for%20reporting%20parallel%20group%20randomised%20trials%20%7C%20The%20BMJ_files/js_-z-2lAhufzBeVjYseT6cTzSICUy9vnoLBpu1sF_zZrs.js"></script>
<script src="CONSORT%202010%20Explanation%20and%20Elaboration_%20updated%20guidelines%20for%20reporting%20parallel%20group%20randomised%20trials%20%7C%20The%20BMJ_files/js_aH9I3umjDL5vzljRwYoP-IrAzNQS0zL1khh9a042dRM.js"></script>
<script src="CONSORT%202010%20Explanation%20and%20Elaboration_%20updated%20guidelines%20for%20reporting%20parallel%20group%20randomised%20trials%20%7C%20The%20BMJ_files/js_Sh2UgvOvuSU9-K8qwk3-2k4jaFfLVCvAG5OTqQOumXM.js"></script>
<script src="CONSORT%202010%20Explanation%20and%20Elaboration_%20updated%20guidelines%20for%20reporting%20parallel%20group%20randomised%20trials%20%7C%20The%20BMJ_files/js_Jy9gYcHgyKIx-iHd2d426mXrWymDK0E8VOsHrftlrcU.js"></script>
<script>(function(i,s,o,g,r,a,m){i["GoogleAnalyticsObject"]=r;i[r]=i[r]||function(){(i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)})(window,document,"script","//www.google-analytics.com/analytics.js","ga");ga("create", "UA-432960-5", {"cookieDomain":"auto"});ga("set", "dimension1", "Research Methods \u0026amp;amp; Reporting");ga("set", "dimension2", "full");ga("set", "dimension3", "2010");ga("set", "dimension5", "not subscribed");ga("send", "pageview");ga('create', 'UA-189672-4', 'auto', {'name': 'hwTracker'});
ga('hwTracker.send', 'pageview');</script>
<script src="CONSORT%202010%20Explanation%20and%20Elaboration_%20updated%20guidelines%20for%20reporting%20parallel%20group%20randomised%20trials%20%7C%20The%20BMJ_files/js_6s3dWVXMu09eT-MUnQ4-2ZlinVpO9JfnB0HB5abrvAY.js"></script>
<script src="CONSORT%202010%20Explanation%20and%20Elaboration_%20updated%20guidelines%20for%20reporting%20parallel%20group%20randomised%20trials%20%7C%20The%20BMJ_files/js_d8nvZsNcH9M1AdbeKkecL0ZPaRgMfWLhCmktg3wHDu4.js"></script><script language="JavaScript1.1" src="CONSORT%202010%20Explanation%20and%20Elaboration_%20updated%20guidelines%20for%20reporting%20parallel%20group%20randomised%20trials%20%7C%20The%20BMJ_files/1819545053Middle1Middle2TopTop2.js"></script>
<script>jQuery.extend(Drupal.settings, {"basePath":"\/","pathPrefix":"","ajaxPageState":{"theme":"the_bmj","theme_token":"41FL0MPI4xmUhk2AU9L56RzJQHQfyLMytoupWYP-5uk","js":{"0":1,"sites\/all\/modules\/highwire\/highwire\/plugins\/highwire_markup_process\/js\/highwire_openurl.js":1,"sites\/all\/libraries\/modernizr\/modernizr.min.js":1,"sites\/all\/modules\/contrib\/jquery_update\/replace\/jquery\/1.8\/jquery.min.js":1,"misc\/jquery.once.js":1,"misc\/drupal.js":1,"sites\/all\/modules\/contrib\/jquery_update\/replace\/ui\/ui\/minified\/jquery.ui.core.min.js":1,"sites\/all\/libraries\/cluetip\/jquery.cluetip.js":1,"sites\/all\/libraries\/cluetip\/lib\/jquery.hoverIntent.js":1,"sites\/all\/libraries\/cluetip\/lib\/jquery.bgiframe.min.js":1,"sites\/all\/modules\/highwire\/highwire\/js\/highwire.equal-heights.js":1,"sites\/all\/modules\/highwire\/highwire\/js\/highwire.panels-ajax-tab.js":1,"sites\/all\/libraries\/colorbox\/colorbox\/jquery.colorbox-min.js":1,"sites\/all\/modules\/contrib\/colorbox\/js\/colorbox.js":1,"sites\/all\/modules\/contrib\/colorbox\/styles\/default\/colorbox_style.js":1,"sites\/all\/modules\/contrib\/panels\/js\/panels.js":1,"sites\/default\/modules\/contrib\/custom_search\/js\/custom_search.js":1,"sites\/all\/modules\/contrib\/service_links\/js\/twitter_button.js":1,"sites\/all\/modules\/contrib\/service_links\/js\/facebook_like.js":1,"sites\/all\/modules\/contrib\/service_links\/js\/google_plus_one.js":1,"sites\/all\/modules\/highwire\/highwire\/highwire_citation\/plugins\/content_types\/js\/highwire_citation_export.js":1,"sites\/default\/modules\/jnl-bmj\/jnl_bmj\/js\/jnl_bmj_item_list_show_less_more.js":1,"sites\/all\/modules\/contrib\/panels_ajax_tab\/js\/panels_ajax_tab.js":1,"sites\/all\/libraries\/enquire.js\/enquire.min.js":1,"sites\/all\/modules\/highwire\/highwire\/highwire_responsive\/js\/highwire-mediaqueries.js":1,"sites\/all\/modules\/contrib\/google_analytics\/googleanalytics.js":1,"1":1,"sites\/all\/modules\/highwire\/highwire\/plugins\/highwire_markup_process\/js\/highwire_at_symbol.js":1,"sites\/all\/modules\/highwire\/highwire\/plugins\/highwire_markup_process\/js\/highwire_article_reference_popup.js":1,"sites\/all\/modules\/highwire\/highwire\/plugins\/highwire_markup_process\/js\/highwire_tables.js":1,"sites\/default\/modules\/jnl-bmj\/jnl_bmj\/plugins\/highwire_markup_process\/js\/bmj_author_affiliates.js":1,"sites\/default\/themes\/bmj\/the_bmj\/bootstrap\/js\/bootstrap.min.js":1,"sites\/default\/themes\/bmj\/the_bmj\/js\/modernizr.min.js":1,"sites\/default\/themes\/bmj\/the_bmj\/js\/bmj_oas.js":1,"sites\/default\/themes\/bmj\/the_bmj\/js\/jquery.cookieBar.js":1,"sites\/default\/themes\/bmj\/the_bmj\/js\/script.js":1},"css":{"modules\/system\/system.base.css":1,"misc\/ui\/jquery.ui.core.css":1,"misc\/ui\/jquery.ui.theme.css":1,"sites\/all\/modules\/contrib\/date\/date_api\/date.css":1,"sites\/all\/modules\/contrib\/date\/date_popup\/themes\/datepicker.1.7.css":1,"modules\/field\/theme\/field.css":1,"sites\/all\/modules\/highwire\/highwire\/highwire_draw\/css\/highwire-draw.css":1,"sites\/all\/modules\/highwire\/highwire\/highwire_folders\/highwire_folders.css":1,"sites\/all\/modules\/highwire\/highwire\/highwire_responsive\/css\/highwire-responsive.css":1,"sites\/all\/modules\/highwire\/highwire\/highwire_saved_searches\/highwire_saved_searches.css":1,"sites\/all\/modules\/highwire\/highwire\/highwire_user\/highwire_user.css":1,"sites\/all\/modules\/contrib\/views\/css\/views.css":1,"sites\/all\/modules\/contrib\/ckeditor\/css\/ckeditor.css":1,"sites\/all\/modules\/contrib\/colorbox\/styles\/default\/colorbox_style.css":1,"sites\/all\/modules\/contrib\/ctools\/css\/ctools.css":1,"sites\/all\/modules\/highwire\/highwire\/highwire.style.highwire.css":1,"sites\/all\/modules\/contrib\/panels\/css\/panels.css":1,"public:\/\/ctools\/css\/263bfdb18936424f0ade19d6bd885f37.css":1,"sites\/all\/modules\/highwire\/highwire\/plugins\/content_types\/css\/highwire_corrections.css":1,"sites\/all\/modules\/contrib\/forward\/forward.css":1,"sites\/default\/modules\/jnl-bmj\/jnl_bmj\/css\/jnl_bmj_item_list_show_less_more.css":1,"sites\/all\/modules\/contrib\/panels\/plugins\/layouts\/onecol\/onecol.css":1,"sites\/all\/modules\/contrib\/panels_ajax_tab\/css\/panels_ajax_tab.css":1,"sites\/default\/modules\/contrib\/custom_search\/custom_search.css":1,"sites\/all\/libraries\/cluetip\/jquery.cluetip.css":1,"sites\/default\/modules\/jnl-bmj\/jnl_bmj\/plugins\/highwire_markup_process\/css\/bmj_author_affiliates.css":1,"sites\/default\/themes\/bmj\/the_bmj\/css\/print.css":1,"sites\/default\/themes\/bmj\/the_bmj\/css\/screen.css":1,"sites\/default\/themes\/bmj\/the_bmj\/css\/screen_2.css":1,"sites\/default\/themes\/bmj\/the_bmj\/css\/screen_3.css":1,"sites\/all\/modules\/highwire\/highwire\/highwire.style.markup.css":1}},"colorbox":{"opacity":"0.85","current":"{current} of {total}","previous":"\u00ab Prev","next":"Next \u00bb","close":"Close","maxWidth":"98%","maxHeight":"98%","fixed":true},"highwire":{"nid":"195507","apath":"\/bmj\/340\/bmj.c869.atom","pisa":"bmj;340\/mar23_1\/c869","ac":{"bmj;340\/mar23_1\/c869":{"access":{"full":true,"reprint":true,"extract":true},"pisa_id":"bmj;340\/mar23_1\/c869","jcode":"bmj","service_id":"bmjjournals-ac.highwire.org","identities":{"urn:ac.highwire.org:guest:identity":{"runtime-id":"urn:ac.highwire.org:guest:identity","type":"guest","service-id":"bmjjournals-ac.highwire.org","privilege":{"urn:ac.highwire.org:guest:privilege":{"runtime-id":"urn:ac.highwire.org:guest:privilege","type":"privilege-set","privilege-set":"GUEST"}},"credentials":{"method":"guest"}}},"reason":{"full":{"identity_id":"urn:ac.highwire.org:guest:identity","privilege_id":"urn:ac.highwire.org:guest:privilege","identity":{"runtime-id":"urn:ac.highwire.org:guest:identity","type":"guest","service-id":"bmjjournals-ac.highwire.org","privilege":{"urn:ac.highwire.org:guest:privilege":{"runtime-id":"urn:ac.highwire.org:guest:privilege","type":"privilege-set","privilege-set":"GUEST"}},"credentials":{"method":"guest"}},"privilege":{"runtime-id":"urn:ac.highwire.org:guest:privilege","type":"privilege-set","privilege-set":"GUEST"}},"extract":{"identity_id":"urn:ac.highwire.org:guest:identity","privilege_id":"urn:ac.highwire.org:guest:privilege","identity":{"runtime-id":"urn:ac.highwire.org:guest:identity","type":"guest","service-id":"bmjjournals-ac.highwire.org","privilege":{"urn:ac.highwire.org:guest:privilege":{"runtime-id":"urn:ac.highwire.org:guest:privilege","type":"privilege-set","privilege-set":"GUEST"}},"credentials":{"method":"guest"}},"privilege":{"runtime-id":"urn:ac.highwire.org:guest:privilege","type":"privilege-set","privilege-set":"GUEST"}}},"identity":{"runtime-id":"urn:ac.highwire.org:guest:identity","type":"guest","service-id":"bmjjournals-ac.highwire.org","privilege":{"urn:ac.highwire.org:guest:privilege":{"runtime-id":"urn:ac.highwire.org:guest:privilege","type":"privilege-set","privilege-set":"GUEST"}},"credentials":{"method":"guest"}},"embargo":{"bmj":false}}},"markup":[{"requested":"full-text","variant":"full-text","view":"full","pisa":"bmj;340\/mar23_1\/c869"},{"requested":"long","variant":"full-text","view":"full","pisa":"bmj;340\/mar23_1\/c869"}]},"custom_search":{"form_target":"_self","solr":1},"panel_ajax_tab":{"path":"sites\/all\/modules\/contrib\/panels_ajax_tab"},"ws_fl":{"width":100,"height":21},"ws_gpo":{"size":"","annotation":"","lang":"","callback":"","width":300},"jnl_bmj":{"container_id_share":"article-share-modal","container_id_response":"article-response-modal"},"highwireResponsive":{"enquire_enabled":1,"breakpoints_configured":0,"breakpoints":[]},"googleanalytics":{"trackOutbound":1,"trackMailto":1,"trackDownload":1,"trackDownloadExtensions":"7z|aac|arc|arj|asf|asx|avi|bin|csv|doc(x|m)?|dot(x|m)?|exe|flv|gif|gz|gzip|hqx|jar|jpe?g|js|mp(2|3|4|e?g)|mov(ie)?|msi|msp|pdf|phps|png|ppt(x|m)?|pot(x|m)?|pps(x|m)?|ppam|sld(x|m)?|thmx|qtm?|ra(m|r)?|sea|sit|tar|tgz|torrent|txt|wav|wma|wmv|wpd|xls(x|m|b)?|xlt(x|m)|xlam|xml|z|zip"},"bootstrap":{"anchorsFix":"1","anchorsSmoothScrolling":"1","popoverEnabled":"1","popoverOptions":{"animation":1,"html":0,"placement":"right","selector":"","trigger":"click","title":"","content":"","delay":0,"container":"body"},"tooltipEnabled":"1","tooltipOptions":{"animation":1,"html":0,"placement":"auto left","selector":"","trigger":"hover focus","delay":0,"container":"body"}}});</script>
 

<script src="CONSORT%202010%20Explanation%20and%20Elaboration_%20updated%20guidelines%20for%20reporting%20parallel%20group%20randomised%20trials%20%7C%20The%20BMJ_files/altmetric_badges-d99e7772b00f31495fed09fece0b7237.js" id="altmetric-embed-js"></script><link href="CONSORT%202010%20Explanation%20and%20Elaboration_%20updated%20guidelines%20for%20reporting%20parallel%20group%20randomised%20trials%20%7C%20The%20BMJ_files/embed-deec67c8878bf9a094e44df5cac3dc81.css" type="text/css" rel="stylesheet" id="altmetric-embed-css"></head>
<!--[if IE 6]><div class="ie-warning">Our New BMJ website does not support IE6 please upgrade your browser to the latest version or use alternative browsers suggested below.
<ul>
<li>- Google Chrome</li>
<li>- Safari</li>
<li>- Firefox</li>
</ul>
</div>
<![endif]-->
<body data-twttr-rendered="true" class="html not-front not-logged-in no-sidebars page-node page-node- page-node-195507 node-type-highwire-article 1 Research Methods &amp;amp; Reporting">
  <div id="skip-link">
    <a href="#main-content" class="element-invisible element-focusable">Skip to main content</a>
  </div>
  <div style="display: block;" id="cookie-notice">
    This site uses cookies. <a class="more-info">More info<i class="fa fa-chevron-down"></i></a>
    <a class="close icontext"><i class="fa fa-times-circle"></i><span class="close-text">Close</span></a>
    <span class="more-info-text">By continuing to browse the site you are agreeing to our use of cookies. <a href="http://company.bmj.com/privacy-policy#cookies">Find out more here</a></span>
    <a class="close ie7">Close</a>
  </div>
    <div id="wrapper-outer">
  <div id="wrapper">
    <header>
        
     <div class="ad-leaderboard"> 
       <script language="JavaScript">
         <!--  
           OAS_AD('Top');  
         //-->  
       </script><a href="http://oas.services.bmj.com/RealMedia/ads/click_nx.ads/www.bmj.com/content/340/bmj.c869/1819545053@Middle1,Middle2,Top,Top2%21Top?" target="_top"><img class="uyhxjywpchhatgbxknae" src="CONSORT%202010%20Explanation%20and%20Elaboration_%20updated%20guidelines%20for%20reporting%20parallel%20group%20randomised%20trials%20%7C%20The%20BMJ_files/1819545053Middle1Middle2TopTop2Top.gif" border="0"></a> 
     </div>
        
     <!-- NAVIGATION -->
      <!-- Top Navigation -->
     <div id="top-nav" role="navigation" class="navbar navbar-static-top">
      <div class="container">
        <div id="userbar-status">
         <div id="status">
            
  <li class="user-status-link user-status-subscribe phone-menu-item">
    <a href="http://www.bmj.com/subscribe">Subscribe</a>
  </li>
        <li class="user-status-myaccount phone-menu-item">
    
<div class="btn-group">
  <a class="btn dropdown-toggle" data-toggle="dropdown" href="#">
    My Account    <span class="caret"></span>
  </a>
  <ul class="jnl-bmj-user-my-account dropdown-menu"><li class="0 first"><a href="http://myaccount.bmj.com/myaccount/account/hw-registration.html?editDetails=true">Update my details</a></li>
<li class="1 last"><a href="http://myaccount.bmj.com/myaccount/account/hw-registration.html">Manage my emails</a></li>
</ul></div>
  </li>


  <li class="user-status-bma phone-menu-item">
    <a href="http://registration.bma.org.uk/bmjverification/?url=http://www.bmj.com/content/340/bmj.c869?sso=">BMA members</a>
  </li>
                  
<div class="btn-group">
  <a class="btn dropdown-toggle" data-toggle="dropdown" href="#">
    Sign in    <span class="caret"></span>
  </a>
  <ul class="jnl-bmj-user-signin-popup dropdown-menu"><li class="0 first last"><span><form action="/login" method="post" id="jnl-bmj-user-login-form" accept-charset="UTF-8"><div><input name="form_build_id" value="form-PVKEl22FjT_WVxGLdZ1MrZHnncteJFWwJlK3SqQglYk" type="hidden">
<input name="form_id" value="jnl_bmj_user_login_form" type="hidden">
<div class="form-type-textfield form-item-name form-item form-group">
  <label for="edit-name--3">Username <span class="form-required" title="This field is required.">*</span></label>
 <input class="form-control form-text required" id="edit-name--3" name="name" size="15" maxlength="60" type="text">
</div>
<div class="form-type-password form-item-pass form-item form-group">
  <label for="edit-pass--2">Password <span class="form-required" title="This field is required.">*</span></label>
 <input class="form-control form-text required" id="edit-pass--2" name="pass" size="15" maxlength="128" type="password">
</div>
<div class="link"><div id="edit-forgot" class="form-type-item form-item form-group">
  <label for="edit-forgot"><a href="http://journals.bmj.com/cgi/changeuserinfo" title="Retrieve your credentials.">Forgot your sign in details?</a> </label>
 
</div>
</div><div class="link"><div id="edit-activate" class="form-type-item form-item form-group">
  <label for="edit-activate"><a href="http://journals.bmj.com/cgi/activate/basic">Need to activate</a> </label>
 
</div>
</div><input class="btn form-submit" id="edit-submit--9" name="op" value="Sign in" type="submit"><div id="edit-message--3" class="form-type-item form-item form-group">
  
</div>
<hr><div id="edit-bma-members" class="form-type-item form-item form-group">
  <label for="edit-bma-members"><a href="http://registration.bma.org.uk/bmjverification/?url=http%3A//www.bmj.com/content/340/bmj.c869%3Fsso%3D" title="Sign in here if you are a BMA member.">BMA members</a> </label>
 
</div>
<div id="edit-athens" class="form-type-item form-item form-group">
  <label for="edit-athens"><a href="http://openathens.highwire.org/initiate-login?subcode=bmjjournals&amp;returnURL=http%253A%252F%252Fwww.bmj.com%252Fcontent%252F340%252Fbmj.c869">Sign in via OpenAthens</a> </label>
 
</div>
<div id="edit-shibboleth" class="form-type-item form-item form-group">
  <label for="edit-shibboleth"><a href="http://www.bmj.com/login/shibboleth?uri=http%3A%2F%2Fwww.bmj.com%2Fcontent%2F340%2Fbmj.c869&amp;subcode=bmjjournals&amp;env=prod">Sign in via your institution</a> </label>
 
</div>
</div></form></span></li>
</ul></div>
         </div><!-- /status -->
                      <div id="userbar">
              <div class="region region-userbar">
    <section id="block-panels-mini-jnl-bmj-country-portal-switcher" class="block block-panels-mini clearfix">

      
  <div class="panel-display panel-1col clearfix" id="mini-panel-jnl_bmj_country_portal_switcher">
  <div class="panel-panel panel-col">
    <div><div class="panel-pane pane-country-switcher">
  
      
  
  <div class="pane-content">
    <span class="country-label">Edition: </span>
<div class="btn-group">
  <a class="btn dropdown-toggle" data-toggle="dropdown" href="#" id="country-switcher">
    US    <span class="caret"></span>
  </a>
  <ul class="jnl-bmj-country-portal-country-switcher  dropdown-menu"><li class="0 first"><a href="http://www.bmj.com/bmj_countries/switch/uk?destination=node/195507">UK</a></li>
<li class="1"><a href="http://www.bmj.com/bmj_countries/switch/india?destination=node/195507">India</a></li>
<li class="2 last"><a href="http://www.bmj.com/bmj_countries/switch/international?destination=node/195507">International</a></li>
</ul></div>
  </div>

  
  </div>
</div>
  </div>
</div>

</section> <!-- /.block -->
  </div>
            </div><!-- /userbar -->
                  </div><!-- /userbar-status -->
      </div><!-- /container -->
     </div><!-- /top-nav -->

     <!-- Main Navigation -->
      <div class="affix-top" id="main-nav" data-spy="affix" data-offset-top="125">
      <div class="primary-navigation-bar">
        <div id="navigation-wrapper">
           
         <div class="container">
           <!-- Navigation toggle -->
           <a href="#" id="btn-nav" class="">
             <span class="sr-only">Toggle navigation</span>
           </a>
           <!-- Logo -->
                      <a class="logo navbar-btn pull-left" href="http://www.bmj.com/thebmj" title="Home">
              <!-- <img src="http://static.www.bmj.com/sites/default/themes/bmj/the_bmj/logo.png" alt="Home" /> -->
              <div class="bmj-logo">The BMJ logo</div>
            </a>
                        <div class="ie6-site-map"><a href="http://www.bmj.com/sitemap">Site map</a></div>
            <!-- Search -->
            <div class="main-nav-search">
              <div id="search">
                <!--<span class="glyphicon glyphicon-search"></span>-->
                <a href="#" class="dropdown-toggle" data-toggle="dropdown" title="Search"><div class="search"><i class="fa fa-search" alt="Search"></i><span class="search-label">Search</span></div></a>
                  <div class="dropdown-menu">
                    <div class="header-search-form container">
                      <div class="searchbar">
                                                    <div class="region region-search-block">
    <section id="block-search-form" class="block block-search clearfix">

      
  <form target="_self" class="search-form form-search content-search" action="/content/340/bmj.c869" method="post" id="search-block-form" accept-charset="UTF-8"><div><div>
      <h2 class="element-invisible">Search form</h2>
    <div class="input-group"><input title="Enter the terms you wish to search for." class="container-inline input-append form-control form-text" placeholder="Search The BMJ" id="edit-search-block-form--2" name="search_block_form" size="15" maxlength="128" type="text"><span class="input-group-btn"><button type="submit" class="btn btn-default">Search</button></span></div><button class="element-invisible btn btn-primary btn btn-primary form-button" type="submit" id="edit-submit--4" name="op" value="Search">Search</button><input name="form_build_id" value="form-cx8JaKhFILr8sCBSYmMOxgLHdPrLo5kjhIPWNYkO81I" type="hidden">
<input name="form_id" value="search_block_form" type="hidden">
<input name="custom_search_paths" value="search/[key]" type="hidden">
</div>
</div></form>
</section> <!-- /.block -->
  </div>
                                              </div>
                    <div class="advanced-search">
                      <a href="http://www.bmj.com/search/advanced" title="Advanced search">Advanced search</a>
                    </div><!-- /advanced-search -->
                  </div><!-- /header-search-form -->
                </div><!-- /dropdown-menu -->
              </div><!-- /search -->
            </div><!-- /main-nav-search -->

            <!-- Mobile top nav -->
            <a href="#" id="toggle-mobile-top-nav">
              <i class="fa fa-cog"></i>
              <span class="sr-only">Toggle top menu</span>
            </a>

            <!-- Navigation -->
            <div id="navigation" class="navigation">
              <!-- Main Navigation -->
              <div class="main-navigation">
                                  <nav role="navigation">
                                    <ul class="menu nav navbar-nav"><li class="first expanded dropdown"><a href="http://www.bmj.com/us/research" data-target="#" class="dropdown-toggle" data-toggle="dropdown">Research</a><ul class="dropdown-menu"><li class="first leaf"><a href="http://www.bmj.com/us/research">At a glance</a></li>
<li class="leaf"><a href="http://www.bmj.com/us/research/research">Research papers</a></li>
<li class="leaf"><a href="http://www.bmj.com/us/research/research%20methods%20%26amp%3B%20reporting">Research methods and reporting</a></li>
<li class="leaf"><a href="http://www.bmj.com/us/research/minerva">Minerva</a></li>
<li class="last leaf"><a href="http://www.bmj.com/us/research/research%20news">Research news</a></li>
</ul></li>
<li class="expanded dropdown"><a href="http://www.bmj.com/us/education" data-target="#" class="dropdown-toggle" data-toggle="dropdown">Education</a><ul class="dropdown-menu"><li class="first leaf"><a href="http://www.bmj.com/us/education">At a glance</a></li>
<li class="leaf"><a href="http://www.bmj.com/us/education/clinical%20review">Clinical reviews</a></li>
<li class="leaf"><a href="http://www.bmj.com/us/education/practice">Practice</a></li>
<li class="leaf"><a href="http://www.bmj.com/us/education/minerva">Minerva</a></li>
<li class="leaf"><a href="http://www.bmj.com/us/education/endgames">Endgames</a></li>
<li class="last leaf"><a href="http://www.bmj.com/specialties/state-art">State of the art</a></li>
</ul></li>
<li class="expanded dropdown"><a href="http://www.bmj.com/us/news" data-target="#" class="dropdown-toggle" data-toggle="dropdown">News &amp; Views</a><ul class="dropdown-menu"><li class="first leaf"><a href="http://www.bmj.com/us/news">At a glance</a></li>
<li class="leaf"><a href="http://www.bmj.com/us/news/news?category=News">News</a></li>
<li class="leaf"><a href="http://www.bmj.com/us/news/feature">Features</a></li>
<li class="leaf"><a href="http://www.bmj.com/us/news/editorial">Editorials</a></li>
<li class="leaf"><a href="http://www.bmj.com/us/news/analysis">Analysis</a></li>
<li class="leaf"><a href="http://www.bmj.com/us/news/observations">Observations</a></li>
<li class="leaf"><a href="http://www.bmj.com/us/news/head%20to%20head">Head to head</a></li>
<li class="leaf"><a href="http://www.bmj.com/us/news/editor%27s%20choice">Editor's choice</a></li>
<li class="leaf"><a href="http://www.bmj.com/us/news/letter">Letters</a></li>
<li class="leaf"><a href="http://www.bmj.com/us/news/obituary">Obituaries</a></li>
<li class="leaf"><a href="http://www.bmj.com/us/news/views%20%26amp%3B%20reviews">Views and reviews</a></li>
<li class="last leaf"><a href="http://www.bmj.com/rapid-responses">Rapid responses</a></li>
</ul></li>
<li class="last leaf"><a href="http://www.bmj.com/campaigns">Campaigns</a></li>
</ul>                                  
                  <!-- Second Navigation -->
                  <div class="second-navigation">
                    <ul class="secondary-nav" id="">
                      <li class="even"><a href="http://www.bmj.com/archive" class="">Archive</a></li>
                      <li class="odd"><a href="http://www.bmj.com/about-bmj/resources-authors" class="">For authors</a></li>
                      <li class="even"><a href="http://jobs.bmj.com/" class="">Jobs</a></li>
                      <li class="odd last"><a href="http://www.bmj.com/hosted-content" class="">Hosted</a></li>
                    </ul>
                  </div><!-- /second-navigation -->
                </nav>
              </div><!-- /main-navigation -->

                  </div><!-- /navigation -->



        
         </div><!-- /container -->
        </div><!-- /navigation-wrapper -->
       </div><!-- /navbar navbar-default navbar-fixed-top -->
      </div><!-- Main nav -->
     </header><!-- /header -->

    <div class="main-container container" id="page"> <!-- #page is for back to top to work -->
    <!-- Remove heading -->
      <div class="row">
        
        <section class="col-sm-12">
                    <ol class="breadcrumb"><li class="first"><a href="http://www.bmj.com/us/research">Research</a></li>
<li>CONSORT 2010...</li>
<li class="active last">CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials</li>
</ol>          <a id="main-content"></a>
                              <!-- Remove heading: <h1 class="page-header">CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials</h1>-->
                                                                                              <div class="region region-content">
    <section id="block-system-main" class="block block-system clearfix">

      
  <div class="panel-display">
  <div class="hero"> <div class="panel-pane pane-bmj-article-open-access">
  
      
  
  <div class="pane-content">
    <div class="creative-commons" title="Creative Commons"><span class="creative-commons-article"><span class="icon-cc">CC</span><span class="icon-by">BY</span><span class="icon-nc">NC</span> <span>Open access</span></span></div>  </div>

  
  </div>
    <div class="hero-wrapper">
      <div class="hero-content" style="position: relative; left: 0px; top: 35.5px;">  </div>
      <!-- hero-content -->
    </div>
    <!-- hero-wrapper -->
  </div>
  <!-- hero -->

  <div class="row">
      <div class="left-content col-xs-12 col-sm-8 col-md-8 col-lg-8">
        <article>
          <div class="panel-pane pane-highwire-article-citation">
  
      
  
  <div class="pane-content">
    <div class="highwire-article-citation highwire-citation-type-highwire-article" data-node-nid="195507" id="node195507" data-pisa="bmj;340/mar23_1/c869" data-pisa-master="bmj;bmj.c869" data-apath="/bmj/340/bmj.c869.atom"><cite class="highwire-cite highwire-citation-bmj-article-top">

            <span class="highwire-cite-article-type">Research Methods &amp; Reporting</span>
    
    
            <h1 class="highwire-cite-title" id="page-title">CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials</h1>    
    <span class="highwire-cite-journal">BMJ</span>
    <span class="highwire-cite-published-year">2010</span>;
    <span class="highwire-cite-volume-issue">340</span>
    <span class="highwire-cite-doi"> doi: http://dx.doi.org/10.1136/bmj.c869</span>
    <span class="highwire-cite-date">(Published 24 March 2010)</span>
  <span class="highwire-cite-article-as">
    Cite this as: <span class="italic">BMJ</span> 2010;340:c869  </span>

    
    
</cite>
</div>  </div>

  
  </div>
<div class="panel-separator"></div><div class="panel-pane pane-highwire-panel-tabs pane-panels-ajax-tab-tabs">
  
      
  
  <div class="pane-content">
    <ul class="tabs inline panels-ajax-tab"><li class="first active"><a style="cursor: pointer;" href="http://www.bmj.com/content/340/bmj.c869" class="panels-ajax-tab-tab panels-ajax-tabs-once-processed panels-ajax-tabs-processed panels-ajax-tabs-first-loaded" data-panel-name="jnl_bmj_tab_art" data-target-id="highwire_article_tabs" data-entity-context="node:195507" data-trigger="" data-url-enabled="1"><span>Article</span></a><a href="http://www.bmj.com/panels_ajax_tab/jnl_bmj_tab_art/node:195507/1" rel="nofollow" style="display:none" class="js-crawler-link"></a></li>
<li><a style="cursor: pointer;" href="http://www.bmj.com/content/340/bmj.c869/related" class="panels-ajax-tab-tab panels-ajax-tabs-once-processed panels-ajax-tabs-processed" data-panel-name="jnl_bmj_tab_related_art" data-target-id="highwire_article_tabs" data-entity-context="node:195507" data-trigger="related" data-url-enabled="1"><span>Related content</span></a><a href="http://www.bmj.com/panels_ajax_tab/jnl_bmj_tab_related_art/node:195507/1" rel="nofollow" style="display:none" class="js-crawler-link"></a></li>
<li><a style="cursor: pointer;" href="http://www.bmj.com/content/340/bmj.c869/article-info" class="panels-ajax-tab-tab panels-ajax-tabs-once-processed panels-ajax-tabs-processed" data-panel-name="jnl_bmj_tab_info" data-target-id="highwire_article_tabs" data-entity-context="node:195507" data-trigger="article-info" data-url-enabled="1"><span>Metrics</span></a><a href="http://www.bmj.com/panels_ajax_tab/jnl_bmj_tab_info/node:195507/1" rel="nofollow" style="display:none" class="js-crawler-link"></a></li>
<li><a style="cursor: pointer;" href="http://www.bmj.com/content/340/bmj.c869/rapid-responses" class="panels-ajax-tab-tab panels-ajax-tabs-once-processed panels-ajax-tabs-processed" data-panel-name="bmj_related_rapid_responses" data-target-id="highwire_article_tabs" data-entity-context="node:195507" data-trigger="rapid-responses" data-url-enabled="1"><span>Responses</span></a><a href="http://www.bmj.com/panels_ajax_tab/bmj_related_rapid_responses/node:195507/1" rel="nofollow" style="display:none" class="js-crawler-link"></a></li>
<li><a style="cursor: pointer;" href="http://www.bmj.com/content/340/bmj.c869/peer-review" class="panels-ajax-tab-tab panels-ajax-tabs-once-processed panels-ajax-tabs-processed" data-panel-name="jnl_bmj_tab_peer_review" data-target-id="highwire_article_tabs" data-entity-context="node:195507" data-trigger="peer-review" data-url-enabled="1"><span>Peer review</span></a><a href="http://www.bmj.com/panels_ajax_tab/jnl_bmj_tab_peer_review/node:195507/1" rel="nofollow" style="display:none" class="js-crawler-link"></a></li>
<li class="last"><a style="cursor: pointer;" href="http://www.bmj.com/content/340/bmj.c869/submit-a-rapid-response" class="panels-ajax-tab-tab panels-ajax-tabs-once-processed panels-ajax-tabs-processed" data-panel-name="bmj_rapid_responses_form" data-target-id="highwire_article_tabs" data-entity-context="node:195507" data-trigger="submit-a-rapid-response" data-url-enabled="1"><i class="fa fa-edit"></i></a><a href="http://www.bmj.com/panels_ajax_tab/bmj_rapid_responses_form/node:195507/1" rel="nofollow" style="display:none" class="js-crawler-link"></a></li>
</ul>  </div>

  
  </div>
<div class="panel-separator"></div><div class="panel-pane pane-highwire-panel-tabs-container">
  
      
  
  <div class="pane-content">
    <div data-panels-ajax-tab-preloaded="jnl_bmj_tab_art" id="panels-ajax-tab-container-highwire_article_tabs" class="panels-ajax-tab-container"><div class="panels-ajax-tab-loading" style="display:none"><img class="loading" src="CONSORT%202010%20Explanation%20and%20Elaboration_%20updated%20guidelines%20for%20reporting%20parallel%20group%20randomised%20trials%20%7C%20The%20BMJ_files/loading.gif" alt="Loading" title="Loading"></div><div class="panels-ajax-tab-wrap-jnl_bmj_tab_art"><div class="panel-display panel-1col clearfix">
  <div class="panel-panel panel-col">
    <div><div class="panel-pane pane-highwire-corrections">
  
      
  
  <div class="pane-content">
    <div class="messages highwire-corrections highwire-correction-type-correction"><h3 class="highwire-corrections-title">This article has a correction. Please see:</h3><ul class="highwire-corrections-list"><li class="relation-1650924 first last"><a href="http://www.bmj.com/content/343/bmj.d6131">Errata - September 29, 2011</a></li>
</ul></div>  </div>

  
  </div>
<div class="panel-separator"></div><div class="panel-pane pane-highwire-markup">
  
      
  
  <div class="pane-content">
    <div class="highwire-markup"><div xmlns="http://www.w3.org/1999/xhtml" id="content-block-markup" xmlns:xhtml="http://www.w3.org/1999/xhtml"><div class="article fulltext-view"><span class="highwire-journal-article-marker-start"></span><div class="contributors"><ol class="contributor-list" id="contrib-group-1"><li class="contributor" id="contrib-1"><span class="name">David Moher</span><span class="contrib-role">, senior scientist</span><a id="xref-aff-1-1" class="xref-aff bmjAuthorAffiliatesMarkupProcessor-processed" href="#aff-1">1</a>, </li><li class="contributor" id="contrib-2"><span class="name">Sally Hopewell</span><span class="contrib-role">, senior research fellow</span><a id="xref-aff-2-1" class="xref-aff bmjAuthorAffiliatesMarkupProcessor-processed" href="#aff-2">2</a>, </li><li class="contributor" id="contrib-3"><span class="name">Kenneth F Schulz</span><span class="contrib-role">, distinguished scientist and vice president</span><a id="xref-aff-3-1" class="xref-aff bmjAuthorAffiliatesMarkupProcessor-processed" href="#aff-3">3</a>, </li><li class="contributor" id="contrib-4"><span class="name">Victor Montori</span><span class="contrib-role">, professor of medicine</span><a id="xref-aff-4-1" class="xref-aff bmjAuthorAffiliatesMarkupProcessor-processed" href="#aff-4">4</a>, </li><li class="contributor" id="contrib-5"><span class="name">Peter C Gøtzsche</span><span class="contrib-role">, director</span><a id="xref-aff-5-1" class="xref-aff bmjAuthorAffiliatesMarkupProcessor-processed" href="#aff-5">5</a>, </li><li class="contributor" id="contrib-6"><span class="name">P J Devereaux</span><span class="contrib-role">, clinical scholar</span><a id="xref-aff-6-1" class="xref-aff bmjAuthorAffiliatesMarkupProcessor-processed" href="#aff-6">6</a>, </li><li class="contributor" id="contrib-7"><span class="name">Diana Elbourne</span><span class="contrib-role">, professor of health care evaluation</span><a id="xref-aff-7-1" class="xref-aff bmjAuthorAffiliatesMarkupProcessor-processed" href="#aff-7">7</a>, </li><li class="contributor" id="contrib-8"><span class="name">Matthias Egger</span><span class="contrib-role">, head of department and professor of epidemiology and public health</span><a id="xref-aff-8-1" class="xref-aff bmjAuthorAffiliatesMarkupProcessor-processed" href="#aff-8">8</a>, </li><li class="last" id="contrib-9"><span class="name">Douglas G Altman</span><span class="contrib-role">, professor</span><a id="xref-aff-2-2" class="xref-aff bmjAuthorAffiliatesMarkupProcessor-processed" href="#aff-2">2</a></li></ol><ol class="affiliation-list-reveal"><a href="#" class="view-more">Author affiliations</a></ol><ol style="display: none;" class="affiliation-list bmjAuthorAffiliatesMarkupProcessor-processed"><li class="aff"><a id="aff-1" name="aff-1"></a><address><sup>1</sup>Ottawa
 Methods Centre, Clinical Epidemiology Program, Ottawa Hospital Research
 Institute, Ottawa Hospital, Ottawa, Ontario, Canada, K1H 8L6</address></li><li class="aff"><a id="aff-2" name="aff-2"></a><address><sup>2</sup>Centre for Statistics in Medicine, University of Oxford, Wolfson College, Oxford </address></li><li class="aff"><a id="aff-3" name="aff-3"></a><address><sup>3</sup>Family Health International, Research Triangle Park, NC 27709, USA</address></li><li class="aff"><a id="aff-4" name="aff-4"></a><address><sup>4</sup>UK Knowledge and Encounter Research Unit, Mayo Clinic, Rochester, MN, USA</address></li><li class="aff"><a id="aff-5" name="aff-5"></a><address><sup>5</sup>The Nordic Cochrane Centre, Rigshospitalet, Blegdamsvej 9, Copenhagen, Denmark</address></li><li class="aff"><a id="aff-6" name="aff-6"></a><address><sup>6</sup>McMaster University Health Sciences Centre, Hamilton, Canada </address></li><li class="aff"><a id="aff-7" name="aff-7"></a><address><sup>7</sup>Medical Statistics Unit, London School of Hygiene and Tropical Medicine, London</address></li><li class="aff"><a id="aff-8" name="aff-8"></a><address><sup>8</sup>Institute of Social and Preventive Medicine (ISPM), University of Bern, Switzerland</address></li></ol><ol class="corresp-list"><li class="corresp" id="corresp-1">Correspondence to: D Moher  <span class="em-link"><span class="em-addr"><a href="mailto:dmoher@ohri.ca">dmoher@ohri.ca</a></span></span></li></ol><ul class="history-list"><li xmlns:hwp="http://schema.highwire.org/Journal" class="accepted" hwp:start="2010-02-08"><span class="accepted-label">Accepted </span>8 February 2010</li></ul></div><div class="source-body"><div class="style1" id="boxed-text-1"><div id="sec-1" class="subsection"><h4>Abstract</h4><p id="p-2">Overwhelming
 evidence shows the quality of reporting of randomised controlled trials
 (RCTs) is not optimal. Without transparent reporting, readers cannot 
judge the reliability and validity of trial findings nor extract 
information for systematic reviews. Recent methodological analyses 
indicate that inadequate reporting and design are associated with biased
 estimates of treatment effects. Such systematic error is seriously 
damaging to RCTs, which are considered the gold standard for evaluating 
interventions because of their ability to minimise or avoid bias.</p><p id="p-3">A
 group of scientists and editors developed the CONSORT (Consolidated 
Standards of Reporting Trials) statement to improve the quality of 
reporting of RCTs. It was first published in 1996 and updated in 2001. 
The statement consists of a checklist and flow diagram that authors can 
use for reporting an RCT. Many leading medical journals and major 
international editorial groups have endorsed the CONSORT statement. The 
statement facilitates critical appraisal and interpretation of RCTs.</p><p id="p-4">During
 the 2001 CONSORT revision, it became clear that explanation and 
elaboration of the principles underlying the CONSORT statement would 
help investigators and others to write or appraise trial reports. A 
CONSORT explanation and elaboration article was published in 2001 
alongside the 2001 version of the CONSORT statement.</p><p id="p-5">After
 an expert meeting in January 2007, the CONSORT statement has been 
further revised and is published as the CONSORT 2010 Statement. This 
update improves the wording and clarity of the previous checklist and 
incorporates recommendations related to topics that have only recently 
received recognition, such as selective outcome reporting bias.</p><p id="p-6">This
 explanatory and elaboration document—intended to enhance the use, 
understanding, and dissemination of the CONSORT statement—has also been 
extensively revised. It presents the meaning and rationale for each new 
and updated checklist item providing examples of good reporting and, 
where possible, references to relevant empirical studies. Several 
examples of flow diagrams are included.</p><p id="p-7">The CONSORT 2010 Statement, this revised explanatory and elaboration document, and the associated website (<a href="http://www.consort-statement.org/">www.consort-statement.org</a>) should be helpful resources to improve reporting of randomised trials.</p></div></div><p id="p-8">“The whole of medicine depends on the transparent reporting of clinical trials.”<a rel="#ref-1~.ref-cit" id="xref-ref-1-1" class="xref-bibr article-ref-popup-processed" href="#ref-1">1</a></p><p id="p-9">Well
 designed and properly executed randomised controlled trials (RCTs) 
provide the most reliable evidence on the efficacy of healthcare 
interventions, but trials with inadequate methods are associated with 
bias, especially exaggerated treatment effects.<a rel="#ref-2~.ref-cit" id="xref-ref-2-1" class="xref-bibr article-ref-popup-processed" href="#ref-2">2</a> <a rel="#ref-3~.ref-cit" id="xref-ref-3-1" class="xref-bibr article-ref-popup-processed" href="#ref-3">3</a> <a rel="#ref-4~.ref-cit" id="xref-ref-4-1" class="xref-bibr article-ref-popup-processed" href="#ref-4">4</a> <a rel="#ref-5~.ref-cit" id="xref-ref-5-1" class="xref-bibr article-ref-popup-processed" href="#ref-5">5</a>
 Biased results from poorly designed and reported trials can mislead 
decision making in health care at all levels, from treatment decisions 
for a patient to formulation of national public health policies.</p><p id="p-10">Critical
 appraisal of the quality of clinical trials is possible only if the 
design, conduct, and analysis of RCTs are thoroughly and accurately 
described in the report. Far from being transparent, the reporting of 
RCTs is often incomplete,<a rel="#ref-6~.ref-cit" id="xref-ref-6-1" class="xref-bibr article-ref-popup-processed" href="#ref-6">6</a> <a rel="#ref-7~.ref-cit" id="xref-ref-7-1" class="xref-bibr article-ref-popup-processed" href="#ref-7">7</a> <a rel="#ref-8~.ref-cit" id="xref-ref-8-1" class="xref-bibr article-ref-popup-processed" href="#ref-8">8</a> <a rel="#ref-9~.ref-cit" id="xref-ref-9-1" class="xref-bibr article-ref-popup-processed" href="#ref-9">9</a> compounding problems arising from poor methodology.<a rel="#ref-10~.ref-cit" id="xref-ref-10-1" class="xref-bibr article-ref-popup-processed" href="#ref-10">10</a> <a rel="#ref-11~.ref-cit" id="xref-ref-11-1" class="xref-bibr article-ref-popup-processed" href="#ref-11">11</a> <a rel="#ref-12~.ref-cit" id="xref-ref-12-1" class="xref-bibr article-ref-popup-processed" href="#ref-12">12</a> <a rel="#ref-13~.ref-cit" id="xref-ref-13-1" class="xref-bibr article-ref-popup-processed" href="#ref-13">13</a> <a rel="#ref-14~.ref-cit" id="xref-ref-14-1" class="xref-bibr article-ref-popup-processed" href="#ref-14">14</a> <a rel="#ref-15~.ref-cit" id="xref-ref-15-1" class="xref-bibr article-ref-popup-processed" href="#ref-15">15</a></p><div class="section" id="sec-2"><h2>Incomplete and inaccurate reporting</h2><p id="p-11">Many
 reviews have documented deficiencies in reports of clinical trials. For
 example, information on the method used in a trial to assign 
participants to comparison groups was reported in only 21% of 519 trial 
reports indexed in PubMed in 2000,<a rel="#ref-16~.ref-cit" id="xref-ref-16-1" class="xref-bibr article-ref-popup-processed" href="#ref-16">16</a> and only 34% of 616 reports indexed in 2006.<a rel="#ref-17~.ref-cit" id="xref-ref-17-1" class="xref-bibr article-ref-popup-processed" href="#ref-17">17</a> Similarly, only 45% of trial reports indexed in PubMed in 2000<a rel="#ref-16~.ref-cit" id="xref-ref-16-2" class="xref-bibr article-ref-popup-processed" href="#ref-16">16</a> and 53% in 2006<a rel="#ref-17~.ref-cit" id="xref-ref-17-2" class="xref-bibr article-ref-popup-processed" href="#ref-17">17</a>
 defined a primary end point, and only 27% in 2000 and 45% in 2006 
reported a sample size calculation. Reporting is not only often 
incomplete but also sometimes inaccurate. Of 119 reports stating that 
all participants were included in the analysis in the groups to which 
they were originally assigned (intention-to-treat analysis), 15 (13%) 
excluded patients or did not analyse all patients as allocated.<a rel="#ref-18~.ref-cit" id="xref-ref-18-1" class="xref-bibr article-ref-popup-processed" href="#ref-18">18</a> Many other reviews have found that inadequate reporting is common in specialty journals<a rel="#ref-16~.ref-cit" id="xref-ref-16-3" class="xref-bibr article-ref-popup-processed" href="#ref-16">16</a> <a rel="#ref-19~.ref-cit" id="xref-ref-19-1" class="xref-bibr article-ref-popup-processed" href="#ref-19">19</a> and journals published in languages other than English.<a rel="#ref-20~.ref-cit" id="xref-ref-20-1" class="xref-bibr article-ref-popup-processed" href="#ref-20">20</a> <a rel="#ref-21~.ref-cit" id="xref-ref-21-1" class="xref-bibr article-ref-popup-processed" href="#ref-21">21</a></p><p id="p-12">Proper randomisation reduces selection bias at trial entry and is the crucial component of high quality RCTs.<a rel="#ref-22~.ref-cit" id="xref-ref-22-1" class="xref-bibr article-ref-popup-processed" href="#ref-22">22</a>
 Successful randomisation hinges on two steps: generation of an 
unpredictable allocation sequence and concealment of this sequence from 
the investigators enrolling participants (see box 1).<a rel="#ref-2~.ref-cit" id="xref-ref-2-2" class="xref-bibr article-ref-popup-processed" href="#ref-2">2</a> <a rel="#ref-23~.ref-cit" id="xref-ref-23-1" class="xref-bibr article-ref-popup-processed" href="#ref-23">23</a></p><div class="style2" id="boxed-text-2"><div id="sec-3" class="subsection"><h4>Box 1: Treatment allocation. What’s so special about randomisation?</h4><p id="p-13">The
 method used to assign interventions to trial participants is a crucial 
aspect of clinical trial design. Random assignment is the preferred 
method; it has been successfully used regularly in trials for more than 
50 years.<a rel="#ref-24~.ref-cit" id="xref-ref-24-1" class="xref-bibr article-ref-popup-processed" href="#ref-24">24</a> Randomisation has three major advantages.<a rel="#ref-25~.ref-cit" id="xref-ref-25-1" class="xref-bibr article-ref-popup-processed" href="#ref-25">25</a>
 First, when properly implemented, it eliminates selection bias, 
balancing both known and unknown prognostic factors, in the assignment 
of treatments. Without randomisation, treatment comparisons may be 
prejudiced, whether consciously or not, by selection of participants of a
 particular kind to receive a particular treatment. Second, random 
assignment permits the use of probability theory to express the 
likelihood that any difference in outcome between intervention groups 
merely reflects chance.<a rel="#ref-26~.ref-cit" id="xref-ref-26-1" class="xref-bibr article-ref-popup-processed" href="#ref-26">26</a>
 Third, random allocation, in some situations, facilitates blinding the 
identity of treatments to the investigators, participants, and 
evaluators, possibly by use of a placebo, which reduces bias after 
assignment of treatments.<a rel="#ref-27~.ref-cit" id="xref-ref-27-1" class="xref-bibr article-ref-popup-processed" href="#ref-27">27</a> Of these three advantages, reducing selection bias at trial entry is usually the most important.<a rel="#ref-28~.ref-cit" id="xref-ref-28-1" class="xref-bibr article-ref-popup-processed" href="#ref-28">28</a></p><p id="p-14">Successful
 randomisation in practice depends on two interrelated aspects—adequate 
generation of an unpredictable allocation sequence and concealment of 
that sequence until assignment occurs.<a rel="#ref-2~.ref-cit" id="xref-ref-2-3" class="xref-bibr article-ref-popup-processed" href="#ref-2">2</a> <a rel="#ref-23~.ref-cit" id="xref-ref-23-2" class="xref-bibr article-ref-popup-processed" href="#ref-23">23</a>
 A key issue is whether the schedule is known or predictable by the 
people involved in allocating participants to the comparison groups.<a rel="#ref-29~.ref-cit" id="xref-ref-29-1" class="xref-bibr article-ref-popup-processed" href="#ref-29">29</a>
 The treatment allocation system should thus be set up so that the 
person enrolling participants does not know in advance which treatment 
the next person will get, a process termed allocation concealment.<a rel="#ref-2~.ref-cit" id="xref-ref-2-4" class="xref-bibr article-ref-popup-processed" href="#ref-2">2</a> <a rel="#ref-23~.ref-cit" id="xref-ref-23-3" class="xref-bibr article-ref-popup-processed" href="#ref-23">23</a>
 Proper allocation concealment shields knowledge of forthcoming 
assignments, whereas proper random sequences prevent correct 
anticipation of future assignments based on knowledge of past 
assignments.</p></div></div><p id="p-15">Unfortunately, despite that 
central role, reporting of the methods used for allocation of 
participants to interventions is also generally inadequate. For example,
 5% of 206 reports of supposed RCTs in obstetrics and gynaecology 
journals described studies that were not truly randomised.<a rel="#ref-23~.ref-cit" id="xref-ref-23-4" class="xref-bibr article-ref-popup-processed" href="#ref-23">23</a> This estimate is conservative, as most reports do not at present provide adequate information about the method of allocation.<a rel="#ref-20~.ref-cit" id="xref-ref-20-2" class="xref-bibr article-ref-popup-processed" href="#ref-20">20</a> <a rel="#ref-23~.ref-cit" id="xref-ref-23-5" class="xref-bibr article-ref-popup-processed" href="#ref-23">23</a> <a rel="#ref-30~.ref-cit" id="xref-ref-30-1" class="xref-bibr article-ref-popup-processed" href="#ref-30">30</a> <a rel="#ref-31~.ref-cit" id="xref-ref-31-1" class="xref-bibr article-ref-popup-processed" href="#ref-31">31</a> <a rel="#ref-32~.ref-cit" id="xref-ref-32-1" class="xref-bibr article-ref-popup-processed" href="#ref-32">32</a> <a rel="#ref-33~.ref-cit" id="xref-ref-33-1" class="xref-bibr article-ref-popup-processed" href="#ref-33">33</a></p></div><div class="section" id="sec-4"><h2>Improving the reporting of RCTs: the CONSORT statement</h2><p id="p-16">DerSimonian
 and colleagues suggested that “editors could greatly improve the 
reporting of clinical trials by providing authors with a list of items 
that they expected to be strictly reported.”<a rel="#ref-34~.ref-cit" id="xref-ref-34-1" class="xref-bibr article-ref-popup-processed" href="#ref-34">34</a>
 Early in the 1990s, two groups of journal editors, trialists, and 
methodologists independently published recommendations on the reporting 
of trials.<a rel="#ref-35~.ref-cit" id="xref-ref-35-1" class="xref-bibr article-ref-popup-processed" href="#ref-35">35</a> <a rel="#ref-36~.ref-cit" id="xref-ref-36-1" class="xref-bibr article-ref-popup-processed" href="#ref-36">36</a> In a subsequent editorial, Rennie urged the two groups to meet and develop a common set of recommendations <a rel="#ref-37~.ref-cit" id="xref-ref-37-1" class="xref-bibr article-ref-popup-processed" href="#ref-37">37</a>; the outcome was the CONSORT statement (Consolidated Standards of Reporting Trials).<a rel="#ref-38~.ref-cit" id="xref-ref-38-1" class="xref-bibr article-ref-popup-processed" href="#ref-38">38</a></p><p id="p-17">The
 CONSORT statement (or simply CONSORT) comprises a checklist of 
essential items that should be included in reports of RCTs and a diagram
 for documenting the flow of participants through a trial. It is aimed 
at primary reports of RCTs with two group, parallel designs. Most of 
CONSORT is also relevant to a wider class of trial designs, such as 
non-inferiority, equivalence, factorial, cluster, and crossover trials. 
Extensions to the CONSORT checklist for reporting trials with some of 
these designs have been published,<a rel="#ref-39~.ref-cit" id="xref-ref-39-1" class="xref-bibr article-ref-popup-processed" href="#ref-39">39</a> <a rel="#ref-40~.ref-cit" id="xref-ref-40-1" class="xref-bibr article-ref-popup-processed" href="#ref-40">40</a> <a rel="#ref-41~.ref-cit" id="xref-ref-41-1" class="xref-bibr article-ref-popup-processed" href="#ref-41">41</a> as have those for reporting certain types of data (harms <a rel="#ref-42~.ref-cit" id="xref-ref-42-1" class="xref-bibr article-ref-popup-processed" href="#ref-42">42</a>), types of interventions (non-pharmacological treatments <a rel="#ref-43~.ref-cit" id="xref-ref-43-1" class="xref-bibr article-ref-popup-processed" href="#ref-43">43</a>, herbal interventions<a rel="#ref-44~.ref-cit" id="xref-ref-44-1" class="xref-bibr article-ref-popup-processed" href="#ref-44">44</a>), and abstracts.<a rel="#ref-45~.ref-cit" id="xref-ref-45-1" class="xref-bibr article-ref-popup-processed" href="#ref-45">45</a></p><p id="p-18">The
 objective of CONSORT is to provide guidance to authors about how to 
improve the reporting of their trials. Trial reports need be clear, 
complete, and transparent. Readers, peer reviewers, and editors can also
 use CONSORT to help them critically appraise and interpret reports of 
RCTs. However, CONSORT was not meant to be used as a quality assessment 
instrument. Rather, the content of CONSORT focuses on items related to 
the internal and external validity of trials. Many items not explicitly 
mentioned in CONSORT should also be included in a report, such as 
information about approval by an ethics committee, obtaining informed 
consent from participants, and, where relevant, existence of a data 
safety and monitoring committee. In addition, any other aspects of a 
trial that are mentioned should be properly reported, such as 
information pertinent to cost effectiveness analysis.<a rel="#ref-46~.ref-cit" id="xref-ref-46-1" class="xref-bibr article-ref-popup-processed" href="#ref-46">46</a> <a rel="#ref-47~.ref-cit" id="xref-ref-47-1" class="xref-bibr article-ref-popup-processed" href="#ref-47">47</a> <a rel="#ref-48~.ref-cit" id="xref-ref-48-1" class="xref-bibr article-ref-popup-processed" href="#ref-48">48</a></p><p id="p-19">Since its publication in 1996, CONSORT has been supported by more than 400 journals (<a href="http://www.consort-statement.org/">www.consort-statement.org</a>) and several editorial groups, such as the International Committee of Medical Journal Editors.<a rel="#ref-49~.ref-cit" id="xref-ref-49-1" class="xref-bibr article-ref-popup-processed" href="#ref-49">49</a> The introduction of CONSORT within journals is associated with improved quality of reports of RCTs.<a rel="#ref-17~.ref-cit" id="xref-ref-17-3" class="xref-bibr article-ref-popup-processed" href="#ref-17">17</a> <a rel="#ref-50~.ref-cit" id="xref-ref-50-1" class="xref-bibr article-ref-popup-processed" href="#ref-50">50</a> <a rel="#ref-51~.ref-cit" id="xref-ref-51-1" class="xref-bibr article-ref-popup-processed" href="#ref-51">51</a> However, CONSORT is an ongoing initiative, and the CONSORT statement is revised periodically.<a rel="#ref-3~.ref-cit" id="xref-ref-3-2" class="xref-bibr article-ref-popup-processed" href="#ref-3">3</a> CONSORT was last revised nine years ago, in 2001.<a rel="#ref-52~.ref-cit" id="xref-ref-52-1" class="xref-bibr article-ref-popup-processed" href="#ref-52">52</a> <a rel="#ref-53~.ref-cit" id="xref-ref-53-1" class="xref-bibr article-ref-popup-processed" href="#ref-53">53</a> <a rel="#ref-54~.ref-cit" id="xref-ref-54-1" class="xref-bibr article-ref-popup-processed" href="#ref-54">54</a>
 Since then the evidence base to inform CONSORT has grown considerably; 
empirical data have highlighted new concerns regarding the reporting of 
RCTs, such as selective outcome reporting.<a rel="#ref-55~.ref-cit" id="xref-ref-55-1" class="xref-bibr article-ref-popup-processed" href="#ref-55">55</a> <a rel="#ref-56~.ref-cit" id="xref-ref-56-1" class="xref-bibr article-ref-popup-processed" href="#ref-56">56</a> <a rel="#ref-57~.ref-cit" id="xref-ref-57-1" class="xref-bibr article-ref-popup-processed" href="#ref-57">57</a>
 A CONSORT Group meeting was therefore convened in January 2007, in 
Canada, to revise the 2001 CONSORT statement and its accompanying 
explanation and elaboration document. The revised checklist is shown in 
table 1<a id="xref-table-wrap-1-1" class="xref-down-link" href="#T1"><span>⇓</span></a> and the flow diagram, not revised, in fig 1<a id="xref-fig-1-1" class="xref-down-link" href="#F1"><span>⇓</span></a>.<a rel="#ref-52~.ref-cit" id="xref-ref-52-2" class="xref-bibr article-ref-popup-processed" href="#ref-52">52</a> <a rel="#ref-53~.ref-cit" id="xref-ref-53-2" class="xref-bibr article-ref-popup-processed" href="#ref-53">53</a> <a rel="#ref-54~.ref-cit" id="xref-ref-54-2" class="xref-bibr article-ref-popup-processed" href="#ref-54">54</a></p><div class="table pos-float" id="T1"><div class="table"><div class="table-caption"><span class="table-label">Table 1</span> <p id="p-20" class="first-child"> CONSORT 2010 checklist of information to include when reporting a randomised trial*</p><div class="sb-div caption-clear"></div></div><div class="table-inline"><div class="callout"><span>View this table:</span><ul class="callout-links"><li><a href="http://www.bmj.com/highwire/markup/591552/expansion?width=1000&amp;height=500&amp;iframe=true&amp;postprocessors=highwire_figures%2Chighwire_math" class="colorbox colorbox-load table-expand-popup init-colorbox-processed cboxElement" rel="gallery-fragment-tables">View popup</a></li><li><a href="##" class="table-expand-inline highwireTablesMarkupProcessor-processed" data-table-url="/highwire/markup/591552/expansion?postprocessors=highwire_figures%2Chighwire_math">View inline</a></li></ul></div></div></div><div></div></div><div id="F1" class="fig pos-float odd"><div class="fig-inline"><div class="highwire-figure colorbox"><div class="fig-inline-img-wrapper"><div class="fig-inline-img"><a href="http://www.bmj.com/content/bmj/340/bmj.c869/F1.large.jpg?width=800&amp;height=600" title="Fig 1 Flow diagram of the progress through the phases of a parallel randomised trial of two groups (that is, enrolment, intervention allocation, follow-up, and data analysis)52 53 54" class="colorbox fragment-images colorbox-load init-colorbox-processed cboxElement" rel="gallery-fragment-images" data-figure-caption="&amp;lt;div class=&amp;quot;fig-caption&amp;quot; xmlns:xhtml=&amp;quot;http://www.w3.org/1999/xhtml&amp;quot;&amp;gt;&amp;lt;p id=&amp;quot;p-22&amp;quot; class=&amp;quot;first-child&amp;quot;&amp;gt;&amp;lt;strong&amp;gt;Fig 1&amp;lt;/strong&amp;gt; Flow diagram of the progress through the phases of a parallel randomised trial of two groups (that is, enrolment, intervention allocation, follow-up, and data analysis)&amp;lt;a id=&amp;quot;xref-ref-52-3&amp;quot; class=&amp;quot;xref-bibr&amp;quot; href=&amp;quot;#ref-52&amp;quot;&amp;gt;52&amp;lt;/a&amp;gt; &amp;lt;a id=&amp;quot;xref-ref-53-3&amp;quot; class=&amp;quot;xref-bibr&amp;quot; href=&amp;quot;#ref-53&amp;quot;&amp;gt;53&amp;lt;/a&amp;gt; &amp;lt;a id=&amp;quot;xref-ref-54-3&amp;quot; class=&amp;quot;xref-bibr&amp;quot; href=&amp;quot;#ref-54&amp;quot;&amp;gt;54&amp;lt;/a&amp;gt;&amp;lt;/p&amp;gt;&amp;lt;div class=&amp;quot;sb-div caption-clear&amp;quot;&amp;gt;&amp;lt;/div&amp;gt;&amp;lt;/div&amp;gt;"><img title="" data-original-title="" class="fragment-image" src="CONSORT%202010%20Explanation%20and%20Elaboration_%20updated%20guidelines%20for%20reporting%20parallel%20group%20randomised%20trials%20%7C%20The%20BMJ_files/F1.gif" alt="Figure1"></a></div></div><div class="fig-caption"><p id="p-22" class="first-child"><strong>Fig 1</strong> 
Flow diagram of the progress through the phases of a parallel randomised
 trial of two groups (that is, enrolment, intervention allocation, 
follow-up, and data analysis)<a rel="#ref-52~.ref-cit" id="xref-ref-52-3" class="xref-bibr article-ref-popup-processed" href="#ref-52">52</a> <a rel="#ref-53~.ref-cit" id="xref-ref-53-3" class="xref-bibr article-ref-popup-processed" href="#ref-53">53</a> <a rel="#ref-54~.ref-cit" id="xref-ref-54-3" class="xref-bibr article-ref-popup-processed" href="#ref-54">54</a></p><div class="sb-div caption-clear"></div></div><ul class="highwire-figure-links list-inline"><li class="0 first"><a href="http://www.bmj.com/content/bmj/340/bmj.c869/F1.large.jpg?download=true" class="highwire-figure-link highwire-figure-link-download" title="Download Figure1">Download figure</a></li>
<li class="1"><a href="http://www.bmj.com/content/bmj/340/bmj.c869/F1.large.jpg" class="highwire-figure-link highwire-figure-link-newtab" target="_blank">Open in new tab</a></li>
<li class="2 last"><a href="http://www.bmj.com/highwire/powerpoint/591535" class="highwire-figure-link highwire-figure-link-ppt">Download powerpoint</a></li>
</ul></div></div><div></div></div></div><div class="section" id="sec-5"><h2>The CONSORT 2010 Statement: explanation and elaboration</h2><p id="p-23">During
 the 2001 CONSORT revision, it became clear that explanation and 
elaboration of the principles underlying the CONSORT statement would 
help investigators and others to write or appraise trial reports. The 
CONSORT explanation and elaboration article<a rel="#ref-58~.ref-cit" id="xref-ref-58-1" class="xref-bibr article-ref-popup-processed" href="#ref-58">58</a>
 was published in 2001 alongside the 2001 version of the CONSORT 
statement. It discussed the rationale and scientific background for each
 item and provided published examples of good reporting. The rationale 
for revising that article is similar to that for revising the statement,
 described above. We briefly describe below the main additions and 
deletions to this version of the explanation and elaboration article.</p></div><div class="section" id="sec-6"><h2>The CONSORT 2010 Explanation and Elaboration: changes</h2><p id="p-24">We
 have made several substantive and some cosmetic changes to this version
 of the CONSORT explanatory document (full details are highlighted in 
the 2010 version of the CONSORT statement<a rel="#ref-59~.ref-cit" id="xref-ref-59-1" class="xref-bibr article-ref-popup-processed" href="#ref-59">59</a>).
 Some reflect changes to the CONSORT checklist; there are three new 
checklist items in the CONSORT 2010 checklist—such as item 24, which 
asks authors to report where their trial protocol can be accessed. We 
have also updated some existing explanations, including adding more 
recent references to methodological evidence, and used some better 
examples. We have removed the glossary, which is now available on the 
CONSORT website (<a href="http://www.consort-statement.org/">www.consort-statement.org</a>).
 Where possible, we describe the findings of relevant empirical studies.
 Many excellent books on clinical trials offer fuller discussion of 
methodological issues.<a rel="#ref-60~.ref-cit" id="xref-ref-60-1" class="xref-bibr article-ref-popup-processed" href="#ref-60">60</a> <a rel="#ref-61~.ref-cit" id="xref-ref-61-1" class="xref-bibr article-ref-popup-processed" href="#ref-61">61</a> <a rel="#ref-62~.ref-cit" id="xref-ref-62-1" class="xref-bibr article-ref-popup-processed" href="#ref-62">62</a>
 Finally, for convenience, we sometimes refer to “treatments” and 
“patients,” although we recognise that not all interventions evaluated 
in RCTs are treatments and not all participants are patients.</p></div><div class="section" id="sec-7"><h2>Checklist items</h2><div id="sec-8" class="subsection"><h3>Title and abstract</h3><div id="sec-9" class="subsection"><h4>Item 1a. Identification as a randomised trial in the title.</h4><p id="p-25"><strong>Example—</strong>“Smoking reduction with oral nicotine inhalers: double blind, randomised clinical trial of efficacy and safety.”<a rel="#ref-63~.ref-cit" id="xref-ref-63-1" class="xref-bibr article-ref-popup-processed" href="#ref-63">63</a></p><p id="p-26"><strong>Explanation—</strong>The
 ability to identify a report of a randomised trial in an electronic 
database depends to a large extent on how it was indexed. Indexers may 
not classify a report as a randomised trial if the authors do not 
explicitly report this information.<a rel="#ref-64~.ref-cit" id="xref-ref-64-1" class="xref-bibr article-ref-popup-processed" href="#ref-64">64</a>
 To help ensure that a study is appropriately indexed and easily 
identified, authors should use the word “randomised” in the title to 
indicate that the participants were randomly assigned to their 
comparison groups.</p></div><div id="sec-10" class="subsection"><h4>Item 1b. Structured summary of trial design, methods, results, and conclusions</h4><p id="p-27">For specific guidance see CONSORT for abstracts.<a rel="#ref-45~.ref-cit" id="xref-ref-45-2" class="xref-bibr article-ref-popup-processed" href="#ref-45">45</a> <a rel="#ref-65~.ref-cit" id="xref-ref-65-1" class="xref-bibr article-ref-popup-processed" href="#ref-65">65</a></p><p id="p-28"><strong>Explanation—</strong>Clear,
 transparent, and sufficiently detailed abstracts are important because 
readers often base their assessment of a trial on such information. Some
 readers use an abstract as a screening tool to decide whether to read 
the full article. However, as not all trials are freely available and 
some health professionals do not have access to the full trial reports, 
healthcare decisions are sometimes made on the basis of abstracts of 
randomised trials.<a rel="#ref-66~.ref-cit" id="xref-ref-66-1" class="xref-bibr article-ref-popup-processed" href="#ref-66">66</a></p><p id="p-29">A
 journal abstract should contain sufficient information about a trial to
 serve as an accurate record of its conduct and findings, providing 
optimal information about the trial within the space constraints and 
format of a journal. A properly constructed and written abstract helps 
individuals to assess quickly the relevance of the findings and aids the
 retrieval of relevant reports from electronic databases.<a rel="#ref-67~.ref-cit" id="xref-ref-67-1" class="xref-bibr article-ref-popup-processed" href="#ref-67">67</a>
 The abstract should accurately reflect what is included in the full 
journal article and should not include information that does not appear 
in the body of the paper. Studies comparing the accuracy of information 
reported in a journal abstract with that reported in the text of the 
full publication have found claims that are inconsistent with, or 
missing from, the body of the full article.<a rel="#ref-68~.ref-cit" id="xref-ref-68-1" class="xref-bibr article-ref-popup-processed" href="#ref-68">68</a> <a rel="#ref-69~.ref-cit" id="xref-ref-69-1" class="xref-bibr article-ref-popup-processed" href="#ref-69">69</a> <a rel="#ref-70~.ref-cit" id="xref-ref-70-1" class="xref-bibr article-ref-popup-processed" href="#ref-70">70</a> <a rel="#ref-71~.ref-cit" id="xref-ref-71-1" class="xref-bibr article-ref-popup-processed" href="#ref-71">71</a> Conversely, omitting important harms from the abstract could seriously mislead someone’s interpretation of the trial findings.<a rel="#ref-42~.ref-cit" id="xref-ref-42-2" class="xref-bibr article-ref-popup-processed" href="#ref-42">42</a> <a rel="#ref-72~.ref-cit" id="xref-ref-72-1" class="xref-bibr article-ref-popup-processed" href="#ref-72">72</a></p><p id="p-30">A
 recent extension to the CONSORT statement provides a list of essential 
items that authors should include when reporting the main results of a 
randomised trial in a journal (or conference) abstract (see table 2<a id="xref-table-wrap-2-1" class="xref-down-link" href="#T2"><span>⇓</span></a>).<a rel="#ref-45~.ref-cit" id="xref-ref-45-3" class="xref-bibr article-ref-popup-processed" href="#ref-45">45</a>
 We strongly recommend the use of structured abstracts for reporting 
randomised trials. They provide readers with information about the trial
 under a series of headings pertaining to the design, conduct, analysis,
 and interpretation.<a rel="#ref-73~.ref-cit" id="xref-ref-73-1" class="xref-bibr article-ref-popup-processed" href="#ref-73">73</a> Some studies have found that structured abstracts are of higher quality than the more traditional descriptive abstracts<a rel="#ref-74~.ref-cit" id="xref-ref-74-1" class="xref-bibr article-ref-popup-processed" href="#ref-74">74</a> <a rel="#ref-75~.ref-cit" id="xref-ref-75-1" class="xref-bibr article-ref-popup-processed" href="#ref-75">75</a> and that they allow readers to find information more easily.<a rel="#ref-76~.ref-cit" id="xref-ref-76-1" class="xref-bibr article-ref-popup-processed" href="#ref-76">76</a>
 We recognise that many journals have developed their own structure and 
word limit for reporting abstracts. It is not our intention to suggest 
changes to these formats, but to recommend what information should be 
reported.</p><div class="table pos-float" id="T2"><div class="table"><div class="table-caption"><span class="table-label">Table 2</span> <p id="p-31" class="first-child"> Items to include when reporting a randomised trial in a journal abstract </p><div class="sb-div caption-clear"></div></div><div class="table-inline"><div class="callout"><span>View this table:</span><ul class="callout-links"><li><a href="http://www.bmj.com/highwire/markup/591558/expansion?width=1000&amp;height=500&amp;iframe=true&amp;postprocessors=highwire_figures%2Chighwire_math" class="colorbox colorbox-load table-expand-popup init-colorbox-processed cboxElement" rel="gallery-fragment-tables">View popup</a></li><li><a href="##" class="table-expand-inline highwireTablesMarkupProcessor-processed" data-table-url="/highwire/markup/591558/expansion?postprocessors=highwire_figures%2Chighwire_math">View inline</a></li></ul></div></div></div><div></div></div></div></div><div id="sec-11" class="subsection"><h3>Introduction</h3><div id="sec-12" class="subsection"><h4>Item 2a. Scientific background and explanation of rationale</h4><p id="p-32"><strong>Example—</strong>“Surgery
 is the treatment of choice for patients with disease stage I and II 
non-small cell lung cancer (NSCLC) … An NSCLC meta-analysis combined the
 results from eight randomised trials of surgery versus surgery plus 
adjuvant cisplatin-based chemotherapy and showed a small, but not 
significant (p=0.08), absolute survival benefit of around 5% at 5 years 
(from 50% to 55%). At the time the current trial was designed 
(mid-1990s), adjuvant chemotherapy had not become standard clinical 
practice … The clinical rationale for neo-adjuvant chemotherapy is 
three-fold: regression of the primary cancer could be achieved thereby 
facilitating and simplifying or reducing subsequent surgery; undetected 
micro-metastases could be dealt with at the start of treatment; and 
there might be inhibition of the putative stimulus to residual cancer by
 growth factors released by surgery and by subsequent wound healing … 
The current trial was therefore set up to compare, in patients with 
resectable NSCLC, surgery alone versus three cycles of platinum-based 
chemotherapy followed by surgery in terms of overall survival, quality 
of life, pathological staging, resectability rates, extent of surgery, 
and time to and site of relapse.”<a rel="#ref-77~.ref-cit" id="xref-ref-77-1" class="xref-bibr article-ref-popup-processed" href="#ref-77">77</a></p><p id="p-33"><strong>Explanation—</strong>Typically,
 the introduction consists of free flowing text, in which authors 
explain the scientific background and rationale for their trial, and its
 general outline. It may also be appropriate to include here the 
objectives of the trial (see item 2b).The rationale may be explanatory 
(for example, to assess the possible influence of a drug on renal 
function) or pragmatic (for example, to guide practice by comparing the 
benefits and harms of two treatments). Authors should report any 
evidence of the benefits and harms of active interventions included in a
 trial and should suggest a plausible explanation for how the 
interventions might work, if this is not obvious.<a rel="#ref-78~.ref-cit" id="xref-ref-78-1" class="xref-bibr article-ref-popup-processed" href="#ref-78">78</a></p><p id="p-34">The
 Declaration of Helsinki states that biomedical research involving 
people should be based on a thorough knowledge of the scientific 
literature.<a rel="#ref-79~.ref-cit" id="xref-ref-79-1" class="xref-bibr article-ref-popup-processed" href="#ref-79">79</a>
 That is, it is unethical to expose humans unnecessarily to the risks of
 research. Some clinical trials have been shown to have been unnecessary
 because the question they addressed had been or could have been 
answered by a systematic review of the existing literature.<a rel="#ref-80~.ref-cit" id="xref-ref-80-1" class="xref-bibr article-ref-popup-processed" href="#ref-80">80</a> <a rel="#ref-81~.ref-cit" id="xref-ref-81-1" class="xref-bibr article-ref-popup-processed" href="#ref-81">81</a>
 Thus, the need for a new trial should be justified in the introduction.
 Ideally, it should include a reference to a systematic review of 
previous similar trials or a note of the absence of such trials.<a rel="#ref-82~.ref-cit" id="xref-ref-82-1" class="xref-bibr article-ref-popup-processed" href="#ref-82">82</a></p></div><div id="sec-13" class="subsection"><h4>Item 2b. Specific objectives or hypotheses</h4><p id="p-35"><strong>Example—</strong>“In
 the current study we tested the hypothesis that a policy of active 
management of nulliparous labour would: 1. reduce the rate of caesarean 
section, 2. reduce the rate of prolonged labour; 3. not influence 
maternal satisfaction with the birth experience.”<a rel="#ref-83~.ref-cit" id="xref-ref-83-1" class="xref-bibr article-ref-popup-processed" href="#ref-83">83</a></p><p id="p-36"><strong>Explanation—</strong>Objectives
 are the questions that the trial was designed to answer. They often 
relate to the efficacy of a particular therapeutic or preventive 
intervention. Hypotheses are pre-specified questions being tested to 
help meet the objectives. Hypotheses are more specific than objectives 
and are amenable to explicit statistical evaluation. In practice, 
objectives and hypotheses are not always easily differentiated. Most 
reports of RCTs provide adequate information about trial objectives and 
hypotheses.<a rel="#ref-84~.ref-cit" id="xref-ref-84-1" class="xref-bibr article-ref-popup-processed" href="#ref-84">84</a></p></div></div><div id="sec-14" class="subsection"><h3>Methods</h3><div id="sec-15" class="subsection"><h4>Item 3a. Description of trial design (such as parallel, factorial) including allocation ratio</h4><p id="p-37"><strong>Example—</strong>“This
 was a multicenter, stratified (6 to 11 years and 12 to 17 years of age,
 with imbalanced randomisation [2:1]), double-blind, placebo-controlled,
 parallel-group study conducted in the United States (41 sites).”<a rel="#ref-85~.ref-cit" id="xref-ref-85-1" class="xref-bibr article-ref-popup-processed" href="#ref-85">85</a></p><p id="p-38"><strong>Explanation—</strong>The
 word “design” is often used to refer to all aspects of how a trial is 
set up, but it also has a narrower interpretation. Many specific aspects
 of the broader trial design, including details of randomisation and 
blinding, are addressed elsewhere in the CONSORT checklist. Here we seek
 information on the type of trial, such as parallel group or factorial, 
and the conceptual framework, such as superiority or non-inferiority, 
and other related issues not addressed elsewhere in the checklist.</p><p id="p-39">The
 CONSORT statement focuses mainly on trials with participants 
individually randomised to one of two “parallel” groups. In fact, little
 more than half of published trials have such a design.<a rel="#ref-16~.ref-cit" id="xref-ref-16-4" class="xref-bibr article-ref-popup-processed" href="#ref-16">16</a> The main alternative designs are multi-arm parallel, crossover, cluster,<a rel="#ref-40~.ref-cit" id="xref-ref-40-2" class="xref-bibr article-ref-popup-processed" href="#ref-40">40</a>
 and factorial designs. Also, most trials are set to identify the 
superiority of a new intervention, if it exists, but others are designed
 to assess non-inferiority or equivalence.<a rel="#ref-39~.ref-cit" id="xref-ref-39-2" class="xref-bibr article-ref-popup-processed" href="#ref-39">39</a>
 It is important that researchers clearly describe these aspects of 
their trial, including the unit of randomisation (such as patient, GP 
practice, lesion). It is desirable also to include these details in the 
abstract (see item 1b).</p><p id="p-40">If a less common design is 
employed, authors are encouraged to explain their choice, especially as 
such designs may imply the need for a larger sample size or more complex
 analysis and interpretation.</p><p id="p-41">Although most trials use 
equal randomisation (such as 1:1 for two groups), it is helpful to 
provide the allocation ratio explicitly. For drug trials, specifying the
 phase of the trial (I-IV) may also be relevant.</p></div><div id="sec-16" class="subsection"><h4>Item 3b. Important changes to methods after trial commencement (such as eligibility criteria), with reasons</h4><p id="p-42"><strong>Example—</strong>“Patients
 were randomly assigned to one of six parallel groups, initially in 
1:1:1:1:1:1 ratio, to receive either one of five otamixaban … regimens …
 or an active control of unfractionated heparin … an independent Data 
Monitoring Committee reviewed unblinded data for patient safety; no 
interim analyses for efficacy or futility were done. During the trial, 
this committee recommended that the group receiving the lowest dose of 
otamixaban (0·035 mg/kg/h) be discontinued because of clinical evidence 
of inadequate anticoagulation. The protocol was immediately amended in 
accordance with that recommendation, and participants were subsequently 
randomly assigned in 2:2:2:2:1 ratio to the remaining otamixaban and 
control groups, respectively.”<a rel="#ref-86~.ref-cit" id="xref-ref-86-1" class="xref-bibr article-ref-popup-processed" href="#ref-86">86</a></p><p id="p-43"><strong>Explanation—</strong>A
 few trials may start without any fixed plan (that is, are entirely 
exploratory), but the most will have a protocol that specifies in great 
detail how the trial will be conducted. There may be deviations from the
 original protocol, as it is impossible to predict every possible change
 in circumstances during the course of a trial. Some trials will 
therefore have important changes to the methods after trial 
commencement.</p><p id="p-44">Changes could be due to external 
information becoming available from other studies, or internal financial
 difficulties, or could be due to a disappointing recruitment rate. Such
 protocol changes should be made without breaking the blinding on the 
accumulating data on participants’ outcomes. In some trials, an 
independent data monitoring committee will have as part of its remit the
 possibility of recommending protocol changes based on seeing unblinded 
data. Such changes might affect the study methods (such as changes to 
treatment regimens, eligibility criteria, randomisation ratio, or 
duration of follow-up) or trial conduct (such as dropping a centre with 
poor data quality).<a rel="#ref-87~.ref-cit" id="xref-ref-87-1" class="xref-bibr article-ref-popup-processed" href="#ref-87">87</a></p><p id="p-45">Some
 trials are set up with a formal “adaptive” design. There is no 
universally accepted definition of these designs, but a working 
definition might be “a multistage study design that uses accumulating 
data to decide how to modify aspects of the study without undermining 
the validity and integrity of the trial.”<a rel="#ref-88~.ref-cit" id="xref-ref-88-1" class="xref-bibr article-ref-popup-processed" href="#ref-88">88</a>
 The modifications are usually to the sample sizes and the number of 
treatment arms and can lead to decisions being made more quickly and 
with more efficient use of resources. There are, however, important 
ethical, statistical, and practical issues in considering such a design.<a rel="#ref-89~.ref-cit" id="xref-ref-89-1" class="xref-bibr article-ref-popup-processed" href="#ref-89">89</a> <a rel="#ref-90~.ref-cit" id="xref-ref-90-1" class="xref-bibr article-ref-popup-processed" href="#ref-90">90</a></p><p id="p-46">Whether
 the modifications are explicitly part of the trial design or in 
response to changing circumstances, it is essential that they are fully 
reported to help the reader interpret the results. Changes from 
protocols are not currently well reported. A review of comparisons with 
protocols showed that about half of journal articles describing RCTs had
 an unexplained discrepancy in the primary outcomes.<a rel="#ref-57~.ref-cit" id="xref-ref-57-2" class="xref-bibr article-ref-popup-processed" href="#ref-57">57</a> Frequent unexplained discrepancies have also been observed for details of randomisation, blinding,<a rel="#ref-91~.ref-cit" id="xref-ref-91-1" class="xref-bibr article-ref-popup-processed" href="#ref-91">91</a> and statistical analyses.<a rel="#ref-92~.ref-cit" id="xref-ref-92-1" class="xref-bibr article-ref-popup-processed" href="#ref-92">92</a></p></div><div id="sec-17" class="subsection"><h4>Item 4a. Eligibility criteria for participants</h4><p id="p-47"><strong>Example—</strong>“Eligible
 participants were all adults aged 18 or over with HIV who met the 
eligibility criteria for antiretroviral therapy according to the 
Malawian national HIV treatment guidelines (WHO clinical stage III or IV
 or any WHO stage with a CD4 count &lt;250/mm<sup>3</sup>) and who were 
starting treatment with a BMI &lt;18.5. Exclusion criteria were 
pregnancy and lactation or participation in another supplementary 
feeding programme.”<a rel="#ref-93~.ref-cit" id="xref-ref-93-1" class="xref-bibr article-ref-popup-processed" href="#ref-93">93</a></p><p id="p-48"><strong>Explanation—</strong>A
 comprehensive description of the eligibility criteria used to select 
the trial participants is needed to help readers interpret the study. In
 particular, a clear understanding of these criteria is one of several 
elements required to judge to whom the results of a trial apply—that is,
 the trial’s generalisability (applicability) and relevance to clinical 
or public health practice (see item 21).<a rel="#ref-94~.ref-cit" id="xref-ref-94-1" class="xref-bibr article-ref-popup-processed" href="#ref-94">94</a>
 A description of the method of recruitment, such as by referral or self
 selection (for example, through advertisements), is also important in 
this context. Because they are applied before randomisation, eligibility
 criteria do not affect the internal validity of a trial, but they are 
central to its external validity.</p><p id="p-49">Typical and widely 
accepted selection criteria relate to the nature and stage of the 
disease being studied, the exclusion of persons thought to be 
particularly vulnerable to harm from the study intervention, and to 
issues required to ensure that the study satisfies legal and ethical 
norms. Informed consent by study participants, for example, is typically
 required in intervention studies. The common distinction between 
inclusion and exclusion criteria is unnecessary; the same criterion can 
be phrased to include or exclude participants.<a rel="#ref-95~.ref-cit" id="xref-ref-95-1" class="xref-bibr article-ref-popup-processed" href="#ref-95">95</a></p><p id="p-50">Despite
 their importance, eligibility criteria are often not reported 
adequately. For example, eight published trials leading to clinical 
alerts by the National Institutes of Health specified an average of 31 
eligibility criteria in their protocols, but only 63% of the criteria 
were mentioned in the journal articles, and only 19% were mentioned in 
the clinical alerts.<a rel="#ref-96~.ref-cit" id="xref-ref-96-1" class="xref-bibr article-ref-popup-processed" href="#ref-96">96</a> Similar deficiencies were found for HIV clinical trials.<a rel="#ref-97~.ref-cit" id="xref-ref-97-1" class="xref-bibr article-ref-popup-processed" href="#ref-97">97</a> Among 364 reports of RCTs in surgery, 25% did not specify any eligibility criteria.<a rel="#ref-98~.ref-cit" id="xref-ref-98-1" class="xref-bibr article-ref-popup-processed" href="#ref-98">98</a></p></div><div id="sec-18" class="subsection"><h4>Item 4b. Settings and locations where the data were collected</h4><p id="p-51"><strong>Example—</strong>“The
 study took place at the antiretroviral therapy clinic of Queen 
Elizabeth Central Hospital in Blantyre, Malawi, from January 2006 to 
April 2007. Blantyre is the major commercial city of Malawi, with a 
population of 1 000 000 and an estimated HIV prevalence of 27% in adults
 in 2004.”<a rel="#ref-93~.ref-cit" id="xref-ref-93-2" class="xref-bibr article-ref-popup-processed" href="#ref-93">93</a></p><p id="p-52"><strong>Explanation—</strong>Along
 with the eligibility criteria for participants (see item 4a) and the 
description of the interventions (see item 5), information on the 
settings and locations is crucial to judge the applicability and 
generalisability of a trial. Were participants recruited from primary, 
secondary, or tertiary health care or from the community? Healthcare 
institutions vary greatly in their organisation, experience, and 
resources and the baseline risk for the condition under investigation. 
Other aspects of the setting (including the social, economic, and 
cultural environment and the climate) may also affect a study’s external
 validity.</p><p id="p-53">Authors should report the number and type of 
settings and describe the care providers involved. They should report 
the locations in which the study was carried out, including the country,
 city if applicable, and immediate environment (for example, community, 
office practice, hospital clinic, or inpatient unit). In particular, it 
should be clear whether the trial was carried out in one or several 
centres (“multicentre trials”). This description should provide enough 
information so that readers can judge whether the results of the trial 
could be relevant to their own setting. The environment in which the 
trial is conducted may differ considerably from the setting in which the
 trial’s results are later used to guide practice and policy.<a rel="#ref-94~.ref-cit" id="xref-ref-94-2" class="xref-bibr article-ref-popup-processed" href="#ref-94">94</a> <a rel="#ref-99~.ref-cit" id="xref-ref-99-1" class="xref-bibr article-ref-popup-processed" href="#ref-99">99</a>
 Authors should also report any other information about the settings and
 locations that could have influenced the observed results, such as 
problems with transportation that might have affected patient 
participation or delays in administering interventions.</p></div><div id="sec-19" class="subsection"><h4>Item
 5. The interventions for each group with sufficient details to allow 
replication, including how and when they were actually administered</h4><p id="p-54"><strong>Examples—</strong>“In
 POISE, patients received the first dose of the study drug (ie, oral 
extended-release metoprolol 100 mg or matching placebo) 2-4 h before 
surgery. Study drug administration required a heart rate of 50 bpm or 
more and a systolic blood pressure of 100 mm Hg or greater; these 
haemodynamics were checked before each administration. If, at any time 
during the first 6 h after surgery, heart rate was 80 bpm or more and 
systolic blood pressure was 100 mm Hg or higher, patients received their
 first postoperative dose (extended-release metoprolol 100 mg or matched
 placebo) orally. If the study drug was not given during the first 6 h, 
patients received their first postoperative dose at 6 h after surgery. 
12 h after the first postoperative dose, patients started taking oral 
extended-release metoprolol 200 mg or placebo every day for 30 days. If a
 patient’s heart rate was consistently below 45 bpm or their systolic 
blood pressure dropped below 100 mm Hg, study drug was withheld until 
their heart rate or systolic blood pressure recovered; the study drug 
was then restarted at 100 mg once daily. Patients whose heart rate was 
consistently 45-49 bpm and systolic blood pressure exceeded 100 mm Hg 
delayed taking the study drug for 12 h.”<a rel="#ref-100~.ref-cit" id="xref-ref-100-1" class="xref-bibr article-ref-popup-processed" href="#ref-100">100</a></p><p id="p-55">“Patients
 were randomly assigned to receive a custom-made neoprene splint to be 
worn at night or to usual care. The splint was a rigid rest orthosis 
recommended for use only at night. It covered the base of the thumb and 
the thenar eminence but not the wrist (Figure 1). Splints were made by 3
 trained occupational therapists, who adjusted the splint for each 
patient so that the first web could be opened and the thumb placed in 
opposition with the first long finger. Patients were encouraged to 
contact the occupational therapist if they felt that the splint needed 
adjustment, pain increased while wearing the splint, or they had adverse
 effects (such as skin erosion). Because no treatment can be considered 
the gold standard in this situation, patients in the control and 
intervention groups received usual care at the discretion of their 
physician (general practitioner or rheumatologist). We decided not to 
use a placebo because, to our knowledge, no placebo for splinting has 
achieved successful blinding of patients, as recommended.”<a rel="#ref-101~.ref-cit" id="xref-ref-101-1" class="xref-bibr article-ref-popup-processed" href="#ref-101">101</a></p><p id="p-56"><strong>Explanation—</strong>Authors
 should describe each intervention thoroughly, including control 
interventions. The description should allow a clinician wanting to use 
the intervention to know exactly how to administer the intervention that
 was evaluated in the trial.<a rel="#ref-102~.ref-cit" id="xref-ref-102-1" class="xref-bibr article-ref-popup-processed" href="#ref-102">102</a>
 For a drug intervention, information would include the drug name, dose,
 method of administration (such as oral, intravenous), timing and 
duration of administration, conditions under which interventions are 
withheld, and titration regimen if applicable. If the control group is 
to receive “usual care” it is important to describe thoroughly what that
 constitutes. If the control group or intervention group is to receive a
 combination of interventions the authors should provide a thorough 
description of each intervention, an explanation of the order in which 
the combination of interventions are introduced or withdrawn, and the 
triggers for their introduction if applicable.</p><p id="p-57">Specific 
extensions of the CONSORT statement address the reporting of 
non-pharmacologic and herbal interventions and their particular 
reporting requirements (such as expertise, details of how the 
interventions were standardised).<a rel="#ref-43~.ref-cit" id="xref-ref-43-2" class="xref-bibr article-ref-popup-processed" href="#ref-43">43</a> <a rel="#ref-44~.ref-cit" id="xref-ref-44-2" class="xref-bibr article-ref-popup-processed" href="#ref-44">44</a> We recommend readers consult the statements for non-pharmacologic and herbal interventions as appropriate.</p></div><div id="sec-20" class="subsection"><h4>Item 6a. Completely defined pre-specified primary and secondary outcome measures, including how and when they were assessed</h4><p id="p-58"><strong>Example—</strong>“The
 primary endpoint with respect to efficacy in psoriasis was the 
proportion of patients achieving a 75% improvement in psoriasis activity
 from baseline to 12 weeks as measured by the PASI [psoriasis area and 
severity index] Additional analyses were done on the percentage change 
in PASI scores and improvement in target psoriasis lesions.”<a rel="#ref-103~.ref-cit" id="xref-ref-103-1" class="xref-bibr article-ref-popup-processed" href="#ref-103">103</a></p><p id="p-59"><strong>Explanation—</strong>All
 RCTs assess response variables, or outcomes (end points), for which the
 groups are compared. Most trials have several outcomes, some of which 
are of more interest than others. The primary outcome measure is the 
pre-specified outcome considered to be of greatest importance to 
relevant stakeholders (such a patients, policy makers, clinicians, 
funders) and is usually the one used in the sample size calculation (see
 item 7). Some trials may have more than one primary outcome. Having 
several primary outcomes, however, incurs the problems of interpretation
 associated with multiplicity of analyses (see items 18 and 20) and is 
not recommended. Primary outcomes should be explicitly indicated as such
 in the report of an RCT. Other outcomes of interest are secondary 
outcomes (additional outcomes). There may be several secondary outcomes,
 which often include unanticipated or unintended effects of the 
intervention (see item 19), although harms should always be viewed as 
important whether they are labelled primary or secondary.</p><p id="p-60">All
 outcome measures, whether primary or secondary, should be identified 
and completely defined. The principle here is that the information 
provided should be sufficient to allow others to use the same outcomes.<a rel="#ref-102~.ref-cit" id="xref-ref-102-2" class="xref-bibr article-ref-popup-processed" href="#ref-102">102</a>
 When outcomes are assessed at several time points after randomisation, 
authors should also indicate the pre-specified time point of primary 
interest. For many non-pharmacological interventions it is helpful to 
specify who assessed outcomes (for example, if special skills are 
required to do so) and how many assessors there were.<a rel="#ref-43~.ref-cit" id="xref-ref-43-3" class="xref-bibr article-ref-popup-processed" href="#ref-43">43</a></p><p id="p-61">Where
 available and appropriate, the use of previously developed and 
validated scales or consensus guidelines should be reported,<a rel="#ref-104~.ref-cit" id="xref-ref-104-1" class="xref-bibr article-ref-popup-processed" href="#ref-104">104</a> <a rel="#ref-105~.ref-cit" id="xref-ref-105-1" class="xref-bibr article-ref-popup-processed" href="#ref-105">105</a> both to enhance quality of measurement and to assist in comparison with similar studies.<a rel="#ref-106~.ref-cit" id="xref-ref-106-1" class="xref-bibr article-ref-popup-processed" href="#ref-106">106</a> For example, assessment of quality of life is likely to be improved by using a validated instrument.<a rel="#ref-107~.ref-cit" id="xref-ref-107-1" class="xref-bibr article-ref-popup-processed" href="#ref-107">107</a> Authors should indicate the provenance and properties of scales.</p><p id="p-62">More than 70 outcomes were used in 196 RCTs of non-steroidal anti-inflammatory drugs for rheumatoid arthritis,<a rel="#ref-108~.ref-cit" id="xref-ref-108-1" class="xref-bibr article-ref-popup-processed" href="#ref-108">108</a> and 640 different instruments had been used in 2000 trials in schizophrenia, of which 369 had been used only once.<a rel="#ref-33~.ref-cit" id="xref-ref-33-2" class="xref-bibr article-ref-popup-processed" href="#ref-33">33</a>
 Investigation of 149 of those 2000 trials showed that unpublished 
scales were a source of bias. In non-pharmacological trials, a third of 
the claims of treatment superiority based on unpublished scales would 
not have been made if a published scale had been used.<a rel="#ref-109~.ref-cit" id="xref-ref-109-1" class="xref-bibr article-ref-popup-processed" href="#ref-109">109</a> Similar data have been reported elsewhere.<a rel="#ref-110~.ref-cit" id="xref-ref-110-1" class="xref-bibr article-ref-popup-processed" href="#ref-110">110</a> <a rel="#ref-111~.ref-cit" id="xref-ref-111-1" class="xref-bibr article-ref-popup-processed" href="#ref-111">111</a> Only 45% of a cohort of 519 RCTs published in 2000 specified the primary outcome<a rel="#ref-16~.ref-cit" id="xref-ref-16-5" class="xref-bibr article-ref-popup-processed" href="#ref-16">16</a>; this compares with 53% for a similar cohort of 614 RCTs published in 2006.<a rel="#ref-17~.ref-cit" id="xref-ref-17-4" class="xref-bibr article-ref-popup-processed" href="#ref-17">17</a></p></div><div id="sec-21" class="subsection"><h4>Item 6b. Any changes to trial outcomes after the trial commenced, with reasons</h4><p id="p-63"><strong>Example—</strong>“The
 original primary endpoint was all-cause mortality, but, during a masked
 analysis, the data and safety monitoring board noted that overall 
mortality was lower than had been predicted and that the study could not
 be completed with the sample size and power originally planned. The 
steering committee therefore decided to adopt co-primary endpoints of 
all-cause mortality (the original primary endpoint), together with 
all-cause mortality or cardiovascular hospital admissions (the first 
prespecified secondary endpoint).”<a rel="#ref-112~.ref-cit" id="xref-ref-112-1" class="xref-bibr article-ref-popup-processed" href="#ref-112">112</a></p><p id="p-64"><strong>Explanation—</strong>There
 are many reasons for departures from the initial study protocol (see 
item 24). Authors should report all major changes to the protocol, 
including unplanned changes to eligibility criteria, interventions, 
examinations, data collection, methods of analysis, and outcomes. Such 
information is not always reported.</p><p id="p-65">As indicated earlier
 (see item 6a), most trials record multiple outcomes, with the risk that
 results will be reported for only a selected subset (see item 17). 
Pre-specification and reporting of primary and secondary outcomes (see 
item 6a) should remove such a risk. In some trials, however, 
circumstances require a change in the way an outcome is assessed or 
even, as in the example above, a switch to a different outcome. For 
example, there may be external evidence from other trials or systematic 
reviews suggesting the end point might not be appropriate, or 
recruitment or the overall event rate in the trial may be lower than 
expected.<a rel="#ref-112~.ref-cit" id="xref-ref-112-2" class="xref-bibr article-ref-popup-processed" href="#ref-112">112</a>
 Changing an end point based on unblinded data is much more problematic,
 although it may be specified in the context of an adaptive trial 
design.<a rel="#ref-88~.ref-cit" id="xref-ref-88-2" class="xref-bibr article-ref-popup-processed" href="#ref-88">88</a>
 Authors should identify and explain any such changes. Likewise, any 
changes after the trial began of the designation of outcomes as primary 
or secondary should be reported and explained.</p><p id="p-66">A 
comparison of protocols and publications of 102 randomised trials found 
that 62% of trials reports had at least one primary outcome that was 
changed, introduced, or omitted compared with the protocol.<a rel="#ref-55~.ref-cit" id="xref-ref-55-2" class="xref-bibr article-ref-popup-processed" href="#ref-55">55</a>
 Primary outcomes also differed between protocols and publications for 
40% of a cohort of 48 trials funded by the Canadian Institutes of Health
 Research.<a rel="#ref-113~.ref-cit" id="xref-ref-113-1" class="xref-bibr article-ref-popup-processed" href="#ref-113">113</a>
 Not one of the subsequent 150 trial reports mentioned, let alone 
explained, changes from the protocol. Similar results from other studies
 have been reported recently in a systematic review of empirical studies
 examining outcome reporting bias.<a rel="#ref-57~.ref-cit" id="xref-ref-57-3" class="xref-bibr article-ref-popup-processed" href="#ref-57">57</a></p></div><div id="sec-22" class="subsection"><h4>Item 7a. How sample size was determined</h4><p id="p-67"><strong>Examples—</strong>“To
 detect a reduction in PHS (postoperative hospital stay) of 3 days (SD 5
 days), which is in agreement with the study of Lobo et al<sup>17</sup> 
with a two-sided 5% significance level and a power of 80%, a sample size
 of 50 patients per group was necessary, given an anticipated dropout 
rate of 10%. To recruit this number of patients a 12-month inclusion 
period was anticipated.”<a rel="#ref-114~.ref-cit" id="xref-ref-114-1" class="xref-bibr article-ref-popup-processed" href="#ref-114">114</a></p><p id="p-68">“Based
 on an expected incidence of the primary composite endpoint of 11% at 
2.25 years in the placebo group, we calculated that we would need 950 
primary endpoint events and a sample size of 9650 patients to give 90% 
power to detect a significant difference between ivabradine and placebo,
 corresponding to a 19% reduction of relative risk (with a two-sided 
type 1 error of 5%). We initially designed an event-driven trial, and 
planned to stop when 950 primary endpoint events had occurred. However, 
the incidence of the primary endpoint was higher than predicted, perhaps
 because of baseline characteristics of the recruited patients, who had 
higher risk than expected (e.g., lower proportion of NYHA class I and 
higher rates of diabetes and hypertension). We calculated that when 950 
primary endpoint events had occurred, the most recently included 
patients would only have been treated for about 3 months. Therefore, in 
January 2007, the executive committee decided to change the study from 
being event-driven to time-driven, and to continue the study until the 
patients who were randomised last had been followed up for 12 months. 
This change did not alter the planned study duration of 3 years.”<a rel="#ref-115~.ref-cit" id="xref-ref-115-1" class="xref-bibr article-ref-popup-processed" href="#ref-115">115</a></p><p id="p-69"><strong>Explanation—</strong>For
 scientific and ethical reasons, the sample size for a trial needs to be
 planned carefully, with a balance between medical and statistical 
considerations. Ideally, a study should be large enough to have a high 
probability (power) of detecting as statistically significant a 
clinically important difference of a given size if such a difference 
exists. The size of effect deemed important is inversely related to the 
sample size necessary to detect it; that is, large samples are necessary
 to detect small differences. Elements of the sample size calculation 
are (1) the estimated outcomes in each group (which implies the 
clinically important target difference between the intervention groups);
 (2) the α (type I) error level; (3) the statistical power (or the β 
(type II) error level); and (4), for continuous outcomes, the standard 
deviation of the measurements.<a rel="#ref-116~.ref-cit" id="xref-ref-116-1" class="xref-bibr article-ref-popup-processed" href="#ref-116">116</a> The interplay of these elements and their reporting will differ for cluster trials<a rel="#ref-40~.ref-cit" id="xref-ref-40-3" class="xref-bibr article-ref-popup-processed" href="#ref-40">40</a> and non-inferiority and equivalence trials.<a rel="#ref-39~.ref-cit" id="xref-ref-39-3" class="xref-bibr article-ref-popup-processed" href="#ref-39">39</a></p><p id="p-70">Authors
 should indicate how the sample size was determined. If a formal power 
calculation was used, the authors should identify the primary outcome on
 which the calculation was based (see item 6a), all the quantities used 
in the calculation, and the resulting target sample size per study 
group. It is preferable to quote the expected result in the control 
group and the difference between the groups one would not like to 
overlook. Alternatively, authors could present the percentage with the 
event or mean for each group used in their calculations. Details should 
be given of any allowance made for attrition or non-compliance during 
the study.</p><p id="p-71">Some methodologists have written that so 
called underpowered trials may be acceptable because they could 
ultimately be combined in a systematic review and meta-analysis,<a rel="#ref-117~.ref-cit" id="xref-ref-117-1" class="xref-bibr article-ref-popup-processed" href="#ref-117">117</a> <a rel="#ref-118~.ref-cit" id="xref-ref-118-1" class="xref-bibr article-ref-popup-processed" href="#ref-118">118</a> <a rel="#ref-119~.ref-cit" id="xref-ref-119-1" class="xref-bibr article-ref-popup-processed" href="#ref-119">119</a>
 and because some information is better than no information. Of note, 
important caveats apply—such as the trial should be unbiased, reported 
properly, and published irrespective of the results, thereby becoming 
available for meta-analysis.<a rel="#ref-118~.ref-cit" id="xref-ref-118-2" class="xref-bibr article-ref-popup-processed" href="#ref-118">118</a>
 On the other hand, many medical researchers worry that underpowered 
trials with indeterminate results will remain unpublished and insist 
that all trials should individually have “sufficient power.” This debate
 will continue, and members of the CONSORT Group have varying views. 
Critically however, the debate and those views are immaterial to 
reporting a trial. Whatever the power of a trial, authors need to 
properly report their intended size with all their methods and 
assumptions.<a rel="#ref-118~.ref-cit" id="xref-ref-118-3" class="xref-bibr article-ref-popup-processed" href="#ref-118">118</a>
 That transparently reveals the power of the trial to readers and gives 
them a measure by which to assess whether the trial attained its planned
 size.</p><p id="p-72">In some trials, interim analyses are used to help
 decide whether to stop early or to continue recruiting sometimes beyond
 the planned trial end (see item 7b). If the actual sample size differed
 from the originally intended sample size for some other reason (for 
example, because of poor recruitment or revision of the target sample 
size), the explanation should be given.</p><p id="p-73">Reports of 
studies with small samples frequently include the erroneous conclusion 
that the intervention groups do not differ, when in fact too few 
patients were studied to make such a claim.<a rel="#ref-120~.ref-cit" id="xref-ref-120-1" class="xref-bibr article-ref-popup-processed" href="#ref-120">120</a>
 Reviews of published trials have consistently found that a high 
proportion of trials have low power to detect clinically meaningful 
treatment effects.<a rel="#ref-121~.ref-cit" id="xref-ref-121-1" class="xref-bibr article-ref-popup-processed" href="#ref-121">121</a> <a rel="#ref-122~.ref-cit" id="xref-ref-122-1" class="xref-bibr article-ref-popup-processed" href="#ref-122">122</a> <a rel="#ref-123~.ref-cit" id="xref-ref-123-1" class="xref-bibr article-ref-popup-processed" href="#ref-123">123</a>
 In reality, small but clinically meaningful true differences are much 
more likely than large differences to exist, but large trials are 
required to detect them.<a rel="#ref-124~.ref-cit" id="xref-ref-124-1" class="xref-bibr article-ref-popup-processed" href="#ref-124">124</a></p><p id="p-74">In general, the reported sample sizes in trials seem small. The median sample size was 54 patients in 196 trials in arthritis,<a rel="#ref-108~.ref-cit" id="xref-ref-108-2" class="xref-bibr article-ref-popup-processed" href="#ref-108">108</a> 46 patients in 73 trials in dermatology,<a rel="#ref-8~.ref-cit" id="xref-ref-8-2" class="xref-bibr article-ref-popup-processed" href="#ref-8">8</a> and 65 patients in 2000 trials in schizophrenia.<a rel="#ref-33~.ref-cit" id="xref-ref-33-3" class="xref-bibr article-ref-popup-processed" href="#ref-33">33</a> These small sample sizes are consistent with those of a study of 519 trials indexed in PubMed in December 2000<a rel="#ref-16~.ref-cit" id="xref-ref-16-6" class="xref-bibr article-ref-popup-processed" href="#ref-16">16</a> and a similar cohort of trials (n=616) indexed in PubMed in 2006,<a rel="#ref-17~.ref-cit" id="xref-ref-17-5" class="xref-bibr article-ref-popup-processed" href="#ref-17">17</a>
 where the median number of patients recruited for parallel group trials
 was 80 across both years. Moreover, many reviews have found that few 
authors report how they determined the sample size.<a rel="#ref-8~.ref-cit" id="xref-ref-8-3" class="xref-bibr article-ref-popup-processed" href="#ref-8">8</a> <a rel="#ref-14~.ref-cit" id="xref-ref-14-2" class="xref-bibr article-ref-popup-processed" href="#ref-14">14</a> <a rel="#ref-32~.ref-cit" id="xref-ref-32-2" class="xref-bibr article-ref-popup-processed" href="#ref-32">32</a> <a rel="#ref-33~.ref-cit" id="xref-ref-33-4" class="xref-bibr article-ref-popup-processed" href="#ref-33">33</a> <a rel="#ref-123~.ref-cit" id="xref-ref-123-2" class="xref-bibr article-ref-popup-processed" href="#ref-123">123</a></p><p id="p-75">There
 is little merit in a post hoc calculation of statistical power using 
the results of a trial; the power is then appropriately indicated by 
confidence intervals (see item 17).<a rel="#ref-125~.ref-cit" id="xref-ref-125-1" class="xref-bibr article-ref-popup-processed" href="#ref-125">125</a></p></div><div id="sec-23" class="subsection"><h4>Item 7b. When applicable, explanation of any interim analyses and stopping guidelines</h4><p id="p-76"><strong>Examples—</strong>“Two
 interim analyses were performed during the trial. The levels of 
significance maintained an overall P value of 0.05 and were calculated 
according to the O’Brien-Fleming stopping boundaries. This final 
analysis used a Z score of 1.985 with an associated P value of 0.0471.”<a rel="#ref-126~.ref-cit" id="xref-ref-126-1" class="xref-bibr article-ref-popup-processed" href="#ref-126">126</a></p><p id="p-77">“An
 independent data and safety monitoring board periodically reviewed the 
efficacy and safety data. Stopping rules were based on modified 
Haybittle-Peto boundaries of 4 SD in the first half of the study and 3 
SD in the second half for efficacy data, and 3 SD in the first half of 
the study and 2 SD in the second half for safety data. Two formal 
interim analyses of efficacy were performed when 50% and 75% of the 
expected number of primary events had accrued; no correction of the 
reported P value for these interim tests was performed.”<a rel="#ref-127~.ref-cit" id="xref-ref-127-1" class="xref-bibr article-ref-popup-processed" href="#ref-127">127</a></p><p id="p-78"><strong>Explanation—</strong>Many
 trials recruit participants over a long period. If an intervention is 
working particularly well or badly, the study may need to be ended early
 for ethical reasons. This concern can be addressed by examining results
 as the data accumulate, preferably by an independent data monitoring 
committee. However, performing multiple statistical examinations of 
accumulating data without appropriate correction can lead to erroneous 
results and interpretations.<a rel="#ref-128~.ref-cit" id="xref-ref-128-1" class="xref-bibr article-ref-popup-processed" href="#ref-128">128</a>
 If the accumulating data from a trial are examined at five interim 
analyses that use a P value of 0.05, the overall false positive rate is 
nearer to 19% than to the nominal 5%.</p><p id="p-79">Several group sequential statistical methods are available to adjust for multiple analyses,<a rel="#ref-129~.ref-cit" id="xref-ref-129-1" class="xref-bibr article-ref-popup-processed" href="#ref-129">129</a> <a rel="#ref-130~.ref-cit" id="xref-ref-130-1" class="xref-bibr article-ref-popup-processed" href="#ref-130">130</a> <a rel="#ref-131~.ref-cit" id="xref-ref-131-1" class="xref-bibr article-ref-popup-processed" href="#ref-131">131</a>
 and their use should be pre-specified in the trial protocol. With these
 methods, data are compared at each interim analysis, and a P value less
 than the critical value specified by the group sequential method 
indicates statistical significance. Some trialists use group sequential 
methods as an aid to decision making,<a rel="#ref-132~.ref-cit" id="xref-ref-132-1" class="xref-bibr article-ref-popup-processed" href="#ref-132">132</a>
 whereas others treat them as a formal stopping rule (with the intention
 that the trial will cease if the observed P value is smaller than the 
critical value).</p><p id="p-80">Authors should report whether they or a
 data monitoring committee took multiple “looks” at the data and, if so,
 how many there were, what triggered them, the statistical methods used 
(including any formal stopping rule), and whether they were planned 
before the start of the trial, before the data monitoring committee saw 
any interim data by allocation, or some time thereafter. This 
information is often not included in published trial reports,<a rel="#ref-133~.ref-cit" id="xref-ref-133-1" class="xref-bibr article-ref-popup-processed" href="#ref-133">133</a> even in trials that report stopping earlier than planned.<a rel="#ref-134~.ref-cit" id="xref-ref-134-1" class="xref-bibr article-ref-popup-processed" href="#ref-134">134</a></p></div><div id="sec-24" class="subsection"><h4>Item 8a. Method used to generate the random allocation sequence</h4><p id="p-81"><strong>Examples—</strong>“Independent pharmacists dispensed either active or placebo inhalers according to a computer generated randomisation list.”<a rel="#ref-63~.ref-cit" id="xref-ref-63-2" class="xref-bibr article-ref-popup-processed" href="#ref-63">63</a></p><p id="p-82">“For allocation of the participants, a computer-generated list of random numbers was used.”<a rel="#ref-135~.ref-cit" id="xref-ref-135-1" class="xref-bibr article-ref-popup-processed" href="#ref-135">135</a></p><p id="p-83"><strong>Explanation—</strong>Participants
 should be assigned to comparison groups in the trial on the basis of a 
chance (random) process characterised by unpredictability (see box 1). 
Authors should provide sufficient information that the reader can assess
 the methods used to generate the random allocation sequence and the 
likelihood of bias in group assignment. It is important that information
 on the process of randomisation is included in the body of the main 
article and not as a separate supplementary file; where it can be missed
 by the reader.</p><p id="p-84">The term “random” has a precise 
technical meaning. With random allocation, each participant has a known 
probability of receiving each intervention before one is assigned, but 
the assigned intervention is determined by a chance process and cannot 
be predicted. However, “random” is often used inappropriately in the 
literature to describe trials in which non-random, deterministic 
allocation methods were used, such as alternation, hospital numbers, or 
date of birth. When investigators use such non-random methods, they 
should describe them precisely and should not use the term “random” or 
any variation of it. Even the term “quasi-random” is unacceptable for 
describing such trials. Trials based on non-random methods generally 
yield biased results.<a rel="#ref-2~.ref-cit" id="xref-ref-2-5" class="xref-bibr article-ref-popup-processed" href="#ref-2">2</a> <a rel="#ref-3~.ref-cit" id="xref-ref-3-3" class="xref-bibr article-ref-popup-processed" href="#ref-3">3</a> <a rel="#ref-4~.ref-cit" id="xref-ref-4-2" class="xref-bibr article-ref-popup-processed" href="#ref-4">4</a> <a rel="#ref-136~.ref-cit" id="xref-ref-136-1" class="xref-bibr article-ref-popup-processed" href="#ref-136">136</a> Bias presumably arises from the inability to conceal these allocation systems adequately (see item 9).</p><p id="p-85">Many
 methods of sequence generation are adequate. However, readers cannot 
judge adequacy from such terms as “random allocation,” “randomisation,” 
or “random” without further elaboration. Authors should specify the 
method of sequence generation, such as a random-number table or a 
computerised random number generator. The sequence may be generated by 
the process of minimisation, a non-random but generally acceptable 
method (see box 2).</p><div class="style2" id="boxed-text-3"><div id="sec-25" class="subsection"><h4>Box 2: Randomisation and minimisation</h4><ul class="list-simple" id="list-1"><li id="list-item-1"><p id="p-86"><strong>Simple randomisation—</strong>Pure
 randomisation based on a single allocation ratio is known as simple 
randomisation. Simple randomisation with a 1:1 allocation ratio is 
analogous to a coin toss, although we do not advocate coin tossing for 
randomisation in an RCT. “Simple” is somewhat of a misnomer. While other
 randomisation schemes sound complex and more sophisticated, in reality,
 simple randomisation is elegantly sophisticated in that it is more 
unpredictable and surpasses the bias prevention levels of all other 
alternatives.</p></li><li id="list-item-2"><p id="p-87"><strong>Restricted randomisation—</strong>Any
 randomised approach that is not simple randomisation. Blocked 
randomisation is the most common form. Other means of restricted 
randomisation include replacement, biased coin, and urn randomisation, 
although these are used much less frequently.<a rel="#ref-141~.ref-cit" id="xref-ref-141-1" class="xref-bibr article-ref-popup-processed" href="#ref-141">141</a></p></li><li id="list-item-3"><p id="p-88"><strong>Blocked randomisation—</strong>Blocking
 is used to ensure that comparison groups will be generated according to
 a predetermined ratio, usually 1:1 or groups of approximately the same 
size. Blocking can be used to ensure close balance of the numbers in 
each group at any time during the trial. For every block of eight 
participants, for example, four would be allocated to each arm of the 
trial.<a rel="#ref-142~.ref-cit" id="xref-ref-142-1" class="xref-bibr article-ref-popup-processed" href="#ref-142">142</a>
 Improved balance comes at the cost of reducing the unpredictability of 
the sequence. Although the order of interventions varies randomly within
 each block, a person running the trial could deduce some of the next 
treatment allocations if he or she knew the block size.<a rel="#ref-143~.ref-cit" id="xref-ref-143-1" class="xref-bibr article-ref-popup-processed" href="#ref-143">143</a> Blinding the interventions, using larger block sizes, and randomly varying the block size can ameliorate this problem.</p></li><li id="list-item-4"><p id="p-89"><strong>Stratified randomisation—</strong>Stratification
 is used to ensure good balance of participant characteristics in each 
group. By chance, particularly in small trials, study groups may not be 
well matched for baseline characteristics, such as age and stage of 
disease. This weakens the trial’s credibility.<a rel="#ref-144~.ref-cit" id="xref-ref-144-1" class="xref-bibr article-ref-popup-processed" href="#ref-144">144</a>
 Such imbalances can be avoided without sacrificing the advantages of 
randomisation. Stratification ensures that the numbers of participants 
receiving each intervention are closely balanced within each stratum. 
Stratified randomisation is achieved by performing a separate 
randomisation procedure within each of two or more subsets of 
participants (for example, those defining each study centre, age, or 
disease severity). Stratification by centre is common in multicentre 
trials. Stratification requires some form of restriction (such as 
blocking within strata). Stratification without blocking is ineffective.</p></li><li id="list-item-5"><p id="p-90"><strong>Minimisation—</strong>Minimisation ensures balance between intervention groups for several selected patient factors (such as age).<a rel="#ref-22~.ref-cit" id="xref-ref-22-2" class="xref-bibr article-ref-popup-processed" href="#ref-22">22</a> <a rel="#ref-60~.ref-cit" id="xref-ref-60-2" class="xref-bibr article-ref-popup-processed" href="#ref-60">60</a>
 The first patient is truly randomly allocated; for each subsequent 
participant, the treatment allocation that minimises the imbalance on 
the selected factors between groups at that time is identified. That 
allocation may then be used, or a choice may be made at random with a 
heavy weighting in favour of the intervention that would minimise 
imbalance (for example, with a probability of 0.8). The use of a random 
component is generally preferable. Minimisation has the advantage of 
making small groups closely similar in terms of participant 
characteristics at all stages of the trial.  Minimisation offers the 
only acceptable alternative to randomisation, and some have argued that 
it is superior.<a rel="#ref-145~.ref-cit" id="xref-ref-145-1" class="xref-bibr article-ref-popup-processed" href="#ref-145">145</a>
 On the other hand, minimisation lacks the theoretical basis for 
eliminating bias on all known and unknown factors. Nevertheless, in 
general, trials that use minimisation are considered methodologically 
equivalent to randomised trials, even when a random element is not 
incorporated.</p></li></ul></div></div><p id="p-91">In some trials, 
participants are intentionally allocated in unequal numbers to each 
intervention: for example, to gain more experience with a new procedure 
or to limit costs of the trial. In such cases, authors should report the
 randomisation ratio (for example, 2:1 or two treatment participants per
 each control participant) (see item 3a).</p><p id="p-92">In a 
representative sample of PubMed indexed trials in 2000, only 21% 
reported an adequate approach to random sequence generation<a rel="#ref-16~.ref-cit" id="xref-ref-16-7" class="xref-bibr article-ref-popup-processed" href="#ref-16">16</a>; this increased to 34% for a similar cohort of PubMed indexed trials in 2006.<a rel="#ref-17~.ref-cit" id="xref-ref-17-6" class="xref-bibr article-ref-popup-processed" href="#ref-17">17</a> In more than 90% of these cases, researchers used a random number generator on a computer or a random number table.</p></div><div id="sec-26" class="subsection"><h4>Item 8b. Type of randomisation; details of any restriction (such as blocking and block size)</h4><p id="p-93"><strong>Examples—</strong>“Randomization
 sequence was created using Stata 9.0 (StataCorp, College Station, TX) 
statistical software and was stratified by center with a 1:1 allocation 
using random block sizes of 2, 4, and 6.”<a rel="#ref-137~.ref-cit" id="xref-ref-137-1" class="xref-bibr article-ref-popup-processed" href="#ref-137">137</a></p><p id="p-94">“Participants
 were randomly assigned following simple randomization procedures 
(computerized random numbers) to 1 of 2 treatment groups.”<a rel="#ref-138~.ref-cit" id="xref-ref-138-1" class="xref-bibr article-ref-popup-processed" href="#ref-138">138</a></p><p id="p-95"><strong>Explanation—</strong>In
 trials of several hundred participants or more simple randomisation can
 usually be trusted to generate similar numbers in the two trial groups<a rel="#ref-139~.ref-cit" id="xref-ref-139-1" class="xref-bibr article-ref-popup-processed" href="#ref-139">139</a> and to generate groups that are roughly comparable in terms of known and unknown prognostic variables.<a rel="#ref-140~.ref-cit" id="xref-ref-140-1" class="xref-bibr article-ref-popup-processed" href="#ref-140">140</a>
 For smaller trials (see item 7a)—and even for trials that are not 
intended to be small, as they may stop before reaching their target 
size—some restricted randomisation (procedures to help achieve balance 
between groups in size or characteristics) may be useful (see box 2).</p><p id="p-96">It
 is important to indicate whether no restriction was used, by stating 
such or by stating that “simple randomisation” was done. Otherwise, the 
methods used to restrict the randomisation, along with the method used 
for random selection, should be specified. For block randomisation, 
authors should provide details on how the blocks were generated (for 
example, by using a permuted block design with a computer random number 
generator), the block size or sizes, and whether the block size was 
fixed or randomly varied. If the trialists became aware of the block 
size(s), that information should also be reported as such knowledge 
could lead to code breaking. Authors should specify whether 
stratification was used, and if so, which factors were involved (such as
 recruitment site, sex, disease stage), the categorisation cut-off 
values within strata, and the method used for restriction. Although 
stratification is a useful technique, especially for smaller trials, it 
is complicated to implement and may be impossible if many stratifying 
factors are used. If minimisation (see box 2) was used, it should be 
explicitly identified, as should the variables incorporated into the 
scheme. If used, a random element should be indicated.</p><p id="p-97">Only 9% of 206 reports of trials in specialty journals<a rel="#ref-23~.ref-cit" id="xref-ref-23-6" class="xref-bibr article-ref-popup-processed" href="#ref-23">23</a> and 39% of 80 trials in general medical journals reported use of stratification.<a rel="#ref-32~.ref-cit" id="xref-ref-32-3" class="xref-bibr article-ref-popup-processed" href="#ref-32">32</a>
 In each case, only about half of the reports mentioned the use of 
restricted randomisation. However, these studies and that of Adetugbo 
and Williams<a rel="#ref-8~.ref-cit" id="xref-ref-8-4" class="xref-bibr article-ref-popup-processed" href="#ref-8">8</a>
 found that the sizes of the treatment groups in many trials were the 
same or quite similar, yet blocking or stratification had not been 
mentioned. One possible explanation for the close balance in numbers is 
underreporting of the use of restricted randomisation.</p></div><div id="sec-27" class="subsection"><h4>Item
 9. Mechanism used to implement the random allocation sequence (such as 
sequentially numbered containers), describing any steps taken to conceal
 the sequence until interventions were assigned</h4><p id="p-98"><strong>Examples—</strong>“The
 doxycycline and placebo were in capsule form and identical in 
appearance. They were prepacked in bottles and consecutively numbered 
for each woman according to the randomisation schedule. Each woman was 
assigned an order number and received the capsules in the corresponding 
prepacked bottle.”<a rel="#ref-146~.ref-cit" id="xref-ref-146-1" class="xref-bibr article-ref-popup-processed" href="#ref-146">146</a></p><p id="p-99">“The
 allocation sequence was concealed from the researcher (JR) enrolling 
and assessing participants in sequentially numbered, opaque, sealed and 
stapled envelopes. Aluminium foil inside the envelope was used to render
 the envelope impermeable to intense light. To prevent subversion of the
 allocation sequence, the name and date of birth of the participant was 
written on the envelope and a video tape made of the sealed envelope 
with participant details visible. Carbon paper inside the envelope 
transferred the information onto the allocation card inside the envelope
 and a second researcher (CC) later viewed video tapes to ensure 
envelopes were still sealed when participants’ names were written on 
them. Corresponding envelopes were opened only after the enrolled 
participants completed all baseline assessments and it was time to 
allocate the intervention.”<a rel="#ref-147~.ref-cit" id="xref-ref-147-1" class="xref-bibr article-ref-popup-processed" href="#ref-147">147</a></p><p id="p-100"><strong>Explanation—</strong>Item
 8a discussed generation of an unpredictable sequence of assignments. Of
 considerable importance is how this sequence is applied when 
participants are enrolled into the trial (see box 1). A generated 
allocation schedule should be implemented by using allocation 
concealment,<a rel="#ref-23~.ref-cit" id="xref-ref-23-7" class="xref-bibr article-ref-popup-processed" href="#ref-23">23</a>
 a critical mechanism that prevents foreknowledge of treatment 
assignment and thus shields those who enroll participants from being 
influenced by this knowledge. The decision to accept or reject a 
participant should be made, and informed consent should be obtained from
 the participant, in ignorance of the next assignment in the sequence.<a rel="#ref-148~.ref-cit" id="xref-ref-148-1" class="xref-bibr article-ref-popup-processed" href="#ref-148">148</a></p><p id="p-101">The
 allocation concealment should not be confused with blinding (see item 
11). Allocation concealment seeks to prevent selection bias, protects 
the assignment sequence until allocation, and can always be successfully
 implemented.<a rel="#ref-2~.ref-cit" id="xref-ref-2-6" class="xref-bibr article-ref-popup-processed" href="#ref-2">2</a>
 In contrast, blinding seeks to prevent performance and ascertainment 
bias, protects the sequence after allocation, and cannot always be 
implemented.<a rel="#ref-23~.ref-cit" id="xref-ref-23-8" class="xref-bibr article-ref-popup-processed" href="#ref-23">23</a> Without adequate allocation concealment, however, even random, unpredictable assignment sequences can be subverted.<a rel="#ref-2~.ref-cit" id="xref-ref-2-7" class="xref-bibr article-ref-popup-processed" href="#ref-2">2</a> <a rel="#ref-149~.ref-cit" id="xref-ref-149-1" class="xref-bibr article-ref-popup-processed" href="#ref-149">149</a></p><p id="p-102">Centralised
 or “third-party” assignment is especially desirable. Many good 
allocation concealment mechanisms incorporate external involvement. Use 
of a pharmacy or central telephone randomisation system are two common 
techniques. Automated assignment systems are likely to become more 
common.<a rel="#ref-150~.ref-cit" id="xref-ref-150-1" class="xref-bibr article-ref-popup-processed" href="#ref-150">150</a>
 When external involvement is not feasible, an excellent method of 
allocation concealment is the use of numbered containers. The 
interventions (often drugs) are sealed in sequentially numbered 
identical containers according to the allocation sequence.<a rel="#ref-151~.ref-cit" id="xref-ref-151-1" class="xref-bibr article-ref-popup-processed" href="#ref-151">151</a>
 Enclosing assignments in sequentially numbered, opaque, sealed 
envelopes can be a good allocation concealment mechanism if it is 
developed and monitored diligently. This method can be corrupted, 
however, particularly if it is poorly executed. Investigators should 
ensure that the envelopes are opaque when held to the light, and opened 
sequentially and only after the participant’s name and other details are
 written on the appropriate envelope.<a rel="#ref-143~.ref-cit" id="xref-ref-143-2" class="xref-bibr article-ref-popup-processed" href="#ref-143">143</a></p><p id="p-103">A number of methodological studies provide empirical evidence to support these precautions.<a rel="#ref-152~.ref-cit" id="xref-ref-152-1" class="xref-bibr article-ref-popup-processed" href="#ref-152">152</a> <a rel="#ref-153~.ref-cit" id="xref-ref-153-1" class="xref-bibr article-ref-popup-processed" href="#ref-153">153</a>
 Trials in which the allocation sequence had been inadequately or 
unclearly concealed yielded larger estimates of treatment effects than 
did trials in which authors reported adequate allocation concealment. 
These findings provide strong empirical evidence that inadequate 
allocation concealment contributes to bias in estimating treatment 
effects.</p><p id="p-104">Despite the importance of the mechanism of 
allocation concealment, published reports often omit such details. The 
mechanism used to allocate interventions was omitted in reports of 89% 
of trials in rheumatoid arthritis,<a rel="#ref-108~.ref-cit" id="xref-ref-108-3" class="xref-bibr article-ref-popup-processed" href="#ref-108">108</a> 48% of trials in obstetrics and gynaecology journals,<a rel="#ref-23~.ref-cit" id="xref-ref-23-9" class="xref-bibr article-ref-popup-processed" href="#ref-23">23</a> and 44% of trials in general medical journals.<a rel="#ref-32~.ref-cit" id="xref-ref-32-4" class="xref-bibr article-ref-popup-processed" href="#ref-32">32</a>
 In a more broadly representative sample of all randomised trials 
indexed on PubMed, only 18% reported any allocation concealment 
mechanism, but some of those reported mechanisms were inadequate.<a rel="#ref-16~.ref-cit" id="xref-ref-16-8" class="xref-bibr article-ref-popup-processed" href="#ref-16">16</a></p></div><div id="sec-28" class="subsection"><h4>Item 10. Who generated the allocation sequence, who enrolled participants, and who assigned participants to interventions</h4><p id="p-105"><strong>Examples—</strong>“Determination
 of whether a patient would be treated by streptomycin and bed-rest (S 
case) or by bed-rest alone (C case) was made by reference to a 
statistical series based on random sampling numbers drawn up for each 
sex at each centre by Professor Bradford Hill; the details of the series
 were unknown to any of the investigators or to the co-ordinator … After
 acceptance of a patient by the panel, and before admission to the 
streptomycin centre, the appropriate numbered envelope was opened at the
 central office; the card inside told if the patient was to be an S or a
 C case, and this information was then given to the medical officer of 
the centre.”<a rel="#ref-24~.ref-cit" id="xref-ref-24-2" class="xref-bibr article-ref-popup-processed" href="#ref-24">24</a></p><p id="p-106">“Details
 of the allocated group were given on coloured cards contained in 
sequentially numbered, opaque, sealed envelopes. These were prepared at 
the NPEU and kept in an agreed location on each ward. Randomisation took
 place at the end of the 2nd stage of labour when the midwife considered
 a vaginal birth was imminent. To enter a women into the study, the 
midwife opened the next consecutively numbered envelope.”<a rel="#ref-154~.ref-cit" id="xref-ref-154-1" class="xref-bibr article-ref-popup-processed" href="#ref-154">154</a></p><p id="p-107">“Block
 randomisation was by a computer generated random number list prepared 
by an investigator with no clinical involvement in the trial. We 
stratified by admission for an oncology related procedure. After the 
research nurse had obtained the patient’s consent, she telephoned a 
contact who was independent of the recruitment process for allocation 
consignment.”<a rel="#ref-155~.ref-cit" id="xref-ref-155-1" class="xref-bibr article-ref-popup-processed" href="#ref-155">155</a></p><p id="p-108"><strong>Explanation—</strong>As
 noted in item 9, concealment of the allocated intervention at the time 
of enrolment is especially important. Thus, in addition to knowing the 
methods used, it is also important to understand how the random sequence
 was implemented—specifically, who generated the allocation sequence, 
who enrolled participants, and who assigned participants to trial 
groups.</p><p id="p-109">The process of randomising participants into a 
trial has three different steps: sequence generation, allocation 
concealment, and implementation (see box 3). Although the same people 
may carry out more than one process under each heading, investigators 
should strive for complete separation of the people involved with 
generation and allocation concealment from the people involved in the 
implementation of assignments. Thus, if someone is involved in the 
sequence generation or allocation concealment steps, ideally they should
 not be involved in the implementation step.</p><div class="style2" id="boxed-text-4"><div id="sec-29" class="subsection"><h4>Box 3: Steps in a typical randomisation process </h4><div id="sec-30" class="subsection"><h5>Sequence generation</h5><ul class="list-unord" id="list-2"><li id="list-item-6"><p id="p-110">Generate allocation sequence by some random procedure</p></li></ul></div><div id="sec-31" class="subsection"><h5>Allocation concealment</h5><ul class="list-unord" id="list-3"><li id="list-item-7"><p id="p-111">Develop
 allocation concealment mechanism (such as numbered, identical bottles 
or sequentially numbered, sealed, opaque envelopes)</p></li><li id="list-item-8"><p id="p-112">Prepare the allocation concealment mechanism using the allocation sequence from the sequence generation step</p></li></ul></div><div id="sec-32" class="subsection"><h5>Implementation</h5><ul class="list-unord" id="list-4"><li id="list-item-9"><p id="p-113">Enrol participants:</p><ul class="list-simple" id="list-5"><li id="list-item-10"><p id="p-114">Assess eligibility</p></li><li id="list-item-11"><p id="p-115">Discuss the trial</p></li><li id="list-item-12"><p id="p-116">Obtain informed consent</p></li><li id="list-item-13"><p id="p-117">Enrol participant in trial</p></li></ul></li><li id="list-item-14"><p id="p-118">Ascertain intervention assignment (such as opening next envelope)</p></li><li id="list-item-15"><p id="p-119">Administer intervention</p></li></ul></div></div></div><p id="p-120">Even
 with flawless sequence generation and allocation concealment, failure 
to separate creation and concealment of the allocation sequence from 
assignment to study group may introduce bias. For example, the person 
who generated an allocation sequence could retain a copy and consult it 
when interviewing potential participants for a trial. Thus, that person 
could bias the enrolment or assignment process, regardless of the 
unpredictability of the assignment sequence. Investigators must then 
ensure that the assignment schedule is unpredictable and locked away 
(such as in a safe deposit box in a building rather inaccessible to the 
enrolment location) from even the person who generated it. The report of
 the trial should specify where the investigators stored the allocation 
list.</p></div><div id="sec-33" class="subsection"><h4>Item 11a. If 
done, who was blinded after assignment to interventions (for example, 
participants, care providers, those assessing outcomes) and how</h4><p id="p-121"><strong>Examples—</strong>“Whereas
 patients and physicians allocated to the intervention group were aware 
of the allocated arm, outcome assessors and data analysts were kept 
blinded to the allocation.”<a rel="#ref-156~.ref-cit" id="xref-ref-156-1" class="xref-bibr article-ref-popup-processed" href="#ref-156">156</a></p><p id="p-122">“Blinding
 and equipoise were strictly maintained by emphasising to intervention 
staff and participants that each diet adheres to healthy principles, and
 each is advocated by certain experts to be superior for long-term 
weight-loss. Except for the interventionists (dieticians and behavioural
 psychologists), investigators and staff were kept blind to diet 
assignment of the participants. The trial adhered to established 
procedures to maintain separation between staff that take outcome 
measurements and staff that deliver the intervention. Staff members who 
obtained outcome measurements were not informed of the diet group 
assignment. Intervention staff, dieticians and behavioural psychologists
 who delivered the intervention did not take outcome measurements. All 
investigators, staff, and participants were kept masked to outcome 
measurements and trial results.”<a rel="#ref-157~.ref-cit" id="xref-ref-157-1" class="xref-bibr article-ref-popup-processed" href="#ref-157">157</a></p><p id="p-123"><strong>Explanation—</strong>The
 term “blinding” or “masking” refers to withholding information about 
the assigned interventions from people involved in the trial who may 
potentially be influenced by this knowledge. Blinding is an important 
safeguard against bias, particularly when assessing subjective outcomes.<a rel="#ref-153~.ref-cit" id="xref-ref-153-2" class="xref-bibr article-ref-popup-processed" href="#ref-153">153</a></p><p id="p-124">Benjamin Franklin has been credited as being the first to use blinding in a scientific experiment.<a rel="#ref-158~.ref-cit" id="xref-ref-158-1" class="xref-bibr article-ref-popup-processed" href="#ref-158">158</a>
 He blindfolded participants so they would not know when he was applying
 mesmerism (a popular “healing fluid” of the 18th century) and in so 
doing showed that mesmerism was a sham. Based on this experiment, the 
scientific community recognised the power of blinding to reduce bias, 
and it has remained a commonly used strategy in scientific experiments.</p><p id="p-125">Box
 4, on blinding terminology, defines the groups of individuals (that is,
 participants, healthcare providers, data collectors, outcome 
adjudicators, and data analysts) who can potentially introduce bias into
 a trial through knowledge of the treatment assignments. Participants 
may respond differently if they are aware of their treatment assignment 
(such as responding more favourably when they receive the new 
treatment).<a rel="#ref-153~.ref-cit" id="xref-ref-153-3" class="xref-bibr article-ref-popup-processed" href="#ref-153">153</a>
 Lack of blinding may also influence compliance with the intervention, 
use of co-interventions, and risk of dropping out of the trial.</p><p id="p-126">Unblinded
 healthcare providers may introduce similar biases, and unblinded data 
collectors may differentially assess outcomes (such as frequency or 
timing), repeat measurements of abnormal findings, or provide 
encouragement during performance testing. Unblinded outcome adjudicators
 may differentially assess subjective outcomes, and unblinded data 
analysts may introduce bias through the choice of analytical strategies,
 such as the selection of favourable time points or outcomes, and by 
decisions to remove patients from the analyses. These biases have been 
well documented.<a rel="#ref-71~.ref-cit" id="xref-ref-71-2" class="xref-bibr article-ref-popup-processed" href="#ref-71">71</a> <a rel="#ref-153~.ref-cit" id="xref-ref-153-4" class="xref-bibr article-ref-popup-processed" href="#ref-153">153</a> <a rel="#ref-159~.ref-cit" id="xref-ref-159-1" class="xref-bibr article-ref-popup-processed" href="#ref-159">159</a> <a rel="#ref-160~.ref-cit" id="xref-ref-160-1" class="xref-bibr article-ref-popup-processed" href="#ref-160">160</a> <a rel="#ref-161~.ref-cit" id="xref-ref-161-1" class="xref-bibr article-ref-popup-processed" href="#ref-161">161</a> <a rel="#ref-162~.ref-cit" id="xref-ref-162-1" class="xref-bibr article-ref-popup-processed" href="#ref-162">162</a></p><p id="p-127">Blinding,
 unlike allocation concealment (see item 10), may not always be 
appropriate or possible. An example is a trial comparing levels of pain 
associated with sampling blood from the ear or thumb.<a rel="#ref-163~.ref-cit" id="xref-ref-163-1" class="xref-bibr article-ref-popup-processed" href="#ref-163">163</a>
 Blinding is particularly important when outcome measures involve some 
subjectivity, such as assessment of pain. Blinding of data collectors 
and outcome adjudicators is unlikely to matter for objective outcomes, 
such as death from any cause. Even then, however, lack of participant or
 healthcare provider blinding can lead to other problems, such as 
differential attrition.<a rel="#ref-164~.ref-cit" id="xref-ref-164-1" class="xref-bibr article-ref-popup-processed" href="#ref-164">164</a>
 In certain trials, especially surgical trials, blinding of participants
 and surgeons is often difficult or impossible, but blinding of data 
collectors and outcome adjudicators is often achievable. For example, 
lesions can be photographed before and after treatment and assessed by 
an external observer.<a rel="#ref-165~.ref-cit" id="xref-ref-165-1" class="xref-bibr article-ref-popup-processed" href="#ref-165">165</a>
 Regardless of whether blinding is possible, authors can and should 
always state who was blinded (that is, participants, healthcare 
providers, data collectors, and outcome adjudicators).</p><p id="p-128">Unfortunately, authors often do not report whether blinding was used.<a rel="#ref-166~.ref-cit" id="xref-ref-166-1" class="xref-bibr article-ref-popup-processed" href="#ref-166">166</a> For example, reports of 51% of 506 trials in cystic fibrosis,<a rel="#ref-167~.ref-cit" id="xref-ref-167-1" class="xref-bibr article-ref-popup-processed" href="#ref-167">167</a> 33% of 196 trials in rheumatoid arthritis,<a rel="#ref-108~.ref-cit" id="xref-ref-108-4" class="xref-bibr article-ref-popup-processed" href="#ref-108">108</a> and 38% of 68 trials in dermatology<a rel="#ref-8~.ref-cit" id="xref-ref-8-5" class="xref-bibr article-ref-popup-processed" href="#ref-8">8</a>
 did not state whether blinding was used. Until authors of trials 
improve their reporting of blinding, readers will have difficulty in 
judging the validity of the trials that they may wish to use to guide 
their clinical practice.</p><p id="p-129">The term masking is sometimes 
used in preference to blinding to avoid confusion with the medical 
condition of being without sight. However, “blinding” in its 
methodological sense seems to be understood worldwide and is acceptable 
for reporting clinical trials.<a rel="#ref-165~.ref-cit" id="xref-ref-165-2" class="xref-bibr article-ref-popup-processed" href="#ref-165">165</a> <a rel="#ref-168~.ref-cit" id="xref-ref-168-1" class="xref-bibr article-ref-popup-processed" href="#ref-168">168</a></p><div class="style2" id="boxed-text-5"><div id="sec-34" class="subsection"><h4>Box 4: Blinding terminology</h4><p id="p-130">In
 order for a technical term to have utility it must have consistency in 
its use and interpretation. Authors of trials commonly use the term 
“double blind” and, less commonly, the terms “single blind”or “triple 
blind.” A problem with this lexicon is that there is great variability 
in clinician interpretations and epidemiological textbook definitions of
 these terms.<a rel="#ref-169~.ref-cit" id="xref-ref-169-1" class="xref-bibr article-ref-popup-processed" href="#ref-169">169</a>
 Moreover, a study of 200 RCTs reported as double blind found 18 
different combinations of groups actually blinded when the authors of 
these trials were surveyed, and about one in every five of these 
trials—reported as double blind—did not blind participants, healthcare 
providers, or data collectors.<a rel="#ref-170~.ref-cit" id="xref-ref-170-1" class="xref-bibr article-ref-popup-processed" href="#ref-170">170</a></p><p id="p-131">This
 research shows that terms are ambiguous and, as such, authors and 
editors should abandon their use. Authors should instead explicitly 
report the blinding status of the people involved for whom blinding may 
influence the validity of a trial.</p><p id="p-132">Healthcare providers
 include all personnel (for example, physicians, chiropractors, 
physiotherapists, nurses) who care for the participants during the 
trial. Data collectors are the individuals who collect data on the trial
 outcomes. Outcome adjudicators are the individuals who determine 
whether a participant did experience the outcomes of interest.</p><p id="p-133">Some
 researchers have also advocated blinding and reporting the blinding 
status of the data monitoring committee and the manuscript writers.<a rel="#ref-160~.ref-cit" id="xref-ref-160-2" class="xref-bibr article-ref-popup-processed" href="#ref-160">160</a> Blinding of these groups is uncommon, and the value of blinding them is debated.<a rel="#ref-171~.ref-cit" id="xref-ref-171-1" class="xref-bibr article-ref-popup-processed" href="#ref-171">171</a></p><p id="p-134">Sometimes
 one group of individuals (such as the healthcare providers) are the 
same individuals fulfilling another role in a trial (such as data 
collectors). Even if this is the case, the authors should explicitly 
state the blinding status of these groups to allow readers to judge the 
validity of the trial.</p></div></div></div><div id="sec-35" class="subsection"><h4>Item 11b. If relevant, description of the similarity of interventions</h4><p id="p-135"><strong>Example—</strong>“Jamieson
 Laboratories Inc provided 500-mg immediate release niacin in a white, 
oblong, bisect caplet. We independently confirmed caplet content using 
high performance liquid chromatography … The placebo was matched to the 
study drug for taste, color, and size, and contained microcrystalline 
cellulose, silicon dioxide, dicalcium phosphate, magnesium stearate, and
 stearic acid.”<a rel="#ref-172~.ref-cit" id="xref-ref-172-1" class="xref-bibr article-ref-popup-processed" href="#ref-172">172</a></p><p id="p-136"><strong>Explanation—</strong>Just
 as we seek evidence of concealment to assure us that assignment was 
truly random, we seek evidence of the method of blinding. In trials with
 blinding of participants or healthcare providers, authors should state 
the similarity of the characteristics of the interventions (such as 
appearance, taste, smell, and method of administration).<a rel="#ref-35~.ref-cit" id="xref-ref-35-2" class="xref-bibr article-ref-popup-processed" href="#ref-35">35</a> <a rel="#ref-173~.ref-cit" id="xref-ref-173-1" class="xref-bibr article-ref-popup-processed" href="#ref-173">173</a></p><p id="p-137">Some
 people have advocated testing for blinding by asking participants or 
healthcare providers at the end of a trial whether they think the 
participant received the experimental or control intervention.<a rel="#ref-174~.ref-cit" id="xref-ref-174-1" class="xref-bibr article-ref-popup-processed" href="#ref-174">174</a>
 Because participants and healthcare providers will usually know whether
 the participant has experienced the primary outcome, this makes it 
difficult to determine if their responses reflect failure of blinding or
 accurate assumptions about the efficacy of the intervention.<a rel="#ref-175~.ref-cit" id="xref-ref-175-1" class="xref-bibr article-ref-popup-processed" href="#ref-175">175</a>
 Given the uncertainty this type of information provides, we have 
removed advocating reporting this type of testing for blinding from the 
CONSORT 2010 Statement. We do, however, advocate that the authors report
 any known compromises in blinding. For example, authors should report 
if it was necessary to unblind any participants at any point during the 
conduct of a trial.</p></div><div id="sec-36" class="subsection"><h4>Item 12a. Statistical methods used to compare groups for primary and secondary outcomes</h4><p id="p-138"><strong>Example—</strong>“The
 primary endpoint was change in bodyweight during the 20 weeks of the 
study in the intention-to-treat population … Secondary efficacy 
endpoints included change in waist circumference, systolic and diastolic
 blood pressure, prevalence of metabolic syndrome … We used an analysis 
of covariance (ANCOVA) for the primary endpoint and for secondary 
endpoints waist circumference, blood pressure, and patient-reported 
outcome scores; this was supplemented by a repeated measures analysis. 
The ANCOVA model included treatment, country, and sex as fixed effects, 
and bodyweight at randomisation as covariate. We aimed to assess whether
 data provided evidence of superiority of each liraglutide dose to 
placebo (primary objective) and to orlistat (secondary objective).”<a rel="#ref-176~.ref-cit" id="xref-ref-176-1" class="xref-bibr article-ref-popup-processed" href="#ref-176">176</a></p><p id="p-139"><strong>Explanation—</strong>Data
 can be analysed in many ways, some of which may not be strictly 
appropriate in a particular situation. It is essential to specify which 
statistical procedure was used for each analysis, and further 
clarification may be necessary in the results section of the report. The
 principle to follow is to, “Describe statistical methods with enough 
detail to enable a knowledgeable reader with access to the original data
 to verify the reported results” (<a href="http://www.icmje.org/">www.icmje.org</a>). It is also important to describe details of the statistical analysis such as intention-to-treat analysis (see box 6).</p><p id="p-140">Almost
 all methods of analysis yield an estimate of the treatment effect, 
which is a contrast between the outcomes in the comparison groups. 
Authors should accompany this by a confidence interval for the estimated
 effect, which indicates a central range of uncertainty for the true 
treatment effect. The confidence interval may be interpreted as the 
range of values for the treatment effect that is compatible with the 
observed data. It is customary to present a 95% confidence interval, 
which gives the range expected to include the true value in 95 of 100 
similar studies.</p><p id="p-141">Study findings can also be assessed in
 terms of their statistical significance. The P value represents the 
probability that the observed data (or a more extreme result) could have
 arisen by chance when the interventions did not truly differ. Actual P 
values (for example, P=0.003) are strongly preferable to imprecise 
threshold reports such as P&lt;0.05.<a rel="#ref-48~.ref-cit" id="xref-ref-48-2" class="xref-bibr article-ref-popup-processed" href="#ref-48">48</a> <a rel="#ref-177~.ref-cit" id="xref-ref-177-1" class="xref-bibr article-ref-popup-processed" href="#ref-177">177</a></p><p id="p-142">Standard
 methods of analysis assume that the data are “independent.” For 
controlled trials, this usually means that there is one observation per 
participant. Treating multiple observations from one participant as 
independent data is a serious error; such data are produced when 
outcomes can be measured on different parts of the body, as in dentistry
 or rheumatology. Data analysis should be based on counting each 
participant once<a rel="#ref-178~.ref-cit" id="xref-ref-178-1" class="xref-bibr article-ref-popup-processed" href="#ref-178">178</a> <a rel="#ref-179~.ref-cit" id="xref-ref-179-1" class="xref-bibr article-ref-popup-processed" href="#ref-179">179</a> or should be done by using more complex statistical procedures.<a rel="#ref-180~.ref-cit" id="xref-ref-180-1" class="xref-bibr article-ref-popup-processed" href="#ref-180">180</a> Incorrect analysis of multiple observations per individual was seen in 123 (63%) of 196 trials in rheumatoid arthritis.<a rel="#ref-108~.ref-cit" id="xref-ref-108-5" class="xref-bibr article-ref-popup-processed" href="#ref-108">108</a></p></div><div id="sec-37" class="subsection"><h4>Item 12b. Methods for additional analyses, such as subgroup analyses and adjusted analyses</h4><p id="p-143"><strong>Examples—</strong>“Proportions of patients responding were compared between treatment groups with the Mantel-Haenszel χ<sup>2</sup> test, adjusted for the stratification variable, methotrexate use.”<a rel="#ref-103~.ref-cit" id="xref-ref-103-2" class="xref-bibr article-ref-popup-processed" href="#ref-103">103</a></p><p id="p-144">“Pre-specified
 subgroup analyses according to antioxidant treatment assignment(s), 
presence or absence of prior CVD, dietary folic acid intake, smoking, 
diabetes, aspirin, hormone therapy, and multivitamin use were performed 
using stratified Cox proportional hazards models. These analyses used 
baseline exposure assessments and were restricted to participants with 
nonmissing subgroup data at baseline.”<a rel="#ref-181~.ref-cit" id="xref-ref-181-1" class="xref-bibr article-ref-popup-processed" href="#ref-181">181</a></p><p id="p-145"><strong>Explanation—</strong>As
 is the case for primary analyses, the method of subgroup analysis 
should be clearly specified. The strongest analyses are those that look 
for evidence of a difference in treatment effect in complementary 
subgroups (for example, older and younger participants), a comparison 
known as a test of interaction.<a rel="#ref-182~.ref-cit" id="xref-ref-182-1" class="xref-bibr article-ref-popup-processed" href="#ref-182">182</a> <a rel="#ref-183~.ref-cit" id="xref-ref-183-1" class="xref-bibr article-ref-popup-processed" href="#ref-183">183</a>
 A common but misleading approach is to compare P values for separate 
analyses of the treatment effect in each group. It is incorrect to infer
 a subgroup effect (interaction) from one significant and one 
non-significant P value.<a rel="#ref-184~.ref-cit" id="xref-ref-184-1" class="xref-bibr article-ref-popup-processed" href="#ref-184">184</a> Such inferences have a high false positive rate.</p><p id="p-146">Because of the high risk for spurious findings, subgroup analyses are often discouraged.<a rel="#ref-14~.ref-cit" id="xref-ref-14-3" class="xref-bibr article-ref-popup-processed" href="#ref-14">14</a> <a rel="#ref-185~.ref-cit" id="xref-ref-185-1" class="xref-bibr article-ref-popup-processed" href="#ref-185">185</a>
 Post hoc subgroup comparisons (analyses done after looking at the data)
 are especially likely not to be confirmed by further studies. Such 
analyses do not have great credibility.</p><p id="p-147">In some 
studies, imbalances in participant characteristics are adjusted for by 
using some form of multiple regression analysis. Although the need for 
adjustment is much less in RCTs than in epidemiological studies, an 
adjusted analysis may be sensible, especially if one or more variables 
is thought to be prognostic.<a rel="#ref-186~.ref-cit" id="xref-ref-186-1" class="xref-bibr article-ref-popup-processed" href="#ref-186">186</a>
 Ideally, adjusted analyses should be specified in the study protocol 
(see item 24). For example, adjustment is often recommended for any 
stratification variables (see item 8b) on the principle that the 
analysis strategy should follow the design. In RCTs, the decision to 
adjust should not be determined by whether baseline differences are 
statistically significant (see item 16).<a rel="#ref-183~.ref-cit" id="xref-ref-183-2" class="xref-bibr article-ref-popup-processed" href="#ref-183">183</a> <a rel="#ref-187~.ref-cit" id="xref-ref-187-1" class="xref-bibr article-ref-popup-processed" href="#ref-187">187</a> The rationale for any adjusted analyses and the statistical methods used should be specified.</p><p id="p-148">Authors
 should clarify the choice of variables that were adjusted for, indicate
 how continuous variables were handled, and specify whether the analysis
 was planned or suggested by the data.<a rel="#ref-188~.ref-cit" id="xref-ref-188-1" class="xref-bibr article-ref-popup-processed" href="#ref-188">188</a> Reviews of published studies show that reporting of adjusted analyses is inadequate with regard to all of these aspects.<a rel="#ref-188~.ref-cit" id="xref-ref-188-2" class="xref-bibr article-ref-popup-processed" href="#ref-188">188</a> <a rel="#ref-189~.ref-cit" id="xref-ref-189-1" class="xref-bibr article-ref-popup-processed" href="#ref-189">189</a> <a rel="#ref-190~.ref-cit" id="xref-ref-190-1" class="xref-bibr article-ref-popup-processed" href="#ref-190">190</a> <a rel="#ref-191~.ref-cit" id="xref-ref-191-1" class="xref-bibr article-ref-popup-processed" href="#ref-191">191</a></p></div></div><div id="sec-38" class="subsection"><h3>Results</h3><div id="sec-39" class="subsection"><h4>Item 13. Participant flow (a diagram is strongly recommended) </h4></div><div id="sec-40" class="subsection"><h4>Item
 13a. For each group, the numbers of participants who were randomly 
assigned, received intended treatment, and were analysed for the primary
 outcome</h4><p id="p-149"><strong>Examples—</strong>See figs 2<a id="xref-fig-2-1" class="xref-down-link" href="#F2"><span>⇓</span></a> and 3<a id="xref-fig-3-1" class="xref-down-link" href="#F3"><span>⇓</span></a>.</p><div id="F2" class="fig pos-float odd"><div class="fig-inline"><div class="highwire-figure colorbox"><div class="fig-inline-img-wrapper"><div class="fig-inline-img"><a href="http://www.bmj.com/content/bmj/340/bmj.c869/F2.large.jpg?width=800&amp;height=600" title="Fig 2 Flow diagram of a multicentre trial of fractional flow reserve versus angiography for guiding percutaneous coronary intervention (PCI) (adapted from Tonino et al313). The diagram includes detailed information on the excluded participants." class="colorbox fragment-images colorbox-load init-colorbox-processed cboxElement" rel="gallery-fragment-images" data-figure-caption="&amp;lt;div class=&amp;quot;fig-caption&amp;quot; xmlns:xhtml=&amp;quot;http://www.w3.org/1999/xhtml&amp;quot;&amp;gt;&amp;lt;p id=&amp;quot;p-150&amp;quot; class=&amp;quot;first-child&amp;quot;&amp;gt;&amp;lt;strong&amp;gt;Fig 2&amp;lt;/strong&amp;gt; Flow diagram of a multicentre trial of fractional flow reserve versus angiography for guiding percutaneous coronary intervention (PCI) (adapted from Tonino et al&amp;lt;a id=&amp;quot;xref-ref-313-1&amp;quot; class=&amp;quot;xref-bibr&amp;quot; href=&amp;quot;#ref-313&amp;quot;&amp;gt;313&amp;lt;/a&amp;gt;). The diagram includes detailed information on the excluded participants.&amp;lt;/p&amp;gt;&amp;lt;div class=&amp;quot;sb-div caption-clear&amp;quot;&amp;gt;&amp;lt;/div&amp;gt;&amp;lt;/div&amp;gt;"><img title="" data-original-title="" class="fragment-image" src="CONSORT%202010%20Explanation%20and%20Elaboration_%20updated%20guidelines%20for%20reporting%20parallel%20group%20randomised%20trials%20%7C%20The%20BMJ_files/F2.gif" alt="Figure2"></a></div></div><div class="fig-caption"><p id="p-150" class="first-child"><strong>Fig 2</strong> 
Flow diagram of a multicentre trial of fractional flow reserve versus 
angiography for guiding percutaneous coronary intervention (PCI) 
(adapted from Tonino et al<a rel="#ref-313~.ref-cit" id="xref-ref-313-1" class="xref-bibr article-ref-popup-processed" href="#ref-313">313</a>). The diagram includes detailed information on the excluded participants.</p><div class="sb-div caption-clear"></div></div><ul class="highwire-figure-links list-inline"><li class="0 first"><a href="http://www.bmj.com/content/bmj/340/bmj.c869/F2.large.jpg?download=true" class="highwire-figure-link highwire-figure-link-download" title="Download Figure2">Download figure</a></li>
<li class="1"><a href="http://www.bmj.com/content/bmj/340/bmj.c869/F2.large.jpg" class="highwire-figure-link highwire-figure-link-newtab" target="_blank">Open in new tab</a></li>
<li class="2 last"><a href="http://www.bmj.com/highwire/powerpoint/591540" class="highwire-figure-link highwire-figure-link-ppt">Download powerpoint</a></li>
</ul></div></div><div></div></div><div id="F3" class="fig pos-float odd"><div class="fig-inline"><div class="highwire-figure colorbox"><div class="fig-inline-img-wrapper"><div class="fig-inline-img"><a href="http://www.bmj.com/content/bmj/340/bmj.c869/F3.large.jpg?width=800&amp;height=600" title="Fig 3 Flow diagram of minimal surgery compared with medical management for chronic gastro-oesophageal reflux disease (adapted from Grant et al196). The diagram shows a multicentre trial with a parallel non-randomised preference group." class="colorbox fragment-images colorbox-load init-colorbox-processed cboxElement" rel="gallery-fragment-images" data-figure-caption="&amp;lt;div class=&amp;quot;fig-caption&amp;quot; xmlns:xhtml=&amp;quot;http://www.w3.org/1999/xhtml&amp;quot;&amp;gt;&amp;lt;p id=&amp;quot;p-151&amp;quot; class=&amp;quot;first-child&amp;quot;&amp;gt;&amp;lt;strong&amp;gt;Fig 3&amp;lt;/strong&amp;gt; Flow diagram of minimal surgery compared with medical management for chronic gastro-oesophageal reflux disease (adapted from Grant et al&amp;lt;a id=&amp;quot;xref-ref-196-1&amp;quot; class=&amp;quot;xref-bibr&amp;quot; href=&amp;quot;#ref-196&amp;quot;&amp;gt;196&amp;lt;/a&amp;gt;). The diagram shows a multicentre trial with a parallel non-randomised preference group. &amp;lt;/p&amp;gt;&amp;lt;div class=&amp;quot;sb-div caption-clear&amp;quot;&amp;gt;&amp;lt;/div&amp;gt;&amp;lt;/div&amp;gt;"><img title="" data-original-title="" class="fragment-image" src="CONSORT%202010%20Explanation%20and%20Elaboration_%20updated%20guidelines%20for%20reporting%20parallel%20group%20randomised%20trials%20%7C%20The%20BMJ_files/F3.gif" alt="Figure3"></a></div></div><div class="fig-caption"><p id="p-151" class="first-child"><strong>Fig 3</strong> 
Flow diagram of minimal surgery compared with medical management for 
chronic gastro-oesophageal reflux disease (adapted from Grant et al<a rel="#ref-196~.ref-cit" id="xref-ref-196-1" class="xref-bibr article-ref-popup-processed" href="#ref-196">196</a>). The diagram shows a multicentre trial with a parallel non-randomised preference group. </p><div class="sb-div caption-clear"></div></div><ul class="highwire-figure-links list-inline"><li class="0 first"><a href="http://www.bmj.com/content/bmj/340/bmj.c869/F3.large.jpg?download=true" class="highwire-figure-link highwire-figure-link-download" title="Download Figure3">Download figure</a></li>
<li class="1"><a href="http://www.bmj.com/content/bmj/340/bmj.c869/F3.large.jpg" class="highwire-figure-link highwire-figure-link-newtab" target="_blank">Open in new tab</a></li>
<li class="2 last"><a href="http://www.bmj.com/highwire/powerpoint/591547" class="highwire-figure-link highwire-figure-link-ppt">Download powerpoint</a></li>
</ul></div></div><div></div></div><p id="p-152"><strong>Explanation—</strong>The
 design and conduct of some RCTs is straightforward, and the flow of 
participants, particularly were there are no losses to follow-up or 
exclusions, through each phase of the study can be described adequately 
in a few sentences. In more complex studies, it may be difficult for 
readers to discern whether and why some participants did not receive the
 treatment as allocated, were lost to follow-up, or were excluded from 
the analysis.<a rel="#ref-51~.ref-cit" id="xref-ref-51-2" class="xref-bibr article-ref-popup-processed" href="#ref-51">51</a>
 This information is crucial for several reasons. Participants who were 
excluded after allocation are unlikely to be representative of all 
participants in the study. For example, patients may not be available 
for follow-up evaluation because they experienced an acute exacerbation 
of their illness or harms of treatment.<a rel="#ref-22~.ref-cit" id="xref-ref-22-3" class="xref-bibr article-ref-popup-processed" href="#ref-22">22</a> <a rel="#ref-192~.ref-cit" id="xref-ref-192-1" class="xref-bibr article-ref-popup-processed" href="#ref-192">192</a></p><p id="p-153">Attrition
 as a result of loss to follow up, which is often unavoidable, needs to 
be distinguished from investigator-determined exclusion for such reasons
 as ineligibility, withdrawal from treatment, and poor adherence to the 
trial protocol. Erroneous conclusions can be reached if participants are
 excluded from analysis, and imbalances in such omissions between groups
 may be especially indicative of bias.<a rel="#ref-192~.ref-cit" id="xref-ref-192-2" class="xref-bibr article-ref-popup-processed" href="#ref-192">192</a> <a rel="#ref-193~.ref-cit" id="xref-ref-193-1" class="xref-bibr article-ref-popup-processed" href="#ref-193">193</a> <a rel="#ref-194~.ref-cit" id="xref-ref-194-1" class="xref-bibr article-ref-popup-processed" href="#ref-194">194</a>
 Information about whether the investigators included in the analysis 
all participants who underwent randomisation, in the groups to which 
they were originally allocated (intention-to-treat analysis (see item 16
 and box 6)), is therefore of particular importance. Knowing the number 
of participants who did not receive the intervention as allocated or did
 not complete treatment permits the reader to assess to what extent the 
estimated efficacy of therapy might be underestimated in comparison with
 ideal circumstances.</p><p id="p-154">If available, the number of 
people assessed for eligibility should also be reported. Although this 
number is relevant to external validity only and is arguably less 
important than the other counts,<a rel="#ref-195~.ref-cit" id="xref-ref-195-1" class="xref-bibr article-ref-popup-processed" href="#ref-195">195</a> it is a useful indicator of whether trial participants were likely to be representative of all eligible participants.</p><p id="p-155">A
 review of RCTs published in five leading general and internal medicine 
journals in 1998 found that reporting of the flow of participants was 
often incomplete, particularly with regard to the number of participants
 receiving the allocated intervention and the number lost to follow-up.<a rel="#ref-51~.ref-cit" id="xref-ref-51-3" class="xref-bibr article-ref-popup-processed" href="#ref-51">51</a>
 Even information as basic as the number of participants who underwent 
randomisation and the number excluded from analyses was not available in
 up to 20% of articles.<a rel="#ref-51~.ref-cit" id="xref-ref-51-4" class="xref-bibr article-ref-popup-processed" href="#ref-51">51</a>
 Reporting was considerably more thorough in articles that included a 
diagram of the flow of participants through a trial, as recommended by 
CONSORT. This study informed the design of the revised flow diagram in 
the revised CONSORT statement.<a rel="#ref-52~.ref-cit" id="xref-ref-52-4" class="xref-bibr article-ref-popup-processed" href="#ref-52">52</a> <a rel="#ref-53~.ref-cit" id="xref-ref-53-4" class="xref-bibr article-ref-popup-processed" href="#ref-53">53</a> <a rel="#ref-54~.ref-cit" id="xref-ref-54-4" class="xref-bibr article-ref-popup-processed" href="#ref-54">54</a> The suggested template is shown in fig 1<a id="xref-fig-1-2" class="xref-up-link" href="#F1"><span>⇑</span></a>, and the counts required are described in detail in table 3<a id="xref-table-wrap-3-1" class="xref-down-link" href="#T3"><span>⇓</span></a>.</p><div class="table pos-float" id="T3"><div class="table"><div class="table-caption"><span class="table-label">Table 3</span> <p id="p-156" class="first-child"> Information required to document the flow of participants through each stage of a randomised trial </p><div class="sb-div caption-clear"></div></div><div class="table-inline"><div class="callout"><span>View this table:</span><ul class="callout-links"><li><a href="http://www.bmj.com/highwire/markup/591561/expansion?width=1000&amp;height=500&amp;iframe=true&amp;postprocessors=highwire_figures%2Chighwire_math" class="colorbox colorbox-load table-expand-popup init-colorbox-processed cboxElement" rel="gallery-fragment-tables">View popup</a></li><li><a href="##" class="table-expand-inline highwireTablesMarkupProcessor-processed" data-table-url="/highwire/markup/591561/expansion?postprocessors=highwire_figures%2Chighwire_math">View inline</a></li></ul></div></div></div><div></div></div><p id="p-157">Some information, such as the number of individuals assessed for eligibility, may not always be known,<a rel="#ref-14~.ref-cit" id="xref-ref-14-4" class="xref-bibr article-ref-popup-processed" href="#ref-14">14</a>
 and, depending on the nature of a trial, some counts may be more 
relevant than others. It will sometimes be useful or necessary to adapt 
the structure of the flow diagram to a particular trial. In some 
situations, other information may usefully be added. For example, the 
flow diagram of a parallel group trial of minimal surgery compared with 
medical management for chronic gastro-oesophageal reflux also included a
 parallel non-randomised preference group (see fig 3).<a rel="#ref-196~.ref-cit" id="xref-ref-196-2" class="xref-bibr article-ref-popup-processed" href="#ref-196">196</a> </p><p id="p-158">The
 exact form and content of the flow diagram may be varied according to 
specific features of a trial. For example, many trials of surgery or 
vaccination do not include the possibility of discontinuation. Although 
CONSORT strongly recommends using this graphical device to communicate 
participant flow throughout the study, there is no specific, prescribed 
format.</p></div><div id="sec-41" class="subsection"><h4>Item 13b. For each group, losses and exclusions after randomisation, together with reasons</h4><p id="p-159"><strong>Examples—</strong>“There
 was only one protocol deviation, in a woman in the study group. She had
 an abnormal pelvic measurement and was scheduled for elective caesarean
 section. However, the attending obstetrician judged a trial of labour 
acceptable; caesarean section was done when there was no progress in the
 first stage of labour.”<a rel="#ref-197~.ref-cit" id="xref-ref-197-1" class="xref-bibr article-ref-popup-processed" href="#ref-197">197</a></p><p id="p-160">“The
 monitoring led to withdrawal of nine centres, in which existence of 
some patients could not be proved, or other serious violations of good 
clinical practice had occurred.”<a rel="#ref-198~.ref-cit" id="xref-ref-198-1" class="xref-bibr article-ref-popup-processed" href="#ref-198">198</a></p><p id="p-161"><strong>Explanation—</strong>Some
 protocol deviations may be reported in the flow diagram (see item 
13a)—for example, participants who did not receive the intended 
intervention. If participants were excluded after randomisation 
(contrary to the intention-to-treat principle) because they were found 
not to meet eligibility criteria (see item 16), they should be included 
in the flow diagram. Use of the term “protocol deviation” in published 
articles is not sufficient to justify exclusion of participants after 
randomisation. The nature of the protocol deviation and the exact reason
 for excluding participants after randomisation should always be 
reported.</p></div><div id="sec-42" class="subsection"><h4>Item 14a. Dates defining the periods of recruitment and follow-up</h4><p id="p-162"><strong>Example—</strong>“Age-eligible
 participants were recruited … from February 1993 to September 1994 … 
Participants attended clinic visits at the time of randomisation 
(baseline) and at 6-month intervals for 3 years.”<a rel="#ref-199~.ref-cit" id="xref-ref-199-1" class="xref-bibr article-ref-popup-processed" href="#ref-199">199</a></p><p id="p-163"><strong>Explanation—</strong>Knowing
 when a study took place and over what period participants were 
recruited places the study in historical context. Medical and surgical 
therapies, including concurrent therapies, evolve continuously and may 
affect the routine care given to participants during a trial. Knowing 
the rate at which participants were recruited may also be useful, 
especially to other investigators.</p><p id="p-164">The length of 
follow-up is not always a fixed period after randomisation. In many RCTs
 in which the outcome is time to an event, follow-up of all participants
 is ended on a specific date. This date should be given, and it is also 
useful to report the minimum, maximum, and median duration of follow-up.<a rel="#ref-200~.ref-cit" id="xref-ref-200-1" class="xref-bibr article-ref-popup-processed" href="#ref-200">200</a> <a rel="#ref-201~.ref-cit" id="xref-ref-201-1" class="xref-bibr article-ref-popup-processed" href="#ref-201">201</a></p><p id="p-165">A review of reports in oncology journals that used survival analysis, most of which were not RCTs, <a rel="#ref-201~.ref-cit" id="xref-ref-201-2" class="xref-bibr article-ref-popup-processed" href="#ref-201">201</a>
 found that nearly 80% (104 of 132 reports) included the starting and 
ending dates for accrual of patients, but only 24% (32 of 132 reports) 
also reported the date on which follow-up ended.</p></div><div id="sec-43" class="subsection"><h4>Item 14b. Why the trial ended or was stopped</h4><p id="p-166"><strong>Examples—</strong>“At
 the time of the interim analysis, the total follow-up included an 
estimated 63% of the total number of patient-years that would have been 
collected at the end of the study, leading to a threshold value of 
0.0095, as determined by the Lan-DeMets alpha-spending function method …
 At the interim analysis, the RR was 0.37 in the intervention group, as 
compared with the control group, with a p value of 0.00073, below the 
threshold value. The Data and Safety Monitoring Board advised the 
investigators to interrupt the trial and offer circumcision to the 
control group, who were then asked to come to the investigation centre, 
where MC (medical circumcision) was advised and proposed … Because the 
study was interrupted, some participants did not have a full follow-up 
on that date, and their visits that were not yet completed are described
 as “planned” in this article.”<a rel="#ref-202~.ref-cit" id="xref-ref-202-1" class="xref-bibr article-ref-popup-processed" href="#ref-202">202</a></p><p id="p-167">“In
 January 2000, problems with vaccine supply necessitated the temporary 
nationwide replacement of the whole cell component of the combined 
DPT/Hib vaccine with acellular pertussis vaccine. As this vaccine has a 
different local reactogenicity profile, we decided to stop the trial 
early.”<a rel="#ref-203~.ref-cit" id="xref-ref-203-1" class="xref-bibr article-ref-popup-processed" href="#ref-203">203</a></p><p id="p-168"><strong>Explanation—</strong>Arguably,
 trialists who arbitrarily conduct unplanned interim analyses after very
 few events accrue using no statistical guidelines run a high risk of 
“catching” the data at a random extreme, which likely represents a large
 overestimate of treatment benefit.<a rel="#ref-204~.ref-cit" id="xref-ref-204-1" class="xref-bibr article-ref-popup-processed" href="#ref-204">204</a></p><p id="p-169">Readers
 will likely draw weaker inferences from a trial that was truncated in a
 data-driven manner versus one that reports its findings after reaching a
 goal independent of results. Thus, RCTs should indicate why the trial 
came to an end (see box 5). The report should also disclose factors 
extrinsic to the trial that affected the decision to stop the trial, and
 who made the decision to stop the trial, including reporting the role 
the funding agency played in the deliberations and in the decision to 
stop the trial.<a rel="#ref-134~.ref-cit" id="xref-ref-134-2" class="xref-bibr article-ref-popup-processed" href="#ref-134">134</a></p><p id="p-170">A
 systematic review of 143 RCTs stopped earlier than planned for benefit 
found that these trials reported stopping after accruing a median of 66 
events, estimated a median relative risk of 0.47 and a strong relation 
between the number of events accrued and the size of the effect, with 
smaller trials with fewer events yielding the largest treatment effects 
(odds ratio 31, 95% conﬁdence interval 12 to 82).<a rel="#ref-134~.ref-cit" id="xref-ref-134-3" class="xref-bibr article-ref-popup-processed" href="#ref-134">134</a>
 While an increasing number of trials published in high impact medical 
journals report stopping early, only 0.1% of trials reported stopping 
early for benefit, which contrasts with estimates arising from 
simulation studies<a rel="#ref-205~.ref-cit" id="xref-ref-205-1" class="xref-bibr article-ref-popup-processed" href="#ref-205">205</a> and surveys of data safety and monitoring committees.<a rel="#ref-206~.ref-cit" id="xref-ref-206-1" class="xref-bibr article-ref-popup-processed" href="#ref-206">206</a>
 Thus, many trials accruing few participants and reporting large 
treatment effects may have been stopped earlier than planned but failed 
to report this action.</p><div class="style2" id="boxed-text-6"><div id="sec-44" class="subsection"><h4>Box 5: Early stopping</h4><p id="p-171">RCTs
 can end when they reach their sample size goal, their event count goal,
 their length of follow-up goal, or when they reach their scheduled date
 of closure. In these situations the trial will stop in a manner 
independent of its results, and stopping is unlikely to introduce bias 
in the results. Alternatively, RCTs can stop earlier than planned 
because of the result of an interim analysis showing larger than 
expected benefit or harm on the experimental intervention. Also RCTs can
 stop earlier than planned when investigators find evidence of no 
important difference between experimental and control interventions 
(that is, stopping for futility). In addition, trials may stop early 
because the trial becomes unviable: funding vanishes, researchers cannot
 access eligible patients or study interventions, or the results of 
other studies make the research question irrelevant.</p><p id="p-172">Full
 reporting of why a trial ended is important for evidence based decision
 making (see item 14b). Researchers examining why 143 trials stopped 
early for benefit found that many failed to report key methodological 
information regarding how the decision to stop was reached—the planned 
sample size (n=28), interim analysis after which the trial was stopped 
(n=45), or whether a stopping rule informed the decision (n=48).<a rel="#ref-134~.ref-cit" id="xref-ref-134-4" class="xref-bibr article-ref-popup-processed" href="#ref-134">134</a>
 Item 7b of the checklist requires the reporting of timing of interim 
analyses, what triggered them, how many took place, whether these were 
planned or ad hoc, and whether there were statistical guidelines and 
stopping rules in place a priori. Furthermore, it is helpful to know 
whether an independent data monitoring committee participated in the 
analyses (and who composed it, with particular attention to the role of 
the funding source) and who made the decision to stop. Often the data 
safety and monitoring committee makes recommendations and the funders 
(sponsors) or the investigators make the decision to stop.</p><p id="p-173">Trials
 that stop early for reasons apparently independent of trial findings, 
and trials that reach their planned termination, are unlikely to 
introduce bias by stopping.<a rel="#ref-207~.ref-cit" id="xref-ref-207-1" class="xref-bibr article-ref-popup-processed" href="#ref-207">207</a>
 In these cases, the authors should report whether interim analyses took
 place and whether these results were available to the funder.</p><p id="p-174">The
 push for trials that change the intervention in response to interim 
results, thus enabling a faster evaluation of promising interventions 
for rapidly evolving and fatal conditions, will require even more 
careful reporting of the process and decision to stop trials early.<a rel="#ref-208~.ref-cit" id="xref-ref-208-1" class="xref-bibr article-ref-popup-processed" href="#ref-208">208</a></p></div></div></div><div id="sec-45" class="subsection"><h4>Item 15. A table showing baseline demographic and clinical characteristics for each group</h4><p id="p-175"><strong>Example—</strong>See table 4<a id="xref-table-wrap-4-1" class="xref-down-link" href="#T4"><span>⇓</span></a></p><div class="table pos-float" id="T4"><div class="table"><div class="table-caption"><span class="table-label">Table 4</span> <p id="p-176" class="first-child"> Example of reporting baseline demographic and clinical characteristics.* (Adapted from table 1 of Yusuf et al<sup>209</sup>)</p><div class="sb-div caption-clear"></div></div><div class="table-inline"><div class="callout"><span>View this table:</span><ul class="callout-links"><li><a href="http://www.bmj.com/highwire/markup/591567/expansion?width=1000&amp;height=500&amp;iframe=true&amp;postprocessors=highwire_figures%2Chighwire_math" class="colorbox colorbox-load table-expand-popup init-colorbox-processed cboxElement" rel="gallery-fragment-tables">View popup</a></li><li><a href="##" class="table-expand-inline highwireTablesMarkupProcessor-processed" data-table-url="/highwire/markup/591567/expansion?postprocessors=highwire_figures%2Chighwire_math">View inline</a></li></ul></div></div></div><div></div></div><p id="p-178"><strong>Explanation—</strong>Although
 the eligibility criteria (see item 4a) indicate who was eligible for 
the trial, it is also important to know the characteristics of the 
participants who were actually included. This information allows 
readers, especially clinicians, to judge how relevant the results of a 
trial might be to an individual patient.</p><p id="p-179">Randomised 
trials aim to compare groups of participants that differ only with 
respect to the intervention (treatment). Although proper random 
assignment prevents selection bias, it does not guarantee that the 
groups are equivalent at baseline. Any differences in baseline 
characteristics are, however, the result of chance rather than bias.<a rel="#ref-32~.ref-cit" id="xref-ref-32-5" class="xref-bibr article-ref-popup-processed" href="#ref-32">32</a>
 The study groups should be compared at baseline for important 
demographic and clinical characteristics so that readers can assess how 
similar they were. Baseline data are especially valuable for outcomes 
that can also be measured at the start of the trial (such as blood 
pressure).</p><p id="p-180">Baseline information is most efficiently presented in a table (see table 4<a id="xref-table-wrap-4-2" class="xref-up-link" href="#T4"><span>⇑</span></a>).
 For continuous variables, such as weight or blood pressure, the 
variability of the data should be reported, along with average values. 
Continuous variables can be summarised for each group by the mean and 
standard deviation. When continuous data have an asymmetrical 
distribution, a preferable approach may be to quote the median and a 
centile range (such as the 25th and 75th centiles).<a rel="#ref-177~.ref-cit" id="xref-ref-177-2" class="xref-bibr article-ref-popup-processed" href="#ref-177">177</a>
 Standard errors and confidence intervals are not appropriate for 
describing variability—they are inferential rather than descriptive 
statistics. Variables with a small number of ordered categories (such as
 stages of disease I to IV) should not be treated as continuous 
variables; instead, numbers and proportions should be reported for each 
category.<a rel="#ref-48~.ref-cit" id="xref-ref-48-3" class="xref-bibr article-ref-popup-processed" href="#ref-48">48</a> <a rel="#ref-177~.ref-cit" id="xref-ref-177-3" class="xref-bibr article-ref-popup-processed" href="#ref-177">177</a></p><p id="p-181">Unfortunately significance tests of baseline differences are still common<a rel="#ref-23~.ref-cit" id="xref-ref-23-10" class="xref-bibr article-ref-popup-processed" href="#ref-23">23</a> <a rel="#ref-32~.ref-cit" id="xref-ref-32-6" class="xref-bibr article-ref-popup-processed" href="#ref-32">32</a> <a rel="#ref-210~.ref-cit" id="xref-ref-210-1" class="xref-bibr article-ref-popup-processed" href="#ref-210">210</a>; they were reported in half of 50 RCTs trials published in leading general journals in 1997.<a rel="#ref-183~.ref-cit" id="xref-ref-183-3" class="xref-bibr article-ref-popup-processed" href="#ref-183">183</a>
 Such significance tests assess the probability that observed baseline 
differences could have occurred by chance; however, we already know that
 any differences are caused by chance. Tests of baseline differences are
 not necessarily wrong, just illogical.<a rel="#ref-211~.ref-cit" id="xref-ref-211-1" class="xref-bibr article-ref-popup-processed" href="#ref-211">211</a>
 Such hypothesis testing is superfluous and can mislead investigators 
and their readers. Rather, comparisons at baseline should be based on 
consideration of the prognostic strength of the variables measured and 
the size of any chance imbalances that have occurred.<a rel="#ref-211~.ref-cit" id="xref-ref-211-2" class="xref-bibr article-ref-popup-processed" href="#ref-211">211</a></p></div><div id="sec-46" class="subsection"><h4>Item
 16. For each group, number of participants (denominator) included in 
each analysis and whether the analysis was by original assigned groups</h4><p id="p-182"><strong>Examples—</strong>“The primary analysis was intention-to-treat and involved all patients who were randomly assigned.”<a rel="#ref-212~.ref-cit" id="xref-ref-212-1" class="xref-bibr article-ref-popup-processed" href="#ref-212">212</a></p><p id="p-183">“One
 patient in the alendronate group was lost to follow up; thus data from 
31 patients were available for the intention-to-treat analysis. Five 
patients were considered protocol violators … consequently 26 patients 
remained for the per-protocol analyses.”<a rel="#ref-213~.ref-cit" id="xref-ref-213-1" class="xref-bibr article-ref-popup-processed" href="#ref-213">213</a></p><p id="p-184"><strong>Explanation—</strong>The
 number of participants in each group is an essential element of the 
analyses. Although the flow diagram (see item 13a) may indicate the 
numbers of participants analysed, these numbers often vary for different
 outcome measures. The number of participants per group should be given 
for all analyses. For binary outcomes, (such as risk ratio and risk 
difference) the denominators or event rates should also be reported. 
Expressing results as fractions also aids the reader in assessing 
whether some of the randomly assigned participants were excluded from 
the analysis. It follows that results should not be presented solely as 
summary measures, such as relative risks.</p><p id="p-185">Participants 
may sometimes not receive the full intervention, or some ineligible 
patients may have been randomly allocated in error. One widely 
recommended way to handle such issues is to analyse all participants 
according to their original group assignment, regardless of what 
subsequently occurred (see box 6). This “intention-to-treat” strategy is
 not always straightforward to implement. It is common for some patients
 not to complete a study—they may drop out or be withdrawn from active 
treatment—and thus are not assessed at the end. If the outcome is 
mortality, such patients may be included in the analysis based on 
register information, whereas imputation techniques may need to be used 
if other outcome data are missing. The term “intention-to-treat 
analysis” is often inappropriately used—for example, when those who did 
not receive the first dose of a trial drug are excluded from the 
analyses.<a rel="#ref-18~.ref-cit" id="xref-ref-18-2" class="xref-bibr article-ref-popup-processed" href="#ref-18">18</a></p><p id="p-186">Conversely,
 analysis can be restricted to only participants who fulfil the protocol
 in terms of eligibility, interventions, and outcome assessment. This 
analysis is known as an “on-treatment” or “per protocol” analysis. 
Excluding participants from the analysis can lead to erroneous 
conclusions. For example, in a trial that compared medical with surgical
 therapy for carotid stenosis, analysis limited to participants who were
 available for follow-up showed that surgery reduced the risk for 
transient ischaemic attack, stroke, and death. However, 
intention-to-treat analysis based on all participants as originally 
assigned did not show a superior effect of surgery.<a rel="#ref-214~.ref-cit" id="xref-ref-214-1" class="xref-bibr article-ref-popup-processed" href="#ref-214">214</a></p><p id="p-187">Intention-to-treat analysis is generally favoured because it avoids bias associated with non-random loss of participants.<a rel="#ref-215~.ref-cit" id="xref-ref-215-1" class="xref-bibr article-ref-popup-processed" href="#ref-215">215</a> <a rel="#ref-216~.ref-cit" id="xref-ref-216-1" class="xref-bibr article-ref-popup-processed" href="#ref-216">216</a> <a rel="#ref-217~.ref-cit" id="xref-ref-217-1" class="xref-bibr article-ref-popup-processed" href="#ref-217">217</a>
 Regardless of whether authors use the term “intention-to-treat,” they 
should make clear which and how many participants are included in each 
analysis (see item 13). Non-compliance with assigned therapy may mean 
that the intention-to-treat analysis underestimates the potential 
benefit of the treatment, and additional analyses, such as a per 
protocol analysis, may therefore be considered.<a rel="#ref-218~.ref-cit" id="xref-ref-218-1" class="xref-bibr article-ref-popup-processed" href="#ref-218">218</a> <a rel="#ref-219~.ref-cit" id="xref-ref-219-1" class="xref-bibr article-ref-popup-processed" href="#ref-219">219</a> It should be noted, however, that such analyses are often considerably flawed.<a rel="#ref-220~.ref-cit" id="xref-ref-220-1" class="xref-bibr article-ref-popup-processed" href="#ref-220">220</a></p><p id="p-188">In
 a review of 403 RCTs published in 10 leading medical journals in 2002, 
249 (62%) reported the use of intention-to-treat analysis for their 
primary analysis. This proportion was higher for journals adhering to 
the CONSORT statement (70% <em>v</em> 48%). Among articles that reported
 the use of intention-to-treat analysis, only 39% actually analysed all 
participants as randomised, with more than 60% of articles having 
missing data in their primary analysis.<a rel="#ref-221~.ref-cit" id="xref-ref-221-1" class="xref-bibr article-ref-popup-processed" href="#ref-221">221</a> Other studies show similar findings.<a rel="#ref-18~.ref-cit" id="xref-ref-18-3" class="xref-bibr article-ref-popup-processed" href="#ref-18">18</a> <a rel="#ref-222~.ref-cit" id="xref-ref-222-1" class="xref-bibr article-ref-popup-processed" href="#ref-222">222</a> <a rel="#ref-223~.ref-cit" id="xref-ref-223-1" class="xref-bibr article-ref-popup-processed" href="#ref-223">223</a>
 Trials with no reported exclusions are methodologically weaker in other
 respects than those that report on some excluded participants,<a rel="#ref-173~.ref-cit" id="xref-ref-173-2" class="xref-bibr article-ref-popup-processed" href="#ref-173">173</a>
 strongly indicating that at least some researchers who have excluded 
participants do not report it. Another study found that reporting an 
intention-to-treat analysis was associated with other aspects of good 
study design and reporting, such as describing a sample size 
calculation.<a rel="#ref-224~.ref-cit" id="xref-ref-224-1" class="xref-bibr article-ref-popup-processed" href="#ref-224">224</a></p><div class="style2" id="boxed-text-7"><div id="sec-47" class="subsection"><h4>Box 6: Intention-to-treat analysis</h4><p id="p-189">The
 special strength of the RCT is the avoidance of bias when allocating 
interventions to trial participants (see box 1). That strength allows 
strong inferences about cause and effect that are not justified with 
other study designs. In order to preserve fully the huge benefit of 
randomisation we should include all randomised participants in the 
analysis, all retained in the group to which they were allocated. Those 
two conditions define an “intention-to-treat” analysis, which is widely 
recommended as the preferred analysis strategy.<a rel="#ref-18~.ref-cit" id="xref-ref-18-4" class="xref-bibr article-ref-popup-processed" href="#ref-18">18</a> <a rel="#ref-223~.ref-cit" id="xref-ref-223-2" class="xref-bibr article-ref-popup-processed" href="#ref-223">223</a>
 Intention-to-treat analysis corresponds to analysing the groups exactly
 as randomised. Strict intention-to-treat analysis is often hard to 
achieve for two main reasons—missing outcomes for some participants and 
non-adherence to the trial protocol.</p><div id="sec-48" class="subsection"><h5>Missing outcomes</h5><p id="p-190">Many
 trialists exclude patients without an observed outcome. Often this is 
reasonable, but once any randomised participants are excluded the 
analysis is not strictly an intention-to-treat analysis. Indeed, most 
randomised trials have some missing observations. Trialists effectively 
must choose between omitting the participants without final outcome data
 or imputing their missing outcome data.<a rel="#ref-225~.ref-cit" id="xref-ref-225-1" class="xref-bibr article-ref-popup-processed" href="#ref-225">225</a>
 A “complete case” (or “available case”) analysis includes only those 
whose outcome is known. While a few missing outcomes will not cause a 
problem, in half of trials more than 10% of randomised patients may have
 missing outcomes.<a rel="#ref-226~.ref-cit" id="xref-ref-226-1" class="xref-bibr article-ref-popup-processed" href="#ref-226">226</a>
 This common approach will lose power by reducing the sample size, and 
bias may well be introduced if being lost to follow-up is related to a 
patient’s response to treatment. There should be concern when the 
frequency or the causes of dropping out differ between the intervention 
groups.</p><p id="p-191">Participants with missing outcomes can be 
included in the analysis only if their outcomes are imputed (that is, 
their outcomes are estimated from other information that was collected).
 Imputation of the missing data allows the analysis to conform to 
intention-to-treat analysis but requires strong assumptions, which may 
be hard to justify.<a rel="#ref-227~.ref-cit" id="xref-ref-227-1" class="xref-bibr article-ref-popup-processed" href="#ref-227">227</a>
 Simple imputation methods are appealing, but their use may be 
inadvisable. In particular, a widely used method is “last observation 
carried forward” in which missing final values of the outcome variable 
are replaced by the last known value before the participant was lost to 
follow up. This is appealing through its simplicity, but the method may 
introduce bias,<a rel="#ref-228~.ref-cit" id="xref-ref-228-1" class="xref-bibr article-ref-popup-processed" href="#ref-228">228</a> and no allowance is made for the uncertainty of imputation.<a rel="#ref-229~.ref-cit" id="xref-ref-229-1" class="xref-bibr article-ref-popup-processed" href="#ref-229">229</a> Many authors have severely criticised last observation carried forward.<a rel="#ref-229~.ref-cit" id="xref-ref-229-2" class="xref-bibr article-ref-popup-processed" href="#ref-229">229</a> <a rel="#ref-230~.ref-cit" id="xref-ref-230-1" class="xref-bibr article-ref-popup-processed" href="#ref-230">230</a> <a rel="#ref-231~.ref-cit" id="xref-ref-231-1" class="xref-bibr article-ref-popup-processed" href="#ref-231">231</a></p></div><div id="sec-49" class="subsection"><h5>Non-adherence to the protocol</h5><p id="p-192">A
 separate issue is that the trial protocol may not have been followed 
fully for some trial participants. Common examples are participants who 
did not meet the inclusion criteria (such as wrong diagnosis, too 
young), received a proscribed co-intervention, did not take all the 
intended treatment, or received a different treatment or no 
intervention. The simple way to deal with any protocol deviations is to 
ignore them: all participants can be included in the analysis regardless
 of adherence to the protocol, and this is the intention-to-treat 
approach. Thus, exclusion of any participants for such reasons is 
incompatible with intention-to-treat analysis.</p><p id="p-193">The term
 “modified intention-to-treat” is quite widely used to describe an 
analysis that excludes participants who did not adequately adhere to the
 protocol, in particular those who did not receive a defined minimum 
amount of the intervention.<a rel="#ref-232~.ref-cit" id="xref-ref-232-1" class="xref-bibr article-ref-popup-processed" href="#ref-232">232</a>
 An alternative term is “per protocol.” Though a per protocol analysis 
may be appropriate in some settings, it should be properly labelled as a
 non-randomised, observational comparison. Any exclusion of patients 
from the analysis compromises the randomisation and may lead to bias in 
the results.</p><p id="p-194">Like “intention-to-treat,” none of these 
other labels reliably clarifies exactly which patients were included. 
Thus, in the CONSORT checklist we have dropped the specific request for 
intention-to-treat analysis in favour of a clear description of exactly 
who was included in each analysis.</p></div></div></div></div><div id="sec-50" class="subsection"><h4>Item
 17a. For each primary and secondary outcome, results for each group, 
and the estimated effect size and its precision (such as 95% confidence 
interval)</h4><p id="p-195"><strong>Examples—</strong>See tables 5<a id="xref-table-wrap-5-1" class="xref-down-link" href="#T5"><span>⇓</span></a> and 6<a id="xref-table-wrap-6-1" class="xref-down-link" href="#T6"><span>⇓</span></a>.</p><div class="table pos-float" id="T5"><div class="table"><div class="table-caption"><span class="table-label">Table 5</span> <p id="p-196" class="first-child"> Example of reporting of summary results for each study group (binary outcomes).* (Adapted from table 2 of Mease et al<sup>103</sup>)</p><div class="sb-div caption-clear"></div></div><div class="table-inline"><div class="callout"><span>View this table:</span><ul class="callout-links"><li><a href="http://www.bmj.com/highwire/markup/591574/expansion?width=1000&amp;height=500&amp;iframe=true&amp;postprocessors=highwire_figures%2Chighwire_math" class="colorbox colorbox-load table-expand-popup init-colorbox-processed cboxElement" rel="gallery-fragment-tables">View popup</a></li><li><a href="##" class="table-expand-inline highwireTablesMarkupProcessor-processed" data-table-url="/highwire/markup/591574/expansion?postprocessors=highwire_figures%2Chighwire_math">View inline</a></li></ul></div></div></div><div></div></div><div class="table pos-float" id="T6"><div class="table"><div class="table-caption"><span class="table-label">Table 6</span> <p id="p-199" class="first-child"> Example of reporting of summary results for each study group (continuous outcomes). (Adapted from table 3 of van Linschoten<sup>234</sup>)</p><div class="sb-div caption-clear"></div></div><div class="table-inline"><div class="callout"><span>View this table:</span><ul class="callout-links"><li><a href="http://www.bmj.com/highwire/markup/591579/expansion?width=1000&amp;height=500&amp;iframe=true&amp;postprocessors=highwire_figures%2Chighwire_math" class="colorbox colorbox-load table-expand-popup init-colorbox-processed cboxElement" rel="gallery-fragment-tables">View popup</a></li><li><a href="##" class="table-expand-inline highwireTablesMarkupProcessor-processed" data-table-url="/highwire/markup/591579/expansion?postprocessors=highwire_figures%2Chighwire_math">View inline</a></li></ul></div></div></div><div></div></div><p id="p-201"><strong>Explanation—</strong>For
 each outcome, study results should be reported as a summary of the 
outcome in each group (for example, the number of participants with or 
without the event and the denominators, or the mean and standard 
deviation of measurements), together with the contrast between the 
groups, known as the effect size. For binary outcomes, the effect size 
could be the risk ratio (relative risk), odds ratio, or risk difference;
 for survival time data, it could be the hazard ratio or difference in 
median survival time; and for continuous data, it is usually the 
difference in means. Confidence intervals should be presented for the 
contrast between groups. A common error is the presentation of separate 
confidence intervals for the outcome in each group rather than for the 
treatment effect.<a rel="#ref-233~.ref-cit" id="xref-ref-233-1" class="xref-bibr article-ref-popup-processed" href="#ref-233">233</a> Trial results are often more clearly displayed in a table rather than in the text, as shown in tables 5<a id="xref-table-wrap-5-2" class="xref-up-link" href="#T5"><span>⇑</span></a> and 6<a id="xref-table-wrap-6-2" class="xref-up-link" href="#T6"><span>⇑</span></a>.</p><p id="p-202">For all outcomes, authors should provide a confidence interval to indicate the precision (uncertainty) of the estimate.<a rel="#ref-48~.ref-cit" id="xref-ref-48-4" class="xref-bibr article-ref-popup-processed" href="#ref-48">48</a> <a rel="#ref-235~.ref-cit" id="xref-ref-235-1" class="xref-bibr article-ref-popup-processed" href="#ref-235">235</a>
 A 95% confidence interval is conventional, but occasionally other 
levels are used. Many journals require or strongly encourage the use of 
confidence intervals.<a rel="#ref-236~.ref-cit" id="xref-ref-236-1" class="xref-bibr article-ref-popup-processed" href="#ref-236">236</a>
 They are especially valuable in relation to differences that do not 
meet conventional statistical significance, for which they often 
indicate that the result does not rule out an important clinical 
difference. The use of confidence intervals has increased markedly in 
recent years, although not in all medical specialties.<a rel="#ref-233~.ref-cit" id="xref-ref-233-2" class="xref-bibr article-ref-popup-processed" href="#ref-233">233</a> Although P values may be provided in addition to confidence intervals, results should not be reported solely as P values.<a rel="#ref-237~.ref-cit" id="xref-ref-237-1" class="xref-bibr article-ref-popup-processed" href="#ref-237">237</a> <a rel="#ref-238~.ref-cit" id="xref-ref-238-1" class="xref-bibr article-ref-popup-processed" href="#ref-238">238</a>
 Results should be reported for all planned primary and secondary end 
points, not just for analyses that were statistically significant or 
“interesting.” Selective reporting within a study is a widespread and 
serious problem.<a rel="#ref-55~.ref-cit" id="xref-ref-55-3" class="xref-bibr article-ref-popup-processed" href="#ref-55">55</a> <a rel="#ref-57~.ref-cit" id="xref-ref-57-4" class="xref-bibr article-ref-popup-processed" href="#ref-57">57</a>
 In trials in which interim analyses were performed, interpretation 
should focus on the final results at the close of the trial, not the 
interim results.<a rel="#ref-239~.ref-cit" id="xref-ref-239-1" class="xref-bibr article-ref-popup-processed" href="#ref-239">239</a></p><p id="p-203">For
 both binary and survival time data, expressing the results also as the 
number needed to treat for benefit or harm can be helpful (see item 21).<a rel="#ref-240~.ref-cit" id="xref-ref-240-1" class="xref-bibr article-ref-popup-processed" href="#ref-240">240</a> <a rel="#ref-241~.ref-cit" id="xref-ref-241-1" class="xref-bibr article-ref-popup-processed" href="#ref-241">241</a></p></div><div id="sec-51" class="subsection"><h4>Item 17b. For binary outcomes, presentation of both absolute and relative effect sizes is recommended</h4><p id="p-204"><strong>Example—</strong>“The
 risk of oxygen dependence or death was reduced by 16% (95% CI 25% to 
7%). The absolute difference was −6.3% (95% CI −9.9% to −2.7%); early 
administration to an estimated 16 babies would therefore prevent 1 baby 
dying or being long-term dependent on oxygen” (also see table 7<a id="xref-table-wrap-7-1" class="xref-down-link" href="#T7"><span>⇓</span></a>).<a rel="#ref-242~.ref-cit" id="xref-ref-242-1" class="xref-bibr article-ref-popup-processed" href="#ref-242">242</a></p><div class="table pos-float" id="T7"><div class="table"><div class="table-caption"><span class="table-label">Table 7</span> <p id="p-205" class="first-child"> Example of reporting both absolute and relative effect sizes. (Adapted from table 3 of The OSIRIS Collaborative Group<sup>242</sup>)</p><div class="sb-div caption-clear"></div></div><div class="table-inline"><div class="callout"><span>View this table:</span><ul class="callout-links"><li><a href="http://www.bmj.com/highwire/markup/591586/expansion?width=1000&amp;height=500&amp;iframe=true&amp;postprocessors=highwire_figures%2Chighwire_math" class="colorbox colorbox-load table-expand-popup init-colorbox-processed cboxElement" rel="gallery-fragment-tables">View popup</a></li><li><a href="##" class="table-expand-inline highwireTablesMarkupProcessor-processed" data-table-url="/highwire/markup/591586/expansion?postprocessors=highwire_figures%2Chighwire_math">View inline</a></li></ul></div></div></div><div></div></div><p id="p-206"><strong>Explanation—</strong>When
 the primary outcome is binary, both the relative effect (risk ratio 
(relative risk) or odds ratio) and the absolute effect (risk difference)
 should be reported (with confidence intervals), as neither the relative
 measure nor the absolute measure alone gives a complete picture of the 
effect and its implications. Different audiences may prefer either 
relative or absolute risk, but both doctors and lay people tend to 
overestimate the effect when it is presented in terms of relative risk.<a rel="#ref-243~.ref-cit" id="xref-ref-243-1" class="xref-bibr article-ref-popup-processed" href="#ref-243">243</a> <a rel="#ref-244~.ref-cit" id="xref-ref-244-1" class="xref-bibr article-ref-popup-processed" href="#ref-244">244</a> <a rel="#ref-245~.ref-cit" id="xref-ref-245-1" class="xref-bibr article-ref-popup-processed" href="#ref-245">245</a>
 The size of the risk difference is less generalisable to other 
populations than the relative risk since it depends on the baseline risk
 in the unexposed group, which tends to vary across populations. For 
diseases where the outcome is common, a relative risk near unity might 
indicate clinically important differences in public health terms. In 
contrast, a large relative risk when the outcome is rare may not be so 
important for public health (although it may be important to an 
individual in a high risk category).</p></div><div id="sec-52" class="subsection"><h4>Item
 18. Results of any other analyses performed, including subgroup 
analyses and adjusted analyses, distinguishing pre-specified from 
exploratory</h4><p id="p-207"><strong>Example—</strong>“On the basis of a
 study that suggested perioperative β-blocker efficacy might vary across
 baseline risk, we prespecified our primary subgroup analysis on the 
basis of the revised cardiac risk index scoring system. We also did 
prespecified secondary subgroup analyses based on sex, type of surgery, 
and use of an epidural or spinal anaesthetic. For all subgroup analyses,
 we used Cox proportional hazard models that incorporated tests for 
interactions, designated to be significant at p&lt;0.05 … Figure 3 shows
 the results of our prespecified subgroup analyses and indicates 
consistency of effects … Our subgroup analyses were underpowered to 
detect the modest differences in subgroup effects that one might expect 
to detect if there was a true subgroup effect.”<a rel="#ref-100~.ref-cit" id="xref-ref-100-2" class="xref-bibr article-ref-popup-processed" href="#ref-100">100</a></p><p id="p-208"><strong>Explanation—</strong>Multiple analyses of the same data create a risk for false positive findings.<a rel="#ref-246~.ref-cit" id="xref-ref-246-1" class="xref-bibr article-ref-popup-processed" href="#ref-246">246</a> Authors should resist the temptation to perform many subgroup analyses.<a rel="#ref-183~.ref-cit" id="xref-ref-183-4" class="xref-bibr article-ref-popup-processed" href="#ref-183">183</a> <a rel="#ref-185~.ref-cit" id="xref-ref-185-2" class="xref-bibr article-ref-popup-processed" href="#ref-185">185</a> <a rel="#ref-247~.ref-cit" id="xref-ref-247-1" class="xref-bibr article-ref-popup-processed" href="#ref-247">247</a>
 Analyses that were prespecified in the trial protocol (see item 24) are
 much more reliable than those suggested by the data, and therefore 
authors should report which analyses were prespecified. If subgroup 
analyses were undertaken, authors should report which subgroups were 
examined, why, if they were prespecified, and how many were 
prespecified. Selective reporting of subgroup analyses could lead to 
bias.<a rel="#ref-248~.ref-cit" id="xref-ref-248-1" class="xref-bibr article-ref-popup-processed" href="#ref-248">248</a>
 When evaluating a subgroup the question is not whether the subgroup 
shows a statistically significant result but whether the subgroup 
treatment effects are significantly different from each other. To 
determine this, a test of interaction is helpful, although the power for
 such tests is typically low. If formal evaluations of interaction are 
undertaken (see item 12b) they should be reported as the estimated 
difference in the intervention effect in each subgroup (with a 
confidence interval), not just as P values.</p><p id="p-209">In one survey, 35 of 50 trial reports included subgroup analyses, of which only 42% used tests of interaction.<a rel="#ref-183~.ref-cit" id="xref-ref-183-5" class="xref-bibr article-ref-popup-processed" href="#ref-183">183</a>
 It was often difficult to determine whether subgroup analyses had been 
specified in the protocol. In another survey of surgical trials 
published in high impact journals, 27 of 72 trials reported 54 subgroup 
analyses, of which 91% were post hoc and only 6% of subgroup analyses 
used a test of interaction to assess whether a subgroup effect existed.<a rel="#ref-249~.ref-cit" id="xref-ref-249-1" class="xref-bibr article-ref-popup-processed" href="#ref-249">249</a></p><p id="p-210">Similar
 recommendations apply to analyses in which adjustment was made for 
baseline variables. If done, both unadjusted and adjusted analyses 
should be reported. Authors should indicate whether adjusted analyses, 
including the choice of variables to adjust for, were planned. Ideally, 
the trial protocol should state whether adjustment is made for nominated
 baseline variables by using analysis of covariance.<a rel="#ref-187~.ref-cit" id="xref-ref-187-2" class="xref-bibr article-ref-popup-processed" href="#ref-187">187</a> Adjustment for variables because they differ significantly at baseline is likely to bias the estimated treatment effect.<a rel="#ref-187~.ref-cit" id="xref-ref-187-3" class="xref-bibr article-ref-popup-processed" href="#ref-187">187</a>
 A survey found that unacknowledged discrepancies between protocols and 
publications were found for all 25 trials reporting subgroup analyses 
and for 23 of 28 trials reporting adjusted analyses.<a rel="#ref-92~.ref-cit" id="xref-ref-92-2" class="xref-bibr article-ref-popup-processed" href="#ref-92">92</a></p></div><div id="sec-53" class="subsection"><h4>Item 19. All important harms or unintended effects in each group</h4><p id="p-211">For specific guidance see CONSORT for harms.<a rel="#ref-42~.ref-cit" id="xref-ref-42-3" class="xref-bibr article-ref-popup-processed" href="#ref-42">42</a></p><p id="p-212"><strong>Example—</strong>“The
 proportion of patients experiencing any adverse event was similar 
between the rBPI21 [recombinant bactericidal/permeability-increasing 
protein] and placebo groups: 168 (88.4%) of 190 and 180 (88.7%) of 203, 
respectively, and it was lower in patients treated with rBPI21 than in 
those treated with placebo for 11 of 12 body systems … the proportion of
 patients experiencing a severe adverse event, as judged by the 
investigators, was numerically lower in the rBPI21 group than the 
placebo group: 53 (27.9%) of 190 versus 74 (36.5%) of 203 patients, 
respectively. There were only three serious adverse events reported as 
drug-related and they all occurred in the placebo group.”<a rel="#ref-250~.ref-cit" id="xref-ref-250-1" class="xref-bibr article-ref-popup-processed" href="#ref-250">250</a></p><p id="p-213"><strong>Explanation—</strong>Readers
 need information about the harms as well as the benefits of 
interventions to make rational and balanced decisions. The existence and
 nature of adverse effects can have a major impact on whether a 
particular intervention will be deemed acceptable and useful. Not all 
reported adverse events observed during a trial are necessarily a 
consequence of the intervention; some may be a consequence of the 
condition being treated. Randomised trials offer the best approach for 
providing safety data as well as efficacy data, although they cannot 
detect rare harms.</p><p id="p-214">Many reports of RCTs provide 
inadequate information on adverse events. A survey of 192 drug trials 
published from 1967 to 1999 showed that only 39% had adequate reporting 
of clinical adverse events and 29% had adequate reporting of laboratory 
defined toxicity.<a rel="#ref-72~.ref-cit" id="xref-ref-72-2" class="xref-bibr article-ref-popup-processed" href="#ref-72">72</a>
 More recently, a comparison between the adverse event data submitted to
 the trials database of the National Cancer Institute, which sponsored 
the trials, and the information reported in journal articles found that 
low grade adverse events were underreported in journal articles. High 
grade events (Common Toxicity Criteria grades 3 to 5) were reported 
inconsistently in the articles, and the information regarding 
attribution to investigational drugs was incomplete.<a rel="#ref-251~.ref-cit" id="xref-ref-251-1" class="xref-bibr article-ref-popup-processed" href="#ref-251">251</a>
 Moreover, a review of trials published in six general medical journals 
in 2006 to 2007 found that, although 89% of 133 reports mentioned 
adverse events, no information on severe adverse events and withdrawal 
of patients due to an adverse event was given on 27% and 48% of 
articles, respectively.<a rel="#ref-252~.ref-cit" id="xref-ref-252-1" class="xref-bibr article-ref-popup-processed" href="#ref-252">252</a></p><p id="p-215">An
 extension of the CONSORT statement has been developed to provide 
detailed recommendations on the reporting of harms in randomised trials.<a rel="#ref-42~.ref-cit" id="xref-ref-42-4" class="xref-bibr article-ref-popup-processed" href="#ref-42">42</a> Recommendations and examples of appropriate reporting are freely available from the CONSORT website (<a href="http://www.consort-statement.org/">www.consort-statement.org</a>).
 They complement the CONSORT 2010 Statement and should be consulted, 
particularly if the study of harms was a key objective. Briefly, if data
 on adverse events were collected, events should be listed and defined, 
with reference to standardised criteria where appropriate. The methods 
used for data collection and attribution of events should be described. 
For each study arm the absolute risk of each adverse event, using 
appropriate metrics for recurrent events, and the number of participants
 withdrawn due to harms should be presented. Finally, authors should 
provide a balanced discussion of benefits and harms.<a rel="#ref-42~.ref-cit" id="xref-ref-42-5" class="xref-bibr article-ref-popup-processed" href="#ref-42">42</a></p></div></div><div id="sec-54" class="subsection"><h3>Discussion</h3><div id="sec-55" class="subsection"><h4>Item 20. Trial limitations, addressing sources of potential bias, imprecision, and, if relevant, multiplicity of analyses</h4><p id="p-216"><strong>Example—</strong>“The
 preponderance of male patients (85%) is a limitation of our study … We 
used bare-metal stents, since drug-eluting stents were not available 
until late during accrual. Although the latter factor may be perceived 
as a limitation, published data indicate no benefit (either short-term 
or long-term) with respect to death and myocardial infarction in 
patients with stable coronary artery disease who receive drug-eluting 
stents, as compared with those who receive bare-metal stents.”<a rel="#ref-253~.ref-cit" id="xref-ref-253-1" class="xref-bibr article-ref-popup-processed" href="#ref-253">253</a></p><p id="p-217"><strong>Explanation—</strong>The discussion sections of scientific reports are often filled with rhetoric supporting the authors’ findings<a rel="#ref-254~.ref-cit" id="xref-ref-254-1" class="xref-bibr article-ref-popup-processed" href="#ref-254">254</a>
 and provide little measured argument of the pros and cons of the study 
and its results. Some journals have attempted to remedy this problem by 
encouraging more structure to authors’ discussion of their results.<a rel="#ref-255~.ref-cit" id="xref-ref-255-1" class="xref-bibr article-ref-popup-processed" href="#ref-255">255</a> <a rel="#ref-256~.ref-cit" id="xref-ref-256-1" class="xref-bibr article-ref-popup-processed" href="#ref-256">256</a> For example, <em>Annals of Internal Medicine</em>
 recommends that authors structure the discussion section by presenting 
(1) a brief synopsis of the key findings, (2) consideration of possible 
mechanisms and explanations, (3) comparison with relevant findings from 
other published studies (whenever possible including a systematic review
 combining the results of the current study with the results of all 
previous relevant studies), (4) limitations of the present study (and 
methods used to minimise and compensate for those limitations), and (5) a
 brief section that summarises the clinical and research implications of
 the work, as appropriate.<a rel="#ref-255~.ref-cit" id="xref-ref-255-2" class="xref-bibr article-ref-popup-processed" href="#ref-255">255</a> We recommend that authors follow these sensible suggestions, perhaps also using suitable subheadings in the discussion section.</p><p id="p-218">Although discussion of limitations is frequently omitted from research reports,<a rel="#ref-257~.ref-cit" id="xref-ref-257-1" class="xref-bibr article-ref-popup-processed" href="#ref-257">257</a> identification and discussion of the weaknesses of a study have particular importance.<a rel="#ref-258~.ref-cit" id="xref-ref-258-1" class="xref-bibr article-ref-popup-processed" href="#ref-258">258</a>
 For example, a surgical group reported that laparoscopic 
cholecystectomy, a technically difficult procedure, had significantly 
lower rates of complications than the more traditional open 
cholecystectomy for management of acute cholecystitis.<a rel="#ref-259~.ref-cit" id="xref-ref-259-1" class="xref-bibr article-ref-popup-processed" href="#ref-259">259</a>
 However, the authors failed to discuss an obvious bias in their 
results. The study investigators had completed all the laparoscopic 
cholecystectomies, whereas 80% of the open cholecystectomies had been 
completed by trainees.</p><p id="p-219">Authors should also discuss any 
imprecision of the results. Imprecision may arise in connection with 
several aspects of a study, including measurement of a primary outcome 
(see item 6a) or diagnosis (see item 4a). Perhaps the scale used was 
validated on an adult population but used in a paediatric one, or the 
assessor was not trained in how to administer the instrument.</p><p id="p-220">The
 difference between statistical significance and clinical importance 
should always be borne in mind. Authors should particularly avoid the 
common error of interpreting a non-significant result as indicating 
equivalence of interventions. The confidence interval (see item 17a) 
provides valuable insight into whether the trial result is compatible 
with a clinically important effect, regardless of the P value.<a rel="#ref-120~.ref-cit" id="xref-ref-120-2" class="xref-bibr article-ref-popup-processed" href="#ref-120">120</a></p><p id="p-221">Authors
 should exercise special care when evaluating the results of trials with
 multiple comparisons. Such multiplicity arises from several 
interventions, outcome measures, time points, subgroup analyses, and 
other factors. In such circumstances, some statistically significant 
findings are likely to result from chance alone.</p></div><div id="sec-56" class="subsection"><h4>Item 21. Generalisability (external validity, applicability) of the trial findings</h4><p id="p-222"><strong>Examples—</strong>“As
 the intervention was implemented for both sexes, all ages, all types of
 sports, and at different levels of sports, the results indicate that 
the entire range of athletes, from young elite to intermediate and 
recreational senior athletes, would benefit from using the presented 
training programme for the prevention of recurrences of ankle sprain. By
 including non-medically treated and medically treated athletes, we 
covered a broad spectrum of injury severity. This suggests that the 
present training programme can be implemented in the treatment of all 
athletes. Furthermore, as it is reasonable to assume that ankle sprains 
not related to sports are comparable with those in sports, the programme
 could benefit the general population.”<a rel="#ref-260~.ref-cit" id="xref-ref-260-1" class="xref-bibr article-ref-popup-processed" href="#ref-260">260</a></p><p id="p-223">“This
 replicates and extends the work of Clarke and colleagues and 
demonstrates that this CB (cognitive behavioural) prevention program can
 be reliably and effectively delivered in different settings by 
clinicians outside of the group who originally developed the 
intervention. The effect size was consistent with those of previously 
reported, single-site, indicated depression prevention studies and was 
robust across sites with respect to both depressive disorders and 
symptoms … In this generalisability trial, we chose a comparison 
condition that is relevant to public health—usual care … The sample also
 was predominantly working class to middle class with access to health 
insurance. Given evidence that CB therapy can be more efficacious for 
adolescents from homes with higher incomes, it will be important to test
 the effects of this prevention program with more economically and 
ethnically diverse samples.”<a rel="#ref-261~.ref-cit" id="xref-ref-261-1" class="xref-bibr article-ref-popup-processed" href="#ref-261">261</a></p><p id="p-224"><strong>Explanation—</strong>External
 validity, also called generalisability or applicability, is the extent 
to which the results of a study can be generalised to other 
circumstances.<a rel="#ref-262~.ref-cit" id="xref-ref-262-1" class="xref-bibr article-ref-popup-processed" href="#ref-262">262</a>
 Internal validity, the extent to which the design and conduct of the 
trial eliminate the possibility of bias, is a prerequisite for external 
validity: the results of a flawed trial are invalid and the question of 
its external validity becomes irrelevant. There is no absolute external 
validity; the term is meaningful only with regard to clearly specified 
conditions that were not directly examined in the trial. Can results be 
generalised to an individual participant or groups that differ from 
those enrolled in the trial with regard to age, sex, severity of 
disease, and comorbid conditions? Are the results applicable to other 
drugs within a class of similar drugs, to a different dose, timing, and 
route of administration, and to different concomitant therapies? Can 
similar results be expected at the primary, secondary, and tertiary 
levels of care? What about the effect on related outcomes that were not 
assessed in the trial, and the importance of length of follow-up and 
duration of treatment, especially with respect to harms?<a rel="#ref-263~.ref-cit" id="xref-ref-263-1" class="xref-bibr article-ref-popup-processed" href="#ref-263">263</a></p><p id="p-225">External
 validity is a matter of judgment and depends on the characteristics of 
the participants included in the trial, the trial setting, the treatment
 regimens tested, and the outcomes assessed.<a rel="#ref-5~.ref-cit" id="xref-ref-5-2" class="xref-bibr article-ref-popup-processed" href="#ref-5">5</a> <a rel="#ref-136~.ref-cit" id="xref-ref-136-2" class="xref-bibr article-ref-popup-processed" href="#ref-136">136</a>
 It is therefore crucial that adequate information be described about 
eligibility criteria and the setting and location (see item 4b), the 
interventions and how they were administered (see item 5), the 
definition of outcomes (see item 6), and the period of recruitment and 
follow-up (see item 14). The proportion of control group participants in
 whom the outcome develops (control group risk) is also important. The 
proportion of eligible participants who refuse to enter the trial as 
indicated on the flowchart (see item 13) is relevant for the 
generalisability of the trial, as it may indicate preferences for or 
acceptability of an intervention. Similar considerations may apply to 
clinician preferences.<a rel="#ref-264~.ref-cit" id="xref-ref-264-1" class="xref-bibr article-ref-popup-processed" href="#ref-264">264</a> <a rel="#ref-265~.ref-cit" id="xref-ref-265-1" class="xref-bibr article-ref-popup-processed" href="#ref-265">265</a></p><p id="p-226">Several issues are important when results of a trial are applied to an individual patient.<a rel="#ref-266~.ref-cit" id="xref-ref-266-1" class="xref-bibr article-ref-popup-processed" href="#ref-266">266</a> <a rel="#ref-267~.ref-cit" id="xref-ref-267-1" class="xref-bibr article-ref-popup-processed" href="#ref-267">267</a> <a rel="#ref-268~.ref-cit" id="xref-ref-268-1" class="xref-bibr article-ref-popup-processed" href="#ref-268">268</a>
 Although some variation in treatment response between an individual 
patient and the patients in a trial or systematic review is to be 
expected, the differences tend to be in magnitude rather than direction.</p><p id="p-227">Although there are important exceptions,<a rel="#ref-268~.ref-cit" id="xref-ref-268-2" class="xref-bibr article-ref-popup-processed" href="#ref-268">268</a> therapies (especially drugs <a rel="#ref-269~.ref-cit" id="xref-ref-269-1" class="xref-bibr article-ref-popup-processed" href="#ref-269">269</a>)
 found to be beneficial in a narrow range of patients generally have 
broader application in actual practice. Frameworks for the evaluation of
 external validity have been proposed, including qualitative studies, 
such as in integral “process evaluations”<a rel="#ref-270~.ref-cit" id="xref-ref-270-1" class="xref-bibr article-ref-popup-processed" href="#ref-270">270</a> and checklists.<a rel="#ref-271~.ref-cit" id="xref-ref-271-1" class="xref-bibr article-ref-popup-processed" href="#ref-271">271</a>
 Measures that incorporate baseline risk when calculating therapeutic 
effects, such as the number needed to treat to obtain one additional 
favourable outcome and the number needed to treat to produce one adverse
 effect, are helpful in assessing the benefit-to-risk balance in an 
individual patient or group with characteristics that differ from the 
typical trial participant.<a rel="#ref-268~.ref-cit" id="xref-ref-268-3" class="xref-bibr article-ref-popup-processed" href="#ref-268">268</a> <a rel="#ref-272~.ref-cit" id="xref-ref-272-1" class="xref-bibr article-ref-popup-processed" href="#ref-272">272</a> <a rel="#ref-273~.ref-cit" id="xref-ref-273-1" class="xref-bibr article-ref-popup-processed" href="#ref-273">273</a>
 Finally, after deriving patient centred estimates for the potential 
benefit and harm from an intervention, the clinician must integrate them
 with the patient’s values and preferences for therapy. Similar 
considerations apply when assessing the generalisability of results to 
different settings and interventions.</p></div><div id="sec-57" class="subsection"><h4>Item 22. Interpretation consistent with results, balancing benefits and harms, and considering other relevant evidence</h4><p id="p-228"><strong>Example—</strong>“Studies
 published before 1990 suggested that prophylactic immunotherapy also 
reduced nosocomial infections in very-low-birth-weight infants. However,
 these studies enrolled small numbers of patients; employed varied 
designs, preparations, and doses; and included diverse study 
populations. In this large multicenter, randomised controlled trial, the
 repeated prophylactic administration of intravenous immune globulin 
failed to reduce the incidence of nosocomial infections significantly in
 premature infants weighing 501 to 1500 g at birth.”<a rel="#ref-274~.ref-cit" id="xref-ref-274-1" class="xref-bibr article-ref-popup-processed" href="#ref-274">274</a></p><p id="p-229"><strong>Explanation—</strong>Readers
 will want to know how the present trial’s results relate to those of 
other RCTs. This can best be achieved by including a formal systematic 
review in the results or discussion section of the report.<a rel="#ref-83~.ref-cit" id="xref-ref-83-2" class="xref-bibr article-ref-popup-processed" href="#ref-83">83</a> <a rel="#ref-275~.ref-cit" id="xref-ref-275-1" class="xref-bibr article-ref-popup-processed" href="#ref-275">275</a> <a rel="#ref-276~.ref-cit" id="xref-ref-276-1" class="xref-bibr article-ref-popup-processed" href="#ref-276">276</a> <a rel="#ref-277~.ref-cit" id="xref-ref-277-1" class="xref-bibr article-ref-popup-processed" href="#ref-277">277</a>
 Such synthesis may be impractical for trial authors, but it is often 
possible to quote a systematic review of similar trials. A systematic 
review may help readers assess whether the results of the RCT are 
similar to those of other trials in the same topic area and whether 
participants are similar across studies. Reports of RCTs have often not 
dealt adequately with these points.<a rel="#ref-277~.ref-cit" id="xref-ref-277-2" class="xref-bibr article-ref-popup-processed" href="#ref-277">277</a> Bayesian methods can be used to statistically combine the trial data with previous evidence.<a rel="#ref-278~.ref-cit" id="xref-ref-278-1" class="xref-bibr article-ref-popup-processed" href="#ref-278">278</a></p><p id="p-230">We
 recommend that, at a minimum, the discussion should be as systematic as
 possible and be based on a comprehensive search, rather than being 
limited to studies that support the results of the current trial.<a rel="#ref-279~.ref-cit" id="xref-ref-279-1" class="xref-bibr article-ref-popup-processed" href="#ref-279">279</a></p></div></div><div id="sec-58" class="subsection"><h3>Other information</h3><div id="sec-59" class="subsection"><h4>Item 23. Registration number and name of trial registry</h4><p id="p-231"><strong>Example—</strong>“The trial is registered at ClinicalTrials.gov, number  <a class="external-ref external-ref-type-clintrialgov" href="http://www.bmj.com/lookup/external-ref?link_type=CLINTRIALGOV&amp;access_num=NCT00244842&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom">NCT00244842</a>. ”<a rel="#ref-280~.ref-cit" id="xref-ref-280-1" class="xref-bibr article-ref-popup-processed" href="#ref-280">280</a></p><p id="p-232"><strong>Explanation—</strong>The consequences of non-publication of entire trials,<a rel="#ref-281~.ref-cit" id="xref-ref-281-1" class="xref-bibr article-ref-popup-processed" href="#ref-281">281</a> <a rel="#ref-282~.ref-cit" id="xref-ref-282-1" class="xref-bibr article-ref-popup-processed" href="#ref-282">282</a>
 selective reporting of outcomes within trials, and of per protocol 
rather than intention-to-treat analysis have been well documented.<a rel="#ref-55~.ref-cit" id="xref-ref-55-4" class="xref-bibr article-ref-popup-processed" href="#ref-55">55</a> <a rel="#ref-56~.ref-cit" id="xref-ref-56-2" class="xref-bibr article-ref-popup-processed" href="#ref-56">56</a> <a rel="#ref-283~.ref-cit" id="xref-ref-283-1" class="xref-bibr article-ref-popup-processed" href="#ref-283">283</a>
 Covert redundant publication of clinical trials can also cause 
problems, particularly for authors of systematic reviews when results 
from the same trial are inadvertently included more than once.<a rel="#ref-284~.ref-cit" id="xref-ref-284-1" class="xref-bibr article-ref-popup-processed" href="#ref-284">284</a></p><p id="p-233">To
 minimise or avoid these problems there have been repeated calls over 
the past 25 years to register clinical trials at their inception, to 
assign unique trial identification numbers, and to record other basic 
information about the trial so that essential details are made publicly 
available.<a rel="#ref-285~.ref-cit" id="xref-ref-285-1" class="xref-bibr article-ref-popup-processed" href="#ref-285">285</a> <a rel="#ref-286~.ref-cit" id="xref-ref-286-1" class="xref-bibr article-ref-popup-processed" href="#ref-286">286</a> <a rel="#ref-287~.ref-cit" id="xref-ref-287-1" class="xref-bibr article-ref-popup-processed" href="#ref-287">287</a> <a rel="#ref-288~.ref-cit" id="xref-ref-288-1" class="xref-bibr article-ref-popup-processed" href="#ref-288">288</a> Provoked by recent serious problems of withholding data,<a rel="#ref-289~.ref-cit" id="xref-ref-289-1" class="xref-bibr article-ref-popup-processed" href="#ref-289">289</a>
 there has been a renewed effort to register randomised trials. Indeed, 
the World Health Organisation states that “the registration of all 
interventional trials is a scientific, ethical and moral responsibility”
 (<a href="http://www.who.int/ictrp/en">www.who.int/ictrp/en</a>). By 
registering a randomised trial, authors typically report a minimal set 
of information and obtain a unique trial registration number.</p><p id="p-234">In
 September 2004 the International Committee of Medical Journal Editors 
(ICMJE) changed their policy, saying that they would consider trials for
 publication only if they had been registered before the enrolment of 
the first participant.<a rel="#ref-290~.ref-cit" id="xref-ref-290-1" class="xref-bibr article-ref-popup-processed" href="#ref-290">290</a> This resulted in a dramatic increase in the number of trials being registered.<a rel="#ref-291~.ref-cit" id="xref-ref-291-1" class="xref-bibr article-ref-popup-processed" href="#ref-291">291</a> The ICMJE gives guidance on acceptable registries (<a href="http://www.icmje.org/faq.pdf">www.icmje.org/faq.pdf</a>).</p><p id="p-235">In
 a recent survey of 165 high impact factor medical journals’ 
instructions to authors, 44 journals specifically stated that all recent
 clinical trials must be registered as a requirement of submission to 
that journal.<a rel="#ref-292~.ref-cit" id="xref-ref-292-1" class="xref-bibr article-ref-popup-processed" href="#ref-292">292</a></p><p id="p-236">Authors
 should provide the name of the register and the trial’s unique 
registration number. If authors had not registered their trial they 
should explicitly state this and give the reason.</p></div><div id="sec-60" class="subsection"><h4>Item 24. Where the full trial protocol can be accessed, if available</h4><p id="p-237"><strong>Example—</strong>“Full details of the trial protocol can be found in the Supplementary Appendix, available with the full text of this article at <a href="http://www.nejm.org/">www.nejm.org</a>.”<a rel="#ref-293~.ref-cit" id="xref-ref-293-1" class="xref-bibr article-ref-popup-processed" href="#ref-293">293</a></p><p id="p-238"><strong>Explanation—</strong>A
 protocol for the complete trial (rather than a protocol of a specific 
procedure within a trial) is important because it pre-specifies the 
methods of the randomised trial, such as the primary outcome (see item 
6a). Having a protocol can help to restrict the likelihood of undeclared
 post hoc changes to the trial methods and selective outcome reporting 
(see item 6b). Elements that may be important for inclusion in the 
protocol for a randomised trial are described elsewhere.<a rel="#ref-294~.ref-cit" id="xref-ref-294-1" class="xref-bibr article-ref-popup-processed" href="#ref-294">294</a></p><p id="p-239">There
 are several options for authors to consider ensuring their trial 
protocol is accessible to interested readers. As described in the 
example above, journals reporting a trial’s primary results can make the
 trial protocol available on their web site. Accessibility to the trial 
results and protocol is enhanced when the journal is open access. Some 
journals (such as <em>Trials</em>) publish trial protocols, and such a 
publication can be referenced when reporting the trial’s principal 
results. Trial registration (see item 23) will also ensure that many 
trial protocol details are available, as the minimum trial 
characteristics included in an approved trial registration database 
includes several protocol items and results (<a href="http://www.who.int/ictrp/en">www.who.int/ictrp/en</a>).
 Trial investigators may also be able to post their trial protocol on a 
website through their employer. Whatever mechanism is used, we encourage
 all trial investigators to make their protocol easily accessible to 
interested readers.</p></div><div id="sec-61" class="subsection"><h4>Item 25. Sources of funding and other support (such as supply of drugs), role of funders</h4><p id="p-240"><strong>Examples—</strong>“Grant
 support was received for the intervention from Plan International and 
for the research from the Wellcome Trust and Joint United Nations 
Programme on HIV/AIDS (UNAIDS). The funders had no role in study design,
 data collection and analysis, decision to publish, or preparation of 
the manuscript.”<a rel="#ref-295~.ref-cit" id="xref-ref-295-1" class="xref-bibr article-ref-popup-processed" href="#ref-295">295</a></p><p id="p-241">“This
 study was funded by GlaxoSmithKline Pharmaceuticals. GlaxoSmithKline 
was involved in the design and conduct of the study and provided 
logistical support during the trial. Employees of the sponsor worked 
with the investigators to prepare the statistical analysis plan, but the
 analyses were performed by the University of Utah. The manuscript was 
prepared by Dr Shaddy and the steering committee members. 
GlaxoSmithKline was permitted to review the manuscript and suggest 
changes, but the final decision on content was exclusively retained by 
the authors.”<a rel="#ref-296~.ref-cit" id="xref-ref-296-1" class="xref-bibr article-ref-popup-processed" href="#ref-296">296</a></p><p id="p-242"><strong>Explanation—</strong>Authors
 should report the sources of funding for the trial, as this is 
important information for readers assessing a trial. Studies have showed
 that research sponsored by the pharmaceutical industry are more likely 
to produce results favouring the product made by the company sponsoring 
the research than studies funded by other sources.<a rel="#ref-297~.ref-cit" id="xref-ref-297-1" class="xref-bibr article-ref-popup-processed" href="#ref-297">297</a> <a rel="#ref-298~.ref-cit" id="xref-ref-298-1" class="xref-bibr article-ref-popup-processed" href="#ref-298">298</a> <a rel="#ref-299~.ref-cit" id="xref-ref-299-1" class="xref-bibr article-ref-popup-processed" href="#ref-299">299</a> <a rel="#ref-300~.ref-cit" id="xref-ref-300-1" class="xref-bibr article-ref-popup-processed" href="#ref-300">300</a>
 A systematic review of 30 studies on funding found that research funded
 by the pharmaceutical industry had four times the odds of having 
outcomes favouring the sponsor than research funded by other sources 
(odds ratio 4.05, 95% confidence interval 2.98 to 5.51).<a rel="#ref-297~.ref-cit" id="xref-ref-297-2" class="xref-bibr article-ref-popup-processed" href="#ref-297">297</a>
 A large proportion of trial publications do not currently report 
sources of funding. The degree of underreporting is difficult to 
quantify. A survey of 370 drug trials found that 29% failed to report 
sources of funding.<a rel="#ref-301~.ref-cit" id="xref-ref-301-1" class="xref-bibr article-ref-popup-processed" href="#ref-301">301</a>
 In another survey, of PubMed indexed randomised trials published in 
December 2000, source of funding was reported for 66% of the 519 trials.<a rel="#ref-16~.ref-cit" id="xref-ref-16-9" class="xref-bibr article-ref-popup-processed" href="#ref-16">16</a></p><p id="p-243">The
 level of involvement by a funder and their influence on the design, 
conduct, analysis, and reporting of a trial varies. It is therefore 
important that authors describe in detail the role of the funders. If 
the funder had no such involvement, the authors should state so. 
Similarly, authors should report any other sources of support, such as 
supply and preparation of drugs or equipment, or in the analysis of data
 and writing of the manuscript.<a rel="#ref-302~.ref-cit" id="xref-ref-302-1" class="xref-bibr article-ref-popup-processed" href="#ref-302">302</a></p></div></div></div><div class="section" id="sec-62"><h2>Reporting RCTs that did not have a two group parallel design</h2><p id="p-244">The
 primary focus of the CONSORT recommendations is RCTs with a parallel 
design and two treatment groups. Most RCTs have that design, but a 
substantial minority do not: 45% (233/519) of RCTs published in December
 2000,<a rel="#ref-16~.ref-cit" id="xref-ref-16-10" class="xref-bibr article-ref-popup-processed" href="#ref-16">16</a> and 39% (242/616) in December 2006.<a rel="#ref-17~.ref-cit" id="xref-ref-17-7" class="xref-bibr article-ref-popup-processed" href="#ref-17">17</a></p><p id="p-245">Most
 of the CONSORT statement applies equally to all trial designs, but 
there are a few additional issues to address for each design. Before the
 publication of the revised CONSORT statement in 2001, the CONSORT Group
 decided to develop extensions to the main CONSORT statement relevant to
 specific trial designs. Extensions have been published relating to 
reporting of cluster randomised trials<a rel="#ref-40~.ref-cit" id="xref-ref-40-4" class="xref-bibr article-ref-popup-processed" href="#ref-40">40</a> and non-inferiority and equivalence trials.<a rel="#ref-39~.ref-cit" id="xref-ref-39-4" class="xref-bibr article-ref-popup-processed" href="#ref-39">39</a>
 Lack of resources has meant that other planned extensions have not been
 completed; they will cover trials with the following designs: multiarm 
parallel, factorial, crossover, within-person.</p><p id="p-246">Authors 
reporting trials with a cluster design or using a non-inferiority or 
equivalence framework should consult the CONSORT recommendations in 
addition to those in this document. Here we make a few interim comments 
about the other designs. In each case, the trial design should be made 
clear in both the main text and the article’s abstract.</p><p id="p-247">Multiarm
 (&gt;2 group) parallel group trials need the least modification of the 
standard CONSORT guidance. The flow diagram can be extended easily. The 
main differences from trials with two groups relate to clarification of 
how the study hypotheses relate to the multiple groups, and the 
consequent methods of data analysis and interpretation. For factorial 
trials, the possibility of interaction between the interventions 
generally needs to be considered. In addition to overall comparisons of 
participants who did or did not receive each intervention under study, 
investigators should consider also reporting results for each treatment 
combination.<a rel="#ref-303~.ref-cit" id="xref-ref-303-1" class="xref-bibr article-ref-popup-processed" href="#ref-303">303</a></p><p id="p-248">In
 crossover trials, each participant receives two (or more) treatments in
 a random order. The main additional issues to address relate to the 
paired nature of the data, which affect design and analysis.<a rel="#ref-304~.ref-cit" id="xref-ref-304-1" class="xref-bibr article-ref-popup-processed" href="#ref-304">304</a>
 Similar issues affect within-person comparisons, in which participants 
receive two treatments simultaneously (often to paired organs). Also, 
because of the risk of temporal or systemic carryover effects, 
respectively, in both cases the choice of design needs justification.</p><p id="p-249">The
 CONSORT Group intends to publish extensions to CONSORT to cover all 
these designs. In addition, we will publish updates to existing guidance
 for cluster randomised trials and non-inferiority and equivalence 
trials to take account of this major update of the generic CONSORT 
guidance.</p></div><div class="section discussion" id="discussion"><h2>Discussion</h2><p id="p-250">Assessment
 of healthcare interventions can be misleading unless investigators 
ensure unbiased comparisons. Random allocation to study groups remains 
the only method that eliminates selection and confounding biases. 
Non-randomised trials tend to result in larger estimated treatment 
effects than randomised trials.<a rel="#ref-305~.ref-cit" id="xref-ref-305-1" class="xref-bibr article-ref-popup-processed" href="#ref-305">305</a> <a rel="#ref-306~.ref-cit" id="xref-ref-306-1" class="xref-bibr article-ref-popup-processed" href="#ref-306">306</a></p><p id="p-251">Bias jeopardises even RCTs, however, if investigators carry out such trials improperly.<a rel="#ref-307~.ref-cit" id="xref-ref-307-1" class="xref-bibr article-ref-popup-processed" href="#ref-307">307</a>
 A recent systematic review, aggregating the results of several 
methodological investigations, found that, for subjective outcomes, 
trials that used inadequate or unclear allocation concealment yielded 
31% larger estimates of effect than those that used adequate 
concealment, and trials that were not blinded yielded 25% larger 
estimates.<a rel="#ref-153~.ref-cit" id="xref-ref-153-5" class="xref-bibr article-ref-popup-processed" href="#ref-153">153</a> As might be expected, there was a strong association between the two.</p><p id="p-252">The design and implementation of an RCT require methodological as well as clinical expertise, meticulous effort,<a rel="#ref-143~.ref-cit" id="xref-ref-143-3" class="xref-bibr article-ref-popup-processed" href="#ref-143">143</a> <a rel="#ref-308~.ref-cit" id="xref-ref-308-1" class="xref-bibr article-ref-popup-processed" href="#ref-308">308</a>
 and a high level of alertness for unanticipated difficulties. Reports 
of RCTs should be written with similarly close attention to reducing 
bias. Readers should not have to speculate; the methods used should be 
complete and transparent so that readers can readily differentiate 
trials with unbiased results from those with questionable results. Sound
 science encompasses adequate reporting, and the conduct of ethical 
trials rests on the footing of sound science.<a rel="#ref-309~.ref-cit" id="xref-ref-309-1" class="xref-bibr article-ref-popup-processed" href="#ref-309">309</a></p><p id="p-253">We
 hope this update of the CONSORT explanatory article will assist authors
 in using the 2010 version of CONSORT and explain in general terms the 
importance of adequately reporting of trials. The CONSORT statement can 
help researchers designing trials in future<a rel="#ref-310~.ref-cit" id="xref-ref-310-1" class="xref-bibr article-ref-popup-processed" href="#ref-310">310</a>
 and can guide peer reviewers and editors in their evaluation of 
manuscripts. Indeed, we encourage peer reviewers and editors to use the 
CONSORT checklist to assess whether authors have reported on these 
items. Such assessments will likely improve the clarity and transparency
 of published trials. Because CONSORT is an evolving document, it 
requires a dynamic process of continual assessment, refinement, and, if 
necessary, change, which is why we have this update of the checklist and
 explanatory article. As new evidence and critical comments accumulate, 
we will evaluate the need for future updates.</p><p id="p-254">The first
 version of the CONSORT statement, from 1996, seems to have led to 
improvement in the quality of reporting of RCTs in the journals that 
have adopted it.<a rel="#ref-50~.ref-cit" id="xref-ref-50-2" class="xref-bibr article-ref-popup-processed" href="#ref-50">50</a> <a rel="#ref-51~.ref-cit" id="xref-ref-51-5" class="xref-bibr article-ref-popup-processed" href="#ref-51">51</a> <a rel="#ref-52~.ref-cit" id="xref-ref-52-5" class="xref-bibr article-ref-popup-processed" href="#ref-52">52</a> <a rel="#ref-53~.ref-cit" id="xref-ref-53-5" class="xref-bibr article-ref-popup-processed" href="#ref-53">53</a> <a rel="#ref-54~.ref-cit" id="xref-ref-54-5" class="xref-bibr article-ref-popup-processed" href="#ref-54">54</a>. Other groups are using the CONSORT template to improve the reporting of other research designs, such as diagnostic tests<a rel="#ref-311~.ref-cit" id="xref-ref-311-1" class="xref-bibr article-ref-popup-processed" href="#ref-311">311</a> and observational studies.<a rel="#ref-312~.ref-cit" id="xref-ref-312-1" class="xref-bibr article-ref-popup-processed" href="#ref-312">312</a></p><p id="p-255">The CONSORT website (<a href="http://www.consort-statement.org/">www.consort-statement.org</a>)
 has been established to provide educational material and a repository 
database of materials relevant to the reporting of RCTs. The site 
includes many examples from real trials, including all of the examples 
included in this article. We will continue to add good and bad examples 
of reporting to the database, and we invite readers to submit further 
suggestions by contacting us through the website. The CONSORT Group will
 continue to survey the literature to find relevant articles that 
address issues relevant to the reporting of RCTs, and we invite authors 
of any such articles to notify us about them. All of this information 
will be made accessible through the CONSORT website, which is updated 
regularly.</p><p id="p-256">More than 400 leading general and specialty 
journals and biomedical editorial groups, including the ICMJE, World 
Association of Medical Journal Editors, and the Council of Science 
Editors, have given their official support to CONSORT. We invite other 
journals concerned about the quality of reporting of clinical trials to 
endorse the CONSORT statement and contact us through our website to let 
us know of their support. The ultimate benefactors of these collective 
efforts should be people who, for whatever reason, require intervention 
from the healthcare community.</p></div></div><div class="section notes" id="notes-2"><h2>Notes</h2><p id="p-261"><strong>Cite this as:</strong> <em>BMJ</em> 2010;340:c869</p></div><div class="section fn-group" id="fn-group-1"><h2>Footnotes</h2><ul><li class="fn" id="fn-1"><p id="p-257">We
 are grateful to Frank Davidoff and Tom Lang for their involvement in 
the 2001 version of CONSORT explanation and elaboration document. A 
special thanks to Mary Ocampo, the Ottawa CONSORT coordinator, who 
helped deliver this explanation and elaboration paper and the CONSORT 
statement.  </p></li><li class="fn-participating-researchers" id="fn-2"><p id="p-258">The
 CONSORT Group contributors to CONSORT 2010: Douglas G Altman, Centre 
for Statistics in Medicine, University of Oxford, UK; Virginia Barbour, <em>PLoS Medicine</em>,
 UK; Jesse A Berlin, Johnson &amp; Johnson Pharmaceutical Research and 
Development, USA; Isabelle Boutron, University Paris 7 Denis Diderot, 
Assistance Publique des Hôpitaux de Paris, INSERM, France; PJ Devereaux,
 McMaster University, Canada; Kay Dickersin, Johns Hopkins Bloomberg 
School of Public Health, USA; Diana Elbourne, London School of Hygiene 
&amp; Tropical Medicine, UK; Susan Ellenberg, University of Pennsylvania
 School of Medicine, USA; Val Gebski, University of Sydney, Australia; 
Steven Goodman, <em>Journal of the Society for Clinical Trials</em>, USA; Peter C Gøtzsche, Nordic Cochrane Centre, Denmark; Trish Groves, <em>BMJ</em>,
 UK; Steven Grunberg, American Society of Clinical Oncology, USA; Brian 
Haynes, McMaster University, Canada; Sally Hopewell, Centre for 
Statistics in Medicine, University of Oxford, UK; Astrid James, <em>Lancet</em>;
 Peter Juhn, Johnson &amp; Johnson, USA; Philippa Middleton, University 
of Adelaide, Australia; Don Minckler, University of California Irvine, 
USA; David Moher, Ottawa Methods Centre, Clinical Epidemiology Program, 
Ottawa Hospital Research Institute, Canada; Victor M Montori, Knowledge 
and Encounter Research Unit, Mayo Clinic College of Medicine, USA; 
Cynthia Mulrow, <em>Annals of Internal Medicine</em>, USA; Stuart Pocock, London School of Hygiene &amp; Tropical Medicine, UK; Drummond Rennie, <em>JAMA</em>, USA; David L Schriger, <em>Annals of Emergency Medicine</em>, USA; Kenneth F Schulz, Family Health International, USA; Iveta Simera, EQUATOR Network, UK; Elizabeth Wager, Sideview, UK.</p></li><li class="fn-financial-disclosure" id="fn-3"><p id="p-259">Funding:
 We gratefully acknowledge financial support from United Kingdom 
National Institute for Health Research; Canadian Institutes of Health 
Research; Presidents Fund, Canadian Institutes of Health Research; 
Johnson &amp; Johnson; <em>BMJ</em>; and the American Society for Clinical Oncology.</p></li><li class="fn" id="fn-4"><p id="p-260">In
 order to encourage dissemination of the CONSORT 2010 Statement, this 
article is freely accessible on bmj.com and will also be published in 
the <em>Journal of Clinical Epidemiology</em>. The authors jointly hold the copyright of this article. For details on further use, see the CONSORT website (<a href="http://www.consort-statement.org/">www.consort-statement.org</a>).</p></li></ul></div><div class="license" id="license-1"><p id="p-1">This
 is an open-access article distributed under the terms of the Creative 
Commons Attribution Non-commercial License, which permits use, 
distribution, and reproduction in any medium, provided the original work
 is properly cited, the use is non commercial and is otherwise in 
compliance with the license. See: <a href="http://creativecommons.org/licenses/by-nc/2.0/">http://creativecommons.org/licenses/by-nc/2.0/</a>  and  <a href="http://creativecommons.org/licenses/by-nc/2.0/legalcode">http://creativecommons.org/licenses/by-nc/2.0/legalcode</a>.</p></div><div class="section ref-list" id="ref-list-1"><h2>References</h2><ol class="cit-list"><li><a class="rev-xref-ref" href="#xref-ref-1-1" title="View reference 1 in text" id="ref-1">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.1" data-doi="10.1001/jama.285.15.2006"><div class="cit-metadata"><cite>Rennie D. CONSORT revised—improving the reporting of randomized trials. <abbr class="cit-jnl-abbrev">JAMA</abbr><span class="cit-pub-date">2001</span>;<span class="cit-vol">285</span>:<span class="cit-fpage">2006</span>-7.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DJAMA%26rft.stitle%253DJAMA%26rft.issn%253D0002-9955%26rft.aulast%253DRennie%26rft.auinit1%253DD.%26rft.volume%253D285%26rft.issue%253D15%26rft.spage%253D2006%26rft.epage%253D2007%26rft.atitle%253DCONSORT%2BRevised--Improving%2Bthe%2BReporting%2Bof%2BRandomized%2BTrials%26rft_id%253Dinfo%253Adoi%252F10.1001%252Fjama.285.15.2006%26rft_id%253Dinfo%253Apmid%252F11308440%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=10.1001/jama.285.15.2006&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=11308440&amp;link_type=MED&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>Medline</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=000167995900032&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-2-1" title="View reference 2 in text" id="ref-2">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.2" data-doi="10.1001/jama.1995.03520290060030"><div class="cit-metadata"><cite>Schulz
 KF, Chalmers I, Hayes RJ, Altman DG. Empirical evidence of bias. 
Dimensions of methodological quality associated with estimates of 
treatment effects in controlled trials. <abbr class="cit-jnl-abbrev">JAMA</abbr><span class="cit-pub-date">1995</span>;<span class="cit-vol">273</span>:<span class="cit-fpage">408</span>-12.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DJAMA%26rft.stitle%253DJAMA%26rft.issn%253D0002-9955%26rft.aulast%253DSchulz%26rft.auinit1%253DK.%2BF.%26rft.volume%253D273%26rft.issue%253D5%26rft.spage%253D408%26rft.epage%253D412%26rft.atitle%253DEmpirical%2BEvidence%2Bof%2BBias%253A%2BDimensions%2Bof%2BMethodological%2BQuality%2BAssociated%2BWith%2BEstimates%2Bof%2BTreatment%2BEffects%2Bin%2BControlled%2BTrials%26rft_id%253Dinfo%253Adoi%252F10.1001%252Fjama.1995.03520290060030%26rft_id%253Dinfo%253Apmid%252F7823387%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=10.1001/jama.1995.03520290060030&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=7823387&amp;link_type=MED&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>Medline</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=A1995QD20300026&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-3-1" title="View reference 3 in text" id="ref-3">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.3" data-doi="10.1001/jama.279.18.1489"><div class="cit-metadata"><cite>Moher
 D. CONSORT: an evolving tool to help improve the quality of reports of 
randomized controlled trials. Consolidated Standards of Reporting 
Trials. <abbr class="cit-jnl-abbrev">JAMA</abbr><span class="cit-pub-date">1998</span>;<span class="cit-vol">279</span>:<span class="cit-fpage">1489</span>-91.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DJAMA%26rft.stitle%253DJAMA%26rft.issn%253D0002-9955%26rft.aulast%253DMoher%26rft.auinit1%253DD.%26rft.volume%253D279%26rft.issue%253D18%26rft.spage%253D1489%26rft.epage%253D1491%26rft.atitle%253DCONSORT%253A%2BAn%2BEvolving%2BTool%2Bto%2BHelp%2BImprove%2Bthe%2BQuality%2Bof%2BReports%2Bof%2BRandomized%2BControlled%2BTrials%26rft_id%253Dinfo%253Adoi%252F10.1001%252Fjama.279.18.1489%26rft_id%253Dinfo%253Apmid%252F9600488%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=10.1001/jama.279.18.1489&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=9600488&amp;link_type=MED&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>Medline</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=000073463500043&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-4-1" title="View reference 4 in text" id="ref-4">↵</a><div class="cit ref-cit ref-other" id="cit-340.mar23_1.c869.4"><div class="cit-metadata unstructured">Kjaergard
 LL, Villumsen J, Gluud C. Quality of randomised clinical trials affects
 estimates of intervention efficacy. 7th Cochrane Colloquium, Rome, 
Italy 1999.</div><div class="cit-extra"></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-5-1" title="View reference 5 in text" id="ref-5">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.5" data-doi="10.1136/bmj.323.7303.42"><div class="cit-metadata"><cite>Jüni P, Altman DG, Egger M. Systematic reviews in health care: Assessing the quality of controlled clinical trials. <abbr class="cit-jnl-abbrev">BMJ</abbr><span class="cit-pub-date">2001</span>;<span class="cit-vol">323</span>:<span class="cit-fpage">42</span>-6.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DBMJ%26rft.stitle%253DBMJ%26rft.issn%253D0007-1447%26rft.aulast%253DJuni%26rft.auinit1%253DP.%26rft.volume%253D323%26rft.issue%253D7303%26rft.spage%253D42%26rft.epage%253D46%26rft.atitle%253DSystematic%2Breviews%2Bin%2Bhealth%2Bcare%253A%2BAssessing%2Bthe%2Bquality%2Bof%2Bcontrolled%2Bclinical%2Btrials%26rft_id%253Dinfo%253Adoi%252F10.1136%252Fbmj.323.7303.42%26rft_id%253Dinfo%253Apmid%252F11440947%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/ijlink?linkType=FULL&amp;journalCode=bmj&amp;resid=323/7303/42&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-ijlink"><span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-6-1" title="View reference 6 in text" id="ref-6">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.6"><div class="cit-metadata"><cite>Veldhuyzen
 van Zanten SJ, Cleary C, Talley NJ, Peterson TC, Nyren O, Bradley LA, 
et al. Drug treatment of functional dyspepsia: a systematic analysis of 
trial methodology with recommendations for design of future trials. <abbr class="cit-jnl-abbrev">Am J Gastroenterol</abbr><span class="cit-pub-date">1996</span>;<span class="cit-vol">91</span>:<span class="cit-fpage">660</span>-73.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DThe%2BAmerican%2Bjournal%2Bof%2Bgastroenterology%26rft.stitle%253DAm%2BJ%2BGastroenterol%26rft.aulast%253DVeldhuyzen%2Bvan%2BZanten%26rft.auinit1%253DS.%2BJ.%26rft.volume%253D91%26rft.issue%253D4%26rft.spage%253D660%26rft.epage%253D673%26rft.atitle%253DDrug%2Btreatment%2Bof%2Bfunctional%2Bdyspepsia%253A%2Ba%2Bsystematic%2Banalysis%2Bof%2Btrial%2Bmethodology%2Bwith%2Brecommendations%2Bfor%2Bdesign%2Bof%2Bfuture%2Btrials.%26rft_id%253Dinfo%253Apmid%252F8677926%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=8677926&amp;link_type=MED&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>Medline</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=A1996UE70100008&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-7-1" title="View reference 7 in text" id="ref-7">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.7"><div class="cit-metadata"><cite>Talley
 NJ, Owen BK, Boyce P, Paterson K. Psychological treatments for 
irritable bowel syndrome: a critique of controlled treatment trials. <abbr class="cit-jnl-abbrev">Am J Gastroenterol</abbr><span class="cit-pub-date">1996</span>;<span class="cit-vol">91</span>:<span class="cit-fpage">277</span>-83.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DThe%2BAmerican%2Bjournal%2Bof%2Bgastroenterology%26rft.stitle%253DAm%2BJ%2BGastroenterol%26rft.aulast%253DTalley%26rft.auinit1%253DN.%2BJ.%26rft.volume%253D91%26rft.issue%253D2%26rft.spage%253D277%26rft.epage%253D283%26rft.atitle%253DPsychological%2Btreatments%2Bfor%2Birritable%2Bbowel%2Bsyndrome%253A%2Ba%2Bcritique%2Bof%2Bcontrolled%2Btreatment%2Btrials.%26rft_id%253Dinfo%253Apmid%252F8607493%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=8607493&amp;link_type=MED&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>Medline</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=A1996TV54400014&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-8-1" title="View reference 8 in text" id="ref-8">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.8" data-doi="10.1001/archderm.136.3.381"><div class="cit-metadata"><cite>Adetugbo K, Williams H. How well are randomized controlled trials reported in the dermatology literature? <abbr class="cit-jnl-abbrev">Arch Dermatol</abbr><span class="cit-pub-date">2000</span>;<span class="cit-vol">136</span>:<span class="cit-fpage">381</span>-5.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DArchives%2Bof%2BDermatology%26rft.stitle%253DArch%2BDermatol%26rft.issn%253D0003-987X%26rft.aulast%253DAdetugbo%26rft.auinit1%253DK.%26rft.volume%253D136%26rft.issue%253D3%26rft.spage%253D381%26rft.epage%253D385%26rft.atitle%253DHow%2BWell%2BAre%2BRandomized%2BControlled%2BTrials%2BReported%2Bin%2Bthe%2BDermatology%2BLiterature%253F%26rft_id%253Dinfo%253Adoi%252F10.1001%252Farchderm.136.3.381%26rft_id%253Dinfo%253Apmid%252F10724201%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=10.1001/archderm.136.3.381&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=10724201&amp;link_type=MED&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>Medline</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=000085879900015&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-9-1" title="View reference 9 in text" id="ref-9">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.9" data-doi="10.1002/hep.510300510"><div class="cit-metadata"><cite>Kjaergard LL, Nikolova D, Gluud C. Randomized clinical trials in HEPATOLOGY: predictors of quality. <abbr class="cit-jnl-abbrev">Hepatology</abbr><span class="cit-pub-date">1999</span>;<span class="cit-vol">30</span>:<span class="cit-fpage">1134</span>-8.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DHepatology%2B%2528Baltimore%252C%2BMd.%2529%26rft.stitle%253DHepatology%26rft.aulast%253DKjaergard%26rft.auinit1%253DL.%2BL.%26rft.volume%253D30%26rft.issue%253D5%26rft.spage%253D1134%26rft.epage%253D1138%26rft.atitle%253DRandomized%2Bclinical%2Btrials%2Bin%2BHEPATOLOGY%253A%2Bpredictors%2Bof%2Bquality.%26rft_id%253Dinfo%253Adoi%252F10.1002%252Fhep.510300510%26rft_id%253Dinfo%253Apmid%252F10534332%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=10.1002/hep.510300510&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=10534332&amp;link_type=MED&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>Medline</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=000083424500004&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-10-1" title="View reference 10 in text" id="ref-10">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.10" data-doi="10.1001/jama.1966.03100130097026"><div class="cit-metadata"><cite>Schor S, Karten I. Statistical evaluation of medical journal manuscripts. <abbr class="cit-jnl-abbrev">JAMA</abbr><span class="cit-pub-date">1966</span>;<span class="cit-vol">195</span>:<span class="cit-fpage">1123</span>-8.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DJAMA%26rft.stitle%253DJAMA%26rft.issn%253D0002-9955%26rft.aulast%253DSchor%26rft.auinit1%253DS.%26rft.volume%253D195%26rft.issue%253D13%26rft.spage%253D1123%26rft.epage%253D1128%26rft.atitle%253DStatistical%2BEvaluation%2Bof%2BMedical%2BJournal%2BManuscripts%26rft_id%253Dinfo%253Adoi%252F10.1001%252Fjama.1966.03100130097026%26rft_id%253Dinfo%253Apmid%252F5952081%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=10.1001/jama.1966.03100130097026&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=5952081&amp;link_type=MED&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>Medline</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-11-1" title="View reference 11 in text" id="ref-11">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.11" data-doi="10.1136/bmj.1.6053.85"><div class="cit-metadata"><cite>Gore SM, Jones IG, Rytter EC. Misuse of statistical methods: critical assessment of articles in BMJ from January to March 1976. <abbr class="cit-jnl-abbrev">BMJ</abbr><span class="cit-pub-date">1977</span>;<span class="cit-vol">1</span>:<span class="cit-fpage">85</span>-7.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DBMJ%26rft.stitle%253DBMJ%26rft.issn%253D0007-1447%26rft.aulast%253DGore%26rft.auinit1%253DS%2BM%26rft.volume%253D1%26rft.issue%253D6053%26rft.spage%253D85%26rft.epage%253D87%26rft.atitle%253DMisuse%2Bof%2Bstatistical%2Bmethods%253A%2Bcritical%2Bassessment%2Bof%2Barticles%2Bin%2BBMJ%2Bfrom%2BJanuary%2Bto%2BMarch%2B1976.%26rft_id%253Dinfo%253Adoi%252F10.1136%252Fbmj.1.6053.85%26rft_id%253Dinfo%253Apmid%252F832023%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/ijlink?linkType=ABST&amp;journalCode=bmj&amp;resid=1/6053/85&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-ijlink"><span><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-12-1" title="View reference 12 in text" id="ref-12">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.12" data-doi="10.1111/j.1445-2197.1982.tb06050.x"><div class="cit-metadata"><cite>Hall JC, Hill D, Watts JM. Misuse of statistical methods in the Australasian surgical literature. <abbr class="cit-jnl-abbrev">Aust N Z J Surg</abbr><span class="cit-pub-date">1982</span>;<span class="cit-vol">52</span>:<span class="cit-fpage">541</span>-3.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DThe%2BAustralian%2Band%2BNew%2BZealand%2Bjournal%2Bof%2Bsurgery%26rft.stitle%253DAust%2BN%2BZ%2BJ%2BSurg%26rft.aulast%253DHall%26rft.auinit1%253DJ.%2BC.%26rft.volume%253D52%26rft.issue%253D5%26rft.spage%253D541%26rft.epage%253D543%26rft.atitle%253DMisuse%2Bof%2Bstatistical%2Bmethods%2Bin%2Bthe%2BAustralasian%2Bsurgical%2Bliterature.%26rft_id%253Dinfo%253Adoi%252F10.1111%252Fj.1445-2197.1982.tb06050.x%26rft_id%253Dinfo%253Apmid%252F6959608%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=10.1111/j.1445-2197.1982.tb06050.x&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=6959608&amp;link_type=MED&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>Medline</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=A1982QA62600022&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-13-1" title="View reference 13 in text" id="ref-13">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.13" data-doi="10.1002/sim.4780010109"><div class="cit-metadata"><cite>Altman DG. Statistics in medical journals. <abbr class="cit-jnl-abbrev">Stat Med</abbr><span class="cit-pub-date">1982</span>;<span class="cit-vol">1</span>:<span class="cit-fpage">59</span>-71.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DStatistics%2Bin%2Bmedicine%26rft.stitle%253DStat%2BMed%26rft.aulast%253DAltman%26rft.auinit1%253DD.%2BG.%26rft.volume%253D1%26rft.issue%253D1%26rft.spage%253D59%26rft.epage%253D71%26rft.atitle%253DStatistics%2Bin%2Bmedical%2Bjournals.%26rft_id%253Dinfo%253Adoi%252F10.1002%252Fsim.4780010109%26rft_id%253Dinfo%253Apmid%252F7187083%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=10.1002/sim.4780010109&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=7187083&amp;link_type=MED&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>Medline</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-14-1" title="View reference 14 in text" id="ref-14">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.14" data-doi="10.1056/NEJM198708133170706"><div class="cit-metadata"><cite>Pocock SJ, Hughes MD, Lee RJ. Statistical problems in the reporting of clinical trials. A survey of three medical journals. <abbr class="cit-jnl-abbrev">N Engl J Med</abbr><span class="cit-pub-date">1987</span>;<span class="cit-vol">317</span>:<span class="cit-fpage">426</span>-32.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DNew%2BEngland%2BJournal%2Bof%2BMedicine%26rft.stitle%253DNEJM%26rft.issn%253D0028-4793%26rft.aulast%253DPocock%26rft.auinit1%253DS.%2BJ.%26rft.volume%253D317%26rft.issue%253D7%26rft.spage%253D426%26rft.epage%253D432%26rft.atitle%253DStatistical%2Bproblems%2Bin%2Bthe%2Breporting%2Bof%2Bclinical%2Btrials.%2BA%2Bsurvey%2Bof%2Bthree%2Bmedical%2Bjournals%26rft_id%253Dinfo%253Adoi%252F10.1056%252FNEJM198708133170706%26rft_id%253Dinfo%253Apmid%252F3614286%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=10.1056/NEJM198708133170706&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=3614286&amp;link_type=MED&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>Medline</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=A1987J520400006&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-15-1" title="View reference 15 in text" id="ref-15">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.15" data-doi="10.1136/bmj.308.6924.283"><div class="cit-metadata"><cite>Altman DG. The scandal of poor medical research. <abbr class="cit-jnl-abbrev">BMJ</abbr><span class="cit-pub-date">1994</span>;<span class="cit-vol">308</span>:<span class="cit-fpage">283</span>-4.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DBMJ%26rft.stitle%253DBMJ%26rft.issn%253D0007-1447%26rft.aulast%253DAltman%26rft.auinit1%253DD%2BG%26rft.volume%253D308%26rft.issue%253D6924%26rft.spage%253D283%26rft.epage%253D284%26rft.atitle%253DThe%2Bscandal%2Bof%2Bpoor%2Bmedical%2Bresearch%26rft_id%253Dinfo%253Adoi%252F10.1136%252Fbmj.308.6924.283%26rft_id%253Dinfo%253Apmid%252F8124111%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/ijlink?linkType=FULL&amp;journalCode=bmj&amp;resid=308/6924/283&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-ijlink"><span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-16-1" title="View reference 16 in text" id="ref-16">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.16" data-doi="10.1016/S0140-6736(05)71879-1"><div class="cit-metadata"><cite>Chan AW, Altman DG. Epidemiology and reporting of randomised trials published in PubMed journals. <abbr class="cit-jnl-abbrev">Lancet</abbr><span class="cit-pub-date">2005</span>;<span class="cit-vol">365</span>:<span class="cit-fpage">1159</span>-62.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DLancet%26rft.stitle%253DLancet%26rft.aulast%253DChan%26rft.auinit1%253DA.%2BW.%26rft.volume%253D365%26rft.issue%253D9465%26rft.spage%253D1159%26rft.epage%253D1162%26rft.atitle%253DEpidemiology%2Band%2Breporting%2Bof%2Brandomised%2Btrials%2Bpublished%2Bin%2BPubMed%2Bjournals.%26rft_id%253Dinfo%253Adoi%252F10.1016%252FS0140-6736%252805%252971879-1%26rft_id%253Dinfo%253Apmid%252F15794971%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=10.1016/S0140-6736%2805%2971879-1&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=15794971&amp;link_type=MED&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>Medline</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=000227909500029&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-17-1" title="View reference 17 in text" id="ref-17">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.17" data-doi="10.1136/bmj.c723"><div class="cit-metadata"><cite>Hopewell
 S, Dutton S, Yu LM, Chan AW, Altman DG. The quality of reports of 
randomised trials in 2000 and 2006: comparative study of articles 
indexed in PubMed. <abbr class="cit-jnl-abbrev">BMJ</abbr><span class="cit-pub-date">2010</span>;<span class="cit-vol">340</span>:<span class="cit-fpage">c723</span></cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DBMJ%26rft_id%253Dinfo%253Adoi%252F10.1136%252Fbmj.c723%26rft_id%253Dinfo%253Apmid%252F20332510%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/ijlink?linkType=ABST&amp;journalCode=bmj&amp;resid=340/mar23_1/c723&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-ijlink"><span><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-18-1" title="View reference 18 in text" id="ref-18">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.18" data-doi="10.1136/bmj.319.7211.670"><div class="cit-metadata"><cite>Hollis S, Campbell F. What is meant by intention to treat analysis? Survey of published randomised controlled trials. <abbr class="cit-jnl-abbrev">BMJ</abbr><span class="cit-pub-date">1999</span>;<span class="cit-vol">319</span>:<span class="cit-fpage">670</span>-4.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DBMJ%26rft.stitle%253DBMJ%26rft.issn%253D0007-1447%26rft.aulast%253DHollis%26rft.auinit1%253DS.%26rft.volume%253D319%26rft.issue%253D7211%26rft.spage%253D670%26rft.epage%253D674%26rft.atitle%253DWhat%2Bis%2Bmeant%2Bby%2Bintention%2Bto%2Btreat%2Banalysis%253F%2BSurvey%2Bof%2Bpublished%2Brandomised%2Bcontrolled%2Btrials%26rft_id%253Dinfo%253Adoi%252F10.1136%252Fbmj.319.7211.670%26rft_id%253Dinfo%253Apmid%252F10480822%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/ijlink?linkType=ABST&amp;journalCode=bmj&amp;resid=319/7211/670&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-ijlink"><span><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-19-1" title="View reference 19 in text" id="ref-19">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.19" data-doi="10.1080/09286580701344399"><div class="cit-metadata"><cite>Lai
 TY, Wong VW, Lam RF, Cheng AC, Lam DS, Leung GM. Quality of reporting 
of key methodological items of randomized controlled trials in clinical 
ophthalmic journals. <abbr class="cit-jnl-abbrev">Ophthalmic Epidemiol</abbr><span class="cit-pub-date">2007</span>;<span class="cit-vol">14</span>:<span class="cit-fpage">390</span>-8.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DOphthalmic%2Bepidemiology%26rft.stitle%253DOphthalmic%2BEpidemiol%26rft.aulast%253DLai%26rft.auinit1%253DT.%2BY.%26rft.volume%253D14%26rft.issue%253D6%26rft.spage%253D390%26rft.epage%253D398%26rft.atitle%253DQuality%2Bof%2Breporting%2Bof%2Bkey%2Bmethodological%2Bitems%2Bof%2Brandomized%2Bcontrolled%2Btrials%2Bin%2Bclinical%2Bophthalmic%2Bjournals.%26rft_id%253Dinfo%253Adoi%252F10.1080%252F09286580701344399%26rft_id%253Dinfo%253Apmid%252F18161613%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=10.1080/09286580701344399&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=18161613&amp;link_type=MED&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>Medline</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=000251932000009&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-20-1" title="View reference 20 in text" id="ref-20">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.20" data-doi="10.1016/S0140-6736(96)90538-3"><div class="cit-metadata"><cite>Moher
 D, Fortin P, Jadad AR, Jüni P, Klassen T, Le LJ, et al. Completeness of
 reporting of trials published in languages other than English: 
implications for conduct and reporting of systematic reviews. <abbr class="cit-jnl-abbrev">Lancet</abbr><span class="cit-pub-date">1996</span>;<span class="cit-vol">347</span>:<span class="cit-fpage">363</span>-6.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DLancet%26rft.stitle%253DLancet%26rft.aulast%253DMoher%26rft.auinit1%253DD.%26rft.volume%253D347%26rft.issue%253D8998%26rft.spage%253D363%26rft.epage%253D366%26rft.atitle%253DCompleteness%2Bof%2Breporting%2Bof%2Btrials%2Bpublished%2Bin%2Blanguages%2Bother%2Bthan%2BEnglish%253A%2Bimplications%2Bfor%2Bconduct%2Band%2Breporting%2Bof%2Bsystematic%2Breviews.%26rft_id%253Dinfo%253Adoi%252F10.1016%252FS0140-6736%252896%252990538-3%26rft_id%253Dinfo%253Apmid%252F8598702%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=10.1016/S0140-6736%2896%2990538-3&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=8598702&amp;link_type=MED&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>Medline</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=A1996TU69500010&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-21-1" title="View reference 21 in text" id="ref-21">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.21" data-doi="10.1001/jama.280.3.247"><div class="cit-metadata"><cite>Junker
 CA. Adherence to published standards of reporting: a comparison of 
placebo-controlled trials published in English or German. <abbr class="cit-jnl-abbrev">JAMA</abbr><span class="cit-pub-date">1998</span>;<span class="cit-vol">280</span>:<span class="cit-fpage">247</span>-9.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DJAMA%26rft.stitle%253DJAMA%26rft.issn%253D0002-9955%26rft.aulast%253DJunker%26rft.auinit1%253DC.%2BA.%26rft.volume%253D280%26rft.issue%253D3%26rft.spage%253D247%26rft.epage%253D249%26rft.atitle%253DAdherence%2Bto%2BPublished%2BStandards%2Bof%2BReporting%253A%2BA%2BComparison%2Bof%2BPlacebo-Controlled%2BTrials%2BPublished%2Bin%2BEnglish%2Bor%2BGerman%26rft_id%253Dinfo%253Adoi%252F10.1001%252Fjama.280.3.247%26rft_id%253Dinfo%253Apmid%252F9676671%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=10.1001/jama.280.3.247&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=9676671&amp;link_type=MED&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>Medline</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=000074706000016&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-22-1" title="View reference 22 in text" id="ref-22">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.22" data-doi="10.1136/bmj.302.6791.1481"><div class="cit-metadata"><cite>Altman DG. Randomisation. <abbr class="cit-jnl-abbrev">BMJ</abbr><span class="cit-pub-date">1991</span>;<span class="cit-vol">302</span>:<span class="cit-fpage">1481</span>-2.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DBMJ%26rft.stitle%253DBMJ%26rft.issn%253D0007-1447%26rft.aulast%253DAltman%26rft.auinit1%253DD%2BG%26rft.volume%253D302%26rft.issue%253D6791%26rft.spage%253D1481%26rft.epage%253D1482%26rft.atitle%253DRandomisation.%26rft_id%253Dinfo%253Adoi%252F10.1136%252Fbmj.302.6791.1481%26rft_id%253Dinfo%253Apmid%252F1855013%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/ijlink?linkType=PDF&amp;journalCode=bmj&amp;resid=302/6791/1481&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-ijlink"><span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-23-1" title="View reference 23 in text" id="ref-23">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.23" data-doi="10.1001/jama.1994.03520020051014"><div class="cit-metadata"><cite>Schulz
 KF, Chalmers I, Grimes DA, Altman DG. Assessing the quality of 
randomization from reports of controlled trials published in obstetrics 
and gynecology journals. <abbr class="cit-jnl-abbrev">JAMA</abbr><span class="cit-pub-date">1994</span>;<span class="cit-vol">272</span>:<span class="cit-fpage">125</span>-8.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DJAMA%26rft.stitle%253DJAMA%26rft.issn%253D0002-9955%26rft.aulast%253DSchulz%26rft.auinit1%253DK.%2BF.%26rft.volume%253D272%26rft.issue%253D2%26rft.spage%253D125%26rft.epage%253D128%26rft.atitle%253DAssessing%2Bthe%2BQuality%2Bof%2BRandomization%2BFrom%2BReports%2Bof%2BControlled%2BTrials%2BPublished%2Bin%2BObstetrics%2Band%2BGynecology%2BJournals%26rft_id%253Dinfo%253Adoi%252F10.1001%252Fjama.1994.03520020051014%26rft_id%253Dinfo%253Apmid%252F8015122%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=10.1001/jama.1994.03520020051014&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=8015122&amp;link_type=MED&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>Medline</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=A1994NV42400012&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-24-1" title="View reference 24 in text" id="ref-24">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.24" data-doi="10.1136/bmj.2.4582.769"><div class="cit-metadata"><cite>Streptomycin treatment of pulmonary tuberculosis: a Medical Research Council investigation. <abbr class="cit-jnl-abbrev">BMJ</abbr><span class="cit-pub-date">1948</span>;<span class="cit-vol">2</span>:<span class="cit-fpage">769</span>-82.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DBMJ%26rft.stitle%253DBMJ%26rft.issn%253D0007-1447%26rft.volume%253D2%26rft.issue%253D4582%26rft.spage%253D769%26rft.epage%253D782%26rft.atitle%253DStreptomycin%2BTreatment%2Bof%2BPulmonary%2BTuberculosis%253A%2BA%2BMedical%2BResearch%2BCouncil%2BInvestigation%26rft_id%253Dinfo%253Adoi%252F10.1136%252Fbmj.2.4582.769%26rft_id%253Dinfo%253Apmid%252F18890300%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/ijlink?linkType=PDF&amp;journalCode=bmj&amp;resid=2/4582/769&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-ijlink"><span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-25-1" title="View reference 25 in text" id="ref-25">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.25" data-doi="10.1097/00003081-199806000-00005"><div class="cit-metadata"><cite>Schulz KF. Randomized controlled trials. <abbr class="cit-jnl-abbrev">Clin Obstet Gynecol</abbr><span class="cit-pub-date">1998</span>;<span class="cit-vol">41</span>:<span class="cit-fpage">245</span>-56.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DClinical%2Bobstetrics%2Band%2Bgynecology%26rft.stitle%253DClin%2BObstet%2BGynecol%26rft.aulast%253DSchulz%26rft.auinit1%253DK.%2BF.%26rft.volume%253D41%26rft.issue%253D2%26rft.spage%253D245%26rft.epage%253D256%26rft.atitle%253DRandomized%2Bcontrolled%2Btrials.%26rft_id%253Dinfo%253Adoi%252F10.1097%252F00003081-199806000-00005%26rft_id%253Dinfo%253Apmid%252F9646957%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=10.1097/00003081-199806000-00005&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=9646957&amp;link_type=MED&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>Medline</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=000074238400003&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-26-1" title="View reference 26 in text" id="ref-26">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.26" data-doi="10.1097/00001648-199011000-00003"><div class="cit-metadata"><cite>Greenland S. Randomization, statistics, and causal inference. <abbr class="cit-jnl-abbrev">Epidemiology</abbr><span class="cit-pub-date">1990</span>;<span class="cit-vol">1</span>:<span class="cit-fpage">421</span>-9.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DEpidemiology%2B%2528Cambridge%252C%2BMass.%2529%26rft.stitle%253DEpidemiology%26rft.aulast%253DGreenland%26rft.auinit1%253DS.%26rft.volume%253D1%26rft.issue%253D6%26rft.spage%253D421%26rft.epage%253D429%26rft.atitle%253DRandomization%252C%2Bstatistics%252C%2Band%2Bcausal%2Binference.%26rft_id%253Dinfo%253Adoi%252F10.1097%252F00001648-199011000-00003%26rft_id%253Dinfo%253Apmid%252F2090279%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=10.1097/00001648-199011000-00003&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=2090279&amp;link_type=MED&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>Medline</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-27-1" title="View reference 27 in text" id="ref-27">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.27" data-doi="10.1002/sim.4780010412"><div class="cit-metadata"><cite>Armitage P. The role of randomization in clinical trials. <abbr class="cit-jnl-abbrev">Stat Med</abbr><span class="cit-pub-date">1982</span>;<span class="cit-vol">1</span>:<span class="cit-fpage">345</span>-52.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DStatistics%2Bin%2Bmedicine%26rft.stitle%253DStat%2BMed%26rft.aulast%253DArmitage%26rft.auinit1%253DP.%26rft.volume%253D1%26rft.issue%253D4%26rft.spage%253D345%26rft.epage%253D352%26rft.atitle%253DThe%2Brole%2Bof%2Brandomization%2Bin%2Bclinical%2Btrials.%26rft_id%253Dinfo%253Adoi%252F10.1002%252Fsim.4780010412%26rft_id%253Dinfo%253Apmid%252F7187102%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=10.1002/sim.4780010412&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=7187102&amp;link_type=MED&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>Medline</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-28-1" title="View reference 28 in text" id="ref-28">↵</a><div class="cit ref-cit ref-other" id="cit-340.mar23_1.c869.28"><div class="cit-metadata"><cite>Kleijnen
 J, Gøtzsche PC, Kunz R, Oxman AD, Chalmers I. So what’s so special 
about randomisation. In: Maynard A, Chalmers I, eds. <span class="cit-source">Non-random reflections on health services research</span>. BMJ Books, <span class="cit-pub-date">1997</span>:93-106.</cite></div><div class="cit-extra"></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-29-1" title="View reference 29 in text" id="ref-29">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.29" data-doi="10.1177/014107689709000706"><div class="cit-metadata"><cite>Chalmers I. Assembling comparison groups to assess the effects of health care. <abbr class="cit-jnl-abbrev">J R Soc Med</abbr><span class="cit-pub-date">1997</span>;<span class="cit-vol">90</span>:<span class="cit-fpage">379</span>-86.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DJournal%2Bof%2Bthe%2BRoyal%2BSociety%2Bof%2BMedicine%26rft.stitle%253DJ%2BR%2BSoc%2BMed%26rft.issn%253D0141-0768%26rft.aulast%253DChalmers%26rft.auinit1%253DI.%26rft.volume%253D90%26rft.issue%253D7%26rft.spage%253D379%26rft.epage%253D386%26rft.atitle%253DAssembling%2BComparison%2BGroups%2Bto%2BAssess%2Bthe%2BEffects%2Bof%2BHealth%2BCare%26rft_id%253Dinfo%253Adoi%252F10.1177%252F014107689709000706%26rft_id%253Dinfo%253Apmid%252F9290419%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/ijlink?linkType=PDF&amp;journalCode=spjrs&amp;resid=90/7/379&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-ijlink"><span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-30-1" title="View reference 30 in text" id="ref-30">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.30" data-doi="10.1001/jama.1989.03430150069028"><div class="cit-metadata"><cite>Nicolucci
 A, Grilli R, Alexanian AA, Apolone G, Torri V, Liberati A. Quality, 
evolution, and clinical implications of randomized, controlled trials on
 the treatment of lung cancer. A lost opportunity for meta-analysis. <abbr class="cit-jnl-abbrev">JAMA</abbr><span class="cit-pub-date">1989</span>;<span class="cit-vol">262</span>:<span class="cit-fpage">2101</span>-7.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DJAMA%26rft.stitle%253DJAMA%26rft.issn%253D0002-9955%26rft.aulast%253DNicolucci%26rft.auinit1%253DA.%26rft.volume%253D262%26rft.issue%253D15%26rft.spage%253D2101%26rft.epage%253D2107%26rft.atitle%253DQuality%252C%2BEvolution%252C%2Band%2BClinical%2BImplications%2Bof%2BRandomized%252C%2BControlled%2BTrials%2Bon%2Bthe%2BTreatment%2Bof%2BLung%2BCancer%253A%2BA%2BLost%2BOpportunity%2Bfor%2BMeta-analysis%26rft_id%253Dinfo%253Adoi%252F10.1001%252Fjama.1989.03430150069028%26rft_id%253Dinfo%253Apmid%252F2677423%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=10.1001/jama.1989.03430150069028&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=2677423&amp;link_type=MED&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>Medline</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=A1989AU86000021&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-31-1" title="View reference 31 in text" id="ref-31">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.31"><div class="cit-metadata"><cite>Ah-See KW, Molony NC. A qualitative assessment of randomized controlled trials in otolaryngology. <abbr class="cit-jnl-abbrev">J Laryngol Otol</abbr><span class="cit-pub-date">1998</span>;<span class="cit-vol">112</span>:<span class="cit-fpage">460</span>-3.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DThe%2BJournal%2Bof%2Blaryngology%2Band%2Botology%26rft.stitle%253DJ%2BLaryngol%2BOtol%26rft.aulast%253DAh-See%26rft.auinit1%253DK.%2BW.%26rft.volume%253D112%26rft.issue%253D5%26rft.spage%253D460%26rft.epage%253D463%26rft.atitle%253DA%2Bqualitative%2Bassessment%2Bof%2Brandomized%2Bcontrolled%2Btrials%2Bin%2Botolaryngology.%26rft_id%253Dinfo%253Apmid%252F9747475%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=9747475&amp;link_type=MED&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>Medline</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=000074246600010&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-32-1" title="View reference 32 in text" id="ref-32">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.32" data-doi="10.1016/0140-6736(90)90014-V"><div class="cit-metadata"><cite>Altman DG, Doré CJ. Randomisation and baseline comparisons in clinical trials. <abbr class="cit-jnl-abbrev">Lancet</abbr><span class="cit-pub-date">1990</span>;<span class="cit-vol">335</span>:<span class="cit-fpage">149</span>-53.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DLancet%26rft.stitle%253DLancet%26rft.aulast%253DAltman%26rft.auinit1%253DD.%2BG.%26rft.volume%253D335%26rft.issue%253D8682%26rft.spage%253D149%26rft.epage%253D153%26rft.atitle%253DRandomisation%2Band%2Bbaseline%2Bcomparisons%2Bin%2Bclinical%2Btrials.%26rft_id%253Dinfo%253Adoi%252F10.1016%252F0140-6736%252890%252990014-V%26rft_id%253Dinfo%253Apmid%252F1967441%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=10.1016/0140-6736%2890%2990014-V&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=1967441&amp;link_type=MED&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>Medline</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=A1990CJ97900013&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-33-1" title="View reference 33 in text" id="ref-33">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.33" data-doi="10.1136/bmj.317.7167.1181"><div class="cit-metadata"><cite>Thornley B, Adams C. Content and quality of 2000 controlled trials in schizophrenia over 50 years. <abbr class="cit-jnl-abbrev">BMJ</abbr><span class="cit-pub-date">1998</span>;<span class="cit-vol">317</span>:<span class="cit-fpage">1181</span>-4.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DBMJ%26rft.stitle%253DBMJ%26rft.issn%253D0007-1447%26rft.aulast%253DThornley%26rft.auinit1%253DB.%26rft.volume%253D317%26rft.issue%253D7167%26rft.spage%253D1181%26rft.epage%253D1184%26rft.atitle%253DContent%2Band%2Bquality%2Bof%2B2000%25A0controlled%2Btrials%2Bin%2Bschizophrenia%2Bover%2B50%25A0years%26rft_id%253Dinfo%253Adoi%252F10.1136%252Fbmj.317.7167.1181%26rft_id%253Dinfo%253Apmid%252F9794850%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/ijlink?linkType=ABST&amp;journalCode=bmj&amp;resid=317/7167/1181&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-ijlink"><span><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-34-1" title="View reference 34 in text" id="ref-34">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.34" data-doi="10.1056/NEJM198206033062204"><div class="cit-metadata"><cite>DerSimonian R, Charette LJ, McPeek B, Mosteller F. Reporting on methods in clinical trials. <abbr class="cit-jnl-abbrev">N Engl J Med</abbr><span class="cit-pub-date">1982</span>;<span class="cit-vol">306</span>:<span class="cit-fpage">1332</span>-7.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DNew%2BEngland%2BJournal%2Bof%2BMedicine%26rft.stitle%253DNEJM%26rft.issn%253D0028-4793%26rft.aulast%253DDerSimonian%26rft.auinit1%253DR.%26rft.volume%253D306%26rft.issue%253D22%26rft.spage%253D1332%26rft.epage%253D1337%26rft.atitle%253DReporting%2Bon%2Bmethods%2Bin%2Bclinical%2Btrials%26rft_id%253Dinfo%253Adoi%252F10.1056%252FNEJM198206033062204%26rft_id%253Dinfo%253Apmid%252F7070458%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=10.1056/NEJM198206033062204&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=7070458&amp;link_type=MED&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>Medline</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=A1982NR61600004&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-35-1" title="View reference 35 in text" id="ref-35">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.35" data-doi="10.1001/jama.1994.03520240054041"><div class="cit-metadata"><cite>A proposal for structured reporting of randomized controlled trials. The Standards of Reporting Trials Group. <abbr class="cit-jnl-abbrev">JAMA</abbr><span class="cit-pub-date">1994</span>;<span class="cit-vol">272</span>:<span class="cit-fpage">1926</span>-31.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DJAMA%26rft.stitle%253DJAMA%26rft.issn%253D0002-9955%26rft.aulast%253DThe%2BStandards%2Bof%2BReporting%2BTrials%2BGroup%26rft.auinit1%253D%2B%26rft.volume%253D272%26rft.issue%253D24%26rft.spage%253D1926%26rft.epage%253D1931%26rft.atitle%253DA%2BProposal%2Bfor%2BStructured%2BReporting%2Bof%2BRandomized%2BControlled%2BTrials%26rft_id%253Dinfo%253Adoi%252F10.1001%252Fjama.1994.03520240054041%26rft_id%253Dinfo%253Apmid%252F7990245%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=10.1001/jama.1994.03520240054041&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=7990245&amp;link_type=MED&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>Medline</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=A1994PX92700038&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-36-1" title="View reference 36 in text" id="ref-36">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.36"><div class="cit-metadata"><cite>Call
 for comments on a proposal to improve reporting of clinical trials in 
the biomedical literature. Working Group on Recommendations for 
Reporting of Clinical Trials in the Biomedical Literature. <abbr class="cit-jnl-abbrev">Ann Intern Med</abbr><span class="cit-pub-date">1994</span>;<span class="cit-vol">121</span>:<span class="cit-fpage">894</span>-5.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DAnnals%2Bof%2BInternal%2BMedicine%26rft.stitle%253DANN%2BINTERN%2BMED%26rft.issn%253D0003-4819%26rft.aulast%253DWorking%2BGroup%2Bon%2BRecommendations%2Bfor%2BReporting%2Bof%26rft.auinit1%253D%2B%26rft.volume%253D121%26rft.issue%253D11%26rft.spage%253D894%26rft.epage%253D895%26rft.atitle%253DCall%2Bfor%2BComments%2Bon%2Ba%2BProposal%2BTo%2BImprove%2BReporting%2Bof%2BClinical%2BTrials%2Bin%2Bthe%2BBiomedical%2BLiterature%26rft_id%253Dinfo%253Apmid%252F7978706%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=7978706&amp;link_type=MED&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>Medline</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=A1994PT62800015&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-37-1" title="View reference 37 in text" id="ref-37">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.37" data-doi="10.1001/jama.1995.03520370096044"><div class="cit-metadata"><cite>Rennie D. Reporting randomized controlled trials. An experiment and a call for responses from readers. <abbr class="cit-jnl-abbrev">JAMA</abbr><span class="cit-pub-date">1995</span>;<span class="cit-vol">273</span>:<span class="cit-fpage">1054</span>-5.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DJAMA%26rft.stitle%253DJAMA%26rft.issn%253D0002-9955%26rft.aulast%253DRennie%26rft.auinit1%253DD.%26rft.volume%253D273%26rft.issue%253D13%26rft.spage%253D1054%26rft.epage%253D1055%26rft.atitle%253DReporting%2BRandomized%2BControlled%2BTrials%253A%2BAn%2BExperiment%2Band%2Ba%2BCall%2Bfor%2BResponses%2BFrom%2BReaders%26rft_id%253Dinfo%253Adoi%252F10.1001%252Fjama.1995.03520370096044%26rft_id%253Dinfo%253Apmid%252F7897791%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=10.1001/jama.1995.03520370096044&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=7897791&amp;link_type=MED&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>Medline</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=A1995QP89000038&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-38-1" title="View reference 38 in text" id="ref-38">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.38" data-doi="10.1001/jama.1996.03540080059030"><div class="cit-metadata"><cite>Begg
 C, Cho M, Eastwood S, Horton R, Moher D, Olkin I, et al. Improving the 
quality of reporting of randomized controlled trials: the CONSORT 
statement. <abbr class="cit-jnl-abbrev">JAMA</abbr><span class="cit-pub-date">1996</span>;<span class="cit-vol">276</span>:<span class="cit-fpage">637</span>-9.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DJAMA%26rft.stitle%253DJAMA%26rft.issn%253D0002-9955%26rft.aulast%253DBegg%26rft.auinit1%253DC.%26rft.volume%253D276%26rft.issue%253D8%26rft.spage%253D637%26rft.epage%253D639%26rft.atitle%253DImproving%2Bthe%2BQuality%2Bof%2BReporting%2Bof%2BRandomized%2BControlled%2BTrials%253A%2BThe%2BCONSORT%2BStatement%26rft_id%253Dinfo%253Adoi%252F10.1001%252Fjama.1996.03540080059030%26rft_id%253Dinfo%253Apmid%252F8773637%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=10.1001/jama.1996.03540080059030&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=8773637&amp;link_type=MED&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>Medline</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=A1996VC85300031&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-39-1" title="View reference 39 in text" id="ref-39">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.39" data-doi="10.1001/jama.295.10.1152"><div class="cit-metadata"><cite>Piaggio
 G, Elbourne DR, Altman DG, Pocock SJ, Evans SJ. Reporting of 
noninferiority and equivalence randomized trials: an extension of the 
CONSORT statement. <abbr class="cit-jnl-abbrev">JAMA</abbr><span class="cit-pub-date">2006</span>;<span class="cit-vol">295</span>:<span class="cit-fpage">1152</span>-60.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DJAMA%26rft.stitle%253DJAMA%26rft.issn%253D0002-9955%26rft.aulast%253DPiaggio%26rft.auinit1%253DG.%26rft.volume%253D295%26rft.issue%253D10%26rft.spage%253D1152%26rft.epage%253D1160%26rft.atitle%253DReporting%2Bof%2BNoninferiority%2Band%2BEquivalence%2BRandomized%2BTrials%253A%2BAn%2BExtension%2Bof%2Bthe%2BCONSORT%2BStatement%26rft_id%253Dinfo%253Adoi%252F10.1001%252Fjama.295.10.1152%26rft_id%253Dinfo%253Apmid%252F16522836%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=10.1001/jama.295.10.1152&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=16522836&amp;link_type=MED&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>Medline</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=000235822500024&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-40-1" title="View reference 40 in text" id="ref-40">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.40" data-doi="10.1136/bmj.328.7441.702"><div class="cit-metadata"><cite>Campbell MK, Elbourne DR, Altman DG. CONSORT statement: extension to cluster randomised trials. <abbr class="cit-jnl-abbrev">BMJ</abbr><span class="cit-pub-date">2004</span>;<span class="cit-vol">328</span>:<span class="cit-fpage">702</span>-8.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DBMJ%26rft.stitle%253DBMJ%26rft.issn%253D0007-1447%26rft.aulast%253DCampbell%26rft.auinit1%253DM.%2BK%26rft.volume%253D328%26rft.issue%253D7441%26rft.spage%253D702%26rft.epage%253D708%26rft.atitle%253DCONSORT%2Bstatement%253A%2Bextension%2Bto%2Bcluster%2Brandomised%2Btrials%26rft_id%253Dinfo%253Adoi%252F10.1136%252Fbmj.328.7441.702%26rft_id%253Dinfo%253Apmid%252F15031246%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/ijlink?linkType=FULL&amp;journalCode=bmj&amp;resid=328/7441/702&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-ijlink"><span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-41-1" title="View reference 41 in text" id="ref-41">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.41" data-doi="10.1136/bmj.a2390"><div class="cit-metadata"><cite>Zwarenstein
 M, Treweek S, Gagnier JJ, Altman DG, Tunis S, Haynes B, et al. 
Improving the reporting of pragmatic trials: an extension of the CONSORT
 statement. <abbr class="cit-jnl-abbrev">BMJ</abbr><span class="cit-pub-date">2008</span>;<span class="cit-vol">337</span>:<span class="cit-fpage">a2390</span>.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DBMJ%26rft.stitle%253DBMJ%26rft.issn%253D0007-1447%26rft.aulast%253DZwarenstein%26rft.auinit1%253DM.%26rft.volume%253D337%26rft.issue%253Dnov11_2%26rft.spage%253Da2390%26rft.epage%253Da2390%26rft.atitle%253DImproving%2Bthe%2Breporting%2Bof%2Bpragmatic%2Btrials%253A%2Ban%2Bextension%2Bof%2Bthe%2BCONSORT%2Bstatement%26rft_id%253Dinfo%253Adoi%252F10.1136%252Fbmj.a2390%26rft_id%253Dinfo%253Apmid%252F19001484%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/ijlink?linkType=ABST&amp;journalCode=bmj&amp;resid=337/nov11_2/a2390&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-ijlink"><span><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-42-1" title="View reference 42 in text" id="ref-42">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.42" data-doi="10.7326/0003-4819-141-10-200411160-00009"><div class="cit-metadata"><cite>Ioannidis
 JP, Evans SJ, Gøtzsche PC, O’Neill RT, Altman DG, Schulz K, et al. 
Better reporting of harms in randomized trials: an extension of the 
CONSORT statement. <abbr class="cit-jnl-abbrev">Ann Intern Med</abbr><span class="cit-pub-date">2004</span>;<span class="cit-vol">141</span>:<span class="cit-fpage">781</span>-8.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DAnnals%2Bof%2BInternal%2BMedicine%26rft.stitle%253DANN%2BINTERN%2BMED%26rft.issn%253D0003-4819%26rft.aulast%253DIoannidis%26rft.auinit1%253DJ.%2BP.A.%26rft.volume%253D141%26rft.issue%253D10%26rft.spage%253D781%26rft.epage%253D788%26rft.atitle%253DBetter%2BReporting%2Bof%2BHarms%2Bin%2BRandomized%2BTrials%253A%2BAn%2BExtension%2Bof%2Bthe%2BCONSORT%2BStatement%26rft_id%253Dinfo%253Adoi%252F10.7326%252F0003-4819-141-10-200411160-00009%26rft_id%253Dinfo%253Apmid%252F15545678%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=10.7326/0003-4819-141-10-200411160-00009&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=15545678&amp;link_type=MED&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>Medline</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=000225206900005&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-43-1" title="View reference 43 in text" id="ref-43">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.43" data-doi="10.7326/0003-4819-148-4-200802190-00008"><div class="cit-metadata"><cite>Boutron
 I, Moher D, Altman DG, Schulz KF, Ravaud P. Extending the CONSORT 
statement to randomized trials of nonpharmacologic treatment: 
explanation and elaboration. <abbr class="cit-jnl-abbrev">Ann Intern Med</abbr><span class="cit-pub-date">2008</span>;<span class="cit-vol">148</span>:<span class="cit-fpage">295</span>-309.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DAnnals%2Bof%2BInternal%2BMedicine%26rft.stitle%253DANN%2BINTERN%2BMED%26rft.issn%253D0003-4819%26rft.aulast%253DBoutron%26rft.auinit1%253DI.%26rft.volume%253D148%26rft.issue%253D4%26rft.spage%253D295%26rft.epage%253D309%26rft.atitle%253DExtending%2Bthe%2BCONSORT%2BStatement%2Bto%2BRandomized%2BTrials%2Bof%2BNonpharmacologic%2BTreatment%253A%2BExplanation%2Band%2BElaboration%26rft_id%253Dinfo%253Adoi%252F10.7326%252F0003-4819-148-4-200802190-00008%26rft_id%253Dinfo%253Apmid%252F18283207%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=10.7326/0003-4819-148-4-200802190-00008&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=18283207&amp;link_type=MED&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>Medline</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=000253316400006&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-44-1" title="View reference 44 in text" id="ref-44">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.44" data-doi="10.7326/0003-4819-144-5-200603070-00013"><div class="cit-metadata"><cite>Gagnier
 JJ, Boon H, Rochon P, Moher D, Barnes J, Bombardier C. Reporting 
randomized, controlled trials of herbal interventions: an elaborated 
CONSORT statement. <abbr class="cit-jnl-abbrev">Ann Intern Med</abbr><span class="cit-pub-date">2006</span>;<span class="cit-vol">144</span>:<span class="cit-fpage">364</span>-7.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DAnnals%2Bof%2BInternal%2BMedicine%26rft.stitle%253DANN%2BINTERN%2BMED%26rft.issn%253D0003-4819%26rft.aulast%253DGagnier%26rft.auinit1%253DJ.%2BJ.%26rft.volume%253D144%26rft.issue%253D5%26rft.spage%253D364%26rft.epage%253D367%26rft.atitle%253DReporting%2Brandomized%252C%2Bcontrolled%2Btrials%2Bof%2Bherbal%2Binterventions%253A%2Ban%2Belaborated%2BCONSORT%2Bstatement.%26rft_id%253Dinfo%253Adoi%252F10.7326%252F0003-4819-144-5-200603070-00013%26rft_id%253Dinfo%253Apmid%252F16520478%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=10.7326/0003-4819-144-5-200603070-00013&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=16520478&amp;link_type=MED&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>Medline</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=000235965300008&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-45-1" title="View reference 45 in text" id="ref-45">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.45" data-doi="10.1371/journal.pmed.0050020"><div class="cit-metadata"><cite>Hopewell
 S, Clarke M, Moher D, Wager E, Middleton P, Altman DG, et al. CONSORT 
for reporting randomized controlled trials in journal and conference 
abstracts: explanation and elaboration. <abbr class="cit-jnl-abbrev">PLoS Med</abbr><span class="cit-pub-date">2008</span>;<span class="cit-vol">5</span>:<span class="cit-fpage">e20</span>.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.stitle%253DPLoS%2BMed%26rft.aulast%253DHopewell%26rft.auinit1%253DS.%26rft.volume%253D5%26rft.issue%253D1%26rft.spage%253De20%26rft.epage%253De20%26rft.atitle%253DCONSORT%2Bfor%2Breporting%2Brandomized%2Bcontrolled%2Btrials%2Bin%2Bjournal%2Band%2Bconference%2Babstracts%253A%2Bexplanation%2Band%2Belaboration.%26rft_id%253Dinfo%253Adoi%252F10.1371%252Fjournal.pmed.0050020%26rft_id%253Dinfo%253Apmid%252F18215107%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=10.1371/journal.pmed.0050020&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=18215107&amp;link_type=MED&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>Medline</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-46-1" title="View reference 46 in text" id="ref-46">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.46" data-doi="10.1001/jama.1996.03540160061034"><div class="cit-metadata"><cite>Siegel
 JE, Weinstein MC, Russell LB, Gold MR. Recommendations for reporting 
cost-effectiveness analyses. Panel on Cost-Effectiveness in Health and 
Medicine. <abbr class="cit-jnl-abbrev">JAMA</abbr><span class="cit-pub-date">1996</span>;<span class="cit-vol">276</span>:<span class="cit-fpage">1339</span>-41.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DJAMA%26rft.stitle%253DJAMA%26rft.issn%253D0002-9955%26rft.aulast%253DSiegel%26rft.auinit1%253DJ.%2BE.%26rft.volume%253D276%26rft.issue%253D16%26rft.spage%253D1339%26rft.epage%253D1341%26rft.atitle%253DRecommendations%2Bfor%2BReporting%2BCost-effectiveness%2BAnalyses%26rft_id%253Dinfo%253Adoi%252F10.1001%252Fjama.1996.03540160061034%26rft_id%253Dinfo%253Apmid%252F8861994%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=10.1001/jama.1996.03540160061034&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=8861994&amp;link_type=MED&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>Medline</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=A1996VM82500038&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-47-1" title="View reference 47 in text" id="ref-47">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.47" data-doi="10.1136/bmj.313.7052.275"><div class="cit-metadata"><cite>Drummond
 MF, Jefferson TO. Guidelines for authors and peer reviewers of economic
 submissions to the BMJ. The BMJ Economic Evaluation Working Party. <abbr class="cit-jnl-abbrev">BMJ</abbr><span class="cit-pub-date">1996</span>;<span class="cit-vol">313</span>:<span class="cit-fpage">275</span>-83.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DBMJ%26rft.stitle%253DBMJ%26rft.issn%253D0007-1447%26rft.aulast%253DDrummond%26rft.auinit1%253DM%2BF%26rft.volume%253D313%26rft.issue%253D7052%26rft.spage%253D275%26rft.epage%253D283%26rft.atitle%253DGuidelines%2Bfor%2Bauthors%2Band%2Bpeer%2Breviewers%2Bof%2Beconomic%2Bsubmissions%2Bto%2Bthe%2BBMJ%26rft_id%253Dinfo%253Adoi%252F10.1136%252Fbmj.313.7052.275%26rft_id%253Dinfo%253Apmid%252F8704542%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/ijlink?linkType=FULL&amp;journalCode=bmj&amp;resid=313/7052/275&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-ijlink"><span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-48-1" title="View reference 48 in text" id="ref-48">↵</a><div class="cit ref-cit ref-other" id="cit-340.mar23_1.c869.48"><div class="cit-metadata"><cite>Lang TA, Secic M. <span class="cit-source">How to report statistics in medicine. Annotated guidelines for authors, editors, and reviewers</span>. ACP, <span class="cit-pub-date">1997</span>.</cite></div><div class="cit-extra"></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-49-1" title="View reference 49 in text" id="ref-49">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.49" data-doi="10.7326/0003-4819-133-3-200008010-00017"><div class="cit-metadata"><cite>Davidoff F. News from the International Committee of Medical Journal Editors. <abbr class="cit-jnl-abbrev">Ann Intern Med</abbr><span class="cit-pub-date">2000</span>;<span class="cit-vol">133</span>:<span class="cit-fpage">229</span>-31.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DAnnals%2Bof%2BInternal%2BMedicine%26rft.stitle%253DANN%2BINTERN%2BMED%26rft.issn%253D0003-4819%26rft.aulast%253DDavidoff%26rft.auinit1%253DF.%26rft.volume%253D133%26rft.issue%253D3%26rft.spage%253D229%26rft.epage%253D231%26rft.atitle%253DNews%2Bfrom%2Bthe%2BInternational%2BCommittee%2Bof%2BMedical%2BJournal%2BEditors%26rft_id%253Dinfo%253Adoi%252F10.7326%252F0003-4819-133-3-200008010-00017%26rft_id%253Dinfo%253Apmid%252F10906840%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=10.7326/0003-4819-133-3-200008010-00017&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=10906840&amp;link_type=MED&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>Medline</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=000088449400010&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-50-1" title="View reference 50 in text" id="ref-50">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.50"><div class="cit-metadata"><cite>Plint
 AC, Moher D, Morrison A, Schulz K, Altman DG, Hill C, et al. Does the 
CONSORT checklist improve the quality of reports of randomised 
controlled trials? A systematic review. <abbr class="cit-jnl-abbrev">Med J Aust</abbr><span class="cit-pub-date">2006</span>;<span class="cit-vol">185</span>:<span class="cit-fpage">263</span>-7.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DMedical%2BJournal%2Bof%2BAustralia%26rft.stitle%253DMedical%2BJournal%2Bof%2BAustralia%26rft.aulast%253DPlint%26rft.auinit1%253DA.%2BC.%26rft.volume%253D185%26rft.issue%253D5%26rft.spage%253D263%26rft.epage%253D267%26rft.atitle%253DDoes%2Bthe%2BCONSORT%2Bchecklist%2Bimprove%2Bthe%2Bquality%2Bof%2Breports%2Bof%2Brandomised%2Bcontrolled%2Btrials%253F%2BA%2Bsystematic%2Breview.%26rft_id%253Dinfo%253Apmid%252F16948622%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=16948622&amp;link_type=MED&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>Medline</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=000241001000008&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-51-1" title="View reference 51 in text" id="ref-51">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.51" data-doi="10.1001/jama.285.15.1996"><div class="cit-metadata"><cite>Egger M, Jüni P, Bartlett C. Value of flow diagrams in reports of randomized controlled trials. <abbr class="cit-jnl-abbrev">JAMA</abbr><span class="cit-pub-date">2001</span>;<span class="cit-vol">285</span>:<span class="cit-fpage">1996</span>-9.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DJAMA%26rft.stitle%253DJAMA%26rft.issn%253D0002-9955%26rft.aulast%253DEgger%26rft.auinit1%253DM.%26rft.volume%253D285%26rft.issue%253D15%26rft.spage%253D1996%26rft.epage%253D1999%26rft.atitle%253DValue%2Bof%2BFlow%2BDiagrams%2Bin%2BReports%2Bof%2BRandomized%2BControlled%2BTrials%26rft_id%253Dinfo%253Adoi%252F10.1001%252Fjama.285.15.1996%26rft_id%253Dinfo%253Apmid%252F11308437%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=10.1001/jama.285.15.1996&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=11308437&amp;link_type=MED&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>Medline</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=000167995900029&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-52-1" title="View reference 52 in text" id="ref-52">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.52" data-doi="10.7326/0003-4819-134-8-200104170-00011"><div class="cit-metadata"><cite>Moher
 D, Schulz KF, Altman DG. The CONSORT statement: revised recommendations
 for improving the quality of reports of parallel-group randomized 
trials. <abbr class="cit-jnl-abbrev">Ann Intern Med</abbr><span class="cit-pub-date">2001</span>;<span class="cit-vol">134</span>:<span class="cit-fpage">657</span>-62.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DAnnals%2Bof%2BInternal%2BMedicine%26rft.stitle%253DANN%2BINTERN%2BMED%26rft.issn%253D0003-4819%26rft.aulast%253DMoher%26rft.auinit1%253DD.%26rft.volume%253D134%26rft.issue%253D8%26rft.spage%253D657%26rft.epage%253D662%26rft.atitle%253DThe%2BCONSORT%2BStatement%253A%2BRevised%2BRecommendations%2Bfor%2BImproving%2Bthe%2BQuality%2Bof%2BReports%2Bof%2BParallel-Group%2BRandomized%2BTrials%26rft_id%253Dinfo%253Adoi%252F10.7326%252F0003-4819-134-8-200104170-00011%26rft_id%253Dinfo%253Apmid%252F11304106%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=10.7326/0003-4819-134-8-200104170-00011&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=11304106&amp;link_type=MED&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>Medline</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=000168177500005&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-53-1" title="View reference 53 in text" id="ref-53">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.53" data-doi="10.1001/jama.285.15.1987"><div class="cit-metadata"><cite>Moher
 D, Schulz KF, Altman D. The CONSORT statement: revised recommendations 
for improving the quality of reports of parallel-group randomized 
trials. <abbr class="cit-jnl-abbrev">JAMA</abbr><span class="cit-pub-date">2001</span>;<span class="cit-vol">285</span>:<span class="cit-fpage">1987</span>-91.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DJAMA%26rft.stitle%253DJAMA%26rft.issn%253D0002-9955%26rft.aulast%253DMoher%26rft.auinit1%253DD.%26rft.volume%253D285%26rft.issue%253D15%26rft.spage%253D1987%26rft.epage%253D1991%26rft.atitle%253DThe%2BCONSORT%2BStatement%253A%2BRevised%2BRecommendations%2Bfor%2BImproving%2Bthe%2BQuality%2Bof%2BReports%2Bof%2BParallel-Group%2BRandomized%2BTrials%26rft_id%253Dinfo%253Adoi%252F10.1001%252Fjama.285.15.1987%26rft_id%253Dinfo%253Apmid%252F11308435%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=10.1001/jama.285.15.1987&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=11308435&amp;link_type=MED&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>Medline</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=000167995900027&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-54-1" title="View reference 54 in text" id="ref-54">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.54" data-doi="10.1016/S0140-6736(00)04337-3"><div class="cit-metadata"><cite>Moher
 D, Schulz KF, Altman DG. The CONSORT statement: revised recommendations
 for improving the quality of reports of parallel-group randomised 
trials. <abbr class="cit-jnl-abbrev">Lancet</abbr><span class="cit-pub-date">2001</span>;<span class="cit-vol">357</span>:<span class="cit-fpage">1191</span>-4.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DLancet%26rft.stitle%253DLancet%26rft.aulast%253DMoher%26rft.auinit1%253DD.%26rft.volume%253D357%26rft.issue%253D9263%26rft.spage%253D1191%26rft.epage%253D1194%26rft.atitle%253DThe%2BCONSORT%2Bstatement%253A%2Brevised%2Brecommendations%2Bfor%2Bimproving%2Bthe%2Bquality%2Bof%2Breports%2Bof%2Bparallel-group%2Brandomised%2Btrials.%26rft_id%253Dinfo%253Adoi%252F10.1016%252FS0140-6736%252800%252904337-3%26rft_id%253Dinfo%253Apmid%252F11323066%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=10.1016/S0140-6736%2800%2904337-3&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=11323066&amp;link_type=MED&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>Medline</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=000168192100032&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-55-1" title="View reference 55 in text" id="ref-55">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.55" data-doi="10.1001/jama.291.20.2457"><div class="cit-metadata"><cite>Chan
 AW, Hróbjartsson A, Haahr MT, Gøtzsche PC, Altman DG. Empirical 
evidence for selective reporting of outcomes in randomized trials: 
comparison of protocols to published articles. <abbr class="cit-jnl-abbrev">JAMA</abbr><span class="cit-pub-date">2004</span>;<span class="cit-vol">291</span>:<span class="cit-fpage">2457</span>-65.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DJAMA%26rft.stitle%253DJAMA%26rft.issn%253D0002-9955%26rft.aulast%253DChan%26rft.auinit1%253DA.-W.%26rft.volume%253D291%26rft.issue%253D20%26rft.spage%253D2457%26rft.epage%253D2465%26rft.atitle%253DEmpirical%2BEvidence%2Bfor%2BSelective%2BReporting%2Bof%2BOutcomes%2Bin%2BRandomized%2BTrials%253A%2BComparison%2Bof%2BProtocols%2Bto%2BPublished%2BArticles%26rft_id%253Dinfo%253Adoi%252F10.1001%252Fjama.291.20.2457%26rft_id%253Dinfo%253Apmid%252F15161896%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=10.1001/jama.291.20.2457&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=15161896&amp;link_type=MED&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>Medline</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=000221599700028&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-56-1" title="View reference 56 in text" id="ref-56">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.56"><div class="cit-metadata"><cite>Al-Marzouki
 S, Roberts I, Evans S, Marshall T. Selective reporting in clinical 
trials: analysis of trial protocols accepted by the Lancet. <abbr class="cit-jnl-abbrev">Lancet</abbr><span class="cit-pub-date">2008</span>;<span class="cit-vol">372</span>:<span class="cit-fpage">201</span>.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DLancet%26rft.stitle%253DLancet%26rft.aulast%253DAl-Marzouki%26rft.auinit1%253DS.%26rft.volume%253D372%26rft.issue%253D9634%26rft.spage%253D201%26rft.epage%253D201%26rft.atitle%253DSelective%2Breporting%2Bin%2Bclinical%2Btrials%253A%2Banalysis%2Bof%2Btrial%2Bprotocols%2Baccepted%2Bby%2BThe%2BLancet.%26rft_id%253Dinfo%253Apmid%252F18640445%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=18640445&amp;link_type=MED&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>Medline</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=000257763900016&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-57-1" title="View reference 57 in text" id="ref-57">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.57" data-doi="10.1371/journal.pone.0003081"><div class="cit-metadata"><cite>Dwan
 K, Altman DG, Arnaiz JA, Bloom J, Chan AW, Cronin E, et al. Systematic 
review of the empirical evidence of study publication bias and outcome 
reporting bias. <abbr class="cit-jnl-abbrev">PLoS ONE</abbr><span class="cit-pub-date">2008</span>;<span class="cit-vol">3</span>:<span class="cit-fpage">e3081</span>.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.stitle%253DPLoS%2BONE%26rft.aulast%253DDwan%26rft.auinit1%253DK.%26rft.volume%253D3%26rft.issue%253D8%26rft.spage%253De3081%26rft.epage%253De3081%26rft.atitle%253DSystematic%2Breview%2Bof%2Bthe%2Bempirical%2Bevidence%2Bof%2Bstudy%2Bpublication%2Bbias%2Band%2Boutcome%2Breporting%2Bbias.%26rft_id%253Dinfo%253Adoi%252F10.1371%252Fjournal.pone.0003081%26rft_id%253Dinfo%253Apmid%252F18769481%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=10.1371/journal.pone.0003081&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=18769481&amp;link_type=MED&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>Medline</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-58-1" title="View reference 58 in text" id="ref-58">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.58" data-doi="10.7326/0003-4819-134-8-200104170-00012"><div class="cit-metadata"><cite>Altman
 DG, Schulz KF, Moher D, Egger M, Davidoff F, Elbourne D, et al. The 
revised CONSORT statement for reporting randomized trials: explanation 
and elaboration. <abbr class="cit-jnl-abbrev">Ann Intern Med</abbr><span class="cit-pub-date">2001</span>;<span class="cit-vol">134</span>:<span class="cit-fpage">663</span>-94.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DAnnals%2Bof%2BInternal%2BMedicine%26rft.stitle%253DANN%2BINTERN%2BMED%26rft.issn%253D0003-4819%26rft.aulast%253DAltman%26rft.auinit1%253DD.%2BG.%26rft.volume%253D134%26rft.issue%253D8%26rft.spage%253D663%26rft.epage%253D694%26rft.atitle%253DThe%2BRevised%2BCONSORT%2BStatement%2Bfor%2BReporting%2BRandomized%2BTrials%253A%2BExplanation%2Band%2BElaboration%26rft_id%253Dinfo%253Adoi%252F10.7326%252F0003-4819-134-8-200104170-00012%26rft_id%253Dinfo%253Apmid%252F11304107%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=10.7326/0003-4819-134-8-200104170-00012&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=11304107&amp;link_type=MED&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>Medline</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=000168177500006&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-59-1" title="View reference 59 in text" id="ref-59">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.59" data-doi="10.1136/bmj.c332"><div class="cit-metadata"><cite>Schulz
 KF, Altman DG, Moher D, for the CONSORT Group. CONSORT 2010 Statement: 
updated guidelines for reporting parallel group randomised trials. <abbr class="cit-jnl-abbrev">BMJ</abbr><span class="cit-pub-date">2010</span>;<span class="cit-vol">340</span>:<span class="cit-fpage">c332</span>.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DBMJ%26rft_id%253Dinfo%253Adoi%252F10.1136%252Fbmj.c332%26rft_id%253Dinfo%253Apmid%252F20332509%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/ijlink?linkType=FULL&amp;journalCode=bmj&amp;resid=340/mar23_1/c332&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-ijlink"><span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-60-1" title="View reference 60 in text" id="ref-60">↵</a><div class="cit ref-cit ref-other" id="cit-340.mar23_1.c869.60"><div class="cit-metadata"><cite>Pocock SJ. <span class="cit-source">Clinical trials: a practical approach</span>. John Wiley, <span class="cit-pub-date">1983</span>.</cite></div><div class="cit-extra"></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-61-1" title="View reference 61 in text" id="ref-61">↵</a><div class="cit ref-cit ref-other" id="cit-340.mar23_1.c869.61"><div class="cit-metadata"><cite>Meinert CL. <span class="cit-source">Clinical trials: design, conduct and analysis</span>. Oxford University Press, <span class="cit-pub-date">1986</span>.</cite></div><div class="cit-extra"></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-62-1" title="View reference 62 in text" id="ref-62">↵</a><div class="cit ref-cit ref-other" id="cit-340.mar23_1.c869.62"><div class="cit-metadata"><cite>Friedman LM, Furberg CD, DeMets DL. <span class="cit-source">Fundamentals of clinical trials</span>. 3rd ed. Springer, <span class="cit-pub-date">1998</span>.</cite></div><div class="cit-extra"></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-63-1" title="View reference 63 in text" id="ref-63">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.63" data-doi="10.1136/bmj.321.7257.329"><div class="cit-metadata"><cite>Bolliger
 CT, Zellweger JP, Danielsson T, van Biljon X, Robidou A, Westin A, et 
al. Smoking reduction with oral nicotine inhalers: double blind, 
randomised clinical trial of efficacy and safety. <abbr class="cit-jnl-abbrev">BMJ</abbr><span class="cit-pub-date">2000</span>;<span class="cit-vol">321</span>:<span class="cit-fpage">329</span>-33.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DBMJ%26rft.stitle%253DBMJ%26rft.issn%253D0007-1447%26rft.aulast%253DBolliger%26rft.auinit1%253DC.%2BT%26rft.volume%253D321%26rft.issue%253D7257%26rft.spage%253D329%26rft.epage%253D333%26rft.atitle%253DSmoking%2Breduction%2Bwith%2Boral%2Bnicotine%2Binhalers%253A%2Bdouble%2Bblind%252C%2Brandomised%2Bclinical%2Btrial%2Bof%2Befficacy%2Band%2Bsafety%26rft_id%253Dinfo%253Adoi%252F10.1136%252Fbmj.321.7257.329%26rft_id%253Dinfo%253Apmid%252F10926587%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/ijlink?linkType=ABST&amp;journalCode=bmj&amp;resid=321/7257/329&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-ijlink"><span><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-64-1" title="View reference 64 in text" id="ref-64">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.64" data-doi="10.1177/016327870202500104"><div class="cit-metadata"><cite>Dickersin
 K, Manheimer E, Wieland S, Robinson KA, Lefebvre C, McDonald S. 
Development of the Cochrane Collaboration’s CENTRAL Register of 
controlled clinical trials. <abbr class="cit-jnl-abbrev">Eval Health Prof</abbr><span class="cit-pub-date">2002</span>;<span class="cit-vol">25</span>:<span class="cit-fpage">38</span>-64.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DEvaluation%2B%2526%2Bthe%2BHealth%2BProfessions%26rft.stitle%253DEval%2BHealth%2BProf%26rft.issn%253D0163-2787%26rft.aulast%253DDickersin%26rft.auinit1%253DK.%26rft.volume%253D25%26rft.issue%253D1%26rft.spage%253D38%26rft.epage%253D64%26rft.atitle%253DDevelopment%2Bof%2Bthe%2BCochrane%2BCollaboration%2527s%2BCentral%2BRegister%2Bof%2BControlled%2BClinical%2BTrials%26rft_id%253Dinfo%253Adoi%252F10.1177%252F016327870202500104%26rft_id%253Dinfo%253Apmid%252F11868444%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/ijlink?linkType=ABST&amp;journalCode=spehp&amp;resid=25/1/38&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-ijlink"><span><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-65-1" title="View reference 65 in text" id="ref-65">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.65" data-doi="10.1016/S0140-6736(07)61835-2"><div class="cit-metadata"><cite>Hopewell
 S, Clarke M, Moher D, Wager E, Middleton P, Altman DG, et al. CONSORT 
for reporting randomised trials in journal and conference abstracts. <abbr class="cit-jnl-abbrev">Lancet</abbr><span class="cit-pub-date">2008</span>;<span class="cit-vol">371</span>:<span class="cit-fpage">281</span>-3.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DLancet%26rft.stitle%253DLancet%26rft.aulast%253DHopewell%26rft.auinit1%253DS.%26rft.volume%253D371%26rft.issue%253D9609%26rft.spage%253D281%26rft.epage%253D283%26rft.atitle%253DCONSORT%2Bfor%2Breporting%2Brandomised%2Btrials%2Bin%2Bjournal%2Band%2Bconference%2Babstracts.%26rft_id%253Dinfo%253Adoi%252F10.1016%252FS0140-6736%252807%252961835-2%26rft_id%253Dinfo%253Apmid%252F18221781%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=10.1016/S0140-6736%2807%2961835-2&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=18221781&amp;link_type=MED&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>Medline</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=000252616500007&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-66-1" title="View reference 66 in text" id="ref-66">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.66" data-doi="10.1371/journal.pmed.0030252"><div class="cit-metadata"><cite>The impact of open access upon public health. <abbr class="cit-jnl-abbrev">PLoS Med</abbr><span class="cit-pub-date">2006</span>;<span class="cit-vol">3</span>:<span class="cit-fpage">e252</span>.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.stitle%253DPLoS%2BMed%26rft.volume%253D3%26rft.issue%253D5%26rft.spage%253De252%26rft.epage%253De252%26rft.atitle%253DThe%2Bimpact%2Bof%2Bopen%2Baccess%2Bupon%2Bpublic%2Bhealth.%26rft_id%253Dinfo%253Adoi%252F10.1371%252Fjournal.pmed.0030252%26rft_id%253Dinfo%253Apmid%252F16719556%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=10.1371/journal.pmed.0030252&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=16719556&amp;link_type=MED&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>Medline</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-67-1" title="View reference 67 in text" id="ref-67">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.67"><div class="cit-metadata"><cite>Harbourt AM, Knecht LS, Humphreys BL. Structured abstracts in MEDLINE, 1989-1991. <abbr class="cit-jnl-abbrev">Bull Med Libr Assoc</abbr><span class="cit-pub-date">1995</span>;<span class="cit-vol">83</span>:<span class="cit-fpage">190</span>-5.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DBulletin%2Bof%2Bthe%2BMedical%2BLibrary%2BAssociation%26rft.stitle%253DBull%2BMed%2BLibr%2BAssoc%26rft.aulast%253DHarbourt%26rft.auinit1%253DA.%2BM.%26rft.volume%253D83%26rft.issue%253D2%26rft.spage%253D190%26rft.epage%253D195%26rft.atitle%253DStructured%2Babstracts%2Bin%2BMEDLINE%252C%2B1989-1991.%26rft_id%253Dinfo%253Apmid%252F7599584%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=7599584&amp;link_type=MED&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>Medline</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=A1995QU67300004&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-68-1" title="View reference 68 in text" id="ref-68">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.68"><div class="cit-metadata"><cite>Harris AH, Standard S, Brunning JL, Casey SL, Goldberg JH, Oliver L, et al. The accuracy of abstracts in psychology journals. <abbr class="cit-jnl-abbrev">J Psychol</abbr><span class="cit-pub-date">2002</span>;<span class="cit-vol">136</span>:<span class="cit-fpage">141</span>-8.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DThe%2BJournal%2Bof%2Bpsychology%26rft.stitle%253DJ%2BPsychol%26rft.aulast%253DHarris%26rft.auinit1%253DA.%2BH.%26rft.volume%253D136%26rft.issue%253D2%26rft.spage%253D141%26rft.epage%253D148%26rft.atitle%253DThe%2Baccuracy%2Bof%2Babstracts%2Bin%2Bpsychology%2Bjournals.%26rft_id%253Dinfo%253Apmid%252F12081089%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=12081089&amp;link_type=MED&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>Medline</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=000176196900003&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-69-1" title="View reference 69 in text" id="ref-69">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.69" data-doi="10.1001/jama.281.12.1110"><div class="cit-metadata"><cite>Pitkin RM, Branagan MA, Burmeister LF. Accuracy of data in abstracts of published research articles. <abbr class="cit-jnl-abbrev">JAMA</abbr><span class="cit-pub-date">1999</span>;<span class="cit-vol">281</span>:<span class="cit-fpage">1110</span>-1.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DJAMA%26rft.stitle%253DJAMA%26rft.issn%253D0002-9955%26rft.aulast%253DPitkin%26rft.auinit1%253DR.%2BM.%26rft.volume%253D281%26rft.issue%253D12%26rft.spage%253D1110%26rft.epage%253D1111%26rft.atitle%253DAccuracy%2Bof%2BData%2Bin%2BAbstracts%2Bof%2BPublished%2BResearch%2BArticles%26rft_id%253Dinfo%253Adoi%252F10.1001%252Fjama.281.12.1110%26rft_id%253Dinfo%253Apmid%252F10188662%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=10.1001/jama.281.12.1110&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=10188662&amp;link_type=MED&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>Medline</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=000079197100033&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-70-1" title="View reference 70 in text" id="ref-70">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.70" data-doi="10.1345/aph.1D416"><div class="cit-metadata"><cite>Ward LG, Kendrach MG, Price SO. Accuracy of abstracts for original research articles in pharmacy journals. <abbr class="cit-jnl-abbrev">Ann Pharmacother</abbr><span class="cit-pub-date">2004</span>;<span class="cit-vol">38</span>:<span class="cit-fpage">1173</span>-7.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DAnn%2BPharmacother%26rft_id%253Dinfo%253Adoi%252F10.1345%252Faph.1D416%26rft_id%253Dinfo%253Apmid%252F15150375%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=10.1345/aph.1D416&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=15150375&amp;link_type=MED&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>Medline</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=000222188800011&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-71-1" title="View reference 71 in text" id="ref-71">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.71" data-doi="10.1136/bmj.38895.410451.79"><div class="cit-metadata"><cite>Gøtzsche PC. Believability of relative risks and odds ratios in abstracts: cross sectional study. <abbr class="cit-jnl-abbrev">BMJ</abbr><span class="cit-pub-date">2006</span>;<span class="cit-vol">333</span>:<span class="cit-fpage">231</span>-4.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DBMJ%26rft_id%253Dinfo%253Adoi%252F10.1136%252Fbmj.38895.410451.79%26rft_id%253Dinfo%253Apmid%252F16854948%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/ijlink?linkType=ABST&amp;journalCode=bmj&amp;resid=333/7561/231&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-ijlink"><span><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-72-1" title="View reference 72 in text" id="ref-72">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.72" data-doi="10.1001/jama.285.4.437"><div class="cit-metadata"><cite>Ioannidis JP, Lau J. Completeness of safety reporting in randomized trials: an evaluation of 7 medical areas. <abbr class="cit-jnl-abbrev">JAMA</abbr><span class="cit-pub-date">2001</span>;<span class="cit-vol">285</span>:<span class="cit-fpage">437</span>-43.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DJAMA%26rft.stitle%253DJAMA%26rft.issn%253D0002-9955%26rft.aulast%253DIoannidis%26rft.auinit1%253DJ.%2BP.%2BA.%26rft.volume%253D285%26rft.issue%253D4%26rft.spage%253D437%26rft.epage%253D443%26rft.atitle%253DCompleteness%2Bof%2BSafety%2BReporting%2Bin%2BRandomized%2BTrials%253A%2BAn%2BEvaluation%2Bof%2B7%2BMedical%2BAreas%26rft_id%253Dinfo%253Adoi%252F10.1001%252Fjama.285.4.437%26rft_id%253Dinfo%253Apmid%252F11242428%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=10.1001/jama.285.4.437&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=11242428&amp;link_type=MED&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>Medline</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=000166506000031&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-73-1" title="View reference 73 in text" id="ref-73">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.73" data-doi="10.7326/0003-4819-113-1-69"><div class="cit-metadata"><cite>Haynes RB, Mulrow CD, Huth EJ, Altman DG, Gardner MJ. More informative abstracts revisited. <abbr class="cit-jnl-abbrev">Ann Intern Med</abbr><span class="cit-pub-date">1990</span>;<span class="cit-vol">113</span>:<span class="cit-fpage">69</span>-76.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DAnnals%2Bof%2BInternal%2BMedicine%26rft.stitle%253DANN%2BINTERN%2BMED%26rft.issn%253D0003-4819%26rft.aulast%253DHaynes%26rft.auinit1%253DR.%2BB.%26rft.volume%253D113%26rft.issue%253D1%26rft.spage%253D69%26rft.epage%253D76%26rft.atitle%253DMore%2BInformative%2BAbstracts%2BRevisited%26rft_id%253Dinfo%253Adoi%252F10.7326%252F0003-4819-113-1-69%26rft_id%253Dinfo%253Apmid%252F2190518%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=10.7326/0003-4819-113-1-69&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=2190518&amp;link_type=MED&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>Medline</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=A1990DL18000012&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-74-1" title="View reference 74 in text" id="ref-74">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.74"><div class="cit-metadata"><cite>Taddio
 A, Pain T, Fassos FF, Boon H, Ilersich AL, Einarson TR. Quality of 
nonstructured and structured abstracts of original research articles in 
the British Medical Journal, the Canadian Medical Association Journal 
and the Journal of the American Medical Association. <abbr class="cit-jnl-abbrev">CMAJ</abbr><span class="cit-pub-date">1994</span>;<span class="cit-vol">150</span>:<span class="cit-fpage">1611</span>-5.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DCanadian%2BMedical%2BAssociation%2BJournal%26rft.stitle%253DCMAJ%26rft.issn%253D0008-4409%26rft.aulast%253DTaddio%26rft.auinit1%253DA.%26rft.volume%253D150%26rft.issue%253D10%26rft.spage%253D1611%26rft.epage%253D1615%26rft.atitle%253DQuality%2Bof%2Bnonstructured%2Band%2Bstructured%2Babstracts%2Bof%2Boriginal%2Bresearch%2Barticles%2Bin%2Bthe%2BBritish%2BMedical%2BJournal%252C%2Bthe%2BCanadian%2BMedical%2BAssociation%2BJournal%2Band%2Bthe%2BJournal%2Bof%2Bthe%2BAmerican%2BMedical%2BAssociation%26rft_id%253Dinfo%253Apmid%252F8174031%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/ijlink?linkType=ABST&amp;journalCode=cmaj&amp;resid=150/10/1611&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-ijlink"><span><span class="cit-reflinks-abstract">Abstract</span></span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-75-1" title="View reference 75 in text" id="ref-75">↵</a><div class="cit ref-cit ref-other" id="cit-340.mar23_1.c869.75"><div class="cit-metadata"><cite>Wager E, Middleton P. Technical editing of research reports in biomedical journals. <span class="cit-source">Cochrane Database Syst Rev</span><span class="cit-pub-date">2008</span>;MR000002.</cite></div><div class="cit-extra"></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-76-1" title="View reference 76 in text" id="ref-76">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.76" data-doi="10.1177/016555159602200503"><div class="cit-metadata"><cite>Hartley J, Sydes M, Blurton A. Obtaining information accurately and quickly: Are structured abstracts more efficient? <abbr class="cit-jnl-abbrev">J Inform Sci</abbr><span class="cit-pub-date">1996</span>;<span class="cit-vol">22</span>:<span class="cit-fpage">349</span>-56.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DJ%2BInform%2BSci%26rft.volume%253D22%26rft.spage%253D349%26rft_id%253Dinfo%253Adoi%252F10.1177%252F016555159602200503%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=10.1177/016555159602200503&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-77-1" title="View reference 77 in text" id="ref-77">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.77" data-doi="10.1016/S0140-6736(07)60714-4"><div class="cit-metadata"><cite>Gilligan
 D, Nicolson M, Smith I, Groen H, Dalesio O, Goldstraw P, et al. 
Preoperative chemotherapy in patients with resectable non-small cell 
lung cancer: results of the MRC LU22/NVALT 2/EORTC 08012 multicentre 
randomised trial and update of systematic review. <abbr class="cit-jnl-abbrev">Lancet</abbr><span class="cit-pub-date">2007</span>;<span class="cit-vol">369</span>:<span class="cit-fpage">1929</span>-37.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DLancet%26rft.stitle%253DLancet%26rft.aulast%253DGilligan%26rft.auinit1%253DD.%26rft.volume%253D369%26rft.issue%253D9577%26rft.spage%253D1929%26rft.epage%253D1937%26rft.atitle%253DPreoperative%2Bchemotherapy%2Bin%2Bpatients%2Bwith%2Bresectable%2Bnon-small%2Bcell%2Blung%2Bcancer%253A%2Bresults%2Bof%2Bthe%2BMRC%2BLU22%252FNVALT%2B2%252FEORTC%2B08012%2Bmulticentre%2Brandomised%2Btrial%2Band%2Bupdate%2Bof%2Bsystematic%2Breview.%26rft_id%253Dinfo%253Adoi%252F10.1016%252FS0140-6736%252807%252960714-4%26rft_id%253Dinfo%253Apmid%252F17544497%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=10.1016/S0140-6736%2807%2960714-4&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=17544497&amp;link_type=MED&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>Medline</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=000247147200026&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-78-1" title="View reference 78 in text" id="ref-78">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.78" data-doi="10.1056/NEJM199912093412404"><div class="cit-metadata"><cite>Sandler
 AD, Sutton KA, DeWeese J, Girardi MA, Sheppard V, Bodfish JW. Lack of 
benefit of a single dose of synthetic human secretin in the treatment of
 autism and pervasive developmental disorder. <abbr class="cit-jnl-abbrev">N Engl J Med</abbr><span class="cit-pub-date">1999</span>;<span class="cit-vol">341</span>:<span class="cit-fpage">1801</span>-6.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DNew%2BEngland%2BJournal%2Bof%2BMedicine%26rft.stitle%253DNEJM%26rft.issn%253D0028-4793%26rft.aulast%253DSandler%26rft.auinit1%253DA.%2BD.%26rft.volume%253D341%26rft.issue%253D24%26rft.spage%253D1801%26rft.epage%253D1806%26rft.atitle%253DLack%2Bof%2BBenefit%2Bof%2Ba%2BSingle%2BDose%2Bof%2BSynthetic%2BHuman%2BSecretin%2Bin%2Bthe%2BTreatment%2Bof%2BAutism%2Band%2BPervasive%2BDevelopmental%2BDisorder%26rft_id%253Dinfo%253Adoi%252F10.1056%252FNEJM199912093412404%26rft_id%253Dinfo%253Apmid%252F10588965%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=10.1056/NEJM199912093412404&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=10588965&amp;link_type=MED&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>Medline</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=000084074000004&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-79-1" title="View reference 79 in text" id="ref-79">↵</a><div class="cit ref-cit ref-other" id="cit-340.mar23_1.c869.79"><div class="cit-metadata unstructured">World
 Medical Association. Declaration of Helsinki: ethical principle for 
medical research involving human subjects. 59th WMA General Assembly, 
Seoul 2008; <a href="http://www.wma.net/e/policy/b3.htm">www.wma.net/e/policy/b3.htm</a> (accessed 2 June 2009).</div><div class="cit-extra"></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-80-1" title="View reference 80 in text" id="ref-80">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.80" data-doi="10.1056/NEJM199207233270406"><div class="cit-metadata"><cite>Lau
 J, Antman EM, Jimenez-Silva J, Kupelnick B, Mosteller F, Chalmers TC. 
Cumulative meta-analysis of therapeutic trials for myocardial 
infarction. <abbr class="cit-jnl-abbrev">N Engl J Med</abbr><span class="cit-pub-date">1992</span>;<span class="cit-vol">327</span>:<span class="cit-fpage">248</span>-54.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DNew%2BEngland%2BJournal%2Bof%2BMedicine%26rft.stitle%253DNEJM%26rft.issn%253D0028-4793%26rft.aulast%253DLau%26rft.auinit1%253DJ.%26rft.volume%253D327%26rft.issue%253D4%26rft.spage%253D248%26rft.epage%253D254%26rft.atitle%253DCumulative%2Bmeta-analysis%2Bof%2Btherapeutic%2Btrials%2Bfor%2Bmyocardial%2Binfarction%26rft_id%253Dinfo%253Adoi%252F10.1056%252FNEJM199207233270406%26rft_id%253Dinfo%253Apmid%252F1614465%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=10.1056/NEJM199207233270406&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=1614465&amp;link_type=MED&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>Medline</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=A1992JE38100006&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-81-1" title="View reference 81 in text" id="ref-81">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.81" data-doi="10.1191/1740774505cn085oa"><div class="cit-metadata"><cite>Fergusson
 D, Glass KC, Hutton B, Shapiro S. Randomized controlled trials of 
aprotinin in cardiac surgery: could clinical equipoise have stopped the 
bleeding? <abbr class="cit-jnl-abbrev">Clin Trials</abbr><span class="cit-pub-date">2005</span>;<span class="cit-vol">2</span>:<span class="cit-fpage">218</span>-29.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DClinical%2BTrials%26rft.stitle%253DClin%2BTrials%26rft.issn%253D1740-7745%26rft.aulast%253DFergusson%26rft.auinit1%253DD.%26rft.volume%253D2%26rft.issue%253D3%26rft.spage%253D218%26rft.epage%253D232%26rft.atitle%253DRandomized%2Bcontrolled%2Btrials%2Bof%2Baprotinin%2Bin%2Bcardiac%2Bsurgery%253A%2Bcould%2Bclinical%2Bequipoise%2Bhave%2Bstopped%2Bthe%2Bbleeding%253F%26rft_id%253Dinfo%253Adoi%252F10.1191%252F1740774505cn085oa%26rft_id%253Dinfo%253Apmid%252F16279145%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/ijlink?linkType=ABST&amp;journalCode=spctj&amp;resid=2/3/218&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-ijlink"><span><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-82-1" title="View reference 82 in text" id="ref-82">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.82"><div class="cit-metadata"><cite>Savulescu
 J, Chalmers I, Blunt J. Are research ethics committees behaving 
unethically? Some suggestions for improving performance and 
accountability. <abbr class="cit-jnl-abbrev">BMJ</abbr><span class="cit-pub-date">1996</span>;<span class="cit-vol">313</span>:<span class="cit-fpage">1390</span>-3.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DBMJ%26rft.stitle%253DBMJ%26rft.issn%253D0007-1447%26rft.aulast%253DSavulescu%26rft.auinit1%253DJ.%26rft.volume%253D313%26rft.issue%253D7069%26rft.spage%253D1390%26rft.epage%253D1393%26rft.atitle%253DAre%2Bresearch%2Bethics%2Bcommittees%2Bbehaving%2Bunethically%253F%2BSome%2Bsuggestions%2Bfor%2Bimproving%2Bperformance%2Band%2Baccountability%26rft_id%253Dinfo%253Apmid%252F8956711%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/ijlink?linkType=FULL&amp;journalCode=bmj&amp;resid=313/7069/1390&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-ijlink"><span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-83-1" title="View reference 83 in text" id="ref-83">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.83" data-doi="10.1111/j.1471-0528.2000.tb11091.x"><div class="cit-metadata"><cite>Sadler LC, Davison T, McCowan LM. A randomised controlled trial and meta-analysis of active management of labour. <abbr class="cit-jnl-abbrev">BJOG</abbr><span class="cit-pub-date">2000</span>;<span class="cit-vol">107</span>:<span class="cit-fpage">909</span>-15.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DBJOG%2B%253A%2B%2Ban%2Binternational%2Bjournal%2Bof%2Bobstetrics%2Band%2Bgynaecology%26rft.stitle%253DBJOG%26rft.aulast%253DSadler%26rft.auinit1%253DL.%2BC.%26rft.volume%253D107%26rft.issue%253D7%26rft.spage%253D909%26rft.epage%253D915%26rft.atitle%253DA%2Brandomised%2Bcontrolled%2Btrial%2Band%2Bmeta-analysis%2Bof%2Bactive%2Bmanagement%2Bof%2Blabour.%26rft_id%253Dinfo%253Adoi%252F10.1111%252Fj.1471-0528.2000.tb11091.x%26rft_id%253Dinfo%253Apmid%252F10901564%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=10.1111/j.1471-0528.2000.tb11091.x&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=10901564&amp;link_type=MED&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>Medline</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-84-1" title="View reference 84 in text" id="ref-84">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.84" data-doi="10.1161/01.STR.29.10.2203"><div class="cit-metadata"><cite>Bath FJ, Owen VE, Bath PM. Quality of full and final publications reporting acute stroke trials: a systematic review. <abbr class="cit-jnl-abbrev">Stroke</abbr><span class="cit-pub-date">1998</span>;<span class="cit-vol">29</span>:<span class="cit-fpage">2203</span>-10.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DStroke%26rft.stitle%253DStroke%26rft.issn%253D0039-2499%26rft.aulast%253DBath%26rft.auinit1%253DF.%2BJ.%26rft.volume%253D29%26rft.issue%253D10%26rft.spage%253D2203%26rft.epage%253D2210%26rft.atitle%253DQuality%2Bof%2BFull%2Band%2BFinal%2BPublications%2BReporting%2BAcute%2BStroke%2BTrials%2B%253A%2BA%2BSystematic%2BReview%26rft_id%253Dinfo%253Adoi%252F10.1161%252F01.STR.29.10.2203%26rft_id%253Dinfo%253Apmid%252F9756604%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/ijlink?linkType=ABST&amp;journalCode=strokeaha&amp;resid=29/10/2203&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-ijlink"><span><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-85-1" title="View reference 85 in text" id="ref-85">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.85" data-doi="10.1542/peds.2008-2945"><div class="cit-metadata"><cite>Blumer
 JL, Findling RL, Shih WJ, Soubrane C, Reed MD. Controlled clinical 
trial of zolpidem for the treatment of insomnia associated with 
attention-deficit/hyperactivity disorder in children 6 to 17 years of 
age. <abbr class="cit-jnl-abbrev">Pediatrics</abbr><span class="cit-pub-date">2009</span>;<span class="cit-vol">123</span>:<span class="cit-fpage">e770</span>-e776.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DPediatrics%26rft.stitle%253DPediatrics%26rft.issn%253D0031-4005%26rft.aulast%253DBlumer%26rft.auinit1%253DJ.%2BL.%26rft.volume%253D123%26rft.issue%253D5%26rft.spage%253De770%26rft.epage%253De776%26rft.atitle%253DControlled%2BClinical%2BTrial%2Bof%2BZolpidem%2Bfor%2Bthe%2BTreatment%2Bof%2BInsomnia%2BAssociated%2BWith%2BAttention-Deficit%252F%2BHyperactivity%2BDisorder%2Bin%2BChildren%2B6%2Bto%2B17%2BYears%2Bof%2BAge%26rft_id%253Dinfo%253Adoi%252F10.1542%252Fpeds.2008-2945%26rft_id%253Dinfo%253Apmid%252F19403468%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/ijlink?linkType=ABST&amp;journalCode=pediatrics&amp;resid=123/5/e770&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-ijlink"><span><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-86-1" title="View reference 86 in text" id="ref-86">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.86" data-doi="10.1016/S0140-6736(09)61454-9"><div class="cit-metadata"><cite>Sabatine
 MS, Antman EM, Widimsky P, Ebrahim IO, Kiss RG, Saaiman A, et al. 
Otamixaban for the treatment of patients with non-ST-elevation acute 
coronary syndromes (SEPIA-ACS1 TIMI 42): a randomised, double-blind, 
active-controlled, phase 2 trial. <abbr class="cit-jnl-abbrev">Lancet</abbr><span class="cit-pub-date">2009</span>;<span class="cit-vol">374</span>:<span class="cit-fpage">787</span>-95.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DLancet%26rft.stitle%253DLancet%26rft.aulast%253DSabatine%26rft.auinit1%253DM.%2BS.%26rft.volume%253D374%26rft.issue%253D9692%26rft.spage%253D787%26rft.epage%253D795%26rft.atitle%253DOtamixaban%2Bfor%2Bthe%2Btreatment%2Bof%2Bpatients%2Bwith%2Bnon-ST-elevation%2Bacute%2Bcoronary%2Bsyndromes%2B%2528SEPIA-ACS1%2BTIMI%2B42%2529%253A%2Ba%2Brandomised%252C%2Bdouble-blind%252C%2Bactive-controlled%252C%2Bphase%2B2%2Btrial.%26rft_id%253Dinfo%253Adoi%252F10.1016%252FS0140-6736%252809%252961454-9%26rft_id%253Dinfo%253Apmid%252F19717184%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=10.1016/S0140-6736%2809%2961454-9&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=19717184&amp;link_type=MED&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>Medline</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=000269675000027&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-87-1" title="View reference 87 in text" id="ref-87">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.87"><div class="cit-metadata"><cite>Grant
 AM, Altman DG, Babiker AB, Campbell MK, Clemens FJ, Darbyshire JH, et 
al. Issues in data monitoring and interim analysis of trials. <abbr class="cit-jnl-abbrev">Health Technol Assess</abbr><span class="cit-pub-date">2005</span>;<span class="cit-vol">9</span>:<span class="cit-fpage">1</span>-iv.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.stitle%253Ddummy%26rft.aulast%253DCastelnuovo%26rft.auinit1%253DE.%26rft.volume%253D9%26rft.issue%253D46%26rft.spage%253D1%26rft.epage%253D%2Biii%26rft.atitle%253DThe%2Beffectiveness%2Bof%2Bthe%2BHeidelberg%2BRetina%2BTomograph%2Band%2Blaser%2Bdiagnostic%2Bglaucoma%2Bscanning%2Bsystem%2B%2528GDx%2529%2Bin%2Bdetecting%2Band%2Bmonitoring%2Bglaucoma.%26rft_id%253Dinfo%253Apmid%252F16303099%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=16303099&amp;link_type=MED&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>Medline</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-88-1" title="View reference 88 in text" id="ref-88">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.88"><div class="cit-metadata"><cite>Gallo P, Krams M. PhRMA Working Group on adaptive designs, “White Paper.” <abbr class="cit-jnl-abbrev">Drug Information Journal</abbr><span class="cit-pub-date">2006</span>;<span class="cit-vol">40</span>:<span class="cit-fpage">421</span>-82.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DDrug%2BInformation%2BJournal%26rft.issn%253D0092-8615%26rft.volume%253D40%26rft.spage%253D421%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=000241956500007&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-89-1" title="View reference 89 in text" id="ref-89">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.89" data-doi="10.1146/annurev.publhealth.031308.100223"><div class="cit-metadata"><cite>Brown CH, Ten Have TR, Jo B, Dagne G, Wyman PA, Muthen B, et al. Adaptive designs for randomized trials in public health. <abbr class="cit-jnl-abbrev">Annu Rev Public Health</abbr><span class="cit-pub-date">2009</span>;<span class="cit-vol">30</span>:<span class="cit-fpage">1</span>-25.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DAnnual%2Breview%2Bof%2Bpublic%2Bhealth%26rft.stitle%253DAnnu%2BRev%2BPublic%2BHealth%26rft.issn%253D0163-7525%26rft.aulast%253DBrown%26rft.auinit1%253DC.%2BH.%26rft.volume%253D30%26rft.spage%253D1%26rft.epage%253D25%26rft.atitle%253DAdaptive%2Bdesigns%2Bfor%2Brandomized%2Btrials%2Bin%2Bpublic%2Bhealth.%26rft_id%253Dinfo%253Adoi%252F10.1146%252Fannurev.publhealth.031308.100223%26rft_id%253Dinfo%253Apmid%252F19296774%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=10.1146/annurev.publhealth.031308.100223&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=19296774&amp;link_type=MED&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>Medline</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=000268071900002&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-90-1" title="View reference 90 in text" id="ref-90">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.90" data-doi="10.1081/BIP-200062859"><div class="cit-metadata"><cite>Kelly PJ, Sooriyarachchi MR, Stallard N, Todd S. A practical comparison of group-sequential and adaptive designs. <abbr class="cit-jnl-abbrev">J Biopharm Stat</abbr><span class="cit-pub-date">2005</span>;<span class="cit-vol">15</span>:<span class="cit-fpage">719</span>-38.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DJournal%2Bof%2Bbiopharmaceutical%2Bstatistics%26rft.stitle%253DJ%2BBiopharm%2BStat%26rft.aulast%253DKelly%26rft.auinit1%253DP.%2BJ.%26rft.volume%253D15%26rft.issue%253D4%26rft.spage%253D719%26rft.epage%253D738%26rft.atitle%253DA%2Bpractical%2Bcomparison%2Bof%2Bgroup-sequential%2Band%2Badaptive%2Bdesigns.%26rft_id%253Dinfo%253Adoi%252F10.1081%252FBIP-200062859%26rft_id%253Dinfo%253Apmid%252F16022175%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=10.1081/BIP-200062859&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=16022175&amp;link_type=MED&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>Medline</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=000236232700015&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-91-1" title="View reference 91 in text" id="ref-91">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.91" data-doi="10.1136/bmj.38414.422650.8F"><div class="cit-metadata"><cite>Pildal
 J, Chan AW, Hróbjartsson A, Forfang E, Altman DG, Gøtzsche PC. 
Comparison of descriptions of allocation concealment in trial protocols 
and the published reports: cohort study. <abbr class="cit-jnl-abbrev">BMJ</abbr><span class="cit-pub-date">2005</span>;<span class="cit-vol">330</span>:<span class="cit-fpage">1049</span>.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DBMJ%26rft_id%253Dinfo%253Adoi%252F10.1136%252Fbmj.38414.422650.8F%26rft_id%253Dinfo%253Apmid%252F15817527%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/ijlink?linkType=ABST&amp;journalCode=bmj&amp;resid=330/7499/1049&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-ijlink"><span><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-92-1" title="View reference 92 in text" id="ref-92">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.92" data-doi="10.1136/bmj.a2299"><div class="cit-metadata"><cite>Chan
 AW, Hróbjartsson A, Jørgensen KJ, Gøtzsche PC, Altman DG. Discrepancies
 in sample size calculations and data analyses reported in randomised 
trials: comparison of publications with protocols. <abbr class="cit-jnl-abbrev">BMJ</abbr><span class="cit-pub-date">2008</span>;<span class="cit-vol">337</span>:<span class="cit-fpage">a2299</span>.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DBMJ%26rft.stitle%253DBMJ%26rft.issn%253D0007-1447%26rft.aulast%253DChan%26rft.auinit1%253DA.-W.%26rft.volume%253D337%26rft.issue%253Ddec04_1%26rft.spage%253Da2299%26rft.epage%253Da2299%26rft.atitle%253DDiscrepancies%2Bin%2Bsample%2Bsize%2Bcalculations%2Band%2Bdata%2Banalyses%2Breported%2Bin%2Brandomised%2Btrials%253A%2Bcomparison%2Bof%2Bpublications%2Bwith%2Bprotocols%26rft_id%253Dinfo%253Adoi%252F10.1136%252Fbmj.a2299%26rft_id%253Dinfo%253Apmid%252F19056791%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/ijlink?linkType=ABST&amp;journalCode=bmj&amp;resid=337/dec04_1/a2299&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-ijlink"><span><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-93-1" title="View reference 93 in text" id="ref-93">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.93" data-doi="10.1136/bmj.b1867"><div class="cit-metadata"><cite>Ndekha
 MJ, van Oosterhout JJ, Zijlstra EE, Manary M, Saloojee H, Manary MJ. 
Supplementary feeding with either ready-to-use fortified spread or 
corn-soy blend in wasted adults starting antiretroviral therapy in 
Malawi: randomised, investigator blinded, controlled trial. <abbr class="cit-jnl-abbrev">BMJ</abbr><span class="cit-pub-date">2009</span>;<span class="cit-vol">338</span>:<span class="cit-fpage">1867</span>-75.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DBMJ%26rft.issn%253D0007-1447%26rft.volume%253D338%26rft.spage%253D1867%26rft_id%253Dinfo%253Adoi%252F10.1136%252Fbmj.b1867%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=10.1136/bmj.b1867&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-94-1" title="View reference 94 in text" id="ref-94">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.94" data-doi="10.1016/S0140-6736(04)17670-8"><div class="cit-metadata"><cite>Rothwell PM. External validity of randomised controlled trials: “to whom do the results of this trial apply?” <abbr class="cit-jnl-abbrev">Lancet</abbr><span class="cit-pub-date">2005</span>;<span class="cit-vol">365</span>:<span class="cit-fpage">82</span>-93.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DLancet%26rft.stitle%253DLancet%26rft.aulast%253DRothwell%26rft.auinit1%253DP.%2BM.%26rft.volume%253D365%26rft.issue%253D9453%26rft.spage%253D82%26rft.epage%253D93%26rft.atitle%253DExternal%2Bvalidity%2Bof%2Brandomised%2Bcontrolled%2Btrials%253A%2B%2526quot%253Bto%2Bwhom%2Bdo%2Bthe%2Bresults%2Bof%2Bthis%2Btrial%2Bapply%253F%2526quot%253B.%26rft_id%253Dinfo%253Adoi%252F10.1016%252FS0140-6736%252804%252917670-8%26rft_id%253Dinfo%253Apmid%252F15639683%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=10.1016/S0140-6736%2804%2917670-8&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=15639683&amp;link_type=MED&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>Medline</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=000226213100032&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-95-1" title="View reference 95 in text" id="ref-95">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.95" data-doi="10.1016/S0895-4356(97)00240-0"><div class="cit-metadata"><cite>Fuks
 A, Weijer C, Freedman B, Shapiro S, Skrutkowska M, Riaz A. A study in 
contrasts: eligibility criteria in a twenty-year sample of NSABP and POG
 clinical trials. National Surgical Adjuvant Breast and Bowel Program. 
Pediatric Oncology Group. <abbr class="cit-jnl-abbrev">J Clin Epidemiol</abbr><span class="cit-pub-date">1998</span>;<span class="cit-vol">51</span>:<span class="cit-fpage">69</span>-79.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DJournal%2Bof%2Bclinical%2Bepidemiology%26rft.stitle%253DJ%2BClin%2BEpidemiol%26rft.aulast%253DFuks%26rft.auinit1%253DA.%26rft.volume%253D51%26rft.issue%253D2%26rft.spage%253D69%26rft.epage%253D79%26rft.atitle%253DA%2Bstudy%2Bin%2Bcontrasts%253A%2Beligibility%2Bcriteria%2Bin%2Ba%2Btwenty-year%2Bsample%2Bof%2BNSABP%2Band%2BPOG%2Bclinical%2Btrials.%2BNational%2BSurgical%2BAdjuvant%2BBreast%2Band%2BBowel%2BProgram.%2BPediatric%2BOncology%2BGroup.%26rft_id%253Dinfo%253Adoi%252F10.1016%252FS0895-4356%252897%252900240-0%26rft_id%253Dinfo%253Apmid%252F9474067%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=10.1016/S0895-4356%2897%2900240-0&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=9474067&amp;link_type=MED&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>Medline</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=000071796000001&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-96-1" title="View reference 96 in text" id="ref-96">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.96" data-doi="10.1016/S0895-4356(00)00227-4"><div class="cit-metadata"><cite>Shapiro SH, Weijer C, Freedman B. Reporting the study populations of clinical trials. Clear transmission or static on the line? <abbr class="cit-jnl-abbrev">J Clin Epidemiol</abbr><span class="cit-pub-date">2000</span>;<span class="cit-vol">53</span>:<span class="cit-fpage">973</span>-9.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DJournal%2Bof%2Bclinical%2Bepidemiology%26rft.stitle%253DJ%2BClin%2BEpidemiol%26rft.aulast%253DShapiro%26rft.auinit1%253DS.%2BH.%26rft.volume%253D53%26rft.issue%253D10%26rft.spage%253D973%26rft.epage%253D979%26rft.atitle%253DReporting%2Bthe%2Bstudy%2Bpopulations%2Bof%2Bclinical%2Btrials.%2BClear%2Btransmission%2Bor%2Bstatic%2Bon%2Bthe%2Bline%253F%26rft_id%253Dinfo%253Adoi%252F10.1016%252FS0895-4356%252800%252900227-4%26rft_id%253Dinfo%253Apmid%252F11027928%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=10.1016/S0895-4356%2800%2900227-4&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=11027928&amp;link_type=MED&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>Medline</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=000089863700001&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-97-1" title="View reference 97 in text" id="ref-97">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.97" data-doi="10.1097/01.aids.0000189866.67182.f7"><div class="cit-metadata"><cite>Gandhi
 M, Ameli N, Bacchetti P, Sharp GB, French AL, Young M, et al. 
Eligibility criteria for HIV clinical trials and generalizability of 
results: the gap between published reports and study protocols. <abbr class="cit-jnl-abbrev">AIDS</abbr><span class="cit-pub-date">2005</span>;<span class="cit-vol">19</span>:<span class="cit-fpage">1885</span>-96.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DAIDS%2B%2528London%252C%2BEngland%2529%26rft.stitle%253DAIDS%26rft.aulast%253DGandhi%26rft.auinit1%253DM.%26rft.volume%253D19%26rft.issue%253D16%26rft.spage%253D1885%26rft.epage%253D1896%26rft.atitle%253DEligibility%2Bcriteria%2Bfor%2BHIV%2Bclinical%2Btrials%2Band%2Bgeneralizability%2Bof%2Bresults%253A%2Bthe%2Bgap%2Bbetween%2Bpublished%2Breports%2Band%2Bstudy%2Bprotocols.%26rft_id%253Dinfo%253Adoi%252F10.1097%252F01.aids.0000189866.67182.f7%26rft_id%253Dinfo%253Apmid%252F16227797%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=10.1097/01.aids.0000189866.67182.f7&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=16227797&amp;link_type=MED&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>Medline</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=000233174300018&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-98-1" title="View reference 98 in text" id="ref-98">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.98" data-doi="10.1016/S0039-6060(96)80149-8"><div class="cit-metadata"><cite>Hall JC, Mills B, Nguyen H, Hall JL. Methodologic standards in surgical trials. <abbr class="cit-jnl-abbrev">Surgery</abbr><span class="cit-pub-date">1996</span>;<span class="cit-vol">119</span>:<span class="cit-fpage">466</span>-72.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DSurgery%26rft.stitle%253DSurgery%26rft.aulast%253DHall%26rft.auinit1%253DJ.%2BC.%26rft.volume%253D119%26rft.issue%253D4%26rft.spage%253D466%26rft.epage%253D472%26rft.atitle%253DMethodologic%2Bstandards%2Bin%2Bsurgical%2Btrials.%26rft_id%253Dinfo%253Adoi%252F10.1016%252FS0039-6060%252896%252980149-8%26rft_id%253Dinfo%253Apmid%252F8644014%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=10.1016/S0039-6060%2896%2980149-8&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=8644014&amp;link_type=MED&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>Medline</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=A1996UD51200017&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-99-1" title="View reference 99 in text" id="ref-99">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.99" data-doi="10.1001/archinternmed.2007.30"><div class="cit-metadata"><cite>Weiss NS, Koepsell TD, Psaty BM. Generalizability of the results of randomized trials. <abbr class="cit-jnl-abbrev">Arch Intern Med</abbr><span class="cit-pub-date">2008</span>;<span class="cit-vol">168</span>:<span class="cit-fpage">133</span>-5.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DArchives%2Bof%2BInternal%2BMedicine%26rft.stitle%253DArch%2BIntern%2BMed%26rft.issn%253D0003-9926%26rft.aulast%253DWeiss%26rft.auinit1%253DN.%2BS.%26rft.volume%253D168%26rft.issue%253D2%26rft.spage%253D133%26rft.epage%253D135%26rft.atitle%253DGeneralizability%2Bof%2Bthe%2BResults%2Bof%2BRandomized%2BTrials%26rft_id%253Dinfo%253Adoi%252F10.1001%252Farchinternmed.2007.30%26rft_id%253Dinfo%253Apmid%252F18227357%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=10.1001/archinternmed.2007.30&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=18227357&amp;link_type=MED&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>Medline</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=000252593800003&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-100-1" title="View reference 100 in text" id="ref-100">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.100" data-doi="10.1016/S0140-6736(08)60601-7"><div class="cit-metadata"><cite>Devereaux
 PJ, Yang H, Yusuf S, Guyatt G, Leslie K, Villar JC, et al. Effects of 
extended-release metoprolol succinate in patients undergoing non-cardiac
 surgery (POISE trial): a randomised controlled trial. <abbr class="cit-jnl-abbrev">Lancet</abbr><span class="cit-pub-date">2008</span>;<span class="cit-vol">371</span>:<span class="cit-fpage">1839</span>-47.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DLancet%26rft.stitle%253DLancet%26rft.volume%253D371%26rft.issue%253D9627%26rft.spage%253D1839%26rft.epage%253D1847%26rft.atitle%253DEffects%2Bof%2Bextended-release%2Bmetoprolol%2Bsuccinate%2Bin%2Bpatients%2Bundergoing%2Bnon-cardiac%2Bsurgery%2B%2528POISE%2Btrial%2529%253A%2Ba%2Brandomised%2Bcontrolled%2Btrial.%26rft_id%253Dinfo%253Adoi%252F10.1016%252FS0140-6736%252808%252960601-7%26rft_id%253Dinfo%253Apmid%252F18479744%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=10.1016/S0140-6736%2808%2960601-7&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=18479744&amp;link_type=MED&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>Medline</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=000256325500027&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-101-1" title="View reference 101 in text" id="ref-101">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.101" data-doi="10.7326/0003-4819-150-10-200905190-00003"><div class="cit-metadata"><cite>Rannou F, Dimet J, Boutron I, Baron G, Fayad F, Macé Y, et al. Splint for base-of-thumb osteoarthritis: a randomized trial. <abbr class="cit-jnl-abbrev">Ann Intern Med</abbr><span class="cit-pub-date">2009</span>;<span class="cit-vol">150</span>:<span class="cit-fpage">661</span>-9.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DAnnals%2Bof%2BInternal%2BMedicine%26rft.stitle%253DANN%2BINTERN%2BMED%26rft.issn%253D0003-4819%26rft.aulast%253DRannou%26rft.auinit1%253DF.%26rft.volume%253D150%26rft.issue%253D10%26rft.spage%253D661%26rft.epage%253D669%26rft.atitle%253DSplint%2Bfor%2BBase-of-Thumb%2BOsteoarthritis%253A%2BA%2BRandomized%2BTrial%26rft_id%253Dinfo%253Adoi%252F10.7326%252F0003-4819-150-10-200905190-00003%26rft_id%253Dinfo%253Apmid%252F19451573%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=10.7326/0003-4819-150-10-200905190-00003&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=19451573&amp;link_type=MED&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>Medline</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=000266285300001&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-102-1" title="View reference 102 in text" id="ref-102">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.102" data-doi="10.1136/bmj.39590.732037.47"><div class="cit-metadata"><cite>Glasziou P, Meats E, Heneghan C, Shepperd S. What is missing from descriptions of treatment in trials and reviews? <abbr class="cit-jnl-abbrev">BMJ</abbr><span class="cit-pub-date">2008</span>;<span class="cit-vol">336</span>:<span class="cit-fpage">1472</span>-4.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DBMJ%26rft.stitle%253DBMJ%26rft.issn%253D0007-1447%26rft.aulast%253DGlasziou%26rft.auinit1%253DP.%26rft.volume%253D336%26rft.issue%253D7659%26rft.spage%253D1472%26rft.epage%253D1474%26rft.atitle%253DWhat%2Bis%2Bmissing%2Bfrom%2Bdescriptions%2Bof%2Btreatment%2Bin%2Btrials%2Band%2Breviews%253F%26rft_id%253Dinfo%253Adoi%252F10.1136%252Fbmj.39590.732037.47%26rft_id%253Dinfo%253Apmid%252F18583680%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/ijlink?linkType=FULL&amp;journalCode=bmj&amp;resid=336/7659/1472&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-ijlink"><span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-103-1" title="View reference 103 in text" id="ref-103">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.103" data-doi="10.1016/S0140-6736(00)02530-7"><div class="cit-metadata"><cite>Mease
 PJ, Goffe BS, Metz J, VanderStoep A, Finck B, Burge DJ. Etanercept in 
the treatment of psoriatic arthritis and psoriasis: a randomised trial. <abbr class="cit-jnl-abbrev">Lancet</abbr><span class="cit-pub-date">2000</span>;<span class="cit-vol">356</span>:<span class="cit-fpage">385</span>-90.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DLancet%26rft.stitle%253DLancet%26rft.aulast%253DMease%26rft.auinit1%253DP.%2BJ.%26rft.volume%253D356%26rft.issue%253D9227%26rft.spage%253D385%26rft.epage%253D390%26rft.atitle%253DEtanercept%2Bin%2Bthe%2Btreatment%2Bof%2Bpsoriatic%2Barthritis%2Band%2Bpsoriasis%253A%2Ba%2Brandomised%2Btrial.%26rft_id%253Dinfo%253Adoi%252F10.1016%252FS0140-6736%252800%252902530-7%26rft_id%253Dinfo%253Apmid%252F10972371%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=10.1016/S0140-6736%2800%2902530-7&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=10972371&amp;link_type=MED&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>Medline</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=000088486000011&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-104-1" title="View reference 104 in text" id="ref-104">↵</a><div class="cit ref-cit ref-other" id="cit-340.mar23_1.c869.104"><div class="cit-metadata unstructured">McDowell
 I, Newell C. Measuring health: a guide to rating scales and 
questionnaires. 3rd ed. New York: Oxford University Press, 2006.</div><div class="cit-extra"></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-105-1" title="View reference 105 in text" id="ref-105">↵</a><div class="cit ref-cit ref-other" id="cit-340.mar23_1.c869.105"><div class="cit-metadata unstructured">Streiner
 D, Norman C. Health measurement scales: a practical guide to their 
development and use. 3rd ed. Oxford: Oxford University Press; 2003.</div><div class="cit-extra"></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-106-1" title="View reference 106 in text" id="ref-106">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.106" data-doi="10.1186/1745-6215-8-39"><div class="cit-metadata"><cite>Clarke M. Standardising outcomes for clinical trials and systematic reviews. <abbr class="cit-jnl-abbrev">Trials</abbr><span class="cit-pub-date">2007</span>;<span class="cit-vol">8</span>:<span class="cit-fpage">39</span>.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.stitle%253DTrials%26rft.aulast%253DClarke%26rft.auinit1%253DM.%26rft.volume%253D8%26rft.spage%253D39%26rft.epage%253D39%26rft.atitle%253DStandardising%2Boutcomes%2Bfor%2Bclinical%2Btrials%2Band%2Bsystematic%2Breviews.%26rft_id%253Dinfo%253Adoi%252F10.1186%252F1745-6215-8-39%26rft_id%253Dinfo%253Apmid%252F18039365%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=10.1186/1745-6215-8-39&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=18039365&amp;link_type=MED&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>Medline</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-107-1" title="View reference 107 in text" id="ref-107">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.107" data-doi="10.1136/bmj.317.7167.1191"><div class="cit-metadata"><cite>Sanders
 C, Egger M, Donovan J, Tallon D, Frankel S. Reporting on quality of 
life in randomised controlled trials: bibliographic study. <abbr class="cit-jnl-abbrev">BMJ</abbr><span class="cit-pub-date">1998</span>;<span class="cit-vol">317</span>:<span class="cit-fpage">1191</span>-4.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DBMJ%26rft.stitle%253DBMJ%26rft.issn%253D0007-1447%26rft.aulast%253DSanders%26rft.auinit1%253DC.%26rft.volume%253D317%26rft.issue%253D7167%26rft.spage%253D1191%26rft.epage%253D1194%26rft.atitle%253DReporting%2Bon%2Bquality%2Bof%2Blife%2Bin%2Brandomised%2Bcontrolled%2Btrials%253A%2Bbibliographic%2Bstudy%26rft_id%253Dinfo%253Adoi%252F10.1136%252Fbmj.317.7167.1191%26rft_id%253Dinfo%253Apmid%252F9794853%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/ijlink?linkType=ABST&amp;journalCode=bmj&amp;resid=317/7167/1191&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-ijlink"><span><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-108-1" title="View reference 108 in text" id="ref-108">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.108" data-doi="10.1016/0197-2456(89)90017-2"><div class="cit-metadata"><cite>Gøtzsche
 PC. Methodology and overt and hidden bias in reports of 196 
double-blind trials of nonsteroidal antiinflammatory drugs in rheumatoid
 arthritis. <abbr class="cit-jnl-abbrev">Control Clin Trials</abbr><span class="cit-pub-date">1989</span>;<span class="cit-vol">10</span>:<span class="cit-fpage">31</span>-56.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DControlled%2Bclinical%2Btrials%26rft.stitle%253DControl%2BClin%2BTrials%26rft.aulast%253DG%25C3%25B8tzsche%26rft.auinit1%253DP.%2BC.%26rft.volume%253D10%26rft.issue%253D1%26rft.spage%253D31%26rft.epage%253D56%26rft.atitle%253DMethodology%2Band%2Bovert%2Band%2Bhidden%2Bbias%2Bin%2Breports%2Bof%2B196%2Bdouble-blind%2Btrials%2Bof%2Bnonsteroidal%2Bantiinflammatory%2Bdrugs%2Bin%2Brheumatoid%2Barthritis.%26rft_id%253Dinfo%253Adoi%252F10.1016%252F0197-2456%252889%252990017-2%26rft_id%253Dinfo%253Apmid%252F2702836%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=10.1016/0197-2456%2889%2990017-2&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=2702836&amp;link_type=MED&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>Medline</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=A1989U002800003&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-109-1" title="View reference 109 in text" id="ref-109">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.109" data-doi="10.1192/bjp.176.3.249"><div class="cit-metadata"><cite>Marshall
 M, Lockwood A, Bradley C, Adams C, Joy C, Fenton M. Unpublished rating 
scales: a major source of bias in randomised controlled trials of 
treatments for schizophrenia. <abbr class="cit-jnl-abbrev">Br J Psychiatry</abbr><span class="cit-pub-date">2000</span>;<span class="cit-vol">176</span>:<span class="cit-fpage">249</span>-52.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DThe%2BBritish%2BJournal%2Bof%2BPsychiatry%26rft.stitle%253DBr.%2BJ.%2BPsychiatry%26rft.issn%253D0007-1250%26rft.aulast%253DMARSHALL%26rft.auinit1%253DM.%26rft.volume%253D176%26rft.issue%253D3%26rft.spage%253D249%26rft.epage%253D252%26rft.atitle%253DUnpublished%2Brating%2Bscales%253A%2Ba%2Bmajor%2Bsource%2Bof%2Bbias%2Bin%2Brandomised%2Bcontrolled%2Btrials%2Bof%2Btreatments%2Bfor%2Bschizophrenia%26rft_id%253Dinfo%253Adoi%252F10.1192%252Fbjp.176.3.249%26rft_id%253Dinfo%253Apmid%252F10755072%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/ijlink?linkType=ABST&amp;journalCode=bjprcpsych&amp;resid=176/3/249&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-ijlink"><span><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-110-1" title="View reference 110 in text" id="ref-110">↵</a><div class="cit ref-cit ref-other" id="cit-340.mar23_1.c869.110"><div class="cit-metadata unstructured">Jadad
 AR, Boyle M, Cunnigham C, Kim M, Schachar R. Treatment of 
Attention-Deficit/Hyperactivity Disorder. Evidence Report/Technology 
Assessment No. 11. Rockville, MD: U.S. Department of Health and Human 
Services, Public Health Service, Agency for Healthcare Research and 
Quality. AHQR publication no. 00-E005; 1999.</div><div class="cit-extra"></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-111-1" title="View reference 111 in text" id="ref-111">↵</a><div class="cit ref-cit ref-other" id="cit-340.mar23_1.c869.111"><div class="cit-metadata unstructured">Schachter
 HM, Pham B, King J, Langford S, Moher D. The efficacy and safety of 
methylphenidate in attention deficit disorder: A systematic review and 
meta-analyis. Prepared for the Therapeutics Initiative, Vancouver, B.C.,
 and the British Columbia Ministry for Children and Families, 2000.</div><div class="cit-extra"></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-112-1" title="View reference 112 in text" id="ref-112">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.112" data-doi="10.1016/S0140-6736(00)04560-8"><div class="cit-metadata"><cite>Dargie
 HJ. Effect of carvedilol on outcome after myocardial infarction in 
patients with left-ventricular dysfunction: the CAPRICORN randomised 
trial. <abbr class="cit-jnl-abbrev">Lancet</abbr><span class="cit-pub-date">2001</span>;<span class="cit-vol">357</span>:<span class="cit-fpage">1385</span>-90.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DLancet%26rft.stitle%253DLancet%26rft.aulast%253DDargie%26rft.auinit1%253DH.%2BJ.%26rft.volume%253D357%26rft.issue%253D9266%26rft.spage%253D1385%26rft.epage%253D1390%26rft.atitle%253DEffect%2Bof%2Bcarvedilol%2Bon%2Boutcome%2Bafter%2Bmyocardial%2Binfarction%2Bin%2Bpatients%2Bwith%2Bleft-ventricular%2Bdysfunction%253A%2Bthe%2BCAPRICORN%2Brandomised%2Btrial.%26rft_id%253Dinfo%253Adoi%252F10.1016%252FS0140-6736%252800%252904560-8%26rft_id%253Dinfo%253Apmid%252F11356434%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=10.1016/S0140-6736%2800%2904560-8&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=11356434&amp;link_type=MED&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>Medline</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=000168478200008&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-113-1" title="View reference 113 in text" id="ref-113">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.113" data-doi="10.1503/cmaj.1041086"><div class="cit-metadata"><cite>Chan
 AW, Krleza-Jeric K, Schmid I, Altman DG. Outcome reporting bias in 
randomized trials funded by the Canadian Institutes of Health Research. <abbr class="cit-jnl-abbrev">CMAJ</abbr><span class="cit-pub-date">2004</span>;<span class="cit-vol">171</span>:<span class="cit-fpage">735</span>-40.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DCanadian%2BMedical%2BAssociation%2BJournal%26rft.stitle%253DCMAJ%26rft.issn%253D0008-4409%26rft.aulast%253DChan%26rft.auinit1%253DA.-W.%26rft.volume%253D171%26rft.issue%253D7%26rft.spage%253D735%26rft.epage%253D740%26rft.atitle%253DOutcome%2Breporting%2Bbias%2Bin%2Brandomized%2Btrials%2Bfunded%2Bby%2Bthe%2BCanadian%2BInstitutes%2Bof%2BHealth%2BResearch%26rft_id%253Dinfo%253Adoi%252F10.1503%252Fcmaj.1041086%26rft_id%253Dinfo%253Apmid%252F15451835%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/ijlink?linkType=ABST&amp;journalCode=cmaj&amp;resid=171/7/735&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-ijlink"><span><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-114-1" title="View reference 114 in text" id="ref-114">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.114" data-doi="10.1186/1745-6215-10-50"><div class="cit-metadata"><cite>Vermeulen
 H, Hofland J, Legemate DA, Ubbink DT. Intravenous fluid restriction 
after major abdominal surgery: a randomized blinded clinical trial. <abbr class="cit-jnl-abbrev">Trials</abbr><span class="cit-pub-date">2009</span>;<span class="cit-vol">10</span>:<span class="cit-fpage">50</span>.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.stitle%253DTrials%26rft.aulast%253DVermeulen%26rft.auinit1%253DH.%26rft.volume%253D10%26rft.spage%253D50%26rft.epage%253D50%26rft.atitle%253DIntravenous%2Bfluid%2Brestriction%2Bafter%2Bmajor%2Babdominal%2Bsurgery%253A%2Ba%2Brandomized%2Bblinded%2Bclinical%2Btrial.%26rft_id%253Dinfo%253Adoi%252F10.1186%252F1745-6215-10-50%26rft_id%253Dinfo%253Apmid%252F19583868%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=10.1186/1745-6215-10-50&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=19583868&amp;link_type=MED&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>Medline</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-115-1" title="View reference 115 in text" id="ref-115">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.115" data-doi="10.1016/S0140-6736(08)61170-8"><div class="cit-metadata"><cite>Fox
 K, Ford I, Steg PG, Tendera M, Ferrari R. Ivabradine for patients with 
stable coronary artery disease and left-ventricular systolic dysfunction
 (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial. <abbr class="cit-jnl-abbrev">Lancet</abbr><span class="cit-pub-date">2008</span>;<span class="cit-vol">372</span>:<span class="cit-fpage">807</span>-16.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DLancet%26rft.stitle%253DLancet%26rft.aulast%253DFox%26rft.auinit1%253DK.%26rft.volume%253D372%26rft.issue%253D9641%26rft.spage%253D807%26rft.epage%253D816%26rft.atitle%253DIvabradine%2Bfor%2Bpatients%2Bwith%2Bstable%2Bcoronary%2Bartery%2Bdisease%2Band%2Bleft-ventricular%2Bsystolic%2Bdysfunction%2B%2528BEAUTIFUL%2529%253A%2Ba%2Brandomised%252C%2Bdouble-blind%252C%2Bplacebo-controlled%2Btrial.%26rft_id%253Dinfo%253Adoi%252F10.1016%252FS0140-6736%252808%252961170-8%26rft_id%253Dinfo%253Apmid%252F18757088%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=10.1016/S0140-6736%2808%2961170-8&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=18757088&amp;link_type=MED&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>Medline</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=000259124900023&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-116-1" title="View reference 116 in text" id="ref-116">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.116"><div class="cit-metadata"><cite>Campbell
 MJ, Julious SA, Altman DG. Estimating sample sizes for binary, ordered 
categorical, and continuous outcomes in two group comparisons. <abbr class="cit-jnl-abbrev">BMJ</abbr><span class="cit-pub-date">1995</span>;<span class="cit-vol">311</span>:<span class="cit-fpage">1145</span>-8.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DBMJ%26rft.stitle%253DBMJ%26rft.issn%253D0007-1447%26rft.aulast%253DCampbell%26rft.auinit1%253DM%2BJ%26rft.volume%253D311%26rft.issue%253D7013%26rft.spage%253D1145%26rft.epage%253D1148%26rft.atitle%253DEstimating%2Bsample%2Bsizes%2Bfor%2Bbinary%252C%2Bordered%2Bcategorical%252C%2Band%2Bcontinuous%2Boutcomes%2Bin%2Btwo%2Bgroup%2Bcomparisons%26rft_id%253Dinfo%253Apmid%252F7580713%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/ijlink?linkType=FULL&amp;journalCode=bmj&amp;resid=311/7013/1145&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-ijlink"><span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-117-1" title="View reference 117 in text" id="ref-117">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.117" data-doi="10.1371/journal.pmed.0050004"><div class="cit-metadata"><cite>Guyatt GH, Mills EJ, Elbourne D. In the era of systematic reviews, does the size of an individual trial still matter. <abbr class="cit-jnl-abbrev">PLoS Med</abbr><span class="cit-pub-date">2008</span>;<span class="cit-vol">5</span>:<span class="cit-fpage">e4</span>.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.stitle%253DPLoS%2BMed%26rft.aulast%253DGuyatt%26rft.auinit1%253DG.%2BH.%26rft.volume%253D5%26rft.issue%253D1%26rft.spage%253De4%26rft.epage%253De4%26rft.atitle%253DIn%2Bthe%2Bera%2Bof%2Bsystematic%2Breviews%252C%2Bdoes%2Bthe%2Bsize%2Bof%2Ban%2Bindividual%2Btrial%2Bstill%2Bmatter.%26rft_id%253Dinfo%253Adoi%252F10.1371%252Fjournal.pmed.0050004%26rft_id%253Dinfo%253Apmid%252F18177203%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=10.1371/journal.pmed.0050004&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=18177203&amp;link_type=MED&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>Medline</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-118-1" title="View reference 118 in text" id="ref-118">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.118" data-doi="10.1016/S0140-6736(05)61034-3"><div class="cit-metadata"><cite>Schulz KF, Grimes DA. Sample size calculations in randomised trials: mandatory and mystical. <abbr class="cit-jnl-abbrev">Lancet</abbr><span class="cit-pub-date">2005</span>;<span class="cit-vol">365</span>:<span class="cit-fpage">1348</span>-53.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DLancet%26rft.stitle%253DLancet%26rft.aulast%253DSchulz%26rft.auinit1%253DK.%2BF.%26rft.volume%253D365%26rft.issue%253D9467%26rft.spage%253D1348%26rft.epage%253D1353%26rft.atitle%253DSample%2Bsize%2Bcalculations%2Bin%2Brandomised%2Btrials%253A%2Bmandatory%2Band%2Bmystical.%26rft_id%253Dinfo%253Adoi%252F10.1016%252FS0140-6736%252805%252961034-3%26rft_id%253Dinfo%253Apmid%252F15823387%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=10.1016/S0140-6736%2805%2961034-3&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=15823387&amp;link_type=MED&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>Medline</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=000228219600032&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-119-1" title="View reference 119 in text" id="ref-119">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.119" data-doi="10.1001/jama.288.3.358"><div class="cit-metadata"><cite>Halpern SD, Karlawish JH, Berlin JA. The continuing unethical conduct of underpowered clinical trials. <abbr class="cit-jnl-abbrev">JAMA</abbr><span class="cit-pub-date">2002</span>;<span class="cit-vol">288</span>:<span class="cit-fpage">358</span>-62.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DJAMA%26rft.stitle%253DJAMA%26rft.issn%253D0002-9955%26rft.aulast%253DHalpern%26rft.auinit1%253DS.%2BD.%26rft.volume%253D288%26rft.issue%253D3%26rft.spage%253D358%26rft.epage%253D362%26rft.atitle%253DThe%2BContinuing%2BUnethical%2BConduct%2Bof%2BUnderpowered%2BClinical%2BTrials%26rft_id%253Dinfo%253Adoi%252F10.1001%252Fjama.288.3.358%26rft_id%253Dinfo%253Apmid%252F12117401%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=10.1001/jama.288.3.358&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=12117401&amp;link_type=MED&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>Medline</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=000176807000028&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-120-1" title="View reference 120 in text" id="ref-120">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.120" data-doi="10.1136/bmj.311.7003.485"><div class="cit-metadata"><cite>Altman DG, Bland JM. Absence of evidence is not evidence of absence. <abbr class="cit-jnl-abbrev">BMJ</abbr><span class="cit-pub-date">1995</span>;<span class="cit-vol">311</span>:<span class="cit-fpage">485</span>.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DBMJ%26rft.stitle%253DBMJ%26rft.issn%253D0007-1447%26rft.aulast%253DAltman%26rft.auinit1%253DD.%2BG%26rft.volume%253D311%26rft.issue%253D7003%26rft.spage%253D485%26rft.epage%253D485%26rft.atitle%253DStatistics%2Bnotes%253A%2BAbsence%2Bof%2Bevidence%2Bis%2Bnot%2Bevidence%2Bof%2Babsence%26rft_id%253Dinfo%253Adoi%252F10.1136%252Fbmj.311.7003.485%26rft_id%253Dinfo%253Apmid%252F7647644%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/ijlink?linkType=FULL&amp;journalCode=bmj&amp;resid=311/7003/485&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-ijlink"><span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-121-1" title="View reference 121 in text" id="ref-121">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.121" data-doi="10.1001/jama.1994.03520020048013"><div class="cit-metadata"><cite>Moher D, Dulberg CS, Wells GA. Statistical power, sample size, and their reporting in randomized controlled trials. <abbr class="cit-jnl-abbrev">JAMA</abbr><span class="cit-pub-date">1994</span>;<span class="cit-vol">272</span>:<span class="cit-fpage">122</span>-4.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DJAMA%26rft.stitle%253DJAMA%26rft.issn%253D0002-9955%26rft.aulast%253DMoher%26rft.auinit1%253DD.%26rft.volume%253D272%26rft.issue%253D2%26rft.spage%253D122%26rft.epage%253D124%26rft.atitle%253DStatistical%2BPower%252C%2BSample%2BSize%252C%2Band%2BTheir%2BReporting%2Bin%2BRandomized%2BControlled%2BTrials%26rft_id%253Dinfo%253Adoi%252F10.1001%252Fjama.1994.03520020048013%26rft_id%253Dinfo%253Apmid%252F8015121%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=10.1001/jama.1994.03520020048013&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=8015121&amp;link_type=MED&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>Medline</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=A1994NV42400011&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-122-1" title="View reference 122 in text" id="ref-122">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.122" data-doi="10.1056/NEJM197809282991304"><div class="cit-metadata"><cite>Freiman
 JA, Chalmers TC, Smith H Jr, Kuebler RR. The importance of beta, the 
type II error and sample size in the design and interpretation of the 
randomized control trial. Survey of 71 “negative” trials. <abbr class="cit-jnl-abbrev">N Engl J Med</abbr><span class="cit-pub-date">1978</span>;<span class="cit-vol">299</span>:<span class="cit-fpage">690</span>-4.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DNew%2BEngland%2BJournal%2Bof%2BMedicine%26rft.stitle%253DNEJM%26rft.issn%253D0028-4793%26rft.aulast%253DFreiman%26rft.auinit1%253DJ.%2BA.%26rft.volume%253D299%26rft.issue%253D13%26rft.spage%253D690%26rft.epage%253D694%26rft.atitle%253DThe%2Bimportance%2Bof%2Bbeta%252C%2Bthe%2Btype%2BII%2Berror%2Band%2Bsample%2Bsize%2Bin%2Bthe%2Bdesign%2Band%2Binterpretation%2Bof%2Bthe%2Brandomized%2Bcontrol%2Btrial.%2BSurvey%2Bof%2B71%2B%2522negative%2522%2Btrials%26rft_id%253Dinfo%253Adoi%252F10.1056%252FNEJM197809282991304%26rft_id%253Dinfo%253Apmid%252F355881%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=10.1056/NEJM197809282991304&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=355881&amp;link_type=MED&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>Medline</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=A1978FQ71300004&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-123-1" title="View reference 123 in text" id="ref-123">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.123" data-doi="10.1136/bmj.b1732"><div class="cit-metadata"><cite>Charles
 P, Giraudeau B, Dechartres A, Baron G, Ravaud P. Reporting of sample 
size calculation in randomised controlled trials: review. <abbr class="cit-jnl-abbrev">BMJ</abbr><span class="cit-pub-date">2009</span>;<span class="cit-vol">338</span>:<span class="cit-fpage">b1732</span>.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DBMJ%26rft_id%253Dinfo%253Adoi%252F10.1136%252Fbmj.b1732%26rft_id%253Dinfo%253Apmid%252F19435763%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/ijlink?linkType=ABST&amp;journalCode=bmj&amp;resid=338/may12_1/b1732&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-ijlink"><span><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-124-1" title="View reference 124 in text" id="ref-124">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.124" data-doi="10.1002/sim.4780030421"><div class="cit-metadata"><cite>Yusuf S, Collins R, Peto R. Why do we need some large, simple randomized trials? <abbr class="cit-jnl-abbrev">Stat Med</abbr><span class="cit-pub-date">1984</span>;<span class="cit-vol">3</span>:<span class="cit-fpage">409</span>-22.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DStatistics%2Bin%2Bmedicine%26rft.stitle%253DStat%2BMed%26rft.aulast%253DYusuf%26rft.auinit1%253DS.%26rft.volume%253D3%26rft.issue%253D4%26rft.spage%253D409%26rft.epage%253D422%26rft.atitle%253DWhy%2Bdo%2Bwe%2Bneed%2Bsome%2Blarge%252C%2Bsimple%2Brandomized%2Btrials%253F%26rft_id%253Dinfo%253Adoi%252F10.1002%252Fsim.4780030421%26rft_id%253Dinfo%253Apmid%252F6528136%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=10.1002/sim.4780030421&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=6528136&amp;link_type=MED&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>Medline</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=A1984TZ65300013&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-125-1" title="View reference 125 in text" id="ref-125">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.125" data-doi="10.7326/0003-4819-121-3-199408010-00008"><div class="cit-metadata"><cite>Goodman
 SN, Berlin JA. The use of predicted confidence intervals when planning 
experiments and the misuse of power when interpreting results. <abbr class="cit-jnl-abbrev">Ann Intern Med</abbr><span class="cit-pub-date">1994</span>;<span class="cit-vol">121</span>:<span class="cit-fpage">200</span>-6.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DAnnals%2Bof%2BInternal%2BMedicine%26rft.stitle%253DANN%2BINTERN%2BMED%26rft.issn%253D0003-4819%26rft.aulast%253DGoodman%26rft.auinit1%253DS.%2BN.%26rft.volume%253D121%26rft.issue%253D3%26rft.spage%253D200%26rft.epage%253D206%26rft.atitle%253DThe%2BUse%2Bof%2BPredicted%2BConfidence%2BIntervals%2BWhen%2BPlanning%2BExperiments%2Band%2Bthe%2BMisuse%2Bof%2BPower%2BWhen%2BInterpreting%2BResults%26rft_id%253Dinfo%253Adoi%252F10.7326%252F0003-4819-121-3-199408010-00008%26rft_id%253Dinfo%253Apmid%252F8017747%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=10.7326/0003-4819-121-3-199408010-00008&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=8017747&amp;link_type=MED&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>Medline</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=A1994NY33800008&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-126-1" title="View reference 126 in text" id="ref-126">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.126" data-doi="10.7326/0003-4819-133-9-200011070-00009"><div class="cit-metadata"><cite>Galgiani
 JN, Catanzaro A, Cloud GA, Johnson RH, Williams PL, Mirels LF, et al. 
Comparison of oral fluconazole and itraconazole for progressive, 
nonmeningeal coccidioidomycosis. A randomized, double-blind trial. 
Mycoses Study Group. <abbr class="cit-jnl-abbrev">Ann Intern Med</abbr><span class="cit-pub-date">2000</span>;<span class="cit-vol">133</span>:<span class="cit-fpage">676</span>-86.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DAnnals%2Bof%2BInternal%2BMedicine%26rft.stitle%253DANN%2BINTERN%2BMED%26rft.issn%253D0003-4819%26rft.aulast%253DGalgiani%26rft.auinit1%253DJ.%2BN.%26rft.volume%253D133%26rft.issue%253D9%26rft.spage%253D676%26rft.epage%253D686%26rft.atitle%253DComparison%2Bof%2BOral%2BFluconazole%2Band%2BItraconazole%2Bfor%2BProgressive%252C%2BNonmeningeal%2BCoccidioidomycosis%253A%2BA%2BRandomized%252C%2BDouble-Blind%2BTrial%26rft_id%253Dinfo%253Adoi%252F10.7326%252F0003-4819-133-9-200011070-00009%26rft_id%253Dinfo%253Apmid%252F11074900%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=10.7326/0003-4819-133-9-200011070-00009&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=11074900&amp;link_type=MED&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>Medline</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=000165075300002&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-127-1" title="View reference 127 in text" id="ref-127">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.127" data-doi="10.1056/NEJMoa0901301"><div class="cit-metadata"><cite>Connolly
 SJ, Pogue J, Hart RG, Hohnloser SH, Pfeffer M, Chrolavicius S, et al. 
Effect of clopidogrel added to aspirin in patients with atrial 
fibrillation. <abbr class="cit-jnl-abbrev">N Engl J Med</abbr><span class="cit-pub-date">2009</span>;<span class="cit-vol">360</span>:<span class="cit-fpage">2066</span>-78.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DN%2BEngl%2BJ%2BMed%26rft_id%253Dinfo%253Adoi%252F10.1056%252FNEJMoa0901301%26rft_id%253Dinfo%253Apmid%252F19336502%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=10.1056/NEJMoa0901301&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=19336502&amp;link_type=MED&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>Medline</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=000266011200005&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-128-1" title="View reference 128 in text" id="ref-128">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.128" data-doi="10.2307/2531962"><div class="cit-metadata"><cite>Geller NL, Pocock SJ. Interim analyses in randomized clinical trials: ramifications and guidelines for practitioners. <abbr class="cit-jnl-abbrev">Biometrics</abbr><span class="cit-pub-date">1987</span>;<span class="cit-vol">43</span>:<span class="cit-fpage">213</span>-23.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DBiometrics%26rft.volume%253D43%26rft.spage%253D213%26rft_id%253Dinfo%253Adoi%252F10.2307%252F2531962%26rft_id%253Dinfo%253Apmid%252F3567306%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=10.2307/2531962&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=3567306&amp;link_type=MED&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>Medline</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=A1987G749100020&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-129-1" title="View reference 129 in text" id="ref-129">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.129" data-doi="10.1002/sim.4780040412"><div class="cit-metadata"><cite>Berry DA. Interim analyses in clinical trials: classical vs. Bayesian approaches. <abbr class="cit-jnl-abbrev">Stat Med</abbr><span class="cit-pub-date">1985</span>;<span class="cit-vol">4</span>:<span class="cit-fpage">521</span>-6.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DStatistics%2Bin%2Bmedicine%26rft.stitle%253DStat%2BMed%26rft.aulast%253DBerry%26rft.auinit1%253DD.%2BA.%26rft.volume%253D4%26rft.issue%253D4%26rft.spage%253D521%26rft.epage%253D526%26rft.atitle%253DInterim%2Banalyses%2Bin%2Bclinical%2Btrials%253A%2Bclassical%2Bvs.%2BBayesian%2Bapproaches.%26rft_id%253Dinfo%253Adoi%252F10.1002%252Fsim.4780040412%26rft_id%253Dinfo%253Apmid%252F4089353%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=10.1002/sim.4780040412&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=4089353&amp;link_type=MED&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>Medline</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=A1985AXH4200011&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-130-1" title="View reference 130 in text" id="ref-130">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.130" data-doi="10.1136/bmj.305.6847.235"><div class="cit-metadata"><cite>Pocock SJ. When to stop a clinical trial. <abbr class="cit-jnl-abbrev">BMJ</abbr><span class="cit-pub-date">1992</span>;<span class="cit-vol">305</span>:<span class="cit-fpage">235</span>-40.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DBMJ%26rft.stitle%253DBMJ%26rft.issn%253D0007-1447%26rft.aulast%253DPocock%26rft.auinit1%253DS.%2BJ.%26rft.volume%253D305%26rft.issue%253D6847%26rft.spage%253D235%26rft.epage%253D240%26rft.atitle%253DWhen%2Bto%2Bstop%2Ba%2Bclinical%2Btrial.%26rft_id%253Dinfo%253Adoi%252F10.1136%252Fbmj.305.6847.235%26rft_id%253Dinfo%253Apmid%252F1392832%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/ijlink?linkType=PDF&amp;journalCode=bmj&amp;resid=305/6847/235&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-ijlink"><span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-131-1" title="View reference 131 in text" id="ref-131">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.131" data-doi="10.1016/S0140-6736(99)03464-9"><div class="cit-metadata"><cite>DeMets DL, Pocock SJ, Julian DG. The agonising negative trend in monitoring of clinical trials. <abbr class="cit-jnl-abbrev">Lancet</abbr><span class="cit-pub-date">1999</span>;<span class="cit-vol">354</span>:<span class="cit-fpage">1983</span>-8.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DLancet%26rft.stitle%253DLancet%26rft.aulast%253DDeMets%26rft.auinit1%253DD.%2BL.%26rft.volume%253D354%26rft.issue%253D9194%26rft.spage%253D1983%26rft.epage%253D1988%26rft.atitle%253DThe%2Bagonising%2Bnegative%2Btrend%2Bin%2Bmonitoring%2Bof%2Bclinical%2Btrials.%26rft_id%253Dinfo%253Adoi%252F10.1016%252FS0140-6736%252899%252903464-9%26rft_id%253Dinfo%253Apmid%252F10622312%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=10.1016/S0140-6736%2899%2903464-9&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=10622312&amp;link_type=MED&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>Medline</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=000084034700042&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-132-1" title="View reference 132 in text" id="ref-132">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.132"><div class="cit-metadata"><cite>Buyse M. Interim analyses, stopping rules and data monitoring in clinical trials in Europe. <abbr class="cit-jnl-abbrev">Stat Med</abbr><span class="cit-pub-date">1993</span>;<span class="cit-vol">12</span>:<span class="cit-fpage">509</span>-20.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DStatistics%2Bin%2Bmedicine%26rft.stitle%253DStat%2BMed%26rft.aulast%253DBuyse%26rft.auinit1%253DM.%26rft.volume%253D12%26rft.issue%253D5-6%26rft.spage%253D509%26rft.epage%253D520%26rft.atitle%253DInterim%2Banalyses%252C%2Bstopping%2Brules%2Band%2Bdata%2Bmonitoring%2Bin%2Bclinical%2Btrials%2Bin%2BEurope.%26rft_id%253Dinfo%253Apmid%252F8493429%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=8493429&amp;link_type=MED&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>Medline</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=A1993KX07100016&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-133-1" title="View reference 133 in text" id="ref-133">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.133" data-doi="10.1191/1740774504cn003oa"><div class="cit-metadata"><cite>Sydes
 MR, Altman DG, Babiker AB, Parmar MK, Spiegelhalter DJ. Reported use of
 data monitoring committees in the main published reports of randomized 
controlled trials: a cross-sectional study. <abbr class="cit-jnl-abbrev">Clin Trials</abbr><span class="cit-pub-date">2004</span>;<span class="cit-vol">1</span>:<span class="cit-fpage">48</span>-59.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DClinical%2BTrials%26rft.stitle%253DClin%2BTrials%26rft.issn%253D1740-7745%26rft.aulast%253DSydes%26rft.auinit1%253DM.%2BR%26rft.volume%253D1%26rft.issue%253D1%26rft.spage%253D48%26rft.epage%253D59%26rft.atitle%253DReported%2Buse%2Bof%2Bdata%2Bmonitoring%2Bcommittees%2Bin%2Bthe%2Bmain%2Bpublished%2Breports%2Bof%2Brandomized%2Bcontrolled%2Btrials%253A%2Ba%2Bcross-sectional%2Bstudy%26rft_id%253Dinfo%253Adoi%252F10.1191%252F1740774504cn003oa%26rft_id%253Dinfo%253Apmid%252F16281462%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/ijlink?linkType=ABST&amp;journalCode=spctj&amp;resid=1/1/48&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-ijlink"><span><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-134-1" title="View reference 134 in text" id="ref-134">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.134" data-doi="10.1001/jama.294.17.2203"><div class="cit-metadata"><cite>Montori
 VM, Devereaux PJ, Adhikari NK, Burns KE, Eggert CH, Briel M, et al. 
Randomized trials stopped early for benefit: a systematic review. <abbr class="cit-jnl-abbrev">JAMA</abbr><span class="cit-pub-date">2005</span>;<span class="cit-vol">294</span>:<span class="cit-fpage">2203</span>-9.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DJAMA%26rft.stitle%253DJAMA%26rft.issn%253D0002-9955%26rft.aulast%253DMontori%26rft.auinit1%253DV.%2BM.%26rft.volume%253D294%26rft.issue%253D17%26rft.spage%253D2203%26rft.epage%253D2209%26rft.atitle%253DRandomized%2BTrials%2BStopped%2BEarly%2Bfor%2BBenefit%253A%2BA%2BSystematic%2BReview%26rft_id%253Dinfo%253Adoi%252F10.1001%252Fjama.294.17.2203%26rft_id%253Dinfo%253Apmid%252F16264162%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=10.1001/jama.294.17.2203&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=16264162&amp;link_type=MED&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>Medline</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=000232957700023&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-135-1" title="View reference 135 in text" id="ref-135">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.135" data-doi="10.1097/AOG.0b013e31816521e2"><div class="cit-metadata"><cite>Coutinho
 IC, Ramos de Amorim MM, Katz L, Bandeira de Ferraz AA. Uterine 
exteriorization compared with in situ repair at cesarean delivery: a 
randomized controlled trial. <abbr class="cit-jnl-abbrev">Obstet Gynecol</abbr><span class="cit-pub-date">2008</span>;<span class="cit-vol">111</span>:<span class="cit-fpage">639</span>-47.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DObstetrics%2B%2526%2BGynecology%26rft.stitle%253DObstet%2BGynecol%26rft.issn%253D0029-7844%26rft.aulast%253DCoutinho%26rft.auinit1%253DI.%2BC.%26rft.volume%253D111%26rft.issue%253D3%26rft.spage%253D639%26rft.epage%253D647%26rft.atitle%253DUterine%2Bexteriorization%2Bcompared%2Bwith%2Bin%2Bsitu%2Brepair%2Bat%2Bcesarean%2Bdelivery%253A%2Ba%2Brandomized%2Bcontrolled%2Btrial.%26rft_id%253Dinfo%253Adoi%252F10.1097%252FAOG.0b013e31816521e2%26rft_id%253Dinfo%253Apmid%252F18310366%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=10.1097/AOG.0b013e31816521e2&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=18310366&amp;link_type=MED&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>Medline</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=000253738900008&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-136-1" title="View reference 136 in text" id="ref-136">↵</a><div class="cit ref-cit ref-other" id="cit-340.mar23_1.c869.136"><div class="cit-metadata"><cite>Jüni P, Altman DG, Egger M. Assessing the quality of controlled clinical trials. In: Egger M, Davey Smith G, Altman DG, eds. <span class="cit-source">Systematic reviews in health care: meta-analysis in context</span>. BMJ Books, <span class="cit-pub-date">2001</span>.</cite></div><div class="cit-extra"></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-137-1" title="View reference 137 in text" id="ref-137">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.137" data-doi="10.1097/01.AOG.0000298338.58511.d1"><div class="cit-metadata"><cite>Creinin
 MD, Meyn LA, Borgatta L, Barnhart K, Jensen J, Burke AE, et al. 
Multicenter comparison of the contraceptive ring and patch: a randomized
 controlled trial. <abbr class="cit-jnl-abbrev">Obstet Gynecol</abbr><span class="cit-pub-date">2008</span>;<span class="cit-vol">111</span>:<span class="cit-fpage">267</span>-77.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DObstetrics%2B%2526%2BGynecology%26rft.stitle%253DObstet%2BGynecol%26rft.issn%253D0029-7844%26rft.aulast%253DCreinin%26rft.auinit1%253DM.%2BD.%26rft.volume%253D111%26rft.issue%253D2%2BPt%2B1%26rft.spage%253D267%26rft.epage%253D277%26rft.atitle%253DMulticenter%2Bcomparison%2Bof%2Bthe%2Bcontraceptive%2Bring%2Band%2Bpatch%253A%2Ba%2Brandomized%2Bcontrolled%2Btrial.%26rft_id%253Dinfo%253Adoi%252F10.1097%252F01.AOG.0000298338.58511.d1%26rft_id%253Dinfo%253Apmid%252F18238962%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=10.1097/01.AOG.0000298338.58511.d1&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=18238962&amp;link_type=MED&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>Medline</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=000252762300003&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-138-1" title="View reference 138 in text" id="ref-138">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.138" data-doi="10.1001/jama.289.14.1833"><div class="cit-metadata"><cite>Tate
 DF, Jackvony EH, Wing RR. Effects of internet behavioral counseling on 
weight loss in adults at risk for type 2 diabetes: a randomized trial. <abbr class="cit-jnl-abbrev">JAMA</abbr><span class="cit-pub-date">2003</span>;<span class="cit-vol">289</span>:<span class="cit-fpage">1833</span>-6.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DJAMA%26rft.stitle%253DJAMA%26rft.issn%253D0002-9955%26rft.aulast%253DTate%26rft.auinit1%253DD.%2BF.%26rft.volume%253D289%26rft.issue%253D14%26rft.spage%253D1833%26rft.epage%253D1836%26rft.atitle%253DEffects%2Bof%2BInternet%2BBehavioral%2BCounseling%2Bon%2BWeight%2BLoss%2Bin%2BAdults%2Bat%2BRisk%2Bfor%2BType%2B2%2BDiabetes%253A%2BA%2BRandomized%2BTrial%26rft_id%253Dinfo%253Adoi%252F10.1001%252Fjama.289.14.1833%26rft_id%253Dinfo%253Apmid%252F12684363%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=10.1001/jama.289.14.1833&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=12684363&amp;link_type=MED&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>Medline</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=000182094900030&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-139-1" title="View reference 139 in text" id="ref-139">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.139" data-doi="10.1016/0197-2456(88)90046-3"><div class="cit-metadata"><cite>Lachin JM. Properties of simple randomization in clinical trials. <abbr class="cit-jnl-abbrev">Control Clin Trials</abbr><span class="cit-pub-date">1988</span>;<span class="cit-vol">9</span>:<span class="cit-fpage">312</span>-26.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DControlled%2Bclinical%2Btrials%26rft.stitle%253DControl%2BClin%2BTrials%26rft.aulast%253DLachin%26rft.auinit1%253DJ.%2BM.%26rft.volume%253D9%26rft.issue%253D4%26rft.spage%253D312%26rft.epage%253D326%26rft.atitle%253DProperties%2Bof%2Bsimple%2Brandomization%2Bin%2Bclinical%2Btrials.%26rft_id%253Dinfo%253Adoi%252F10.1016%252F0197-2456%252888%252990046-3%26rft_id%253Dinfo%253Apmid%252F3203523%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=10.1016/0197-2456%2888%2990046-3&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=3203523&amp;link_type=MED&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>Medline</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=A1988Q981800003&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-140-1" title="View reference 140 in text" id="ref-140">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.140" data-doi="10.1038/bjc.1976.220"><div class="cit-metadata"><cite>Peto
 R, Pike MC, Armitage P, Breslow NE, Cox DR, Howard SV, et al. Design 
and analysis of randomized clinical trials requiring prolonged 
observation of each patient. I. Introduction and design. <abbr class="cit-jnl-abbrev">Br J Cancer</abbr><span class="cit-pub-date">1976</span>;<span class="cit-vol">34</span>:<span class="cit-fpage">585</span>-612.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DBritish%2BJournal%2Bof%2BCancer%26rft.stitle%253DBritish%2BJournal%2Bof%2BCancer%26rft.aulast%253DPeto%26rft.auinit1%253DR.%26rft.volume%253D34%26rft.issue%253D6%26rft.spage%253D585%26rft.epage%253D612%26rft.atitle%253DDesign%2Band%2Banalysis%2Bof%2Brandomized%2Bclinical%2Btrials%2Brequiring%2Bprolonged%2Bobservation%2Bof%2Beach%2Bpatient.%2BI.%2BIntroduction%2Band%2Bdesign.%26rft_id%253Dinfo%253Adoi%252F10.1038%252Fbjc.1976.220%26rft_id%253Dinfo%253Apmid%252F795448%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=10.1038/bjc.1976.220&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=795448&amp;link_type=MED&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>Medline</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=A1976CQ95300002&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-141-1" title="View reference 141 in text" id="ref-141">↵</a><div class="cit ref-cit ref-other" id="cit-340.mar23_1.c869.141"><div class="cit-metadata"><cite>Schulz KF, Grimes DA. <span class="cit-source">The Lancet handbook of essential concepts in clinical research</span>. Elsevier, <span class="cit-pub-date">2006</span>.</cite></div><div class="cit-extra"></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-142-1" title="View reference 142 in text" id="ref-142">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.142"><div class="cit-metadata"><cite>Altman DG, Bland JM. How to randomise. <abbr class="cit-jnl-abbrev">BMJ</abbr><span class="cit-pub-date">1999</span>;<span class="cit-vol">319</span>:<span class="cit-fpage">703</span>-4.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DBMJ%26rft.stitle%253DBMJ%26rft.issn%253D0007-1447%26rft.aulast%253DAltman%26rft.auinit1%253DD.%2BG%26rft.volume%253D319%26rft.issue%253D7211%26rft.spage%253D703%26rft.epage%253D704%26rft.atitle%253DStatistics%2Bnotes%253A%2BHow%2Bto%2Brandomise%26rft_id%253Dinfo%253Apmid%252F10480833%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/ijlink?linkType=FULL&amp;journalCode=bmj&amp;resid=319/7211/703&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-ijlink"><span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-143-1" title="View reference 143 in text" id="ref-143">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.143" data-doi="10.1001/jama.1995.03530180050029"><div class="cit-metadata"><cite>Schulz KF. Subverting randomization in controlled trials. <abbr class="cit-jnl-abbrev">JAMA</abbr><span class="cit-pub-date">1995</span>;<span class="cit-vol">274</span>:<span class="cit-fpage">1456</span>-8.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DJAMA%26rft.stitle%253DJAMA%26rft.issn%253D0002-9955%26rft.aulast%253DSchulz%26rft.auinit1%253DK.%2BF.%26rft.volume%253D274%26rft.issue%253D18%26rft.spage%253D1456%26rft.epage%253D1458%26rft.atitle%253DSubverting%2BRandomization%2Bin%2BControlled%2BTrials%26rft_id%253Dinfo%253Adoi%252F10.1001%252Fjama.1995.03530180050029%26rft_id%253Dinfo%253Apmid%252F7474192%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=10.1001/jama.1995.03530180050029&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=7474192&amp;link_type=MED&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>Medline</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=A1995TC47700028&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-144-1" title="View reference 144 in text" id="ref-144">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.144" data-doi="10.1177/009286159002400312"><div class="cit-metadata"><cite>Enas
 GG, Enas NH, Spradlin CT, Wilson MG, Wiltse CG. Baseline comparability 
in clinical trials: prevention of poststudy anxiety. <abbr class="cit-jnl-abbrev">Drug Information Journal</abbr><span class="cit-pub-date">1990</span>;<span class="cit-vol">24</span>:<span class="cit-fpage">541</span>-8.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DDrug%2BInformation%2BJournal%26rft.stitle%253DDrug%2BInformation%2BJournal%26rft.issn%253D0092-8615%26rft.aulast%253DEnas%26rft.auinit1%253DG.%2BG.%26rft.volume%253D24%26rft.issue%253D3%26rft.spage%253D541%26rft.epage%253D548%26rft.atitle%253DBaseline%2BComparability%2Bin%2BClinical%2BTrials%253A%2BPrevention%2Bof%2B%2522Poststudy%2BAnxiety%2522%26rft_id%253Dinfo%253Adoi%252F10.1177%252F009286159002400312%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/ijlink?linkType=ABST&amp;journalCode=spdij&amp;resid=24/3/541&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-ijlink"><span><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-145-1" title="View reference 145 in text" id="ref-145">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.145" data-doi="10.1136/bmj.317.7155.362"><div class="cit-metadata"><cite>Treasure
 T, MacRae KD. Minimisation: the platinum standard for trials? 
Randomisation doesn’t guarantee similarity of groups; minimisation does.
 <abbr class="cit-jnl-abbrev">BMJ</abbr><span class="cit-pub-date">1998</span>;<span class="cit-vol">317</span>:<span class="cit-fpage">362</span>-3.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DBMJ%26rft.stitle%253DBMJ%26rft.issn%253D0007-1447%26rft.aulast%253DTreasure%26rft.auinit1%253DT.%26rft.volume%253D317%26rft.issue%253D7155%26rft.spage%253D362%26rft.epage%253D363%26rft.atitle%253DMinimisation%253A%2Bthe%2Bplatinum%2Bstandard%2Bfor%2Btrials%253F%26rft_id%253Dinfo%253Adoi%252F10.1136%252Fbmj.317.7155.362%26rft_id%253Dinfo%253Apmid%252F9694748%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/ijlink?linkType=FULL&amp;journalCode=bmj&amp;resid=317/7155/362&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-ijlink"><span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-146-1" title="View reference 146 in text" id="ref-146">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.146"><div class="cit-metadata"><cite>Sinei
 SK, Schulz KF, Lamptey PR, Grimes DA, Mati JK, Rosenthal SM, et al. 
Preventing IUCD-related pelvic infection: the efficacy of prophylactic 
doxycycline at insertion. <abbr class="cit-jnl-abbrev">Br J Obstet Gynaecol</abbr><span class="cit-pub-date">1990</span>;<span class="cit-vol">97</span>:<span class="cit-fpage">412</span>-9.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DBritish%2Bjournal%2Bof%2Bobstetrics%2Band%2Bgynaecology%26rft.stitle%253DBr%2BJ%2BObstet%2BGynaecol%26rft.aulast%253DSinei%26rft.auinit1%253DS.%2BK.%26rft.volume%253D97%26rft.issue%253D5%26rft.spage%253D412%26rft.epage%253D419%26rft.atitle%253DPreventing%2BIUCD-related%2Bpelvic%2Binfection%253A%2Bthe%2Befficacy%2Bof%2Bprophylactic%2Bdoxycycline%2Bat%2Binsertion.%26rft_id%253Dinfo%253Apmid%252F2196934%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=2196934&amp;link_type=MED&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>Medline</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=A1990DF72300008&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-147-1" title="View reference 147 in text" id="ref-147">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.147" data-doi="10.1186/1471-2474-7-64"><div class="cit-metadata"><cite>Radford
 JA, Landorf KB, Buchbinder R, Cook C. Effectiveness of low-Dye taping 
for the short-term treatment of plantar heel pain: a randomised trial. <abbr class="cit-jnl-abbrev">BMC Musculoskelet Disord</abbr><span class="cit-pub-date">2006</span>;<span class="cit-vol">7</span>:<span class="cit-fpage">64</span>.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DBMC%2Bmusculoskeletal%2Bdisorders%2B%255Belectronic%2Bresource%255D%26rft.stitle%253DBMC%2BMusculoskelet%2BDisord%26rft.aulast%253DRadford%26rft.auinit1%253DJ.%2BA.%26rft.volume%253D7%26rft.spage%253D64%26rft.epage%253D64%26rft.atitle%253DEffectiveness%2Bof%2Blow-Dye%2Btaping%2Bfor%2Bthe%2Bshort-term%2Btreatment%2Bof%2Bplantar%2Bheel%2Bpain%253A%2Ba%2Brandomised%2Btrial.%26rft_id%253Dinfo%253Adoi%252F10.1186%252F1471-2474-7-64%26rft_id%253Dinfo%253Apmid%252F16895612%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=10.1186/1471-2474-7-64&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=16895612&amp;link_type=MED&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>Medline</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-148-1" title="View reference 148 in text" id="ref-148">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.148"><div class="cit-metadata"><cite>Chalmers
 TC, Levin H, Sacks HS, Reitman D, Berrier J, Nagalingam R. 
Meta-analysis of clinical trials as a scientific discipline. I: Control 
of bias and comparison with large co-operative trials. <abbr class="cit-jnl-abbrev">Stat Med</abbr><span class="cit-pub-date">1987</span>;<span class="cit-vol">6</span>:<span class="cit-fpage">315</span>-28.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DStatistics%2Bin%2Bmedicine%26rft.stitle%253DStat%2BMed%26rft.aulast%253DChalmers%26rft.auinit1%253DT.%2BC.%26rft.volume%253D6%26rft.issue%253D3%26rft.spage%253D315%26rft.epage%253D328%26rft.atitle%253DMeta-analysis%2Bof%2Bclinical%2Btrials%2Bas%2Ba%2Bscientific%2Bdiscipline.%2BI%253A%2BControl%2Bof%2Bbias%2Band%2Bcomparison%2Bwith%2Blarge%2Bco-operative%2Btrials.%26rft_id%253Dinfo%253Apmid%252F2887023%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=2887023&amp;link_type=MED&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>Medline</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=A1987H713900010&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-149-1" title="View reference 149 in text" id="ref-149">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.149" data-doi="10.2307/2988097"><div class="cit-metadata"><cite>Pocock SJ. Statistical aspects of clinical trial design. <abbr class="cit-jnl-abbrev">Statistician</abbr><span class="cit-pub-date">1982</span>;<span class="cit-vol">31</span>:<span class="cit-fpage">1</span>-18.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DStatistician%26rft.volume%253D31%26rft.spage%253D1%26rft_id%253Dinfo%253Adoi%252F10.2307%252F2988097%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=10.2307/2988097&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=A1982NJ90900001&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-150-1" title="View reference 150 in text" id="ref-150">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.150"><div class="cit-metadata"><cite>Haag U. Technologies for automating randomized treatment assignment in clinical trials. <abbr class="cit-jnl-abbrev">Drug Information Journal</abbr><span class="cit-pub-date">1998</span>;<span class="cit-vol">32</span>:<span class="cit-fpage">11</span>.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DDrug%2BInformation%2BJournal%26rft.issn%253D0092-8615%26rft.volume%253D32%26rft.spage%253D11%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=000076396700002&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-151-1" title="View reference 151 in text" id="ref-151">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.151" data-doi="10.1186/1471-2288-3-19"><div class="cit-metadata"><cite>Piaggio
 G, Elbourne D, Schulz KF, Villar J, Pinol AP, Gülmezoglu AM. The 
reporting of methods for reducing and detecting bias: an example from 
the WHO Misoprostol Third Stage of Labour equivalence randomised 
controlled trial. <abbr class="cit-jnl-abbrev">BMC Med Res Methodol</abbr><span class="cit-pub-date">2003</span>;<span class="cit-vol">3</span>:<span class="cit-fpage">19</span>.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DBMC%2Bmedical%2Bresearch%2Bmethodology%2B%255Belectronic%2Bresource%255D%26rft.stitle%253DBMC%2BMed%2BRes%2BMethodol%26rft.aulast%253DPiaggio%26rft.auinit1%253DG.%26rft.volume%253D3%26rft.spage%253D19%26rft.epage%253D19%26rft.atitle%253DThe%2Breporting%2Bof%2Bmethods%2Bfor%2Breducing%2Band%2Bdetecting%2Bbias%253A%2Ban%2Bexample%2Bfrom%2Bthe%2BWHO%2BMisoprostol%2BThird%2BStage%2Bof%2BLabour%2Bequivalence%2Brandomised%2Bcontrolled%2Btrial.%26rft_id%253Dinfo%253Adoi%252F10.1186%252F1471-2288-3-19%26rft_id%253Dinfo%253Apmid%252F14525622%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=10.1186/1471-2288-3-19&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=14525622&amp;link_type=MED&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>Medline</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-152-1" title="View reference 152 in text" id="ref-152">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.152" data-doi="10.1093/ije/dym087"><div class="cit-metadata"><cite>Pildal
 J, Hróbjartsson A, Jórgensen KJ, Hilden J, Altman DG, Gøtzsche PC. 
Impact of allocation concealment on conclusions drawn from meta-analyses
 of randomized trials. <abbr class="cit-jnl-abbrev">Int J Epidemiol</abbr><span class="cit-pub-date">2007</span>;<span class="cit-vol">36</span>:<span class="cit-fpage">847</span>-57.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DInt%2BJ%2BEpidemiol%26rft_id%253Dinfo%253Adoi%252F10.1093%252Fije%252Fdym087%26rft_id%253Dinfo%253Apmid%252F17517809%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/ijlink?linkType=ABST&amp;journalCode=intjepid&amp;resid=36/4/847&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-ijlink"><span><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-153-1" title="View reference 153 in text" id="ref-153">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.153" data-doi="10.1136/bmj.39465.451748.AD"><div class="cit-metadata"><cite>Wood
 L, Egger M, Gluud LL, Schulz KF, Jüni P, Altman DG, et al. Empirical 
evidence of bias in treatment effect estimates in controlled trials with
 different interventions and outcomes: meta-epidemiological study. <abbr class="cit-jnl-abbrev">BMJ</abbr><span class="cit-pub-date">2008</span>;<span class="cit-vol">336</span>:<span class="cit-fpage">601</span>-5.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DBMJ%26rft_id%253Dinfo%253Adoi%252F10.1136%252Fbmj.39465.451748.AD%26rft_id%253Dinfo%253Apmid%252F18316340%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/ijlink?linkType=ABST&amp;journalCode=bmj&amp;resid=336/7644/601&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-ijlink"><span><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-154-1" title="View reference 154 in text" id="ref-154">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.154"><div class="cit-metadata"><cite>McCandlish
 R, Bowler U, van Asten H, Berridge G, Winter C, Sames L, et al. A 
randomised controlled trial of care of the perineum during second stage 
of normal labour. <abbr class="cit-jnl-abbrev">Br J Obstet Gynaecol</abbr><span class="cit-pub-date">1998</span>;<span class="cit-vol">105</span>:<span class="cit-fpage">1262</span>-72.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DBritish%2Bjournal%2Bof%2Bobstetrics%2Band%2Bgynaecology%26rft.stitle%253DBr%2BJ%2BObstet%2BGynaecol%26rft.aulast%253DMcCandlish%26rft.auinit1%253DR.%26rft.volume%253D105%26rft.issue%253D12%26rft.spage%253D1262%26rft.epage%253D1272%26rft.atitle%253DA%2Brandomised%2Bcontrolled%2Btrial%2Bof%2Bcare%2Bof%2Bthe%2Bperineum%2Bduring%2Bsecond%2Bstage%2Bof%2Bnormal%2Blabour.%26rft_id%253Dinfo%253Apmid%252F9883917%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=9883917&amp;link_type=MED&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>Medline</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=000077809700007&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-155-1" title="View reference 155 in text" id="ref-155">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.155" data-doi="10.1136/bmj.a339"><div class="cit-metadata"><cite>Webster
 J, Clarke S, Paterson D, Hutton A, van Dyk S, Gale C, et al. Routine 
care of peripheral intravenous catheters versus clinically indicated 
replacement: randomised controlled trial. <abbr class="cit-jnl-abbrev">BMJ</abbr><span class="cit-pub-date">2008</span>;<span class="cit-vol">337</span>:<span class="cit-fpage">a339</span>.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DBMJ%26rft.stitle%253DBMJ%26rft.issn%253D0007-1447%26rft.aulast%253DWebster%26rft.auinit1%253DJ.%26rft.volume%253D337%26rft.issue%253Djul08_1%26rft.spage%253Da339%26rft.epage%253Da339%26rft.atitle%253DRoutine%2Bcare%2Bof%2Bperipheral%2Bintravenous%2Bcatheters%2Bversus%2Bclinically%2Bindicated%2Breplacement%253A%2Brandomised%2Bcontrolled%2Btrial%26rft_id%253Dinfo%253Adoi%252F10.1136%252Fbmj.a339%26rft_id%253Dinfo%253Apmid%252F18614482%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/ijlink?linkType=ABST&amp;journalCode=bmj&amp;resid=337/jul08_1/a339&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-ijlink"><span><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-156-1" title="View reference 156 in text" id="ref-156">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.156" data-doi="10.4065/83.7.747"><div class="cit-metadata"><cite>Smith
 SA, Shah ND, Bryant SC, Christianson TJ, Bjornsen SS, Giesler PD, et 
al. Chronic care model and shared care in diabetes: randomized trial of 
an electronic decision support system. <abbr class="cit-jnl-abbrev">Mayo Clin Proc</abbr><span class="cit-pub-date">2008</span>;<span class="cit-vol">83</span>:<span class="cit-fpage">747</span>-57.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DMayo%2BClinic%2BProceedings%26rft.stitle%253DMayo%2BClin%2BProc.%26rft.issn%253D0025-6196%26rft.aulast%253DSmith%26rft.auinit1%253DS.%2BA.%26rft.volume%253D83%26rft.issue%253D7%26rft.spage%253D747%26rft.epage%253D757%26rft.atitle%253DChronic%2BCare%2BModel%2Band%2BShared%2BCare%2Bin%2BDiabetes%253A%2BRandomized%2BTrial%2Bof%2Ban%2BElectronic%2BDecision%2BSupport%2BSystem%26rft_id%253Dinfo%253Adoi%252F10.4065%252F83.7.747%26rft_id%253Dinfo%253Apmid%252F18613991%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=10.4065/83.7.747&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=18613991&amp;link_type=MED&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>Medline</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=000257198000003&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-157-1" title="View reference 157 in text" id="ref-157">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.157" data-doi="10.1056/NEJMoa0804748"><div class="cit-metadata"><cite>Sacks
 FM, Bray GA, Carey VJ, Smith SR, Ryan DH, Anton SD, et al. Comparison 
of weight-loss diets with different compositions of fat, protein, and 
carbohydrates. <abbr class="cit-jnl-abbrev">N Engl J Med</abbr><span class="cit-pub-date">2009</span>;<span class="cit-vol">360</span>:<span class="cit-fpage">859</span>-73.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DNew%2BEngland%2BJournal%2Bof%2BMedicine%26rft.stitle%253DNEJM%26rft.issn%253D0028-4793%26rft.aulast%253DSacks%26rft.auinit1%253DF.%2BM.%26rft.volume%253D360%26rft.issue%253D9%26rft.spage%253D859%26rft.epage%253D873%26rft.atitle%253DComparison%2Bof%2Bweight-loss%2Bdiets%2Bwith%2Bdifferent%2Bcompositions%2Bof%2Bfat%252C%2Bprotein%252C%2Band%2Bcarbohydrates.%26rft_id%253Dinfo%253Adoi%252F10.1056%252FNEJMoa0804748%26rft_id%253Dinfo%253Apmid%252F19246357%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=10.1056/NEJMoa0804748&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=19246357&amp;link_type=MED&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>Medline</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=000263624700004&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-158-1" title="View reference 158 in text" id="ref-158">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.158" data-doi="10.1353/bhm.1998.0159"><div class="cit-metadata"><cite>Kaptchuk TJ. Intentional ignorance: a history of blind assessment and placebo controls in medicine. <abbr class="cit-jnl-abbrev">Bull Hist Med</abbr><span class="cit-pub-date">1998</span>;<span class="cit-vol">72</span>:<span class="cit-fpage">389</span>-433.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DBulletin%2Bof%2Bthe%2BHistory%2Bof%2BMedicine%26rft.stitle%253DBulletin%2Bof%2Bthe%2BHistory%2Bof%2BMedicine%26rft.issn%253D0007-5140%26rft.aulast%253DKaptchuk%26rft.auinit1%253DT.%2BJ.%26rft.volume%253D72%26rft.issue%253D3%26rft.spage%253D389%26rft.epage%253D433%26rft.atitle%253DIntentional%2Bignorance%253A%2Ba%2Bhistory%2Bof%2Bblind%2Bassessment%2Band%2Bplacebo%2Bcontrols%2Bin%2Bmedicine.%26rft_id%253Dinfo%253Adoi%252F10.1353%252Fbhm.1998.0159%26rft_id%253Dinfo%253Apmid%252F9780448%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=10.1353/bhm.1998.0159&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=9780448&amp;link_type=MED&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>Medline</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=000076087100001&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-159-1" title="View reference 159 in text" id="ref-159">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.159" data-doi="10.1136/thx.39.11.818"><div class="cit-metadata"><cite>Guyatt
 GH, Pugsley SO, Sullivan MJ, Thompson PJ, Berman L, Jones NL, et al. 
Effect of encouragement on walking test performance. <abbr class="cit-jnl-abbrev">Thorax</abbr><span class="cit-pub-date">1984</span>;<span class="cit-vol">39</span>:<span class="cit-fpage">818</span>-22.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DThorax%26rft.stitle%253DThorax%26rft.issn%253D0040-6376%26rft.aulast%253DGuyatt%26rft.auinit1%253DG%2BH%26rft.volume%253D39%26rft.issue%253D11%26rft.spage%253D818%26rft.epage%253D822%26rft.atitle%253DEffect%2Bof%2Bencouragement%2Bon%2Bwalking%2Btest%2Bperformance.%26rft_id%253Dinfo%253Adoi%252F10.1136%252Fthx.39.11.818%26rft_id%253Dinfo%253Apmid%252F6505988%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/ijlink?linkType=ABST&amp;journalCode=thoraxjnl&amp;resid=39/11/818&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-ijlink"><span><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-160-1" title="View reference 160 in text" id="ref-160">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.160" data-doi="10.1016/0197-2456(95)00263-4"><div class="cit-metadata"><cite>Gøtzsche PC. Blinding during data analysis and writing of manuscripts. <abbr class="cit-jnl-abbrev">Control Clin Trials</abbr><span class="cit-pub-date">1996</span>;<span class="cit-vol">17</span>:<span class="cit-fpage">285</span>-90.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DControlled%2Bclinical%2Btrials%26rft.stitle%253DControl%2BClin%2BTrials%26rft.aulast%253DG%25C3%25B8tzsche%26rft.auinit1%253DP.%2BC.%26rft.volume%253D17%26rft.issue%253D4%26rft.spage%253D285%26rft.epage%253D290%26rft.atitle%253DBlinding%2Bduring%2Bdata%2Banalysis%2Band%2Bwriting%2Bof%2Bmanuscripts.%26rft_id%253Dinfo%253Adoi%252F10.1016%252F0197-2456%252895%252900263-4%26rft_id%253Dinfo%253Apmid%252F8889343%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=10.1016/0197-2456%2895%2900263-4&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=8889343&amp;link_type=MED&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>Medline</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=A1996VK40600002&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-161-1" title="View reference 161 in text" id="ref-161">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.161" data-doi="10.1001/jama.1975.03240220018013"><div class="cit-metadata"><cite>Karlowski
 TR, Chalmers TC, Frenkel LD, Kapikian AZ, Lewis TL, Lynch JM. Ascorbic 
acid for the common cold. A prophylactic and therapeutic trial. <abbr class="cit-jnl-abbrev">JAMA</abbr><span class="cit-pub-date">1975</span>;<span class="cit-vol">231</span>:<span class="cit-fpage">1038</span>-42.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DJAMA%26rft.stitle%253DJAMA%26rft.issn%253D0002-9955%26rft.aulast%253DKarlowski%26rft.auinit1%253DT.%2BR.%26rft.volume%253D231%26rft.issue%253D10%26rft.spage%253D1038%26rft.epage%253D1042%26rft.atitle%253DAscorbic%2BAcid%2Bfor%2Bthe%2BCommon%2BCold%253A%2BA%2BProphylactic%2Band%2BTherapeutic%2BTrial%26rft_id%253Dinfo%253Adoi%252F10.1001%252Fjama.1975.03240220018013%26rft_id%253Dinfo%253Apmid%252F163386%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=10.1001/jama.1975.03240220018013&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=163386&amp;link_type=MED&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>Medline</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=A1975V757500010&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-162-1" title="View reference 162 in text" id="ref-162">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.162" data-doi="10.1212/WNL.44.1.16"><div class="cit-metadata"><cite>Noseworthy
 JH, Ebers GC, Vandervoort MK, Farquhar RE, Yetisir E, Roberts R. The 
impact of blinding on the results of a randomized, placebo-controlled 
multiple sclerosis clinical trial. <abbr class="cit-jnl-abbrev">Neurology</abbr><span class="cit-pub-date">1994</span>;<span class="cit-vol">44</span>:<span class="cit-fpage">16</span>-20.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DNeurology%26rft.stitle%253DNeurology%26rft.issn%253D0028-3878%26rft.aulast%253DNoseworthy%26rft.auinit1%253DJ.%2BH.%26rft.volume%253D44%26rft.issue%253D1%26rft.spage%253D16%26rft.epage%253D16%26rft.atitle%253DThe%2Bimpact%2Bof%2Bblinding%2Bon%2Bthe%2Bresults%2Bof%2Ba%2Brandomized%252C%2Bplacebo-controlled%2Bmultiple%2Bsclerosis%2Bclinical%2Btrial%26rft_id%253Dinfo%253Adoi%252F10.1212%252FWNL.44.1.16%26rft_id%253Dinfo%253Apmid%252F8290055%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/ijlink?linkType=ABST&amp;journalCode=neurology&amp;resid=44/1/16&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-ijlink"><span><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-163-1" title="View reference 163 in text" id="ref-163">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.163" data-doi="10.1136/bmj.321.7252.20"><div class="cit-metadata"><cite>Carley
 SD, Libetta C, Flavin B, Butler J, Tong N, Sammy I. An open prospective
 randomised trial to reduce the pain of blood glucose testing: ear 
versus thumb. <abbr class="cit-jnl-abbrev">BMJ</abbr><span class="cit-pub-date">2000</span>;<span class="cit-vol">321</span>:<span class="cit-fpage">20</span>.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DBMJ%26rft.stitle%253DBMJ%26rft.issn%253D0007-1447%26rft.aulast%253DCarley%26rft.auinit1%253DS.%2BD%26rft.volume%253D321%26rft.issue%253D7252%26rft.spage%253D20%26rft.epage%253D20%26rft.atitle%253DAn%2Bopen%2Bprospective%2Brandomised%2Btrial%2Bto%2Breduce%2Bthe%2Bpain%2Bof%2Bblood%2Bglucose%2Btesting%253A%2Bear%2Bversus%2Bthumb%26rft_id%253Dinfo%253Adoi%252F10.1136%252Fbmj.321.7252.20%26rft_id%253Dinfo%253Apmid%252F10875827%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/ijlink?linkType=FULL&amp;journalCode=bmj&amp;resid=321/7252/20&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-ijlink"><span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-164-1" title="View reference 164 in text" id="ref-164">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.164" data-doi="10.7326/0003-4819-136-3-200202050-00022"><div class="cit-metadata"><cite>Schulz KF, Chalmers I, Altman DG. The landscape and lexicon of blinding in randomized trials. <abbr class="cit-jnl-abbrev">Ann Intern Med</abbr><span class="cit-pub-date">2002</span>;<span class="cit-vol">136</span>:<span class="cit-fpage">254</span>-9.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DAnnals%2Bof%2BInternal%2BMedicine%26rft.stitle%253DANN%2BINTERN%2BMED%26rft.issn%253D0003-4819%26rft.aulast%253DSchulz%26rft.auinit1%253DK.%2BF.%26rft.volume%253D136%26rft.issue%253D3%26rft.spage%253D254%26rft.epage%253D259%26rft.atitle%253DThe%2BLandscape%2Band%2BLexicon%2Bof%2BBlinding%2Bin%2BRandomized%2BTrials%26rft_id%253Dinfo%253Adoi%252F10.7326%252F0003-4819-136-3-200202050-00022%26rft_id%253Dinfo%253Apmid%252F11827510%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=10.7326/0003-4819-136-3-200202050-00022&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=11827510&amp;link_type=MED&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>Medline</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=000173637400016&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-165-1" title="View reference 165 in text" id="ref-165">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.165" data-doi="10.1136/bmj.321.7259.504"><div class="cit-metadata"><cite>Day SJ, Altman DG. Statistics notes: blinding in clinical trials and other studies. <abbr class="cit-jnl-abbrev">BMJ</abbr><span class="cit-pub-date">2000</span>;<span class="cit-vol">321</span>:<span class="cit-fpage">504</span>.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DBMJ%26rft.stitle%253DBMJ%26rft.issn%253D0007-1447%26rft.aulast%253DDay%26rft.auinit1%253DS.%2BJ%26rft.volume%253D321%26rft.issue%253D7259%26rft.spage%253D504%26rft.epage%253D504%26rft.atitle%253DStatistics%2BNotes%253A%2BBlinding%2Bin%2Bclinical%2Btrials%2Band%2Bother%2Bstudies%26rft_id%253Dinfo%253Adoi%252F10.1136%252Fbmj.321.7259.504%26rft_id%253Dinfo%253Apmid%252F10948038%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/ijlink?linkType=FULL&amp;journalCode=bmj&amp;resid=321/7259/504&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-ijlink"><span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-166-1" title="View reference 166 in text" id="ref-166">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.166" data-doi="10.1016/S0895-4356(02)00446-8"><div class="cit-metadata"><cite>Montori
 VM, Bhandari M, Devereaux PJ, Manns BJ, Ghali WA, Guyatt GH. In the 
dark: the reporting of blinding status in randomized controlled trials. <abbr class="cit-jnl-abbrev">J Clin Epidemiol</abbr><span class="cit-pub-date">2002</span>;<span class="cit-vol">55</span>:<span class="cit-fpage">787</span>-90.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DJournal%2Bof%2Bclinical%2Bepidemiology%26rft.stitle%253DJ%2BClin%2BEpidemiol%26rft.aulast%253DMontori%26rft.auinit1%253DV.%2BM.%26rft.volume%253D55%26rft.issue%253D8%26rft.spage%253D787%26rft.epage%253D790%26rft.atitle%253DIn%2Bthe%2Bdark%253A%2Bthe%2Breporting%2Bof%2Bblinding%2Bstatus%2Bin%2Brandomized%2Bcontrolled%2Btrials.%26rft_id%253Dinfo%253Adoi%252F10.1016%252FS0895-4356%252802%252900446-8%26rft_id%253Dinfo%253Apmid%252F12384193%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=10.1016/S0895-4356%2802%2900446-8&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=12384193&amp;link_type=MED&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>Medline</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=000178037500008&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-167-1" title="View reference 167 in text" id="ref-167">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.167" data-doi="10.1002/(SICI)1099-0496(200001)29:1&lt;1::AID-PPUL1&gt;3.0.CO;2-1"><div class="cit-metadata"><cite>Cheng
 K, Smyth RL, Motley J, O’Hea U, Ashby D. Randomized controlled trials 
in cystic fibrosis (1966-1997) categorized by time, design, and 
intervention. <abbr class="cit-jnl-abbrev">Pediatr Pulmonol</abbr><span class="cit-pub-date">2000</span>;<span class="cit-vol">29</span>:<span class="cit-fpage">1</span>-7.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DPediatric%2Bpulmonology%26rft.stitle%253DPediatr%2BPulmonol%26rft.aulast%253DCheng%26rft.auinit1%253DK.%26rft.volume%253D29%26rft.issue%253D1%26rft.spage%253D1%26rft.epage%253D7%26rft.atitle%253DRandomized%2Bcontrolled%2Btrials%2Bin%2Bcystic%2Bfibrosis%2B%25281966-1997%2529%2Bcategorized%2Bby%2Btime%252C%2Bdesign%252C%2Band%2Bintervention.%26rft_id%253Dinfo%253Adoi%252F10.1002%252F%2528SICI%25291099-0496%2528200001%252929%253A1%253C1%253A%253AAID-PPUL1%253E3.0.CO%253B2-1%26rft_id%253Dinfo%253Apmid%252F10613779%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=10.1002/%28SICI%291099-0496%28200001%2929:1%3C1::AID-PPUL1%3E3.0.CO;2-1&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=10613779&amp;link_type=MED&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>Medline</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=000084587800001&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-168-1" title="View reference 168 in text" id="ref-168">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.168"><div class="cit-metadata"><cite>Lang T. Masking or blinding? An unscientific survey of mostly medical journal editors on the great debate. <abbr class="cit-jnl-abbrev">Med Gen Med</abbr><span class="cit-pub-date">2000</span>;<span class="cit-vol">2</span>:<span class="cit-fpage">E25</span>.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DMed%2BGen%2BMed%26rft.volume%253D2%26rft.spage%253D25E%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-169-1" title="View reference 169 in text" id="ref-169">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.169" data-doi="10.1001/jama.285.15.2000"><div class="cit-metadata"><cite>Devereaux
 PJ, Manns BJ, Ghali WA, Quan H, Lacchetti C, Montori VM, et al. 
Physician interpretations and textbook definitions of blinding 
terminology in randomized controlled trials. <abbr class="cit-jnl-abbrev">JAMA</abbr><span class="cit-pub-date">2001</span>;<span class="cit-vol">285</span>:<span class="cit-fpage">2000</span>-3.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DJAMA%26rft.stitle%253DJAMA%26rft.issn%253D0002-9955%26rft.aulast%253DDevereaux%26rft.auinit1%253DP.%2BJ.%26rft.volume%253D285%26rft.issue%253D15%26rft.spage%253D2000%26rft.epage%253D2003%26rft.atitle%253DPhysician%2BInterpretations%2Band%2BTextbook%2BDefinitions%2Bof%2BBlinding%2BTerminology%2Bin%2BRandomized%2BControlled%2BTrials%26rft_id%253Dinfo%253Adoi%252F10.1001%252Fjama.285.15.2000%26rft_id%253Dinfo%253Apmid%252F11308438%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=10.1001/jama.285.15.2000&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=11308438&amp;link_type=MED&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>Medline</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=000167995900030&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-170-1" title="View reference 170 in text" id="ref-170">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.170" data-doi="10.1177/1740774506069153"><div class="cit-metadata"><cite>Haahr MT, Hróbjartsson A. Who is blinded in randomized clinical trials? A study of 200 trials and a survey of authors. <abbr class="cit-jnl-abbrev">Clin Trials</abbr><span class="cit-pub-date">2006</span>;<span class="cit-vol">3</span>:<span class="cit-fpage">360</span>-5.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DClinical%2BTrials%26rft.stitle%253DClin%2BTrials%26rft.issn%253D1740-7745%26rft.aulast%253DHaahr%26rft.auinit1%253DM.%2BT.%26rft.volume%253D3%26rft.issue%253D4%26rft.spage%253D360%26rft.epage%253D365%26rft.atitle%253DWho%2Bis%2Bblinded%2Bin%2Brandomized%2Bclinical%2Btrials%253F%2BA%2Bstudy%2Bof%2B200%2Btrials%2Band%2Ba%2B%2B%2B%2B%2B%2B%2B%2B%2Bsurvey%2Bof%2Bauthors%26rft_id%253Dinfo%253Adoi%252F10.1177%252F1740774506069153%26rft_id%253Dinfo%253Apmid%252F17060210%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/ijlink?linkType=ABST&amp;journalCode=spctj&amp;resid=3/4/360&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-ijlink"><span><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-171-1" title="View reference 171 in text" id="ref-171">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.171" data-doi="10.1056/NEJM199805073381911"><div class="cit-metadata"><cite>Meinert CL. Masked monitoring in clinical trials—blind stupidity? <abbr class="cit-jnl-abbrev">N Engl J Med</abbr><span class="cit-pub-date">1998</span>;<span class="cit-vol">338</span>:<span class="cit-fpage">1381</span>-2.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DNew%2BEngland%2BJournal%2Bof%2BMedicine%26rft.stitle%253DNEJM%26rft.issn%253D0028-4793%26rft.aulast%253DMeinert%26rft.auinit1%253DC.%2BL.%26rft.volume%253D338%26rft.issue%253D19%26rft.spage%253D1381%26rft.epage%253D1382%26rft.atitle%253DMasked%2BMonitoring%2Bin%2BClinical%2BTrials%2B--%2BBlind%2BStupidity%253F%26rft_id%253Dinfo%253Adoi%252F10.1056%252FNEJM199805073381911%26rft_id%253Dinfo%253Apmid%252F9571262%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=10.1056/NEJM199805073381911&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=9571262&amp;link_type=MED&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>Medline</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=000073463700011&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-172-1" title="View reference 172 in text" id="ref-172">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.172" data-doi="10.1186/1472-6904-3-4"><div class="cit-metadata"><cite>Mills
 E, Prousky J, Raskin G, Gagnier J, Rachlis B, Montori VM, et al. The 
safety of over-the-counter niacin. A randomized placebo-controlled trial
  [<a href="http://www.bmj.com/external-ref?link_type=ISRCTN&amp;access_num=ISRCTN18054903" class="external-ref external-ref-type-isrctn">ISRCTN18054903</a>] . <abbr class="cit-jnl-abbrev">BMC Clin Pharmacol</abbr><span class="cit-pub-date">2003</span>;<span class="cit-vol">3</span>:<span class="cit-fpage">4</span>.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DBMC%2Bclinical%2Bpharmacology%2B%255Belectronic%2Bresource%255D%26rft.stitle%253DBMC%2BClin%2BPharmacol%26rft.aulast%253DMills%26rft.auinit1%253DE.%26rft.volume%253D3%26rft.spage%253D4%26rft.epage%253D4%26rft.atitle%253DThe%2Bsafety%2Bof%2Bover-the-counter%2Bniacin.%2BA%2Brandomized%2Bplacebo-controlled%2Btrial%2B%255BISRCTN18054903%255D.%26rft_id%253Dinfo%253Adoi%252F10.1186%252F1472-6904-3-4%26rft_id%253Dinfo%253Apmid%252F14614780%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=10.1186/1472-6904-3-4&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=14614780&amp;link_type=MED&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>Medline</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-173-1" title="View reference 173 in text" id="ref-173">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.173" data-doi="10.1136/bmj.312.7033.742"><div class="cit-metadata"><cite>Schulz
 KF, Grimes DA, Altman DG, Hayes RJ. Blinding and exclusions after 
allocation in randomised controlled trials: survey of published parallel
 group trials in obstetrics and gynaecology. <abbr class="cit-jnl-abbrev">BMJ</abbr><span class="cit-pub-date">1996</span>;<span class="cit-vol">312</span>:<span class="cit-fpage">742</span>-4.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DBMJ%26rft.stitle%253DBMJ%26rft.issn%253D0007-1447%26rft.aulast%253DSchulz%26rft.auinit1%253DK.%2BF%26rft.volume%253D312%26rft.issue%253D7033%26rft.spage%253D742%26rft.epage%253D744%26rft.atitle%253DBlinding%2Band%2Bexclusions%2Bafter%2Ballocation%2Bin%2Brandomised%2Bcontrolled%2Btrials%253A%2Bsurvey%2Bof%2Bpublished%2Bparallel%2Bgroup%2Btrials%2Bin%2Bobstetrics%2Band%2Bgynaecology%26rft_id%253Dinfo%253Adoi%252F10.1136%252Fbmj.312.7033.742%26rft_id%253Dinfo%253Apmid%252F8605459%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/ijlink?linkType=ABST&amp;journalCode=bmj&amp;resid=312/7033/742&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-ijlink"><span><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-174-1" title="View reference 174 in text" id="ref-174">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.174" data-doi="10.1136/bmj.37952.631667.EE"><div class="cit-metadata"><cite>Fergusson
 D, Glass KC, Waring D, Shapiro S. Turning a blind eye: the success of 
blinding reported in a random sample of randomised, placebo controlled 
trials. <abbr class="cit-jnl-abbrev">BMJ</abbr><span class="cit-pub-date">2004</span>;<span class="cit-vol">328</span>:<span class="cit-fpage">432</span>.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DBMJ%26rft_id%253Dinfo%253Adoi%252F10.1136%252Fbmj.37952.631667.EE%26rft_id%253Dinfo%253Apmid%252F14761905%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/ijlink?linkType=ABST&amp;journalCode=bmj&amp;resid=328/7437/432&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-ijlink"><span><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-175-1" title="View reference 175 in text" id="ref-175">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.175"><div class="cit-metadata"><cite>Sackett DL. Turning a blind eye: why we don’t test for blindness at the end of our trials. <abbr class="cit-jnl-abbrev">BMJ</abbr><span class="cit-pub-date">2004</span>;<span class="cit-vol">328</span>:<span class="cit-fpage">1136</span>.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DBMJ%26rft.stitle%253DBMJ%26rft.issn%253D0007-1447%26rft.aulast%253DSackett%26rft.auinit1%253DD.%2BL%26rft.volume%253D328%26rft.issue%253D7448%26rft.spage%253D1136%26rft.epage%253D1136%26rft.atitle%253DTurning%2Ba%2Bblind%2Beye%253A%2BWhy%2Bwe%2Bdon%2527t%2Btest%2Bfor%2Bblindness%2Bat%2Bthe%2Bend%2Bof%2Bour%2Btrials%26rft_id%253Dinfo%253Apmid%252F15130997%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/ijlink?linkType=FULL&amp;journalCode=bmj&amp;resid=328/7448/1136-a&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-ijlink"><span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-176-1" title="View reference 176 in text" id="ref-176">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.176" data-doi="10.1016/S0140-6736(09)61375-1"><div class="cit-metadata"><cite>Astrup
 A, Rössner S, Van Gaal L, Rissanen A, Niskanen L, Al HM, et al. Effects
 of liraglutide in the treatment of obesity: a randomised, double-blind,
 placebo-controlled study. <abbr class="cit-jnl-abbrev">Lancet</abbr><span class="cit-pub-date">2009</span>;<span class="cit-vol">374</span>:<span class="cit-fpage">1606</span>-16.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DLancet%26rft.stitle%253DLancet%26rft.aulast%253DAstrup%26rft.auinit1%253DA.%26rft.volume%253D374%26rft.issue%253D9701%26rft.spage%253D1606%26rft.epage%253D1616%26rft.atitle%253DEffects%2Bof%2Bliraglutide%2Bin%2Bthe%2Btreatment%2Bof%2Bobesity%253A%2Ba%2Brandomised%252C%2Bdouble-blind%252C%2Bplacebo-controlled%2Bstudy.%26rft_id%253Dinfo%253Adoi%252F10.1016%252FS0140-6736%252809%252961375-1%26rft_id%253Dinfo%253Apmid%252F19853906%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=10.1016/S0140-6736%2809%2961375-1&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=19853906&amp;link_type=MED&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>Medline</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=000271674600034&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-177-1" title="View reference 177 in text" id="ref-177">↵</a><div class="cit ref-cit ref-other" id="cit-340.mar23_1.c869.177"><div class="cit-metadata"><cite>Altman
 DG, Gore SM, Gardner MJ, Pocock SJ. Statistical guidelines for 
contributors to medical journals. In: Altman DG, Machin D, Bryant TN, 
Gardner MJ, eds. <span class="cit-source">Statistics with confidence: confidence intervals and statistical guidelines</span>. 2nd ed. BMJ Books, <span class="cit-pub-date">2000</span>:171-90.</cite></div><div class="cit-extra"></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-178-1" title="View reference 178 in text" id="ref-178">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.178" data-doi="10.1136/bmj.314.7098.1874"><div class="cit-metadata"><cite>Altman DG, Bland JM. Statistics notes. Units of analysis. <abbr class="cit-jnl-abbrev">BMJ</abbr><span class="cit-pub-date">1997</span>;<span class="cit-vol">314</span>:<span class="cit-fpage">1874</span>.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DBMJ%26rft.stitle%253DBMJ%26rft.issn%253D0007-1447%26rft.aulast%253DAltman%26rft.auinit1%253DD.%2BG%26rft.volume%253D314%26rft.issue%253D7098%26rft.spage%253D1874%26rft.epage%253D1874%26rft.atitle%253DStatistics%2BNotes%253A%2BUnits%2Bof%2Banalysis%26rft_id%253Dinfo%253Adoi%252F10.1136%252Fbmj.314.7098.1874%26rft_id%253Dinfo%253Apmid%252F9224131%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/ijlink?linkType=FULL&amp;journalCode=bmj&amp;resid=314/7098/1874&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-ijlink"><span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-179-1" title="View reference 179 in text" id="ref-179">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.179"><div class="cit-metadata"><cite>Bolton S. Independence and statistical inference in clinical trial designs: a tutorial review. <abbr class="cit-jnl-abbrev">J Clin Pharmacol</abbr><span class="cit-pub-date">1998</span>;<span class="cit-vol">38</span>:<span class="cit-fpage">408</span>-12.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DThe%2BJournal%2Bof%2BClinical%2BPharmacology%26rft.stitle%253DJ%2BClin%2BPharmacol%26rft.issn%253D0021-9754%26rft.aulast%253DBolton%26rft.auinit1%253DS%26rft.volume%253D38%26rft.issue%253D5%26rft.spage%253D408%26rft.epage%253D412%26rft.atitle%253DIndependence%2Band%2Bstatistical%2Binference%2Bin%2Bclinical%2Btrial%2Bdesigns%253A%2Ba%2Btutorial%2Breview%26rft_id%253Dinfo%253Apmid%252F9602951%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=9602951&amp;link_type=MED&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>Medline</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=000073563900003&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-180-1" title="View reference 180 in text" id="ref-180">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.180" data-doi="10.1093/ije/29.1.158"><div class="cit-metadata"><cite>Greenland S. Principles of multilevel modelling. <abbr class="cit-jnl-abbrev">Int J Epidemiol</abbr><span class="cit-pub-date">2000</span>;<span class="cit-vol">29</span>:<span class="cit-fpage">158</span>-67.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DInternational%2BJournal%2Bof%2BEpidemiology%26rft.stitle%253DInt%2BJ%2BEpidemiol%26rft.issn%253D0300-5771%26rft.aulast%253DGreenland%26rft.auinit1%253DS.%26rft.volume%253D29%26rft.issue%253D1%26rft.spage%253D158%26rft.epage%253D167%26rft.atitle%253DPrinciples%2Bof%2Bmultilevel%2Bmodelling%26rft_id%253Dinfo%253Adoi%252F10.1093%252Fije%252F29.1.158%26rft_id%253Dinfo%253Apmid%252F10750618%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/ijlink?linkType=ABST&amp;journalCode=intjepid&amp;resid=29/1/158&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-ijlink"><span><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-181-1" title="View reference 181 in text" id="ref-181">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.181" data-doi="10.1001/jama.299.17.2027"><div class="cit-metadata"><cite>Albert
 CM, Cook NR, Gaziano JM, Zaharris E, MacFadyen J, Danielson E, et al. 
Effect of folic acid and B vitamins on risk of cardiovascular events and
 total mortality among women at high risk for cardiovascular disease: a 
randomized trial. <abbr class="cit-jnl-abbrev">JAMA</abbr><span class="cit-pub-date">2008</span>;<span class="cit-vol">299</span>:<span class="cit-fpage">2027</span>-36.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DJAMA%26rft.stitle%253DJAMA%26rft.issn%253D0002-9955%26rft.aulast%253DAlbert%26rft.auinit1%253DC.%2BM.%26rft.volume%253D299%26rft.issue%253D17%26rft.spage%253D2027%26rft.epage%253D2036%26rft.atitle%253DEffect%2Bof%2BFolic%2BAcid%2Band%2BB%2BVitamins%2Bon%2BRisk%2Bof%2BCardiovascular%2BEvents%2Band%2BTotal%2BMortality%2BAmong%2BWomen%2Bat%2BHigh%2BRisk%2Bfor%2BCardiovascular%2BDisease%253A%2BA%2BRandomized%2BTrial%26rft_id%253Dinfo%253Adoi%252F10.1001%252Fjama.299.17.2027%26rft_id%253Dinfo%253Apmid%252F18460663%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=10.1001/jama.299.17.2027&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=18460663&amp;link_type=MED&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>Medline</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=000255552700019&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-182-1" title="View reference 182 in text" id="ref-182">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.182" data-doi="10.1136/bmj.313.7061.862"><div class="cit-metadata"><cite>Matthews JN, Altman DG. Interaction 3: How to examine heterogeneity. <abbr class="cit-jnl-abbrev">BMJ</abbr><span class="cit-pub-date">1996</span>;<span class="cit-vol">313</span>:<span class="cit-fpage">862</span>.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DBMJ%26rft.stitle%253DBMJ%26rft.issn%253D0007-1447%26rft.aulast%253DMatthews%26rft.auinit1%253DJ.%2BN%2BS%26rft.volume%253D313%26rft.issue%253D7061%26rft.spage%253D862%26rft.epage%253D862%26rft.atitle%253DStatistics%2Bnotes%253A%2BInteraction%2B3%253A%2BHow%2Bto%2Bexamine%2Bheterogeneity%26rft_id%253Dinfo%253Adoi%252F10.1136%252Fbmj.313.7061.862%26rft_id%253Dinfo%253Apmid%252F8870577%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/ijlink?linkType=FULL&amp;journalCode=bmj&amp;resid=313/7061/862&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-ijlink"><span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-183-1" title="View reference 183 in text" id="ref-183">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.183" data-doi="10.1016/S0140-6736(00)02039-0"><div class="cit-metadata"><cite>Assmann SF, Pocock SJ, Enos LE, Kasten LE. Subgroup analysis and other (mis)uses of baseline data in clinical trials. <abbr class="cit-jnl-abbrev">Lancet</abbr><span class="cit-pub-date">2000</span>;<span class="cit-vol">355</span>:<span class="cit-fpage">1064</span>-9.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DLancet%26rft.stitle%253DLancet%26rft.aulast%253DAssmann%26rft.auinit1%253DS.%2BF.%26rft.volume%253D355%26rft.issue%253D9209%26rft.spage%253D1064%26rft.epage%253D1069%26rft.atitle%253DSubgroup%2Banalysis%2Band%2Bother%2B%2528mis%2529uses%2Bof%2Bbaseline%2Bdata%2Bin%2Bclinical%2Btrials.%26rft_id%253Dinfo%253Adoi%252F10.1016%252FS0140-6736%252800%252902039-0%26rft_id%253Dinfo%253Apmid%252F10744093%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=10.1016/S0140-6736%2800%2902039-0&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=10744093&amp;link_type=MED&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>Medline</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=000086380800014&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-184-1" title="View reference 184 in text" id="ref-184">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.184" data-doi="10.1136/bmj.313.7060.808"><div class="cit-metadata"><cite>Matthews JN, Altman DG. Statistics notes. Interaction 2: Compare effect sizes not P values. <abbr class="cit-jnl-abbrev">BMJ</abbr><span class="cit-pub-date">1996</span>;<span class="cit-vol">313</span>:<span class="cit-fpage">808</span>.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DBMJ%26rft.stitle%253DBMJ%26rft.issn%253D0007-1447%26rft.aulast%253DMatthews%26rft.auinit1%253DJ.%2BN%2BS%26rft.volume%253D313%26rft.issue%253D7060%26rft.spage%253D808%26rft.epage%253D808%26rft.atitle%253DStatistics%2BNotes%253A%2BInteraction%2B2%253A%2Bcompare%2Beffect%2Bsizes%2Bnot%2BP%2Bvalues%26rft_id%253Dinfo%253Adoi%252F10.1136%252Fbmj.313.7060.808%26rft_id%253Dinfo%253Apmid%252F8842080%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/ijlink?linkType=FULL&amp;journalCode=bmj&amp;resid=313/7060/808&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-ijlink"><span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-185-1" title="View reference 185 in text" id="ref-185">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.185" data-doi="10.7326/0003-4819-116-1-78"><div class="cit-metadata"><cite>Oxman AD, Guyatt GH. A consumer’s guide to subgroup analyses. <abbr class="cit-jnl-abbrev">Ann Intern Med</abbr><span class="cit-pub-date">1992</span>;<span class="cit-vol">116</span>:<span class="cit-fpage">78</span>-84.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DAnnals%2Bof%2BInternal%2BMedicine%26rft.stitle%253DANN%2BINTERN%2BMED%26rft.issn%253D0003-4819%26rft.aulast%253DOxman%26rft.auinit1%253DA.%2BD.%26rft.volume%253D116%26rft.issue%253D1%26rft.spage%253D78%26rft.epage%253D84%26rft.atitle%253DA%2BConsumer%2527s%2BGuide%2Bto%2BSubgroup%2BAnalyses%26rft_id%253Dinfo%253Adoi%252F10.7326%252F0003-4819-116-1-78%26rft_id%253Dinfo%253Apmid%252F1530753%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=10.7326/0003-4819-116-1-78&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=1530753&amp;link_type=MED&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>Medline</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=A1992GX15700012&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-186-1" title="View reference 186 in text" id="ref-186">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.186" data-doi="10.1016/S0002-8703(00)90001-2"><div class="cit-metadata"><cite>Steyerberg
 EW, Bossuyt PM, Lee KL. Clinical trials in acute myocardial infarction:
 should we adjust for baseline characteristics? <abbr class="cit-jnl-abbrev">Am Heart J</abbr><span class="cit-pub-date">2000</span>;<span class="cit-vol">139</span>:<span class="cit-fpage">745</span>-51.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DAmerican%2Bheart%2Bjournal%26rft.stitle%253DAm%2BHeart%2BJ%26rft.aulast%253DSteyerberg%26rft.auinit1%253DE.%2BW.%26rft.volume%253D139%26rft.issue%253D5%26rft.spage%253D745%26rft.epage%253D751%26rft.atitle%253DClinical%2Btrials%2Bin%2Bacute%2Bmyocardial%2Binfarction%253A%2Bshould%2Bwe%2Badjust%2Bfor%2Bbaseline%2Bcharacteristics%253F%26rft_id%253Dinfo%253Adoi%252F10.1016%252FS0002-8703%252800%252990001-2%26rft_id%253Dinfo%253Apmid%252F10783203%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=10.1016/S0002-8703%2800%2990001-2&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=10783203&amp;link_type=MED&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>Medline</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=000086970400001&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-187-1" title="View reference 187 in text" id="ref-187">↵</a><div class="cit ref-cit ref-other" id="cit-340.mar23_1.c869.187"><div class="cit-metadata"><cite>Altman DG. Adjustment for covariate imbalance. In: Armitage P, Colton T, eds. <span class="cit-source">Encyclopedia of biostatistics</span>. John Wiley, <span class="cit-pub-date">1998</span>:1000-5.</cite></div><div class="cit-extra"></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-188-1" title="View reference 188 in text" id="ref-188">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.188"><div class="cit-metadata"><cite>Mullner M, Matthews H, Altman DG. Reporting on statistical methods to adjust for confounding: a cross-sectional survey. <abbr class="cit-jnl-abbrev">Ann Intern Med</abbr><span class="cit-pub-date">2002</span>;<span class="cit-vol">136</span>:<span class="cit-fpage">122</span>-6.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DAnnals%2Bof%2BInternal%2BMedicine%26rft.stitle%253DANN%2BINTERN%2BMED%26rft.issn%253D0003-4819%26rft.aulast%253DMullner%26rft.auinit1%253DM.%26rft.volume%253D136%26rft.issue%253D2%26rft.spage%253D122%26rft.epage%253D126%26rft.atitle%253DReporting%2Bon%2BStatistical%2BMethods%2BTo%2BAdjust%2Bfor%2BConfounding%253A%2BA%2BCross-Sectional%2BSurvey%26rft_id%253Dinfo%253Apmid%252F11790063%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=11790063&amp;link_type=MED&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>Medline</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=000173333900004&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-189-1" title="View reference 189 in text" id="ref-189">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.189" data-doi="10.7326/0003-4819-118-3-199302010-00009"><div class="cit-metadata"><cite>Concato J, Feinstein AR, Holford TR. The risk of determining risk with multivariable models. <abbr class="cit-jnl-abbrev">Ann Intern Med</abbr><span class="cit-pub-date">1993</span>;<span class="cit-vol">118</span>:<span class="cit-fpage">201</span>-10.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DAnnals%2Bof%2BInternal%2BMedicine%26rft.stitle%253DANN%2BINTERN%2BMED%26rft.issn%253D0003-4819%26rft.aulast%253DConcato%26rft.auinit1%253DJ.%26rft.volume%253D118%26rft.issue%253D3%26rft.spage%253D201%26rft.epage%253D210%26rft.atitle%253DThe%2BRisk%2Bof%2BDetermining%2BRisk%2Bwith%2BMultivariable%2BModels%26rft_id%253Dinfo%253Adoi%252F10.7326%252F0003-4819-118-3-199302010-00009%26rft_id%253Dinfo%253Apmid%252F8417638%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=10.7326/0003-4819-118-3-199302010-00009&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=8417638&amp;link_type=MED&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>Medline</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=A1993KJ43900009&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-190-1" title="View reference 190 in text" id="ref-190">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.190" data-doi="10.1136/bmj.313.7057.628"><div class="cit-metadata"><cite>Bender R, Grouven U. Logistic regression models used in medical research are poorly presented. <abbr class="cit-jnl-abbrev">BMJ</abbr><span class="cit-pub-date">1996</span>;<span class="cit-vol">313</span>:<span class="cit-fpage">628</span>.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DBMJ%26rft.stitle%253DBMJ%26rft.issn%253D0007-1447%26rft.aulast%253DBender%26rft.auinit1%253DR.%26rft.volume%253D313%26rft.issue%253D7057%26rft.spage%253D628%26rft.epage%253D628%26rft.atitle%253DLogistic%2Bregression%2Bmodels%2Bused%2Bin%2Bmedical%2Bresearch%2Bare%2Bpoorly%2Bpresented%26rft_id%253Dinfo%253Adoi%252F10.1136%252Fbmj.313.7057.628%26rft_id%253Dinfo%253Apmid%252F8845725%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/ijlink?linkType=FULL&amp;journalCode=bmj&amp;resid=313/7057/628&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-ijlink"><span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-191-1" title="View reference 191 in text" id="ref-191">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.191" data-doi="10.1016/S0029-7844(98)00537-7"><div class="cit-metadata"><cite>Khan KS, Chien PF, Dwarakanath LS. Logistic regression models in obstetrics and gynecology literature. <abbr class="cit-jnl-abbrev">Obstet Gynecol</abbr><span class="cit-pub-date">1999</span>;<span class="cit-vol">93</span>:<span class="cit-fpage">1014</span>-20.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DObstetrics%2B%2526%2BGynecology%26rft.stitle%253DObstet%2BGynecol%26rft.issn%253D0029-7844%26rft.aulast%253DKHAN%26rft.auinit1%253DK.%2BS.%26rft.volume%253D93%26rft.issue%253D6%26rft.spage%253D1014%26rft.epage%253D1020%26rft.atitle%253DLogistic%2Bregression%2Bmodels%2Bin%2Bobstetrics%2Band%2Bgynecology%2Bliterature.%26rft_id%253Dinfo%253Adoi%252F10.1016%252FS0029-7844%252898%252900537-7%26rft_id%253Dinfo%253Apmid%252F10362173%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=10.1016/S0029-7844%2898%2900537-7&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=10362173&amp;link_type=MED&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>Medline</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=000080583900024&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-192-1" title="View reference 192 in text" id="ref-192">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.192" data-doi="10.1056/NEJM197912273012602"><div class="cit-metadata"><cite>Sackett DL, Gent M. Controversy in counting and attributing events in clinical trials. <abbr class="cit-jnl-abbrev">N Engl J Med</abbr><span class="cit-pub-date">1979</span>;<span class="cit-vol">301</span>:<span class="cit-fpage">1410</span>-2.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DNew%2BEngland%2BJournal%2Bof%2BMedicine%26rft.stitle%253DNEJM%26rft.issn%253D0028-4793%26rft.aulast%253DSackett%26rft.auinit1%253DD.%2BL.%26rft.volume%253D301%26rft.issue%253D26%26rft.spage%253D1410%26rft.epage%253D1412%26rft.atitle%253DControversy%2Bin%2Bcounting%2Band%2Battributing%2Bevents%2Bin%2Bclinical%2Btrials%26rft_id%253Dinfo%253Adoi%252F10.1056%252FNEJM197912273012602%26rft_id%253Dinfo%253Apmid%252F514321%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=10.1056/NEJM197912273012602&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=514321&amp;link_type=MED&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>Medline</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=A1979HY34300002&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-193-1" title="View reference 193 in text" id="ref-193">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.193"><div class="cit-metadata"><cite>May GS, DeMets DL, Friedman LM, Furberg C, Passamani E. The randomized clinical trial: bias in analysis. <abbr class="cit-jnl-abbrev">Circulation</abbr><span class="cit-pub-date">1981</span>;<span class="cit-vol">64</span>:<span class="cit-fpage">669</span>-73.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DCirculation%26rft.stitle%253DCirculation%26rft.issn%253D0009-7322%26rft.aulast%253DMay%26rft.auinit1%253DG.%2BS.%26rft.volume%253D64%26rft.issue%253D4%26rft.spage%253D669%26rft.epage%253D673%26rft.atitle%253DThe%2Brandomized%2Bclinical%2Btrial%253A%2Bbias%2Bin%2Banalysis%26rft_id%253Dinfo%253Apmid%252F7023743%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/ijlink?linkType=ABST&amp;journalCode=circulationaha&amp;resid=64/4/669&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-ijlink"><span><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-194-1" title="View reference 194 in text" id="ref-194">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.194" data-doi="10.1056/NEJM199406163302415"><div class="cit-metadata"><cite>Altman DG, Cuzick J, Peto J. More on zidovudine in asymptomatic HIV infection. <abbr class="cit-jnl-abbrev">N Engl J Med</abbr><span class="cit-pub-date">1994</span>;<span class="cit-vol">330</span>:<span class="cit-fpage">1758</span>-9.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DNew%2BEngland%2BJournal%2Bof%2BMedicine%26rft.stitle%253DNEJM%26rft.issn%253D0028-4793%26rft.aulast%253DAltman%26rft.auinit1%253DD.%2BG.%26rft.volume%253D330%26rft.issue%253D24%26rft.spage%253D1758%26rft.epage%253D1759%26rft.atitle%253DMore%2Bon%2BZidovudine%2Bin%2BAsymptomatic%2BHIV%2BInfection%26rft_id%253Dinfo%253Adoi%252F10.1056%252FNEJM199406163302415%26rft_id%253Dinfo%253Apmid%252F8190146%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=10.1056/NEJM199406163302415&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=8190146&amp;link_type=MED&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>Medline</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=A1994NR10900023&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-195-1" title="View reference 195 in text" id="ref-195">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.195" data-doi="10.1001/jama.279.18.1487"><div class="cit-metadata"><cite>Meinert
 CL. Beyond CONSORT: need for improved reporting standards for clinical 
trials. Consolidated Standards of Reporting Trials. <abbr class="cit-jnl-abbrev">JAMA</abbr><span class="cit-pub-date">1998</span>;<span class="cit-vol">279</span>:<span class="cit-fpage">1487</span>-9.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DJAMA%26rft.stitle%253DJAMA%26rft.issn%253D0002-9955%26rft.aulast%253DMeinert%26rft.auinit1%253DC.%2BL.%26rft.volume%253D279%26rft.issue%253D18%26rft.spage%253D1487%26rft.epage%253D1489%26rft.atitle%253DBeyond%2BCONSORT%253A%2BNeed%2Bfor%2BImproved%2BReporting%2BStandards%2Bfor%2BClinical%2BTrials%26rft_id%253Dinfo%253Adoi%252F10.1001%252Fjama.279.18.1487%26rft_id%253Dinfo%253Apmid%252F9600487%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=10.1001/jama.279.18.1487&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=9600487&amp;link_type=MED&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>Medline</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=000073463500042&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-196-1" title="View reference 196 in text" id="ref-196">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.196" data-doi="10.1136/bmj.a2664"><div class="cit-metadata"><cite>Grant
 AM, Wileman SM, Ramsay CR, Mowat NA, Krukowski ZH, Heading RC, et al. 
Minimal access surgery compared with medical management for chronic 
gastro-oesophageal reflux disease: UK collaborative randomised trial. <abbr class="cit-jnl-abbrev">BMJ</abbr><span class="cit-pub-date">2008</span>;<span class="cit-vol">337</span>:<span class="cit-fpage">a2664</span>.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DBMJ%26rft.stitle%253DBMJ%26rft.issn%253D0007-1447%26rft.aulast%253DGrant%26rft.auinit1%253DA.%2BM%26rft.volume%253D337%26rft.issue%253Ddec15_2%26rft.spage%253Da2664%26rft.epage%253Da2664%26rft.atitle%253DMinimal%2Baccess%2Bsurgery%2Bcompared%2Bwith%2Bmedical%2Bmanagement%2Bfor%2Bchronic%2Bgastro-oesophageal%2Breflux%2Bdisease%253A%2BUK%2Bcollaborative%2Brandomised%2Btrial%26rft_id%253Dinfo%253Adoi%252F10.1136%252Fbmj.a2664%26rft_id%253Dinfo%253Apmid%252F19074946%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/ijlink?linkType=ABST&amp;journalCode=bmj&amp;resid=337/dec15_2/a2664&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-ijlink"><span><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-197-1" title="View reference 197 in text" id="ref-197">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.197" data-doi="10.1016/S0140-6736(97)05431-7"><div class="cit-metadata"><cite>van
 Loon AJ, Mantingh A, Serlier EK, Kroon G, Mooyaart EL, Huisjes HJ. 
Randomised controlled trial of magnetic-resonance pelvimetry in breech 
presentation at term. <abbr class="cit-jnl-abbrev">Lancet</abbr><span class="cit-pub-date">1997</span>;<span class="cit-vol">350</span>:<span class="cit-fpage">1799</span>-804.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DLancet%26rft.stitle%253DLancet%26rft.aulast%253Dvan%2BLoon%26rft.auinit1%253DA.%2BJ.%26rft.volume%253D350%26rft.issue%253D9094%26rft.spage%253D1799%26rft.epage%253D1804%26rft.atitle%253DRandomised%2Bcontrolled%2Btrial%2Bof%2Bmagnetic-resonance%2Bpelvimetry%2Bin%2Bbreech%2Bpresentation%2Bat%2Bterm.%26rft_id%253Dinfo%253Adoi%252F10.1016%252FS0140-6736%252897%252905431-7%26rft_id%253Dinfo%253Apmid%252F9428250%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=10.1016/S0140-6736%2897%2905431-7&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=9428250&amp;link_type=MED&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>Medline</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=000071102500008&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-198-1" title="View reference 198 in text" id="ref-198">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.198" data-doi="10.1016/S0140-6736(00)02527-7"><div class="cit-metadata"><cite>Brown
 MJ, Palmer CR, Castaigne A, de Leeuw PW, Mancia G, Rosenthal T, et al. 
Morbidity and mortality in patients randomised to double-blind treatment
 with a long-acting calcium-channel blocker or diuretic in the 
International Nifedipine GITS study: Intervention as a Goal in 
Hypertension Treatment (INSIGHT). <abbr class="cit-jnl-abbrev">Lancet</abbr><span class="cit-pub-date">2000</span>;<span class="cit-vol">356</span>:<span class="cit-fpage">366</span>-72.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DLancet%26rft.stitle%253DLancet%26rft.aulast%253DBrown%26rft.auinit1%253DM.%2BJ.%26rft.volume%253D356%26rft.issue%253D9227%26rft.spage%253D366%26rft.epage%253D372%26rft.atitle%253DMorbidity%2Band%2Bmortality%2Bin%2Bpatients%2Brandomised%2Bto%2Bdouble-blind%2Btreatment%2Bwith%2Ba%2Blong-acting%2Bcalcium-channel%2Bblocker%2Bor%2Bdiuretic%2Bin%2Bthe%2BInternational%2BNifedipine%2BGITS%2Bstudy%253A%2BIntervention%2Bas%2Ba%2BGoal%2Bin%2BHypertension%2BTreatment%2B%2528INSIGHT%2529.%26rft_id%253Dinfo%253Adoi%252F10.1016%252FS0140-6736%252800%252902527-7%26rft_id%253Dinfo%253Apmid%252F10972368%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=10.1016/S0140-6736%2800%2902527-7&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=10972368&amp;link_type=MED&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>Medline</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=000088486000008&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-199-1" title="View reference 199 in text" id="ref-199">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.199" data-doi="10.7326/0003-4819-133-7-200010030-00010"><div class="cit-metadata"><cite>LaCroix
 AZ, Ott SM, Ichikawa L, Scholes D, Barlow WE. Low-dose 
hydrochlorothiazide and preservation of bone mineral density in older 
adults. A randomized, double-blind, placebo-controlled trial. <abbr class="cit-jnl-abbrev">Ann Intern Med</abbr><span class="cit-pub-date">2000</span>;<span class="cit-vol">133</span>:<span class="cit-fpage">516</span>-26.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DAnnals%2Bof%2BInternal%2BMedicine%26rft.stitle%253DANN%2BINTERN%2BMED%26rft.issn%253D0003-4819%26rft.aulast%253DLaCroix%26rft.auinit1%253DA.%2BZ.%26rft.volume%253D133%26rft.issue%253D7%26rft.spage%253D516%26rft.epage%253D526%26rft.atitle%253DLow-Dose%2BHydrochlorothiazide%2Band%2BPreservation%2Bof%2BBone%2BMineral%2BDensity%2Bin%2BOlder%2BAdults%253A%2BA%2BRandomized%252C%2BDouble-Blind%252C%2BPlacebo-Controlled%2BTrial%26rft_id%253Dinfo%253Adoi%252F10.7326%252F0003-4819-133-7-200010030-00010%26rft_id%253Dinfo%253Apmid%252F11015164%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=10.7326/0003-4819-133-7-200010030-00010&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=11015164&amp;link_type=MED&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>Medline</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=000089678300003&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-200-1" title="View reference 200 in text" id="ref-200">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.200"><div class="cit-metadata"><cite>Shuster JJ. Median follow-up in clinical trials. <abbr class="cit-jnl-abbrev">J Clin Oncol</abbr><span class="cit-pub-date">1991</span>;<span class="cit-vol">9</span>:<span class="cit-fpage">191</span>-2.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DJournal%2Bof%2BClinical%2BOncology%26rft.stitle%253DJCO%26rft.issn%253D0732-183X%26rft.aulast%253DShuster%26rft.auinit1%253DJ.%2BJ.%26rft.volume%253D9%26rft.issue%253D1%26rft.spage%253D191%26rft.epage%253D192%26rft.atitle%253DMedian%2Bfollow-up%2Bin%2Bclinical%2Btrials%26rft_id%253Dinfo%253Apmid%252F1985169%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/ijlink?linkType=PDF&amp;journalCode=jco&amp;resid=9/1/191&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-ijlink"><span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-201-1" title="View reference 201 in text" id="ref-201">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.201" data-doi="10.1038/bjc.1995.364"><div class="cit-metadata"><cite>Altman DG, de Stavola BL, Love SB, Stepniewska KA. Review of survival analyses published in cancer journals. <abbr class="cit-jnl-abbrev">Br J Cancer</abbr><span class="cit-pub-date">1995</span>;<span class="cit-vol">72</span>:<span class="cit-fpage">511</span>-8.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DBritish%2BJournal%2Bof%2BCancer%26rft.stitle%253DBritish%2BJournal%2Bof%2BCancer%26rft.aulast%253DAltman%26rft.auinit1%253DD.%2BG.%26rft.volume%253D72%26rft.issue%253D2%26rft.spage%253D511%26rft.epage%253D518%26rft.atitle%253DReview%2Bof%2Bsurvival%2Banalyses%2Bpublished%2Bin%2Bcancer%2Bjournals.%26rft_id%253Dinfo%253Adoi%252F10.1038%252Fbjc.1995.364%26rft_id%253Dinfo%253Apmid%252F7640241%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=10.1038/bjc.1995.364&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=7640241&amp;link_type=MED&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>Medline</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=A1995RM11600042&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-202-1" title="View reference 202 in text" id="ref-202">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.202" data-doi="10.1371/journal.pmed.0020298"><div class="cit-metadata"><cite>Auvert
 B, Taljaard D, Lagarde E, Sobngwi-Tambekou J, Sitta R, Puren A. 
Randomized, controlled intervention trial of male circumcision for 
reduction of HIV infection risk: the ANRS 1265 Trial. <abbr class="cit-jnl-abbrev">PLoS Med</abbr><span class="cit-pub-date">2005</span>;<span class="cit-vol">2</span>:<span class="cit-fpage">e298</span>.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.stitle%253DPLoS%2BMed%26rft.aulast%253DAuvert%26rft.auinit1%253DB.%26rft.volume%253D2%26rft.issue%253D11%26rft.spage%253De298%26rft.epage%253De298%26rft.atitle%253DRandomized%252C%2Bcontrolled%2Bintervention%2Btrial%2Bof%2Bmale%2Bcircumcision%2Bfor%2Breduction%2Bof%2BHIV%2Binfection%2Brisk%253A%2Bthe%2BANRS%2B1265%2BTrial.%26rft_id%253Dinfo%253Adoi%252F10.1371%252Fjournal.pmed.0020298%26rft_id%253Dinfo%253Apmid%252F16231970%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=10.1371/journal.pmed.0020298&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=16231970&amp;link_type=MED&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>Medline</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-203-1" title="View reference 203 in text" id="ref-203">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.203" data-doi="10.1136/bmj.321.7266.931"><div class="cit-metadata"><cite>Diggle
 L, Deeks J. Effect of needle length on incidence of local reactions to 
routine immunisation in infants aged 4 months: randomised controlled 
trial. <abbr class="cit-jnl-abbrev">BMJ</abbr><span class="cit-pub-date">2000</span>;<span class="cit-vol">321</span>:<span class="cit-fpage">931</span>-3.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DBMJ%26rft.stitle%253DBMJ%26rft.issn%253D0007-1447%26rft.aulast%253DDiggle%26rft.auinit1%253DL.%26rft.volume%253D321%26rft.issue%253D7266%26rft.spage%253D931%26rft.epage%253D933%26rft.atitle%253DEffect%2Bof%2Bneedle%2Blength%2Bon%2Bincidence%2Bof%2Blocal%2Breactions%2Bto%2Broutine%2Bimmunisation%2Bin%2Binfants%2Baged%2B4%2Bmonths%253A%2Brandomised%2Bcontrolled%2Btrial%26rft_id%253Dinfo%253Adoi%252F10.1136%252Fbmj.321.7266.931%26rft_id%253Dinfo%253Apmid%252F11030682%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/ijlink?linkType=ABST&amp;journalCode=bmj&amp;resid=321/7266/931&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-ijlink"><span><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-204-1" title="View reference 204 in text" id="ref-204">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.204" data-doi="10.1016/S0140-6736(98)00379-1"><div class="cit-metadata"><cite>Pocock S, White I. Trials stopped early: too good to be true? <abbr class="cit-jnl-abbrev">Lancet</abbr><span class="cit-pub-date">1999</span>;<span class="cit-vol">353</span>:<span class="cit-fpage">943</span>-4.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DLancet%26rft.stitle%253DLancet%26rft.aulast%253DPocock%26rft.auinit1%253DS.%26rft.volume%253D353%26rft.issue%253D9157%26rft.spage%253D943%26rft.epage%253D944%26rft.atitle%253DTrials%2Bstopped%2Bearly%253A%2Btoo%2Bgood%2Bto%2Bbe%2Btrue%253F%26rft_id%253Dinfo%253Adoi%252F10.1016%252FS0140-6736%252898%252900379-1%26rft_id%253Dinfo%253Apmid%252F10459899%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=10.1016/S0140-6736%2898%2900379-1&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=10459899&amp;link_type=MED&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>Medline</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=000079421600005&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-205-1" title="View reference 205 in text" id="ref-205">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.205" data-doi="10.1002/sim.4780071204"><div class="cit-metadata"><cite>Hughes MD, Pocock SJ. Stopping rules and estimation problems in clinical trials. <abbr class="cit-jnl-abbrev">Stat Med</abbr><span class="cit-pub-date">1988</span>;<span class="cit-vol">7</span>:<span class="cit-fpage">1231</span>-42.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DStatistics%2Bin%2Bmedicine%26rft.stitle%253DStat%2BMed%26rft.aulast%253DHughes%26rft.auinit1%253DM.%2BD.%26rft.volume%253D7%26rft.issue%253D12%26rft.spage%253D1231%26rft.epage%253D1242%26rft.atitle%253DStopping%2Brules%2Band%2Bestimation%2Bproblems%2Bin%2Bclinical%2Btrials.%26rft_id%253Dinfo%253Adoi%252F10.1002%252Fsim.4780071204%26rft_id%253Dinfo%253Apmid%252F3231947%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=10.1002/sim.4780071204&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=3231947&amp;link_type=MED&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>Medline</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=A1988R444200003&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-206-1" title="View reference 206 in text" id="ref-206">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.206" data-doi="10.1191/1740774504cn014oa"><div class="cit-metadata"><cite>Kiri A, Tonascia S, Meinert CL. Treatment effects monitoring committees and early stopping in large clinical trials. <abbr class="cit-jnl-abbrev">Clin Trials</abbr><span class="cit-pub-date">2004</span>;<span class="cit-vol">1</span>:<span class="cit-fpage">40</span>-7.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DClinical%2BTrials%26rft.stitle%253DClin%2BTrials%26rft.issn%253D1740-7745%26rft.aulast%253DKiri%26rft.auinit1%253DA.%26rft.volume%253D1%26rft.issue%253D1%26rft.spage%253D40%26rft.epage%253D47%26rft.atitle%253DTreatment%2Beffects%2Bmonitoring%2Bcommittees%2Band%2Bearly%2Bstopping%2Bin%2Blarge%2Bclinical%2Btrials%26rft_id%253Dinfo%253Adoi%252F10.1191%252F1740774504cn014oa%26rft_id%253Dinfo%253Apmid%252F16281461%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/ijlink?linkType=ABST&amp;journalCode=spctj&amp;resid=1/1/40&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-ijlink"><span><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-207-1" title="View reference 207 in text" id="ref-207">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.207" data-doi="10.1001/jama.289.16.2128"><div class="cit-metadata"><cite>Psaty BM, Rennie D. Stopping medical research to save money: a broken pact with researchers and patients. <abbr class="cit-jnl-abbrev">JAMA</abbr><span class="cit-pub-date">2003</span>;<span class="cit-vol">289</span>:<span class="cit-fpage">2128</span>-31.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DJAMA%26rft.stitle%253DJAMA%26rft.issn%253D0002-9955%26rft.aulast%253DPsaty%26rft.auinit1%253DB.%2BM.%26rft.volume%253D289%26rft.issue%253D16%26rft.spage%253D2128%26rft.epage%253D2131%26rft.atitle%253DStopping%2BMedical%2BResearch%2Bto%2BSave%2BMoney%253A%2BA%2BBroken%2BPact%2BWith%2BResearchers%2Band%2BPatients%26rft_id%253Dinfo%253Adoi%252F10.1001%252Fjama.289.16.2128%26rft_id%253Dinfo%253Apmid%252F12709471%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=10.1001/jama.289.16.2128&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=12709471&amp;link_type=MED&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>Medline</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=000182374300029&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-208-1" title="View reference 208 in text" id="ref-208">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.208" data-doi="10.1002/sim.2631"><div class="cit-metadata"><cite>Temple R. FDA perspective on trials with interim efficacy evaluations. <abbr class="cit-jnl-abbrev">Stat Med</abbr><span class="cit-pub-date">2006</span>;<span class="cit-vol">25</span>:<span class="cit-fpage">3245</span>-9.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DStatistics%2Bin%2Bmedicine%26rft.stitle%253DStat%2BMed%26rft.aulast%253DTemple%26rft.auinit1%253DR.%26rft.volume%253D25%26rft.issue%253D19%26rft.spage%253D3245%26rft.epage%253D3249%26rft.atitle%253DFDA%2Bperspective%2Bon%2Btrials%2Bwith%2Binterim%2Befficacy%2Bevaluations.%26rft_id%253Dinfo%253Adoi%252F10.1002%252Fsim.2631%26rft_id%253Dinfo%253Apmid%252F16847824%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=10.1002/sim.2631&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=16847824&amp;link_type=MED&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>Medline</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=000240880300004&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><div class="cit ref-cit ref-journal no-rev-xref" id="cit-340.mar23_1.c869.209" data-doi="10.1016/S0140-6736(08)61242-8"><div class="cit-metadata"><cite>Yusuf
 S, Teo K, Anderson C, Pogue J, Dyal L, Copland I, et al. Effects of the
 angiotensin-receptor blocker telmisartan on cardiovascular events in 
high-risk patients intolerant to angiotensin-converting enzyme 
inhibitors: a randomised controlled trial. <abbr class="cit-jnl-abbrev">Lancet</abbr><span class="cit-pub-date">2008</span>;<span class="cit-vol">372</span>:<span class="cit-fpage">1174</span>-83.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DLancet%26rft.stitle%253DLancet%26rft.volume%253D372%26rft.issue%253D9644%26rft.spage%253D1174%26rft.epage%253D1183%26rft.atitle%253DEffects%2Bof%2Bthe%2Bangiotensin-receptor%2Bblocker%2Btelmisartan%2Bon%2Bcardiovascular%2Bevents%2Bin%2Bhigh-risk%2Bpatients%2Bintolerant%2Bto%2Bangiotensin-converting%2Benzyme%2Binhibitors%253A%2Ba%2Brandomised%2Bcontrolled%2Btrial.%26rft_id%253Dinfo%253Adoi%252F10.1016%252FS0140-6736%252808%252961242-8%26rft_id%253Dinfo%253Apmid%252F18757085%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=10.1016/S0140-6736%2808%2961242-8&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=18757085&amp;link_type=MED&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>Medline</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=000259734700032&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-210-1" title="View reference 210 in text" id="ref-210">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.210" data-doi="10.3109/10601339509019426"><div class="cit-metadata"><cite>Senn S. Base logic: tests of baseline balance in randomized clinical trials. <abbr class="cit-jnl-abbrev">Clin Res Regulatory Affairs</abbr><span class="cit-pub-date">1995</span>;<span class="cit-vol">12</span>:<span class="cit-fpage">171</span>-82.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DClin%2BRes%2BRegulatory%2BAffairs%26rft.volume%253D12%26rft.spage%253D171%26rft_id%253Dinfo%253Adoi%252F10.3109%252F10601339509019426%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=10.3109/10601339509019426&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-211-1" title="View reference 211 in text" id="ref-211">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.211" data-doi="10.2307/2987510"><div class="cit-metadata"><cite>Altman DG. Comparability of randomised groups. <abbr class="cit-jnl-abbrev">Statistician</abbr><span class="cit-pub-date">1985</span>;<span class="cit-vol">34</span>:<span class="cit-fpage">125</span>-36.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DStatistician%26rft.volume%253D34%26rft.spage%253D125%26rft_id%253Dinfo%253Adoi%252F10.2307%252F2987510%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=10.2307/2987510&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=A1985AFM3200011&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-212-1" title="View reference 212 in text" id="ref-212">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.212"><div class="cit-metadata"><cite>Heit
 JA, Elliott CG, Trowbridge AA, Morrey BF, Gent M, Hirsh J. Ardeparin 
sodium for extended out-of-hospital prophylaxis against venous 
thromboembolism after total hip or knee replacement. A randomized, 
double-blind, placebo-controlled trial. <abbr class="cit-jnl-abbrev">Ann Intern Med</abbr><span class="cit-pub-date">2000</span>;<span class="cit-vol">132</span>:<span class="cit-fpage">853</span>-61.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DAnnals%2Bof%2BInternal%2BMedicine%26rft.stitle%253DANN%2BINTERN%2BMED%26rft.issn%253D0003-4819%26rft.aulast%253DHeit%26rft.auinit1%253DJ.%2BA.%26rft.volume%253D132%26rft.issue%253D11%26rft.spage%253D853%26rft.epage%253D861%26rft.atitle%253DArdeparin%2BSodium%2Bfor%2BExtended%2BOut-of-Hospital%2BProphylaxis%2Bagainst%2BVenous%2BThromboembolism%2Bafter%2BTotal%2BHip%2Bor%2BKnee%2BReplacement%253A%2BA%2BRandomized%252C%2BDouble-Blind%252C%2BPlacebo-Controlled%2BTrial%26rft_id%253Dinfo%253Apmid%252F10836911%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=10836911&amp;link_type=MED&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>Medline</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=000087334900001&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-213-1" title="View reference 213 in text" id="ref-213">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.213" data-doi="10.1053/gast.2000.16518"><div class="cit-metadata"><cite>Haderslev
 KV, Tjellesen L, Sorensen HA, Staun M. Alendronate increases lumbar 
spine bone mineral density in patients with Crohn’s disease. <abbr class="cit-jnl-abbrev">Gastroenterology</abbr><span class="cit-pub-date">2000</span>;<span class="cit-vol">119</span>:<span class="cit-fpage">639</span>-46.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DGastroenterology%26rft.volume%253D119%26rft.spage%253D639%26rft_id%253Dinfo%253Adoi%252F10.1053%252Fgast.2000.16518%26rft_id%253Dinfo%253Apmid%252F10982756%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=10.1053/gast.2000.16518&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=10982756&amp;link_type=MED&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>Medline</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=000089087000010&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-214-1" title="View reference 214 in text" id="ref-214">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.214" data-doi="10.1001/jama.1970.03170120039008"><div class="cit-metadata"><cite>Fields
 WS, Maslenikov V, Meyer JS, Hass WK, Remington RD, Macdonald M. Joint 
study of extracranial arterial occlusion. V. Progress report of 
prognosis following surgery or nonsurgical treatment for transient 
cerebral ischemic attacks and cervical carotid artery lesions. <abbr class="cit-jnl-abbrev">JAMA</abbr><span class="cit-pub-date">1970</span>;<span class="cit-vol">211</span>:<span class="cit-fpage">1993</span>-2003.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DJAMA%26rft.stitle%253DJAMA%26rft.issn%253D0002-9955%26rft.aulast%253DFields%26rft.auinit1%253DW.%2BS.%26rft.volume%253D211%26rft.issue%253D12%26rft.spage%253D1993%26rft.epage%253D2003%26rft.atitle%253DJoint%2BStudy%2Bof%2BExtracranial%2BArterial%2BOcclusion%253A%2BV.%2BProgress%2BReport%2Bof%2BPrognosis%2BFollowing%2BSurgery%2Bor%2BNonsurgical%2BTreatment%2Bfor%2BTransient%2BCerebral%2BIschemic%2BAttacks%2Band%2BCervical%2BCarotid%2BArtery%2BLesions%26rft_id%253Dinfo%253Adoi%252F10.1001%252Fjama.1970.03170120039008%26rft_id%253Dinfo%253Apmid%252F5467158%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=10.1001/jama.1970.03170120039008&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=5467158&amp;link_type=MED&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>Medline</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=A1970G621700005&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-215-1" title="View reference 215 in text" id="ref-215">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.215" data-doi="10.1002/sim.4780101011"><div class="cit-metadata"><cite>Lee YJ, Ellenberg JH, Hirtz DG, Nelson KB. Analysis of clinical trials by treatment actually received: is it really an option? <abbr class="cit-jnl-abbrev">Stat Med</abbr><span class="cit-pub-date">1991</span>;<span class="cit-vol">10</span>:<span class="cit-fpage">1595</span>-605.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DStatistics%2Bin%2Bmedicine%26rft.stitle%253DStat%2BMed%26rft.aulast%253DLee%26rft.auinit1%253DY.%2BJ.%26rft.volume%253D10%26rft.issue%253D10%26rft.spage%253D1595%26rft.epage%253D1605%26rft.atitle%253DAnalysis%2Bof%2Bclinical%2Btrials%2Bby%2Btreatment%2Bactually%2Breceived%253A%2Bis%2Bit%2Breally%2Ban%2Boption%253F%26rft_id%253Dinfo%253Adoi%252F10.1002%252Fsim.4780101011%26rft_id%253Dinfo%253Apmid%252F1947515%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=10.1002/sim.4780101011&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=1947515&amp;link_type=MED&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>Medline</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=A1991GH68700010&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-216-1" title="View reference 216 in text" id="ref-216">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.216" data-doi="10.1038/bjc.1993.402"><div class="cit-metadata"><cite>Lewis JA, Machin D. Intention to treat—who should use ITT? <abbr class="cit-jnl-abbrev">Br J Cancer</abbr><span class="cit-pub-date">1993</span>;<span class="cit-vol">68</span>:<span class="cit-fpage">647</span>-50.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DBritish%2BJournal%2Bof%2BCancer%26rft.stitle%253DBritish%2BJournal%2Bof%2BCancer%26rft.aulast%253DLewis%26rft.auinit1%253DJ.%2BA.%26rft.volume%253D68%26rft.issue%253D4%26rft.spage%253D647%26rft.epage%253D650%26rft.atitle%253DIntention%2Bto%2Btreat--who%2Bshould%2Buse%2BITT%253F%26rft_id%253Dinfo%253Adoi%252F10.1038%252Fbjc.1993.402%26rft_id%253Dinfo%253Apmid%252F8398686%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=10.1038/bjc.1993.402&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=8398686&amp;link_type=MED&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>Medline</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=A1993MA92200001&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-217-1" title="View reference 217 in text" id="ref-217">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.217" data-doi="10.1016/S0197-2456(00)00092-1"><div class="cit-metadata"><cite>Lachin JL. Statistical considerations in the intent-to-treat principle. <abbr class="cit-jnl-abbrev">Control Clin Trials</abbr><span class="cit-pub-date">2000</span>;<span class="cit-vol">21</span>:<span class="cit-fpage">526</span>.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DControlled%2Bclinical%2Btrials%26rft.stitle%253DControl%2BClin%2BTrials%26rft.aulast%253DLachin%26rft.auinit1%253DJ.%2BL.%26rft.volume%253D21%26rft.issue%253D5%26rft.spage%253D526%26rft.epage%253D526%26rft.atitle%253DStatistical%2Bconsiderations%2Bin%2Bthe%2Bintent-to-treat%2Bprinciple%26rft_id%253Dinfo%253Adoi%252F10.1016%252FS0197-2456%252800%252900092-1%26rft_id%253Dinfo%253Apmid%252F11018568%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=10.1016/S0197-2456%2800%2900092-1&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=11018568&amp;link_type=MED&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>Medline</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=000089699200010&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-218-1" title="View reference 218 in text" id="ref-218">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.218" data-doi="10.1016/0009-9236(95)90260-0"><div class="cit-metadata"><cite>Sheiner LB, Rubin DB. Intention-to-treat analysis and the goals of clinical trials. <abbr class="cit-jnl-abbrev">Clin Pharmacol Ther</abbr><span class="cit-pub-date">1995</span>;<span class="cit-vol">57</span>:<span class="cit-fpage">6</span>-15.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DClinical%2Bpharmacology%2Band%2Btherapeutics%26rft.stitle%253DClin%2BPharmacol%2BTher%26rft.aulast%253DSheiner%26rft.auinit1%253DL.%2BB.%26rft.volume%253D57%26rft.issue%253D1%26rft.spage%253D6%26rft.epage%253D15%26rft.atitle%253DIntention-to-treat%2Banalysis%2Band%2Bthe%2Bgoals%2Bof%2Bclinical%2Btrials.%26rft_id%253Dinfo%253Adoi%252F10.1016%252F0009-9236%252895%252990260-0%26rft_id%253Dinfo%253Apmid%252F7828382%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=10.1016/0009-9236%2895%2990260-0&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=7828382&amp;link_type=MED&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>Medline</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=A1995QC62900002&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-219-1" title="View reference 219 in text" id="ref-219">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.219" data-doi="10.1002/1097-0258(20000730)19:14&lt;1849::AID-SIM506&gt;3.0.CO;2-1"><div class="cit-metadata"><cite>Nagelkerke
 N, Fidler V, Bernsen R, Borgdorff M. Estimating treatment effects in 
randomized clinical trials in the presence of non-compliance. <abbr class="cit-jnl-abbrev">Stat Med</abbr><span class="cit-pub-date">2000</span>;<span class="cit-vol">19</span>:<span class="cit-fpage">1849</span>-64.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DStatistics%2Bin%2Bmedicine%26rft.stitle%253DStat%2BMed%26rft.aulast%253DNagelkerke%26rft.auinit1%253DN.%26rft.volume%253D19%26rft.issue%253D14%26rft.spage%253D1849%26rft.epage%253D1864%26rft.atitle%253DEstimating%2Btreatment%2Beffects%2Bin%2Brandomized%2Bclinical%2Btrials%2Bin%2Bthe%2Bpresence%2Bof%2Bnon-compliance.%26rft_id%253Dinfo%253Adoi%252F10.1002%252F1097-0258%252820000730%252919%253A14%253C1849%253A%253AAID-SIM506%253E3.0.CO%253B2-1%26rft_id%253Dinfo%253Apmid%252F10867675%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=10.1002/1097-0258%2820000730%2919:14%3C1849::AID-SIM506%3E3.0.CO;2-1&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=10867675&amp;link_type=MED&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>Medline</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=000088211000002&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-220-1" title="View reference 220 in text" id="ref-220">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.220" data-doi="10.1136/bmj.326.7400.1171"><div class="cit-metadata"><cite>Melander
 H, Ahlqvist-Rastad J, Meijer G, Beermann B. Evidence b(i)ased 
medicine--selective reporting from studies sponsored by pharmaceutical 
industry: review of studies in new drug applications. <abbr class="cit-jnl-abbrev">BMJ</abbr><span class="cit-pub-date">2003</span>;<span class="cit-vol">326</span>:<span class="cit-fpage">1171</span>-3.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DBMJ%26rft.stitle%253DBMJ%26rft.issn%253D0007-1447%26rft.aulast%253DMelander%26rft.auinit1%253DH.%26rft.volume%253D326%26rft.issue%253D7400%26rft.spage%253D1171%26rft.epage%253D1173%26rft.atitle%253DEvidence%2Bb%2528i%2529ased%2Bmedicine--selective%2Breporting%2Bfrom%2Bstudies%2Bsponsored%2Bby%2Bpharmaceutical%2Bindustry%253A%2Breview%2Bof%2Bstudies%2Bin%2Bnew%2Bdrug%2Bapplications%26rft_id%253Dinfo%253Adoi%252F10.1136%252Fbmj.326.7400.1171%26rft_id%253Dinfo%253Apmid%252F12775615%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/ijlink?linkType=ABST&amp;journalCode=bmj&amp;resid=326/7400/1171&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-ijlink"><span><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-221-1" title="View reference 221 in text" id="ref-221">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.221" data-doi="10.1177/1740774507081223"><div class="cit-metadata"><cite>Gravel
 J, Opatrny L, Shapiro S. The intention-to-treat approach in randomized 
controlled trials: are authors saying what they do and doing what they 
say? <abbr class="cit-jnl-abbrev">Clin Trials</abbr><span class="cit-pub-date">2007</span>;<span class="cit-vol">4</span>:<span class="cit-fpage">350</span>-6.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DClinical%2BTrials%26rft.stitle%253DClin%2BTrials%26rft.issn%253D1740-7745%26rft.aulast%253DGravel%26rft.auinit1%253DJ.%26rft.volume%253D4%26rft.issue%253D4%26rft.spage%253D350%26rft.epage%253D356%26rft.atitle%253DThe%2Bintention-to-treat%2Bapproach%2Bin%2Brandomized%2Bcontrolled%2Btrials%253A%2BAre%2Bauthors%2Bsaying%2Bwhat%2Bthey%2Bdo%2Band%2Bdoing%2Bwhat%2Bthey%2Bsay%253F%26rft_id%253Dinfo%253Adoi%252F10.1177%252F1740774507081223%26rft_id%253Dinfo%253Apmid%252F17848496%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/ijlink?linkType=ABST&amp;journalCode=spctj&amp;resid=4/4/350&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-ijlink"><span><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-222-1" title="View reference 222 in text" id="ref-222">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.222"><div class="cit-metadata"><cite>Kruse RL, Alper BS, Reust C, Stevermer JJ, Shannon S, Williams RH. Intention-to-treat analysis: who is in? Who is out? <abbr class="cit-jnl-abbrev">J Fam Pract</abbr><span class="cit-pub-date">2002</span>;<span class="cit-vol">51</span>:<span class="cit-fpage">969</span>-71.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DThe%2BJournal%2Bof%2Bfamily%2Bpractice%26rft.stitle%253DJ%2BFam%2BPract%26rft.aulast%253DKruse%26rft.auinit1%253DR.%2BL.%26rft.volume%253D51%26rft.issue%253D11%26rft.spage%253D969%26rft.epage%253D971%26rft.atitle%253DIntention-to-treat%2Banalysis%253A%2Bwho%2Bis%2Bin%253F%2BWho%2Bis%2Bout%253F%26rft_id%253Dinfo%253Apmid%252F12485553%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=12485553&amp;link_type=MED&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>Medline</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=000179199100010&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-223-1" title="View reference 223 in text" id="ref-223">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.223" data-doi="10.2106/JBJS.H.01481"><div class="cit-metadata"><cite>Herman
 A, Botser IB, Tenenbaum S, Chechick A. Intention-to-treat analysis and 
accounting for missing data in orthopaedic randomized clinical trials. <abbr class="cit-jnl-abbrev">J Bone Joint Surg Am</abbr><span class="cit-pub-date">2009</span>;<span class="cit-vol">91</span>:<span class="cit-fpage">2137</span>-43.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DThe%2BJournal%2Bof%2BBone%2Band%2BJoint%2BSurgery%26rft.stitle%253DJBJS%26rft.issn%253D0021-9355%26rft.aulast%253DHerman%26rft.auinit1%253DA.%26rft.volume%253D91%26rft.issue%253D9%26rft.spage%253D2137%26rft.epage%253D2143%26rft.atitle%253DIntention-to-Treat%2BAnalysis%2Band%2BAccounting%2Bfor%2BMissing%2BData%2Bin%2BOrthopaedic%2BRandomized%2BClinical%2BTrials%26rft_id%253Dinfo%253Adoi%252F10.2106%252FJBJS.H.01481%26rft_id%253Dinfo%253Apmid%252F19723990%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=10.2106/JBJS.H.01481&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=19723990&amp;link_type=MED&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>Medline</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-224-1" title="View reference 224 in text" id="ref-224">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.224" data-doi="10.1136/bmj.320.7240.1007"><div class="cit-metadata"><cite>Ruiz-Canela M, Martinez-González MA, de Irala-Estévez J. Intention to treat analysis is related to methodological quality. <abbr class="cit-jnl-abbrev">BMJ</abbr><span class="cit-pub-date">2000</span>;<span class="cit-vol">320</span>:<span class="cit-fpage">1007</span>-8.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DBMJ%26rft.stitle%253DBMJ%26rft.issn%253D0007-1447%26rft.aulast%253DRuiz-Canela%26rft.auinit1%253DM.%26rft.volume%253D320%26rft.issue%253D7240%26rft.spage%253D1007%26rft.epage%253D1007%26rft.atitle%253DIntention%2Bto%2Btreat%2Banalysis%2Bis%2Brelated%2Bto%2Bmethodological%2Bquality%26rft_id%253Dinfo%253Adoi%252F10.1136%252Fbmj.320.7240.1007%26rft_id%253Dinfo%253Apmid%252F10809554%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/ijlink?linkType=FULL&amp;journalCode=bmj&amp;resid=320/7240/1007&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-ijlink"><span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-225-1" title="View reference 225 in text" id="ref-225">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.225"><div class="cit-metadata"><cite>Altman DG. Missing outcomes in randomised trials: addressing the dilemma. <abbr class="cit-jnl-abbrev">Open Med</abbr><span class="cit-pub-date">2009</span>;<span class="cit-vol">3</span>:<span class="cit-fpage">e21</span>-3.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DOpen%2BMed%26rft.volume%253D3%26rft.spage%253De21%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-226-1" title="View reference 226 in text" id="ref-226">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.226" data-doi="10.1191/1740774504cn032oa"><div class="cit-metadata"><cite>Wood
 AM, White IR, Thompson SG. Are missing outcome data adequately handled?
 A review of published randomized controlled trials in major medical 
journals. <abbr class="cit-jnl-abbrev">Clin Trials</abbr><span class="cit-pub-date">2004</span>;<span class="cit-vol">1</span>:<span class="cit-fpage">368</span>-76.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DClinical%2BTrials%26rft.stitle%253DClin%2BTrials%26rft.issn%253D1740-7745%26rft.aulast%253DWood%26rft.auinit1%253DA.%2BM%26rft.volume%253D1%26rft.issue%253D4%26rft.spage%253D368%26rft.epage%253D376%26rft.atitle%253DAre%2Bmissing%2Boutcome%2Bdata%2Badequately%2Bhandled%253F%2BA%2Breview%2Bof%2Bpublished%2Brandomized%2Bcontrolled%2Btrials%2Bin%2Bmajor%2Bmedical%2Bjournals%26rft_id%253Dinfo%253Adoi%252F10.1191%252F1740774504cn032oa%26rft_id%253Dinfo%253Apmid%252F16279275%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/ijlink?linkType=ABST&amp;journalCode=spctj&amp;resid=1/4/368&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-ijlink"><span><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-227-1" title="View reference 227 in text" id="ref-227">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.227" data-doi="10.1136/ebmh.11.1.3"><div class="cit-metadata"><cite>Streiner DL. Missing data and the trouble with LOCF. <abbr class="cit-jnl-abbrev">Evid Based Ment Health</abbr><span class="cit-pub-date">2008</span>;<span class="cit-vol">11</span>:<span class="cit-fpage">3</span>-5.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DEvidence-Based%2BMental%2BHealth%26rft.stitle%253DEvid.%2BBased%2BMent.%2BHealth%26rft.issn%253D1362-0347%26rft.aulast%253DReid%26rft.auinit1%253DS.%26rft.volume%253D11%26rft.issue%253D1%26rft.spage%253D3%26rft.epage%253D3%26rft.atitle%253DA%2Bdifferent%2Blook%26rft_id%253Dinfo%253Adoi%252F10.1136%252Febmh.11.1.3%26rft_id%253Dinfo%253Apmid%252F18223040%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/ijlink?linkType=FULL&amp;journalCode=ebmental&amp;resid=11/1/3&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-ijlink"><span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-228-1" title="View reference 228 in text" id="ref-228">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.228" data-doi="10.1503/cmaj.080820"><div class="cit-metadata"><cite>Molnar FJ, Hutton B, Fergusson D. Does analysis using “last observation carried forward” introduce bias in dementia research? <abbr class="cit-jnl-abbrev">CMAJ</abbr><span class="cit-pub-date">2008</span>;<span class="cit-vol">179</span>:<span class="cit-fpage">751</span>-3.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DCanadian%2BMedical%2BAssociation%2BJournal%26rft.stitle%253DCMAJ%26rft.issn%253D0008-4409%26rft.aulast%253DMolnar%26rft.auinit1%253DF.%2BJ.%26rft.volume%253D179%26rft.issue%253D8%26rft.spage%253D751%26rft.epage%253D753%26rft.atitle%253DDoes%2Banalysis%2Busing%2B%2522last%2Bobservation%2Bcarried%2Bforward%2522%2Bintroduce%2Bbias%2Bin%2Bdementia%2Bresearch%253F%26rft_id%253Dinfo%253Adoi%252F10.1503%252Fcmaj.080820%26rft_id%253Dinfo%253Apmid%252F18838445%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/ijlink?linkType=FULL&amp;journalCode=cmaj&amp;resid=179/8/751&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-ijlink"><span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-229-1" title="View reference 229 in text" id="ref-229">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.229" data-doi="10.1056/NEJMe030054"><div class="cit-metadata"><cite>Ware JH. Interpreting incomplete data in studies of diet and weight loss. <abbr class="cit-jnl-abbrev">N Engl J Med</abbr><span class="cit-pub-date">2003</span>;<span class="cit-vol">348</span>:<span class="cit-fpage">2136</span>-7.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DNew%2BEngland%2BJournal%2Bof%2BMedicine%26rft.stitle%253DNEJM%26rft.issn%253D0028-4793%26rft.aulast%253DWare%26rft.auinit1%253DJ.%2BH.%26rft.volume%253D348%26rft.issue%253D21%26rft.spage%253D2136%26rft.epage%253D2137%26rft.atitle%253DInterpreting%2BIncomplete%2BData%2Bin%2BStudies%2Bof%2BDiet%2Band%2BWeight%2BLoss%26rft_id%253Dinfo%253Adoi%252F10.1056%252FNEJMe030054%26rft_id%253Dinfo%253Apmid%252F12761370%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=10.1056/NEJMe030054&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=12761370&amp;link_type=MED&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>Medline</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=000183008300012&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-230-1" title="View reference 230 in text" id="ref-230">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.230"><div class="cit-metadata"><cite>Streiner DL. The case of the missing data: methods of dealing with dropouts and other research vagaries. <abbr class="cit-jnl-abbrev">Can J Psychiatry</abbr><span class="cit-pub-date">2002</span>;<span class="cit-vol">47</span>:<span class="cit-fpage">68</span>-75.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DCanadian%2Bjournal%2Bof%2Bpsychiatry.%2B%2BRevue%2Bcanadienne%2Bde%2Bpsychiatrie%26rft.stitle%253DCan%2BJ%2BPsychiatry%26rft.aulast%253DStreiner%26rft.auinit1%253DD.%2BL.%26rft.volume%253D47%26rft.issue%253D1%26rft.spage%253D68%26rft.epage%253D75%26rft.atitle%253DThe%2Bcase%2Bof%2Bthe%2Bmissing%2Bdata%253A%2Bmethods%2Bof%2Bdealing%2Bwith%2Bdropouts%2Band%2Bother%2Bresearch%2Bvagaries.%26rft_id%253Dinfo%253Apmid%252F11873711%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=11873711&amp;link_type=MED&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>Medline</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=000174016500008&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-231-1" title="View reference 231 in text" id="ref-231">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.231" data-doi="10.1002/pst.267"><div class="cit-metadata"><cite>Lane P. Handling drop-out in longitudinal clinical trials: a comparison of the LOCF and MMRM approaches. <abbr class="cit-jnl-abbrev">Pharm Stat</abbr><span class="cit-pub-date">2008</span>;<span class="cit-vol">7</span>:<span class="cit-fpage">93</span>-106.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.stitle%253DPharm%2BStat%26rft.aulast%253DLane%26rft.auinit1%253DP.%26rft.volume%253D7%26rft.issue%253D2%26rft.spage%253D93%26rft.epage%253D106%26rft.atitle%253DHandling%2Bdrop-out%2Bin%2Blongitudinal%2Bclinical%2Btrials%253A%2Ba%2Bcomparison%2Bof%2Bthe%2BLOCF%2Band%2BMMRM%2Bapproaches.%26rft_id%253Dinfo%253Adoi%252F10.1002%252Fpst.267%26rft_id%253Dinfo%253Apmid%252F17351897%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=10.1002/pst.267&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=17351897&amp;link_type=MED&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>Medline</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=000256786300003&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-232-1" title="View reference 232 in text" id="ref-232">↵</a><div class="cit ref-cit ref-other" id="cit-340.mar23_1.c869.232"><div class="cit-metadata unstructured">Abraha
 I, Montedori A, Romagnoli C. Modified intention to treat: frequency, 
definition and implication for clinical trials [abstract]. Sao Paulo, 
Brazil: XV Cochrane Colloquium, 2007: 86-7.</div><div class="cit-extra"></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-233-1" title="View reference 233 in text" id="ref-233">↵</a><div class="cit ref-cit ref-other" id="cit-340.mar23_1.c869.233"><div class="cit-metadata"><cite>Altman DG. Confidence intervals in practice. In: Altman DG, Machin D, Bryant TN, Gardner MJ, eds. <span class="cit-source">Statistics with confidence</span>. 2nd ed. BMJ Books, <span class="cit-pub-date">2000</span>:6-14.</cite></div><div class="cit-extra"></div></div></li><li><div class="cit ref-cit ref-journal no-rev-xref" id="cit-340.mar23_1.c869.234" data-doi="10.1136/bmj.b4074"><div class="cit-metadata"><cite>van
 Linschoten R, van Middelkoop M, Berger MY, Heintjes EM, Verhaar JA, 
Willemsen SP, et al. Supervised exercise therapy versus usual care for 
patellofemoral pain syndrome: an open label randomised controlled trial.
 <abbr class="cit-jnl-abbrev">BMJ</abbr><span class="cit-pub-date">2009</span>;<span class="cit-vol">339</span>:<span class="cit-fpage">b4074</span>.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DBMJ%26rft_id%253Dinfo%253Adoi%252F10.1136%252Fbmj.b4074%26rft_id%253Dinfo%253Apmid%252F19843565%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/ijlink?linkType=ABST&amp;journalCode=bmj&amp;resid=339/oct20_1/b4074&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-ijlink"><span><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-235-1" title="View reference 235 in text" id="ref-235">↵</a><div class="cit ref-cit ref-other" id="cit-340.mar23_1.c869.235"><div class="cit-metadata"><cite>Altman DG. Clinical trials and meta-analyses. In: Altman DG, Machin D, Bryant TN, Gardner MJ, eds. <span class="cit-source">Statistics with confidence</span>. 2nd ed. BMJ Books, <span class="cit-pub-date">2000</span>:120-38.</cite></div><div class="cit-extra"></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-236-1" title="View reference 236 in text" id="ref-236">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.236" data-doi="10.7326/0003-4819-126-1-199701010-00006"><div class="cit-metadata"><cite>Uniform requirements for manuscripts submitted to biomedical journals. International Committee of Medical Journal Editors. <abbr class="cit-jnl-abbrev">Ann Intern Med</abbr><span class="cit-pub-date">1997</span>;<span class="cit-vol">126</span>:<span class="cit-fpage">36</span>-47.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DAnnals%2Bof%2BInternal%2BMedicine%26rft.stitle%253DANN%2BINTERN%2BMED%26rft.issn%253D0003-4819%26rft.volume%253D126%26rft.issue%253D1%26rft.spage%253D36%26rft.epage%253D47%26rft.atitle%253DUniform%2BRequirements%2Bfor%2BManuscripts%2BSubmitted%2Bto%2BBiomedical%2BJournals%26rft_id%253Dinfo%253Adoi%252F10.7326%252F0003-4819-126-1-199701010-00006%26rft_id%253Dinfo%253Apmid%252F8992922%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=10.7326/0003-4819-126-1-199701010-00006&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=8992922&amp;link_type=MED&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>Medline</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=A1997WA16500006&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-237-1" title="View reference 237 in text" id="ref-237">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.237" data-doi="10.1136/bmj.292.6522.746"><div class="cit-metadata"><cite>Gardner MJ, Altman DG. Confidence intervals rather than P values: estimation rather than hypothesis testing. <abbr class="cit-jnl-abbrev">BMJ </abbr><span class="cit-pub-date">1986</span>;<span class="cit-vol">292</span>:<span class="cit-fpage">746</span>-50.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DBMJ%26rft.stitle%253DBMJ%26rft.issn%253D0007-1447%26rft.aulast%253DGardner%26rft.auinit1%253DM%2BJ%26rft.volume%253D292%26rft.issue%253D6522%26rft.spage%253D746%26rft.epage%253D750%26rft.atitle%253DConfidence%2Bintervals%2Brather%2Bthan%2BP%2Bvalues%253A%2Bestimation%2Brather%2Bthan%2Bhypothesis%2Btesting.%26rft_id%253Dinfo%253Adoi%252F10.1136%252Fbmj.292.6522.746%26rft_id%253Dinfo%253Apmid%252F3082422%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/ijlink?linkType=ABST&amp;journalCode=bmj&amp;resid=292/6522/746&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-ijlink"><span><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-238-1" title="View reference 238 in text" id="ref-238">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.238"><div class="cit-metadata"><cite>Bailar
 JC, III, Mosteller F. Guidelines for statistical reporting in articles 
for medical journals. Amplifications and explanations. <abbr class="cit-jnl-abbrev">Ann Intern Med</abbr><span class="cit-pub-date">1988</span>;<span class="cit-vol">108</span>:<span class="cit-fpage">266</span>-73.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DAnnals%2Bof%2BInternal%2BMedicine%26rft.stitle%253DANN%2BINTERN%2BMED%26rft.issn%253D0003-4819%26rft.aulast%253DBAILAR%26rft.auinit1%253DJ.%2BC.%26rft.volume%253D108%26rft.issue%253D2%26rft.spage%253D266%26rft.epage%253D273%26rft.atitle%253DGuidelines%2Bfor%2BStatistical%2BReporting%2Bin%2BArticles%2Bfor%2BMedical%2BJournals%253A%2BAmplifications%2Band%2BExplanations%26rft_id%253Dinfo%253Apmid%252F3341656%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=3341656&amp;link_type=MED&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>Medline</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=A1988L976500019&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-239-1" title="View reference 239 in text" id="ref-239">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.239" data-doi="10.1136/bmj.314.7098.1907"><div class="cit-metadata"><cite>Bland JM. Quoting intermediate analyses can only mislead. <abbr class="cit-jnl-abbrev">BMJ</abbr><span class="cit-pub-date">1997</span>;<span class="cit-vol">314</span>:<span class="cit-fpage">1907</span>-8.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DBMJ%26rft.stitle%253DBMJ%26rft.issn%253D0007-1447%26rft.aulast%253DSas%26rft.auinit1%253DG.%26rft.volume%253D314%26rft.issue%253D7098%26rft.spage%253D1907%26rft.epage%253D1907%26rft.atitle%253DTreatment%2Bfor%2Bhaemophilia%2Bby%2Bcalendar%2Bin%2BHungary%26rft_id%253Dinfo%253Adoi%252F10.1136%252Fbmj.314.7098.1907%26rft_id%253Dinfo%253Apmid%252F9224155%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/ijlink?linkType=FULL&amp;journalCode=bmj&amp;resid=314/7098/1907&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-ijlink"><span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-240-1" title="View reference 240 in text" id="ref-240">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.240" data-doi="10.1136/bmj.310.6977.452"><div class="cit-metadata"><cite>Cook RJ, Sackett DL. The number needed to treat: a clinically useful measure of treatment effect. <abbr class="cit-jnl-abbrev">BMJ</abbr><span class="cit-pub-date">1995</span>;<span class="cit-vol">310</span>:<span class="cit-fpage">452</span>-4.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DBMJ%26rft.stitle%253DBMJ%26rft.issn%253D0007-1447%26rft.aulast%253DCook%26rft.auinit1%253DR.%2BJ%26rft.volume%253D310%26rft.issue%253D6977%26rft.spage%253D452%26rft.epage%253D454%26rft.atitle%253DThe%2Bnumber%2Bneeded%2Bto%2Btreat%253A%2Ba%2Bclinically%2Buseful%2Bmeasure%2Bof%2Btreatment%2Beffect%26rft_id%253Dinfo%253Adoi%252F10.1136%252Fbmj.310.6977.452%26rft_id%253Dinfo%253Apmid%252F7873954%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/ijlink?linkType=FULL&amp;journalCode=bmj&amp;resid=310/6977/452&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-ijlink"><span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-241-1" title="View reference 241 in text" id="ref-241">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.241" data-doi="10.1136/bmj.319.7223.1492"><div class="cit-metadata"><cite>Altman DG, Andersen PK. Calculating the number needed to treat for trials where the outcome is time to an event. <abbr class="cit-jnl-abbrev">BMJ</abbr><span class="cit-pub-date">1999</span>;<span class="cit-vol">319</span>:<span class="cit-fpage">1492</span>-5.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DBMJ%26rft.stitle%253DBMJ%26rft.issn%253D0007-1447%26rft.aulast%253DAltman%26rft.auinit1%253DD.%2BG%26rft.volume%253D319%26rft.issue%253D7223%26rft.spage%253D1492%26rft.epage%253D1495%26rft.atitle%253DCalculating%2Bthe%2Bnumber%2Bneeded%2Bto%2Btreat%2Bfor%2Btrials%2Bwhere%2Bthe%2Boutcome%2Bis%2Btime%2Bto%2Ban%2Bevent%26rft_id%253Dinfo%253Adoi%252F10.1136%252Fbmj.319.7223.1492%26rft_id%253Dinfo%253Apmid%252F10582940%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/ijlink?linkType=FULL&amp;journalCode=bmj&amp;resid=319/7223/1492&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-ijlink"><span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-242-1" title="View reference 242 in text" id="ref-242">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.242" data-doi="10.1016/0140-6736(92)92557-V"><div class="cit-metadata"><cite>The
 OSIRIS Collaborative Group. Early versus delayed neonatal 
administration of a synthetic surfactant—the judgment of OSIRIS (open 
study of infants at high risk of or with respiratory insufficiency—the 
role of surfactant). <abbr class="cit-jnl-abbrev">Lancet</abbr><span class="cit-pub-date">1992</span>;<span class="cit-vol">340</span>:<span class="cit-fpage">1363</span>-9.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DLancet%26rft.stitle%253DLancet%26rft.volume%253D340%26rft.issue%253D8832%26rft.spage%253D1363%26rft.epage%253D1369%26rft.atitle%253DEarly%2Bversus%2Bdelayed%2Bneonatal%2Badministration%2Bof%2Ba%2Bsynthetic%2Bsurfactant--the%2Bjudgment%2Bof%2BOSIRIS.%2BThe%2BOSIRIS%2BCollaborative%2BGroup%2B%2528open%2Bstudy%2Bof%2Binfants%2Bat%2Bhigh%2Brisk%2Bof%2Bor%2Bwith%2Brespiratory%2Binsufficiency--the%2Brole%2Bof%2Bsurfactant.%26rft_id%253Dinfo%253Adoi%252F10.1016%252F0140-6736%252892%252992557-V%26rft_id%253Dinfo%253Apmid%252F1360087%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=10.1016/0140-6736%2892%2992557-V&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=1360087&amp;link_type=MED&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>Medline</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=A1992KB20200001&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-243-1" title="View reference 243 in text" id="ref-243">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.243" data-doi="10.1186/1472-6947-8-31"><div class="cit-metadata"><cite>Sorensen
 L, Gyrd-Hansen D, Kristiansen IS, Nexøe J, Nielsen JB. Laypersons’ 
understanding of relative risk reductions: randomised cross-sectional 
study. <abbr class="cit-jnl-abbrev">BMC Med Inform Decis Mak</abbr><span class="cit-pub-date">2008</span>;<span class="cit-vol">8</span>:<span class="cit-fpage">31</span>.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DBMC%2Bmedical%2Binformatics%2Band%2Bdecision%2Bmaking%2B%255Belectronic%2Bresource%255D%26rft.stitle%253DBMC%2BMed%2BInform%2BDecis%2BMak%26rft.aulast%253DSorensen%26rft.auinit1%253DL.%26rft.volume%253D8%26rft.spage%253D31%26rft.epage%253D31%26rft.atitle%253DLaypersons%2527%2Bunderstanding%2Bof%2Brelative%2Brisk%2Breductions%253A%2Brandomised%2Bcross-sectional%2Bstudy.%26rft_id%253Dinfo%253Adoi%252F10.1186%252F1472-6947-8-31%26rft_id%253Dinfo%253Apmid%252F18631406%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=10.1186/1472-6947-8-31&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=18631406&amp;link_type=MED&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>Medline</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-244-1" title="View reference 244 in text" id="ref-244">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.244" data-doi="10.1016/S0140-6736(94)92407-4"><div class="cit-metadata"><cite>Bobbio M, Demichelis B, Giustetto G. Completeness of reporting trial results: effect on physicians’ willingness to prescribe. <abbr class="cit-jnl-abbrev">Lancet</abbr><span class="cit-pub-date">1994</span>;<span class="cit-vol">343</span>:<span class="cit-fpage">1209</span>-11.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DLancet%26rft.stitle%253DLancet%26rft.aulast%253DBobbio%26rft.auinit1%253DM.%26rft.volume%253D343%26rft.issue%253D8907%26rft.spage%253D1209%26rft.epage%253D1211%26rft.atitle%253DCompleteness%2Bof%2Breporting%2Btrial%2Bresults%253A%2Beffect%2Bon%2Bphysicians%2527%2Bwillingness%2Bto%2Bprescribe.%26rft_id%253Dinfo%253Adoi%252F10.1016%252FS0140-6736%252894%252992407-4%26rft_id%253Dinfo%253Apmid%252F7909875%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=10.1016/S0140-6736%2894%2992407-4&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=7909875&amp;link_type=MED&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>Medline</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=A1994NL17500016&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-245-1" title="View reference 245 in text" id="ref-245">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.245" data-doi="10.7326/0003-4819-117-11-916"><div class="cit-metadata"><cite>Naylor
 CD, Chen E, Strauss B. Measured enthusiasm: does the method of 
reporting trial results alter perceptions of therapeutic effectiveness? <abbr class="cit-jnl-abbrev">Ann Intern Med</abbr><span class="cit-pub-date">1992</span>;<span class="cit-vol">117</span>:<span class="cit-fpage">916</span>-21.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DAnnals%2Bof%2BInternal%2BMedicine%26rft.stitle%253DANN%2BINTERN%2BMED%26rft.issn%253D0003-4819%26rft.aulast%253DNaylor%26rft.auinit1%253DC.%2BD.%26rft.volume%253D117%26rft.issue%253D11%26rft.spage%253D916%26rft.epage%253D921%26rft.atitle%253DMeasured%2BEnthusiasm%253A%2BDoes%2Bthe%2BMethod%2Bof%2BReporting%2BTrial%2BResults%2BAlter%2BPerceptions%2Bof%2BTherapeutic%2BEffectiveness%253F%26rft_id%253Dinfo%253Adoi%252F10.7326%252F0003-4819-117-11-916%26rft_id%253Dinfo%253Apmid%252F1443954%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=10.7326/0003-4819-117-11-916&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=1443954&amp;link_type=MED&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>Medline</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=A1992JZ27600008&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-246-1" title="View reference 246 in text" id="ref-246">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.246" data-doi="10.1126/science.333584"><div class="cit-metadata"><cite>Tukey JW. Some thoughts on clinical trials, especially problems of multiplicity. <abbr class="cit-jnl-abbrev">Science</abbr><span class="cit-pub-date">1977</span>;<span class="cit-vol">198</span>:<span class="cit-fpage">679</span>-84.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DScience%26rft.stitle%253DScience%26rft.issn%253D0036-8075%26rft.aulast%253DTukey%26rft.auinit1%253DJ.%26rft.volume%253D198%26rft.issue%253D4318%26rft.spage%253D679%26rft.epage%253D684%26rft.atitle%253DSome%2Bthoughts%2Bon%2Bclinical%2Btrials%252C%2Bespecially%2Bproblems%2Bof%2Bmultiplicity%26rft_id%253Dinfo%253Adoi%252F10.1126%252Fscience.333584%26rft_id%253Dinfo%253Apmid%252F333584%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/ijlink?linkType=ABST&amp;journalCode=sci&amp;resid=198/4318/679&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-ijlink"><span><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-247-1" title="View reference 247 in text" id="ref-247">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.247" data-doi="10.1001/jama.1991.03470010097038"><div class="cit-metadata"><cite>Yusuf
 S, Wittes J, Probstfield J, Tyroler HA. Analysis and interpretation of 
treatment effects in subgroups of patients in randomized clinical 
trials. <abbr class="cit-jnl-abbrev">JAMA</abbr><span class="cit-pub-date">1991</span>;<span class="cit-vol">266</span>:<span class="cit-fpage">93</span>-8.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DJAMA%26rft.stitle%253DJAMA%26rft.issn%253D0002-9955%26rft.aulast%253DYusuf%26rft.auinit1%253DS.%26rft.volume%253D266%26rft.issue%253D1%26rft.spage%253D93%26rft.epage%253D98%26rft.atitle%253DAnalysis%2Band%2BInterpretation%2Bof%2BTreatment%2BEffects%2Bin%2BSubgroups%2Bof%2BPatients%2Bin%2BRandomized%2BClinical%2BTrials%26rft_id%253Dinfo%253Adoi%252F10.1001%252Fjama.1991.03470010097038%26rft_id%253Dinfo%253Apmid%252F2046134%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=10.1001/jama.1991.03470010097038&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=2046134&amp;link_type=MED&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>Medline</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=A1991FT93400034&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-248-1" title="View reference 248 in text" id="ref-248">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.248" data-doi="10.1002/1097-0258(20001230)19:24&lt;3325::AID-SIM827&gt;3.0.CO;2-D"><div class="cit-metadata"><cite>Hahn
 S, Williamson PR, Hutton JL, Garner P, Flynn EV. Assessing the 
potential for bias in meta-analysis due to selective reporting of 
subgroup analyses within studies. <abbr class="cit-jnl-abbrev">Stat Med</abbr><span class="cit-pub-date">2000</span>;<span class="cit-vol">19</span>:<span class="cit-fpage">3325</span>-36.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DStatistics%2Bin%2Bmedicine%26rft.stitle%253DStat%2BMed%26rft.aulast%253DHahn%26rft.auinit1%253DS.%26rft.volume%253D19%26rft.issue%253D24%26rft.spage%253D3325%26rft.epage%253D3336%26rft.atitle%253DAssessing%2Bthe%2Bpotential%2Bfor%2Bbias%2Bin%2Bmeta-analysis%2Bdue%2Bto%2Bselective%2Breporting%2Bof%2Bsubgroup%2Banalyses%2Bwithin%2Bstudies.%26rft_id%253Dinfo%253Adoi%252F10.1002%252F1097-0258%252820001230%252919%253A24%253C3325%253A%253AAID-SIM827%253E3.0.CO%253B2-D%26rft_id%253Dinfo%253Apmid%252F11122498%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=10.1002/1097-0258%2820001230%2919:24%3C3325::AID-SIM827%3E3.0.CO;2-D&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=11122498&amp;link_type=MED&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>Medline</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=000166395500003&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-249-1" title="View reference 249 in text" id="ref-249">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.249" data-doi="10.1097/01.blo.0000218736.23506.fe"><div class="cit-metadata"><cite>Bhandari
 M, Devereaux PJ, Li P, Mah D, Lim K, Schünemann HJ, et al. Misuse of 
baseline comparison tests and subgroup analyses in surgical trials. <abbr class="cit-jnl-abbrev">Clin Orthop Relat Res</abbr><span class="cit-pub-date">2006</span>;<span class="cit-vol">447</span>:<span class="cit-fpage">247</span>-51.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DClinical%2Borthopaedics%2Band%2Brelated%2Bresearch%26rft.stitle%253DClin%2BOrthop%26rft.aulast%253DBhandari%26rft.auinit1%253DM.%26rft.volume%253D447%26rft.spage%253D247%26rft.epage%253D251%26rft.atitle%253DMisuse%2Bof%2Bbaseline%2Bcomparison%2Btests%2Band%2Bsubgroup%2Banalyses%2Bin%2Bsurgical%2Btrials.%26rft_id%253Dinfo%253Adoi%252F10.1097%252F01.blo.0000218736.23506.fe%26rft_id%253Dinfo%253Apmid%252F16672904%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=10.1097/01.blo.0000218736.23506.fe&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=16672904&amp;link_type=MED&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>Medline</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-250-1" title="View reference 250 in text" id="ref-250">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.250" data-doi="10.1016/S0140-6736(00)02712-4"><div class="cit-metadata"><cite>Levin
 M, Quint PA, Goldstein B, Barton P, Bradley JS, Shemie SD, et al. 
Recombinant bactericidal/permeability-increasing protein (rBPI21) as 
adjunctive treatment for children with severe meningococcal sepsis: a 
randomised trial. rBPI21 Meningococcal Sepsis Study Group. <abbr class="cit-jnl-abbrev">Lancet</abbr><span class="cit-pub-date">2000</span>;<span class="cit-vol">356</span>:<span class="cit-fpage">961</span>-7.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DLancet%26rft.stitle%253DLancet%26rft.aulast%253DLevin%26rft.auinit1%253DM.%26rft.volume%253D356%26rft.issue%253D9234%26rft.spage%253D961%26rft.epage%253D967%26rft.atitle%253DRecombinant%2Bbactericidal%252Fpermeability-increasing%2Bprotein%2B%2528rBPI21%2529%2Bas%2Badjunctive%2Btreatment%2Bfor%2Bchildren%2Bwith%2Bsevere%2Bmeningococcal%2Bsepsis%253A%2Ba%2Brandomised%2Btrial.%2BrBPI21%2BMeningococcal%2BSepsis%2BStudy%2BGroup.%26rft_id%253Dinfo%253Adoi%252F10.1016%252FS0140-6736%252800%252902712-4%26rft_id%253Dinfo%253Apmid%252F11041396%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=10.1016/S0140-6736%2800%2902712-4&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=11041396&amp;link_type=MED&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>Medline</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=000089293600009&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-251-1" title="View reference 251 in text" id="ref-251">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.251" data-doi="10.1200/JCO.2005.05.3959"><div class="cit-metadata"><cite>Scharf O, Colevas AD. Adverse event reporting in publications compared with sponsor database for cancer clinical trials. <abbr class="cit-jnl-abbrev">J Clin Oncol</abbr><span class="cit-pub-date">2006</span>;<span class="cit-vol">24</span>:<span class="cit-fpage">3933</span>-8.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DJournal%2Bof%2BClinical%2BOncology%26rft.stitle%253DJCO%26rft.issn%253D0732-183X%26rft.aulast%253DScharf%26rft.auinit1%253DO.%26rft.volume%253D24%26rft.issue%253D24%26rft.spage%253D3933%26rft.epage%253D3938%26rft.atitle%253DAdverse%2BEvent%2BReporting%2Bin%2BPublications%2BCompared%2BWith%2BSponsor%2BDatabase%2Bfor%2BCancer%2BClinical%2BTrials%26rft_id%253Dinfo%253Adoi%252F10.1200%252FJCO.2005.05.3959%26rft_id%253Dinfo%253Apmid%252F16921045%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/ijlink?linkType=ABST&amp;journalCode=jco&amp;resid=24/24/3933&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-ijlink"><span><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-252-1" title="View reference 252 in text" id="ref-252">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.252" data-doi="10.1001/archinternmed.2009.306"><div class="cit-metadata"><cite>Pitrou I, Boutron I, Ahmad N, Ravaud P. Reporting of safety results in published reports of randomized controlled trials. <abbr class="cit-jnl-abbrev">Arch Intern Med</abbr><span class="cit-pub-date">2009</span>;<span class="cit-vol">169</span>:<span class="cit-fpage">1756</span>-61.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DArchives%2Bof%2BInternal%2BMedicine%26rft.stitle%253DArch%2BIntern%2BMed%26rft.issn%253D0003-9926%26rft.aulast%253DPitrou%26rft.auinit1%253DI.%26rft.volume%253D169%26rft.issue%253D19%26rft.spage%253D1756%26rft.epage%253D1761%26rft.atitle%253DReporting%2Bof%2BSafety%2BResults%2Bin%2BPublished%2BReports%2Bof%2BRandomized%2BControlled%2BTrials%26rft_id%253Dinfo%253Adoi%252F10.1001%252Farchinternmed.2009.306%26rft_id%253Dinfo%253Apmid%252F19858432%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=10.1001/archinternmed.2009.306&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=19858432&amp;link_type=MED&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>Medline</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=000271163800006&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-253-1" title="View reference 253 in text" id="ref-253">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.253" data-doi="10.1056/NEJMoa070829"><div class="cit-metadata"><cite>Boden
 WE, O’Rourke RA, Teo KK, Hartigan PM, Maron DJ, Kostuk WJ, et al. 
Optimal medical therapy with or without PCI for stable coronary disease.
 <abbr class="cit-jnl-abbrev">N Engl J Med</abbr><span class="cit-pub-date">2007</span>;<span class="cit-vol">356</span>:<span class="cit-fpage">1503</span>-16.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DNew%2BEngland%2BJournal%2Bof%2BMedicine%26rft.stitle%253DNEJM%26rft.issn%253D0028-4793%26rft.volume%253D356%26rft.issue%253D15%26rft.spage%253D1503%26rft.epage%253D1516%26rft.atitle%253DOptimal%2Bmedical%2Btherapy%2Bwith%2Bor%2Bwithout%2BPCI%2Bfor%2Bstable%2Bcoronary%2Bdisease.%26rft_id%253Dinfo%253Adoi%252F10.1056%252FNEJMoa070829%26rft_id%253Dinfo%253Apmid%252F17387127%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=10.1056/NEJMoa070829&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=17387127&amp;link_type=MED&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>Medline</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=000245624400004&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-254-1" title="View reference 254 in text" id="ref-254">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.254"><div class="cit-metadata"><cite>Horton R. The rhetoric of research. <abbr class="cit-jnl-abbrev">BMJ</abbr><span class="cit-pub-date">1995</span>;<span class="cit-vol">310</span>:<span class="cit-fpage">985</span>-7.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DBMJ%26rft.stitle%253DBMJ%26rft.issn%253D0007-1447%26rft.aulast%253DHorton%26rft.auinit1%253DR.%26rft.volume%253D310%26rft.issue%253D6985%26rft.spage%253D985%26rft.epage%253D987%26rft.atitle%253DThe%2Brhetoric%2Bof%2Bresearch%26rft_id%253Dinfo%253Apmid%252F7728037%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/ijlink?linkType=FULL&amp;journalCode=bmj&amp;resid=310/6985/985&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-ijlink"><span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-255-1" title="View reference 255 in text" id="ref-255">↵</a><div class="cit ref-cit ref-other" id="cit-340.mar23_1.c869.255"><div class="cit-metadata unstructured">Annals of Internal Medicine. Information for authors. Available at <a href="http://www.annals.org/">www.annals.org</a> (accessed 15 Jan 2008).</div><div class="cit-extra"></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-256-1" title="View reference 256 in text" id="ref-256">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.256" data-doi="10.1136/bmj.318.7193.1224"><div class="cit-metadata"><cite>Docherty M, Smith R. The case for structuring the discussion of scientific papers. <abbr class="cit-jnl-abbrev">BMJ</abbr><span class="cit-pub-date">1999</span>;<span class="cit-vol">318</span>:<span class="cit-fpage">1224</span>-5.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DBMJ%26rft.stitle%253DBMJ%26rft.issn%253D0007-1447%26rft.aulast%253DDocherty%26rft.auinit1%253DM.%26rft.volume%253D318%26rft.issue%253D7193%26rft.spage%253D1224%26rft.epage%253D1225%26rft.atitle%253DThe%2Bcase%2Bfor%2Bstructuring%2Bthe%2Bdiscussion%2Bof%2Bscientific%2Bpapers%26rft_id%253Dinfo%253Adoi%252F10.1136%252Fbmj.318.7193.1224%26rft_id%253Dinfo%253Apmid%252F10231230%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/ijlink?linkType=FULL&amp;journalCode=bmj&amp;resid=318/7193/1224&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-ijlink"><span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-257-1" title="View reference 257 in text" id="ref-257">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.257" data-doi="10.1001/jama.280.3.227"><div class="cit-metadata"><cite>Purcell
 GP, Donovan SL, Davidoff F. Changes to manuscripts during the editorial
 process: characterizing the evolution of a clinical paper. <abbr class="cit-jnl-abbrev">JAMA</abbr><span class="cit-pub-date">1998</span>;<span class="cit-vol">280</span>:<span class="cit-fpage">227</span>-8.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DJAMA%26rft.stitle%253DJAMA%26rft.issn%253D0002-9955%26rft.aulast%253DPurcell%26rft.auinit1%253DG.%2BP.%26rft.volume%253D280%26rft.issue%253D3%26rft.spage%253D227%26rft.epage%253D228%26rft.atitle%253DChanges%2Bto%2BManuscripts%2BDuring%2Bthe%2BEditorial%2BProcess%253A%2BCharacterizing%2Bthe%2BEvolution%2Bof%2Ba%2BClinical%2BPaper%26rft_id%253Dinfo%253Adoi%252F10.1001%252Fjama.280.3.227%26rft_id%253Dinfo%253Apmid%252F9676663%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=10.1001/jama.280.3.227&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=9676663&amp;link_type=MED&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>Medline</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=000074706000008&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-258-1" title="View reference 258 in text" id="ref-258">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.258" data-doi="10.1016/j.jclinepi.2006.09.011"><div class="cit-metadata"><cite>Ioannidis JP. Limitations are not properly acknowledged in the scientific literature. <abbr class="cit-jnl-abbrev">J Clin Epidemiol</abbr><span class="cit-pub-date">2007</span>;<span class="cit-vol">60</span>:<span class="cit-fpage">324</span>-9.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DJournal%2Bof%2Bclinical%2Bepidemiology%26rft.stitle%253DJ%2BClin%2BEpidemiol%26rft.aulast%253DIoannidis%26rft.auinit1%253DJ.%2BP.%26rft.volume%253D60%26rft.issue%253D4%26rft.spage%253D324%26rft.epage%253D329%26rft.atitle%253DLimitations%2Bare%2Bnot%2Bproperly%2Backnowledged%2Bin%2Bthe%2Bscientific%2Bliterature.%26rft_id%253Dinfo%253Adoi%252F10.1016%252Fj.jclinepi.2006.09.011%26rft_id%253Dinfo%253Apmid%252F17346604%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=10.1016/j.jclinepi.2006.09.011&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=17346604&amp;link_type=MED&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>Medline</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=000245094200002&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-259-1" title="View reference 259 in text" id="ref-259">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.259" data-doi="10.1016/S0140-6736(97)08447-X"><div class="cit-metadata"><cite>Kiviluoto
 T, Sirén J, Luukkonen P, Kivilaakso E. Randomised trial of laparoscopic
 versus open cholecystectomy for acute and gangrenous cholecystitis. <abbr class="cit-jnl-abbrev">Lancet</abbr><span class="cit-pub-date">1998</span>;<span class="cit-vol">351</span>:<span class="cit-fpage">321</span>-5.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DLancet%26rft.stitle%253DLancet%26rft.aulast%253DKiviluoto%26rft.auinit1%253DT.%26rft.volume%253D351%26rft.issue%253D9099%26rft.spage%253D321%26rft.epage%253D325%26rft.atitle%253DRandomised%2Btrial%2Bof%2Blaparoscopic%2Bversus%2Bopen%2Bcholecystectomy%2Bfor%2Bacute%2Band%2Bgangrenous%2Bcholecystitis.%26rft_id%253Dinfo%253Adoi%252F10.1016%252FS0140-6736%252897%252908447-X%26rft_id%253Dinfo%253Apmid%252F9652612%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=10.1016/S0140-6736%2897%2908447-X&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=9652612&amp;link_type=MED&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>Medline</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=000071864000010&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-260-1" title="View reference 260 in text" id="ref-260">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.260" data-doi="10.1136/bmj.b2684"><div class="cit-metadata"><cite>Hupperets
 MD, Verhagen EA, van Mechelen W. Effect of unsupervised home based 
proprioceptive training on recurrences of ankle sprain: randomised 
controlled trial. <abbr class="cit-jnl-abbrev">BMJ</abbr><span class="cit-pub-date">2009</span>;<span class="cit-vol">339</span>:<span class="cit-fpage">b2684</span>.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DBMJ%26rft_id%253Dinfo%253Adoi%252F10.1136%252Fbmj.b2684%26rft_id%253Dinfo%253Apmid%252F19589822%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/ijlink?linkType=ABST&amp;journalCode=bmj&amp;resid=339/jul09_1/b2684&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-ijlink"><span><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-261-1" title="View reference 261 in text" id="ref-261">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.261" data-doi="10.1001/jama.2009.788"><div class="cit-metadata"><cite>Garber
 J, Clarke GN, Weersing VR, Beardslee WR, Brent DA, Gladstone TR, et al.
 Prevention of depression in at-risk adolescents: a randomized 
controlled trial. <abbr class="cit-jnl-abbrev">JAMA</abbr><span class="cit-pub-date">2009</span>;<span class="cit-vol">301</span>:<span class="cit-fpage">2215</span>-24.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DJAMA%26rft.stitle%253DJAMA%26rft.issn%253D0002-9955%26rft.aulast%253DGarber%26rft.auinit1%253DJ.%26rft.volume%253D301%26rft.issue%253D21%26rft.spage%253D2215%26rft.epage%253D2224%26rft.atitle%253DPrevention%2Bof%2Bdepression%2Bin%2Bat-risk%2Badolescents%253A%2Ba%2Brandomized%2Bcontrolled%2Btrial.%26rft_id%253Dinfo%253Adoi%252F10.1001%252Fjama.2009.788%26rft_id%253Dinfo%253Apmid%252F19491183%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=10.1001/jama.2009.788&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=19491183&amp;link_type=MED&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>Medline</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=000266554100019&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-262-1" title="View reference 262 in text" id="ref-262">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.262" data-doi="10.1037/h0040950"><div class="cit-metadata"><cite>Campbell D. Factors relevant to the validity of experiments in social settings. <abbr class="cit-jnl-abbrev">Psychol Bull</abbr><span class="cit-pub-date">1957</span>;<span class="cit-vol">54</span>:<span class="cit-fpage">297</span>-312.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DPsychological%2Bbulletin%26rft.stitle%253DPsychol%2BBull%26rft.aulast%253DCampbell%26rft.auinit1%253DD.%2BT.%26rft.volume%253D54%26rft.issue%253D4%26rft.spage%253D297%26rft.epage%253D312%26rft.atitle%253DFactors%2Brelevant%2Bto%2Bthe%2Bvalidity%2Bof%2Bexperiments%2Bin%2Bsocial%2Bsettings.%26rft_id%253Dinfo%253Adoi%252F10.1037%252Fh0040950%26rft_id%253Dinfo%253Apmid%252F13465924%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=10.1037/h0040950&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=13465924&amp;link_type=MED&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>Medline</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=A1957WD15300002&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-263-1" title="View reference 263 in text" id="ref-263">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.263" data-doi="10.1371/journal.pctr.0010009"><div class="cit-metadata"><cite>Rothwell PM. Factors that can affect the external validity of randomised controlled trials. <abbr class="cit-jnl-abbrev">PLoS Clin Trials</abbr><span class="cit-pub-date">2006</span>;<span class="cit-vol">1</span>:<span class="cit-fpage">e9</span>.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.stitle%253DPLoS%2BClin%2BTrials%26rft.aulast%253DRothwell%26rft.auinit1%253DP.%2BM.%26rft.volume%253D1%26rft.issue%253D1%26rft.spage%253De9%26rft.epage%253De9%26rft.atitle%253DFactors%2Bthat%2Bcan%2Baffect%2Bthe%2Bexternal%2Bvalidity%2Bof%2Brandomised%2Bcontrolled%2Btrials.%26rft_id%253Dinfo%253Adoi%252F10.1371%252Fjournal.pctr.0010009%26rft_id%253Dinfo%253Apmid%252F16871331%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=10.1371/journal.pctr.0010009&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=16871331&amp;link_type=MED&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>Medline</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-264-1" title="View reference 264 in text" id="ref-264">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.264"><div class="cit-metadata"><cite>King
 M, Nazareth I, Lampe F, Bower P, Chandler M, Morou M, et al. Conceptual
 framework and systematic review of the effects of participants’ and 
professionals’ preferences in randomised controlled trials. <abbr class="cit-jnl-abbrev">Health Technol Assess</abbr><span class="cit-pub-date">2005</span>;<span class="cit-vol">9</span>:<span class="cit-fpage">1</span>-iv.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.stitle%253Ddummy%26rft.aulast%253DCastelnuovo%26rft.auinit1%253DE.%26rft.volume%253D9%26rft.issue%253D46%26rft.spage%253D1%26rft.epage%253D%2Biii%26rft.atitle%253DThe%2Beffectiveness%2Bof%2Bthe%2BHeidelberg%2BRetina%2BTomograph%2Band%2Blaser%2Bdiagnostic%2Bglaucoma%2Bscanning%2Bsystem%2B%2528GDx%2529%2Bin%2Bdetecting%2Band%2Bmonitoring%2Bglaucoma.%26rft_id%253Dinfo%253Apmid%252F16303099%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=16303099&amp;link_type=MED&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>Medline</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-265-1" title="View reference 265 in text" id="ref-265">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.265" data-doi="10.1016/S0140-6736(00)02605-2"><div class="cit-metadata"><cite>Djulbegovic
 B, Lacevic M, Cantor A, Fields KK, Bennett CL, Adams JR, et al. The 
uncertainty principle and industry-sponsored research. <abbr class="cit-jnl-abbrev">Lancet</abbr><span class="cit-pub-date">2000</span>;<span class="cit-vol">356</span>:<span class="cit-fpage">635</span>-8.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DLancet%26rft.stitle%253DLancet%26rft.aulast%253DDjulbegovic%26rft.auinit1%253DB.%26rft.volume%253D356%26rft.issue%253D9230%26rft.spage%253D635%26rft.epage%253D638%26rft.atitle%253DThe%2Buncertainty%2Bprinciple%2Band%2Bindustry-sponsored%2Bresearch.%26rft_id%253Dinfo%253Adoi%252F10.1016%252FS0140-6736%252800%252902605-2%26rft_id%253Dinfo%253Apmid%252F10968436%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=10.1016/S0140-6736%2800%2902605-2&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=10968436&amp;link_type=MED&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>Medline</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=000088884100011&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-266-1" title="View reference 266 in text" id="ref-266">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.266" data-doi="10.1001/jama.279.7.545"><div class="cit-metadata"><cite>Dans
 AL, Dans LF, Guyatt GH, Richardson S. Users’ guides to the medical 
literature: XIV. How to decide on the applicability of clinical trial 
results to your patient. Evidence-Based Medicine Working Group. <abbr class="cit-jnl-abbrev">JAMA</abbr><span class="cit-pub-date">1998</span>;<span class="cit-vol">279</span>:<span class="cit-fpage">545</span>-9.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DJAMA%26rft.stitle%253DJAMA%26rft.issn%253D0002-9955%26rft.aulast%253DDans%26rft.auinit1%253DA.%2BL.%26rft.volume%253D279%26rft.issue%253D7%26rft.spage%253D545%26rft.epage%253D549%26rft.atitle%253DUsers%2527%2BGuides%2Bto%2Bthe%2BMedical%2BLiterature%253A%2BXIV.%2BHow%2Bto%2BDecide%2Bon%2Bthe%2BApplicability%2Bof%2BClinical%2BTrial%2BResults%2Bto%2BYour%2BPatient%26rft_id%253Dinfo%253Adoi%252F10.1001%252Fjama.279.7.545%26rft_id%253Dinfo%253Apmid%252F9480367%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=10.1001/jama.279.7.545&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=9480367&amp;link_type=MED&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>Medline</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=000071938900038&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-267-1" title="View reference 267 in text" id="ref-267">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.267"><div class="cit-metadata"><cite>Smith GD, Egger M. Who benefits from medical interventions? <abbr class="cit-jnl-abbrev">BMJ</abbr><span class="cit-pub-date">1994</span>;<span class="cit-vol">308</span>:<span class="cit-fpage">72</span>-4.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DBMJ%26rft.stitle%253DBMJ%26rft.issn%253D0007-1447%26rft.aulast%253DSmith%26rft.auinit1%253DG%2BD%26rft.volume%253D308%26rft.issue%253D6921%26rft.spage%253D72%26rft.epage%253D4%26rft.atitle%253DWho%2Bbenefits%2Bfrom%2Bmedical%2Binterventions%253F%26rft_id%253Dinfo%253Apmid%252F8298415%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/ijlink?linkType=FULL&amp;journalCode=bmj&amp;resid=308/6921/72&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-ijlink"><span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-268-1" title="View reference 268 in text" id="ref-268">↵</a><div class="cit ref-cit ref-other" id="cit-340.mar23_1.c869.268"><div class="cit-metadata"><cite>McAlister FA. Applying the results of systematic reviews at the bedside. In: Egger M, Davey Smith G, Altman DG, eds. <span class="cit-source">Systematic reviews in health care: meta-analysis in context</span>. BMJ Books, <span class="cit-pub-date">2001</span>.</cite></div><div class="cit-extra"></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-269-1" title="View reference 269 in text" id="ref-269">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.269"><div class="cit-metadata"><cite>Bartlett
 C, Doyal L, Ebrahim S, Davey P, Bachmann M, Egger M, et al. The causes 
and effects of socio-demographic exclusions from clinical trials. <abbr class="cit-jnl-abbrev">Health Technol Assess</abbr><span class="cit-pub-date">2005</span>;<span class="cit-vol">9</span>:<span class="cit-fpage">iii</span>-x, 1.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DHealth%2Btechnology%2Bassessment%2B%2528Winchester%252C%2BEngland%2529%26rft.stitle%253DHealth%2BTechnol%2BAssess%26rft.aulast%253DFowler%26rft.auinit1%253DC.%26rft.volume%253D9%26rft.issue%253D4%26rft.spage%253Diii%26rft.epage%253Diii-iv%252C30%26rft.atitle%253DRandomised%2Bevaluation%2Bof%2Balternative%2Belectrosurgical%2Bmodalities%2Bto%2Btreat%2Bbladder%2Boutflow%2Bobstruction%2Bin%2Bmen%2Bwith%2Bbenign%2Bprostatic%2Bhyperplasia.%26rft_id%253Dinfo%253Apmid%252F15698525%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=15698525&amp;link_type=MED&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>Medline</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-270-1" title="View reference 270 in text" id="ref-270">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.270" data-doi="10.1136/bmj.333.7563.346"><div class="cit-metadata"><cite>Bonell
 C, Oakley A, Hargreaves J, Strange V, Rees R. Assessment of 
generalisability in trials of health interventions: suggested framework 
and systematic review. <abbr class="cit-jnl-abbrev">BMJ</abbr><span class="cit-pub-date">2006</span>;<span class="cit-vol">333</span>:<span class="cit-fpage">346</span>-9.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DBMJ%26rft.stitle%253DBMJ%26rft.issn%253D0007-1447%26rft.aulast%253DBonell%26rft.auinit1%253DC%26rft.volume%253D333%26rft.issue%253D7563%26rft.spage%253D346%26rft.epage%253D349%26rft.atitle%253DAssessment%2Bof%2Bgeneralisability%2Bin%2Btrials%2Bof%2Bhealth%2Binterventions%253A%2Bsuggested%2Bframework%2Band%2Bsystematic%2Breview%26rft_id%253Dinfo%253Adoi%252F10.1136%252Fbmj.333.7563.346%26rft_id%253Dinfo%253Apmid%252F16902217%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/ijlink?linkType=FULL&amp;journalCode=bmj&amp;resid=333/7563/346&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-ijlink"><span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-271-1" title="View reference 271 in text" id="ref-271">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.271" data-doi="10.1186/1471-2288-6-56"><div class="cit-metadata"><cite>Bornhöft
 G, Maxion-Bergemann S, Wolf U, Kienle GS, Michalsen A, Vollmar HC, et 
al. Checklist for the qualitative evaluation of clinical studies with 
particular focus on external validity and model validity. <abbr class="cit-jnl-abbrev">BMC Med Res Methodol</abbr><span class="cit-pub-date">2006</span>;<span class="cit-vol">6</span>:<span class="cit-fpage">56</span>.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DBMC%2Bmedical%2Bresearch%2Bmethodology%2B%255Belectronic%2Bresource%255D%26rft.stitle%253DBMC%2BMed%2BRes%2BMethodol%26rft.aulast%253DBornhoft%26rft.auinit1%253DG.%26rft.volume%253D6%26rft.spage%253D56%26rft.epage%253D56%26rft.atitle%253DChecklist%2Bfor%2Bthe%2Bqualitative%2Bevaluation%2Bof%2Bclinical%2Bstudies%2Bwith%2Bparticular%2Bfocus%2Bon%2Bexternal%2Bvalidity%2Band%2Bmodel%2Bvalidity.%26rft_id%253Dinfo%253Adoi%252F10.1186%252F1471-2288-6-56%26rft_id%253Dinfo%253Apmid%252F17156475%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=10.1186/1471-2288-6-56&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=17156475&amp;link_type=MED&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>Medline</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-272-1" title="View reference 272 in text" id="ref-272">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.272" data-doi="10.1056/NEJM198806303182605"><div class="cit-metadata"><cite>Laupacis A, Sackett DL, Roberts RS. An assessment of clinically useful measures of the consequences of treatment. <abbr class="cit-jnl-abbrev">N Engl J Med</abbr><span class="cit-pub-date">1988</span>;<span class="cit-vol">318</span>:<span class="cit-fpage">1728</span>-33.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DNew%2BEngland%2BJournal%2Bof%2BMedicine%26rft.stitle%253DNEJM%26rft.issn%253D0028-4793%26rft.aulast%253DLaupacis%26rft.auinit1%253DA.%26rft.volume%253D318%26rft.issue%253D26%26rft.spage%253D1728%26rft.epage%253D1733%26rft.atitle%253DAn%2Bassessment%2Bof%2Bclinically%2Buseful%2Bmeasures%2Bof%2Bthe%2Bconsequences%2Bof%2Btreatment%26rft_id%253Dinfo%253Adoi%252F10.1056%252FNEJM198806303182605%26rft_id%253Dinfo%253Apmid%252F3374545%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=10.1056/NEJM198806303182605&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=3374545&amp;link_type=MED&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>Medline</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=A1988N994800005&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-273-1" title="View reference 273 in text" id="ref-273">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.273" data-doi="10.1136/bmj.317.7168.1309"><div class="cit-metadata"><cite>Altman DG. Confidence intervals for the number needed to treat. <abbr class="cit-jnl-abbrev">BMJ</abbr><span class="cit-pub-date">1998</span>;<span class="cit-vol">317</span>:<span class="cit-fpage">1309</span>-12.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DBMJ%26rft.stitle%253DBMJ%26rft.issn%253D0007-1447%26rft.aulast%253DAltman%26rft.auinit1%253DD.%2BG%26rft.volume%253D317%26rft.issue%253D7168%26rft.spage%253D1309%26rft.epage%253D1312%26rft.atitle%253DConfidence%2Bintervals%2Bfor%2Bthe%2Bnumber%2Bneeded%2Bto%2Btreat%26rft_id%253Dinfo%253Adoi%252F10.1136%252Fbmj.317.7168.1309%26rft_id%253Dinfo%253Apmid%252F9804726%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/ijlink?linkType=FULL&amp;journalCode=bmj&amp;resid=317/7168/1309&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-ijlink"><span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-274-1" title="View reference 274 in text" id="ref-274">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.274" data-doi="10.1056/NEJM199404213301602"><div class="cit-metadata"><cite>Fanaroff
 AA, Korones SB, Wright LL, Wright EC, Poland RL, Bauer CB, et al. A 
controlled trial of intravenous immune globulin to reduce nosocomial 
infections in very-low-birth-weight infants. National Institute of Child
 Health and Human Development Neonatal Research Network. <abbr class="cit-jnl-abbrev">N Engl J Med</abbr><span class="cit-pub-date">1994</span>;<span class="cit-vol">330</span>:<span class="cit-fpage">1107</span>-13.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DNew%2BEngland%2BJournal%2Bof%2BMedicine%26rft.stitle%253DNEJM%26rft.issn%253D0028-4793%26rft.aulast%253DFanaroff%26rft.auinit1%253DA.%2BA.%26rft.volume%253D330%26rft.issue%253D16%26rft.spage%253D1107%26rft.epage%253D1113%26rft.atitle%253DA%2BControlled%2BTrial%2Bof%2BIntravenous%2BImmune%2BGlobulin%2Bto%2BReduce%2BNosocomial%2BInfections%2Bin%2BVery-Low-Birth-Weight%2BInfants%26rft_id%253Dinfo%253Adoi%252F10.1056%252FNEJM199404213301602%26rft_id%253Dinfo%253Apmid%252F8133853%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=10.1056/NEJM199404213301602&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=8133853&amp;link_type=MED&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>Medline</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=A1994NF69900002&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-275-1" title="View reference 275 in text" id="ref-275">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.275" data-doi="10.1016/S0140-6736(02)92899-0"><div class="cit-metadata"><cite>Randomised
 trial of intravenous atenolol among 16 027 cases of suspected acute 
myocardial infarction: ISIS-1. First International Study of Infarct 
Survival Collaborative Group. <abbr class="cit-jnl-abbrev">Lancet</abbr><span class="cit-pub-date">1986</span>;<span class="cit-vol">2</span>:<span class="cit-fpage">57</span>-66.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DLancet%26rft.stitle%253DLancet%26rft.volume%253D2%26rft.issue%253D8498%26rft.spage%253D57%26rft.epage%253D66%26rft.atitle%253DRandomised%2Btrial%2Bof%2Bintravenous%2Batenolol%2Bamong%2B16%2B027%2Bcases%2Bof%2Bsuspected%2Bacute%2Bmyocardial%2Binfarction%253A%2BISIS-1.%2BFirst%2BInternational%2BStudy%2Bof%2BInfarct%2BSurvival%2BCollaborative%2BGroup.%26rft_id%253Dinfo%253Adoi%252F10.1016%252FS0140-6736%252802%252992899-0%26rft_id%253Dinfo%253Apmid%252F2873379%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=10.1016/S0140-6736%2802%2992899-0&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=2873379&amp;link_type=MED&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>Medline</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=A1986D125800001&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-276-1" title="View reference 276 in text" id="ref-276">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.276"><div class="cit-metadata"><cite>Gøtzsche
 PC, Gjørup I, Bonnén H, Brahe NE, Becker U, Burcharth F. Somatostatin v
 placebo in bleeding oesophageal varices: randomised trial and 
meta-analysis. <abbr class="cit-jnl-abbrev">BMJ</abbr><span class="cit-pub-date">1995</span>;<span class="cit-vol">310</span>:<span class="cit-fpage">1495</span>-8.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DBMJ%26rft.stitle%253DBMJ%26rft.issn%253D0007-1447%26rft.aulast%253DGotzsche%26rft.auinit1%253DP.%2BC%26rft.volume%253D310%26rft.issue%253D6993%26rft.spage%253D1495%26rft.epage%253D1498%26rft.atitle%253DSomatostatin%2Bv%2Bplacebo%2Bin%2Bbleeding%2Boesophageal%2Bvarices%253A%2Brandomised%2Btrial%2Band%2Bmeta-analysis%26rft_id%253Dinfo%253Apmid%252F7787594%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/ijlink?linkType=ABST&amp;journalCode=bmj&amp;resid=310/6993/1495&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-ijlink"><span><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-277-1" title="View reference 277 in text" id="ref-277">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.277" data-doi="10.1258/jrsm.100.4.187"><div class="cit-metadata"><cite>Clarke
 M, Hopewell S, Chalmers I. Reports of clinical trials should begin and 
end with up-to-date systematic reviews of other relevant evidence: a 
status report. <abbr class="cit-jnl-abbrev">J R Soc Med</abbr><span class="cit-pub-date">2007</span>;<span class="cit-vol">100</span>:<span class="cit-fpage">187</span>-90.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DJournal%2Bof%2Bthe%2BRoyal%2BSociety%2Bof%2BMedicine%26rft.stitle%253DJ%2BR%2BSoc%2BMed%26rft.issn%253D0141-0768%26rft.aulast%253DClarke%26rft.auinit1%253DM.%26rft.volume%253D100%26rft.issue%253D4%26rft.spage%253D187%26rft.epage%253D190%26rft.atitle%253DReports%2Bof%2Bclinical%2Btrials%2Bshould%2Bbegin%2Band%2Bend%2Bwith%2Bup-to-datesystematic%2Breviews%2Bof%2Bother%2Brelevant%2Bevidence%253A%2Ba%2Bstatus%2Breport%26rft_id%253Dinfo%253Adoi%252F10.1258%252Fjrsm.100.4.187%26rft_id%253Dinfo%253Apmid%252F17404342%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/ijlink?linkType=ABST&amp;journalCode=spjrs&amp;resid=100/4/187&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-ijlink"><span><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-278-1" title="View reference 278 in text" id="ref-278">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.278" data-doi="10.7326/0003-4819-130-12-199906150-00008"><div class="cit-metadata"><cite>Goodman SN. Toward evidence-based medical statistics. 1: The P value fallacy. <abbr class="cit-jnl-abbrev">Ann Intern Med</abbr><span class="cit-pub-date">1999</span>;<span class="cit-vol">130</span>:<span class="cit-fpage">995</span>-1004.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DAnnals%2Bof%2BInternal%2BMedicine%26rft.stitle%253DANN%2BINTERN%2BMED%26rft.issn%253D0003-4819%26rft.aulast%253DGoodman%26rft.auinit1%253DS.%2BN.%26rft.volume%253D130%26rft.issue%253D12%26rft.spage%253D995%26rft.epage%253D1004%26rft.atitle%253DToward%2BEvidence-Based%2BMedical%2BStatistics.%2B1%253A%2BThe%2BP%2BValue%2BFallacy%26rft_id%253Dinfo%253Adoi%252F10.7326%252F0003-4819-130-12-199906150-00008%26rft_id%253Dinfo%253Apmid%252F10383371%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=10.7326/0003-4819-130-12-199906150-00008&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=10383371&amp;link_type=MED&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>Medline</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=000080894700007&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-279-1" title="View reference 279 in text" id="ref-279">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.279" data-doi="10.1136/bmj.295.6599.654"><div class="cit-metadata"><cite>Gøtzsche PC. Reference bias in reports of drug trials. <abbr class="cit-jnl-abbrev">BMJ</abbr><span class="cit-pub-date">1987</span>;<span class="cit-vol">295</span>:<span class="cit-fpage">654</span>-6.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DBMJ%26rft.stitle%253DBMJ%26rft.issn%253D0007-1447%26rft.aulast%253DGotzsche%26rft.auinit1%253DP%2BC%26rft.volume%253D295%26rft.issue%253D6599%26rft.spage%253D654%26rft.epage%253D656%26rft.atitle%253DReference%2Bbias%2Bin%2Breports%2Bof%2Bdrug%2Btrials.%26rft_id%253Dinfo%253Adoi%252F10.1136%252Fbmj.295.6599.654%26rft_id%253Dinfo%253Apmid%252F3117277%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/ijlink?linkType=ABST&amp;journalCode=bmj&amp;resid=295/6599/654&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-ijlink"><span><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-280-1" title="View reference 280 in text" id="ref-280">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.280" data-doi="10.1016/S0140-6736(08)60593-0"><div class="cit-metadata"><cite>Papp
 K, Bissonnette R, Rosoph L, Wasel N, Lynde CW, Searles G, et al. 
Efficacy of ISA247 in plaque psoriasis: a randomised, multicentre, 
double-blind, placebo-controlled phase III study. <abbr class="cit-jnl-abbrev">Lancet</abbr><span class="cit-pub-date">2008</span>;<span class="cit-vol">371</span>:<span class="cit-fpage">1337</span>-42.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DLancet%26rft.stitle%253DLancet%26rft.aulast%253DPapp%26rft.auinit1%253DK.%26rft.volume%253D371%26rft.issue%253D9621%26rft.spage%253D1337%26rft.epage%253D1342%26rft.atitle%253DEfficacy%2Bof%2BISA247%2Bin%2Bplaque%2Bpsoriasis%253A%2Ba%2Brandomised%252C%2Bmulticentre%252C%2Bdouble-blind%252C%2Bplacebo-controlled%2Bphase%2BIII%2Bstudy.%26rft_id%253Dinfo%253Adoi%252F10.1016%252FS0140-6736%252808%252960593-0%26rft_id%253Dinfo%253Apmid%252F18424323%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=10.1016/S0140-6736%2808%2960593-0&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=18424323&amp;link_type=MED&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>Medline</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=000255208500024&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-281-1" title="View reference 281 in text" id="ref-281">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.281"><div class="cit-metadata"><cite>Dickersin K. How important is publication bias? A synthesis of available data. <abbr class="cit-jnl-abbrev">AIDS Educ Prev</abbr><span class="cit-pub-date">1997</span>;<span class="cit-vol">9</span>:<span class="cit-fpage">15</span>-21.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DAIDS%2Beducation%2Band%2Bprevention%2B%253A%2B%2Bofficial%2Bpublication%2Bof%2Bthe%2BInternational%2BSociety%2Bfor%2BAIDS%2BEducation%26rft.stitle%253DAIDS%2BEduc%2BPrev%26rft.aulast%253DDickersin%26rft.auinit1%253DK.%26rft.volume%253D9%26rft.issue%253D1%2BSuppl%26rft.spage%253D15%26rft.epage%253D21%26rft.atitle%253DHow%2Bimportant%2Bis%2Bpublication%2Bbias%253F%2BA%2Bsynthesis%2Bof%2Bavailable%2Bdata.%26rft_id%253Dinfo%253Apmid%252F9083596%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=9083596&amp;link_type=MED&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>Medline</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=A1997WN36200002&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-282-1" title="View reference 282 in text" id="ref-282">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.282"><div class="cit-metadata"><cite>Song F, Eastwood AJ, Gilbody S, Duley L, Sutton AJ. Publication and related biases. <abbr class="cit-jnl-abbrev">Health Technol Assess</abbr><span class="cit-pub-date">2000</span>;<span class="cit-vol">4</span>:<span class="cit-fpage">1</span>-115.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DHealth%2Btechnology%2Bassessment%2B%2528Winchester%252C%2BEngland%2529%26rft.stitle%253DHealth%2BTechnol%2BAssess%26rft.aulast%253DReeves%26rft.auinit1%253DD.%2BJ.%26rft.volume%253D4%26rft.issue%253D4%26rft.spage%253D1%26rft.epage%253D120%26rft.atitle%253DCommunity%2Bprovision%2Bof%2Bhearing%2Baids%2Band%2Brelated%2Baudiology%2Bservices.%26rft_id%253Dinfo%253Apmid%252F10858636%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=10858636&amp;link_type=MED&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>Medline</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-283-1" title="View reference 283 in text" id="ref-283">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.283" data-doi="10.1002/sim.2025"><div class="cit-metadata"><cite>Williamson PR, Gamble C. Identification and impact of outcome selection bias in meta-analysis. <abbr class="cit-jnl-abbrev">Stat Med</abbr><span class="cit-pub-date">2005</span>;<span class="cit-vol">24</span>:<span class="cit-fpage">1547</span>-61.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DStatistics%2Bin%2Bmedicine%26rft.stitle%253DStat%2BMed%26rft.aulast%253DWilliamson%26rft.auinit1%253DP.%2BR.%26rft.volume%253D24%26rft.issue%253D10%26rft.spage%253D1547%26rft.epage%253D1561%26rft.atitle%253DIdentification%2Band%2Bimpact%2Bof%2Boutcome%2Bselection%2Bbias%2Bin%2Bmeta-analysis.%26rft_id%253Dinfo%253Adoi%252F10.1002%252Fsim.2025%26rft_id%253Dinfo%253Apmid%252F15580591%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=10.1002/sim.2025&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=15580591&amp;link_type=MED&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>Medline</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=000229261700007&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-284-1" title="View reference 284 in text" id="ref-284">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.284" data-doi="10.1136/bmj.315.7109.635"><div class="cit-metadata"><cite>Tramèr MR, Reynolds DJ, Moore RA, McQuay HJ. Impact of covert duplicate publication on meta-analysis: a case study. <abbr class="cit-jnl-abbrev">BMJ</abbr><span class="cit-pub-date">1997</span>;<span class="cit-vol">315</span>:<span class="cit-fpage">635</span>-40.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DBMJ%26rft.stitle%253DBMJ%26rft.issn%253D0007-1447%26rft.aulast%253DTramer%26rft.auinit1%253DM.%2BR%26rft.volume%253D315%26rft.issue%253D7109%26rft.spage%253D635%26rft.epage%253D640%26rft.atitle%253DImpact%2Bof%2Bcovert%2Bduplicate%2Bpublication%2Bon%2Bmeta-analysis%253A%2Ba%2Bcase%2Bstudy%26rft_id%253Dinfo%253Adoi%252F10.1136%252Fbmj.315.7109.635%26rft_id%253Dinfo%253Apmid%252F9310564%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/ijlink?linkType=ABST&amp;journalCode=bmj&amp;resid=315/7109/635&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-ijlink"><span><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-285-1" title="View reference 285 in text" id="ref-285">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.285"><div class="cit-metadata"><cite>Simes RJ. Publication bias: the case for an international registry of clinical trials. <abbr class="cit-jnl-abbrev">J Clin Oncol</abbr><span class="cit-pub-date">1986</span>;<span class="cit-vol">4</span>:<span class="cit-fpage">1529</span>-41.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DJournal%2Bof%2BClinical%2BOncology%26rft.stitle%253DJCO%26rft.issn%253D0732-183X%26rft.aulast%253DSimes%26rft.auinit1%253DR.%2BJ.%26rft.volume%253D4%26rft.issue%253D10%26rft.spage%253D1529%26rft.epage%253D1541%26rft.atitle%253DPublication%2Bbias%253A%2Bthe%2Bcase%2Bfor%2Ban%2Binternational%2Bregistry%2Bof%2Bclinical%2Btrials%26rft_id%253Dinfo%253Apmid%252F3760920%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/ijlink?linkType=ABST&amp;journalCode=jco&amp;resid=4/10/1529&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-ijlink"><span><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-286-1" title="View reference 286 in text" id="ref-286">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.286" data-doi="10.1258/jrsm.99.7.337"><div class="cit-metadata"><cite>Chalmers I. From optimism to disillusion about commitment to transparency in the medico-industrial complex. <abbr class="cit-jnl-abbrev">J R Soc Med</abbr><span class="cit-pub-date">2006</span>;<span class="cit-vol">99</span>:<span class="cit-fpage">337</span>-41.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DJournal%2Bof%2Bthe%2BRoyal%2BSociety%2Bof%2BMedicine%26rft.stitle%253DJ%2BR%2BSoc%2BMed%26rft.issn%253D0141-0768%26rft.aulast%253DChalmers%26rft.auinit1%253DI.%26rft.volume%253D99%26rft.issue%253D7%26rft.spage%253D337%26rft.epage%253D341%26rft.atitle%253DFrom%2Boptimism%2Bto%2Bdisillusion%2Babout%2Bcommitment%2Bto%2Btransparency%2Bin%2Bthemedico-industrial%2Bcomplex%26rft_id%253Dinfo%253Adoi%252F10.1258%252Fjrsm.99.7.337%26rft_id%253Dinfo%253Apmid%252F16816262%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/ijlink?linkType=FULL&amp;journalCode=spjrs&amp;resid=99/7/337&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-ijlink"><span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-287-1" title="View reference 287 in text" id="ref-287">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.287" data-doi="10.1136/bmj.325.7376.1314"><div class="cit-metadata"><cite>Tonks A. A clinical trials register for Europe. <abbr class="cit-jnl-abbrev">BMJ</abbr><span class="cit-pub-date">2002</span>;<span class="cit-vol">325</span>:<span class="cit-fpage">1314</span>-5.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DBMJ%26rft.stitle%253DBMJ%26rft.issn%253D0007-1447%26rft.aulast%253DTonks%26rft.auinit1%253DA.%26rft.volume%253D325%26rft.issue%253D7376%26rft.spage%253D1314%26rft.epage%253D1315%26rft.atitle%253DA%2Bclinical%2Btrials%2Bregister%2Bfor%2BEurope%26rft_id%253Dinfo%253Adoi%252F10.1136%252Fbmj.325.7376.1314%26rft_id%253Dinfo%253Apmid%252F12468459%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/ijlink?linkType=FULL&amp;journalCode=bmj&amp;resid=325/7376/1314&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-ijlink"><span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-288-1" title="View reference 288 in text" id="ref-288">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.288" data-doi="10.1001/jama.290.4.516"><div class="cit-metadata"><cite>Dickersin K, Rennie D. Registering clinical trials. <abbr class="cit-jnl-abbrev">JAMA</abbr><span class="cit-pub-date">2003</span>;<span class="cit-vol">290</span>:<span class="cit-fpage">516</span>-23.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DJAMA%26rft.stitle%253DJAMA%26rft.issn%253D0002-9955%26rft.aulast%253DDickersin%26rft.auinit1%253DK.%26rft.volume%253D290%26rft.issue%253D4%26rft.spage%253D516%26rft.epage%253D523%26rft.atitle%253DRegistering%2BClinical%2BTrials%26rft_id%253Dinfo%253Adoi%252F10.1001%252Fjama.290.4.516%26rft_id%253Dinfo%253Apmid%252F12876095%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=10.1001/jama.290.4.516&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=12876095&amp;link_type=MED&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>Medline</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=000184275300024&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-289-1" title="View reference 289 in text" id="ref-289">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.289" data-doi="10.1016/S0140-6736(04)16043-1"><div class="cit-metadata"><cite>Whittington
 CJ, Kendall T, Fonagy P, Cottrell D, Cotgrove A, Boddington E. 
Selective serotonin reuptake inhibitors in childhood depression: 
systematic review of published versus unpublished data. <abbr class="cit-jnl-abbrev">Lancet</abbr><span class="cit-pub-date">2004</span>;<span class="cit-vol">363</span>:<span class="cit-fpage">1341</span>-5.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DLancet%26rft.stitle%253DLancet%26rft.aulast%253DWhittington%26rft.auinit1%253DC.%2BJ.%26rft.volume%253D363%26rft.issue%253D9418%26rft.spage%253D1341%26rft.epage%253D1345%26rft.atitle%253DSelective%2Bserotonin%2Breuptake%2Binhibitors%2Bin%2Bchildhood%2Bdepression%253A%2Bsystematic%2Breview%2Bof%2Bpublished%2Bversus%2Bunpublished%2Bdata.%26rft_id%253Dinfo%253Adoi%252F10.1016%252FS0140-6736%252804%252916043-1%26rft_id%253Dinfo%253Apmid%252F15110490%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=10.1016/S0140-6736%2804%2916043-1&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=15110490&amp;link_type=MED&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>Medline</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=000220996300007&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-290-1" title="View reference 290 in text" id="ref-290">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.290" data-doi="10.1016/S0140-6736(05)66588-9"><div class="cit-metadata"><cite>De
 Angelis CD, Drazen JM, Frizelle FA, Haug C, Hoey J, Horton R, et al. Is
 this clinical trial fully registered? A statement from the 
International Committee of Medical Journal Editors. <abbr class="cit-jnl-abbrev">Lancet</abbr><span class="cit-pub-date">2005</span>;<span class="cit-vol">365</span>:<span class="cit-fpage">1827</span>-9.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DLancet%26rft.stitle%253DLancet%26rft.aulast%253DDe%2BAngelis%26rft.auinit1%253DC.%2BD.%26rft.volume%253D365%26rft.issue%253D9474%26rft.spage%253D1827%26rft.epage%253D1829%26rft.atitle%253DIs%2Bthis%2Bclinical%2Btrial%2Bfully%2Bregistered%253F%2BA%2Bstatement%2Bfrom%2Bthe%2BInternational%2BCommittee%2Bof%2BMedical%2BJournal%2BEditors.%26rft_id%253Dinfo%253Adoi%252F10.1016%252FS0140-6736%252805%252966588-9%26rft_id%253Dinfo%253Apmid%252F15924965%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=10.1016/S0140-6736%2805%2966588-9&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=15924965&amp;link_type=MED&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>Medline</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=000229481400004&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-291-1" title="View reference 291 in text" id="ref-291">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.291" data-doi="10.1001/jama.297.19.2112"><div class="cit-metadata"><cite>Zarin DA, Ide NC, Tse T, Harlan WR, West JC, Lindberg DA. Issues in the registration of clinical trials. <abbr class="cit-jnl-abbrev">JAMA</abbr><span class="cit-pub-date">2007</span>;<span class="cit-vol">297</span>:<span class="cit-fpage">2112</span>-20.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DJAMA%26rft.stitle%253DJAMA%26rft.issn%253D0002-9955%26rft.aulast%253DZarin%26rft.auinit1%253DD.%2BA.%26rft.volume%253D297%26rft.issue%253D19%26rft.spage%253D2112%26rft.epage%253D2120%26rft.atitle%253DIssues%2Bin%2Bthe%2BRegistration%2Bof%2BClinical%2BTrials%26rft_id%253Dinfo%253Adoi%252F10.1001%252Fjama.297.19.2112%26rft_id%253Dinfo%253Apmid%252F17507347%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=10.1001/jama.297.19.2112&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=17507347&amp;link_type=MED&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>Medline</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=000246477400024&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-292-1" title="View reference 292 in text" id="ref-292">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.292" data-doi="10.1186/1745-6215-9-20"><div class="cit-metadata"><cite>Hopewell
 S, Altman DG, Moher D, Schulz KF. Endorsement of the CONSORT Statement 
by high impact factor medical journals: a survey of journal editors and 
journal ‘instructions to authors’. <abbr class="cit-jnl-abbrev">Trials</abbr><span class="cit-pub-date">2008</span>;<span class="cit-vol">9</span>:<span class="cit-fpage">20</span>.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.stitle%253DTrials%26rft.aulast%253DHopewell%26rft.auinit1%253DS.%26rft.volume%253D9%26rft.spage%253D20%26rft.epage%253D20%26rft.atitle%253DEndorsement%2Bof%2Bthe%2BCONSORT%2BStatement%2Bby%2Bhigh%2Bimpact%2Bfactor%2Bmedical%2Bjournals%253A%2Ba%2Bsurvey%2Bof%2Bjournal%2Beditors%2Band%2Bjournal%2B%2527Instructions%2Bto%2BAuthors%2527.%26rft_id%253Dinfo%253Adoi%252F10.1186%252F1745-6215-9-20%26rft_id%253Dinfo%253Apmid%252F18423021%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=10.1186/1745-6215-9-20&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=18423021&amp;link_type=MED&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>Medline</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-293-1" title="View reference 293 in text" id="ref-293">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.293" data-doi="10.1056/NEJMoa067373"><div class="cit-metadata"><cite>Russell
 JA, Walley KR, Singer J, Gordon AC, Hébert PC, Cooper DJ, et al. 
Vasopressin versus norepinephrine infusion in patients with septic 
shock. <abbr class="cit-jnl-abbrev">N Engl J Med</abbr><span class="cit-pub-date">2008</span>;<span class="cit-vol">358</span>:<span class="cit-fpage">877</span>-87.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DNew%2BEngland%2BJournal%2Bof%2BMedicine%26rft.stitle%253DNEJM%26rft.issn%253D0028-4793%26rft.aulast%253DRussell%26rft.auinit1%253DJ.%2BA.%26rft.volume%253D358%26rft.issue%253D9%26rft.spage%253D877%26rft.epage%253D887%26rft.atitle%253DVasopressin%2Bversus%2BNorepinephrine%2BInfusion%2Bin%2BPatients%2Bwith%2BSeptic%2BShock%26rft_id%253Dinfo%253Adoi%252F10.1056%252FNEJMoa067373%26rft_id%253Dinfo%253Apmid%252F18305265%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=10.1056/NEJMoa067373&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=18305265&amp;link_type=MED&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>Medline</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=000253430200003&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-294-1" title="View reference 294 in text" id="ref-294">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.294"><div class="cit-metadata"><cite>Chan
 AW, Tetzlaff J, Altman D, Gøtzsche PC, Hróbjartsson A, Krleza-Jeric K, 
et al. The SPIRIT initiative: defining standard protocol items for 
randomised trials. Oral presentation at the 16th Cochrane Colloquium: 
Evidence in the era of globalisation; 2008 Oct 3-7; Freiburg, Germany 
[abstract]. <abbr class="cit-jnl-abbrev">Zeitschrift fur Evidenz, Fortbildung und Qualitat im Gesundheitswesen</abbr><span class="cit-pub-date">2008</span>;<span class="cit-vol">102</span>:<span class="cit-fpage">27</span>.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DZeitschrift%2Bfur%2BEvidenz%252C%2BFortbildung%2Bund%2BQualitat%2Bim%2BGesundheitswesen%26rft.volume%253D102%26rft.spage%253D27%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-295-1" title="View reference 295 in text" id="ref-295">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.295" data-doi="10.1371/journal.pmed.0040102"><div class="cit-metadata"><cite>Gregson
 S, Adamson S, Papaya S, Mundondo J, Nyamukapa CA, Mason PR, et al. 
Impact and process evaluation of integrated community and clinic-based 
HIV-1 control: a cluster-randomised trial in eastern Zimbabwe. <abbr class="cit-jnl-abbrev">PLoS Med</abbr><span class="cit-pub-date">2007</span>;<span class="cit-vol">4</span>:<span class="cit-fpage">e102</span>.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.stitle%253DPLoS%2BMed%26rft.aulast%253DGregson%26rft.auinit1%253DS.%26rft.volume%253D4%26rft.issue%253D3%26rft.spage%253De102%26rft.epage%253De102%26rft.atitle%253DImpact%2Band%2Bprocess%2Bevaluation%2Bof%2Bintegrated%2Bcommunity%2Band%2Bclinic-based%2BHIV-1%2Bcontrol%253A%2Ba%2Bcluster-randomised%2Btrial%2Bin%2Beastern%2BZimbabwe.%26rft_id%253Dinfo%253Adoi%252F10.1371%252Fjournal.pmed.0040102%26rft_id%253Dinfo%253Apmid%252F17388666%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=10.1371/journal.pmed.0040102&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=17388666&amp;link_type=MED&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>Medline</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-296-1" title="View reference 296 in text" id="ref-296">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.296" data-doi="10.1001/jama.298.10.1171"><div class="cit-metadata"><cite>Shaddy
 RE, Boucek MM, Hsu DT, Boucek RJ, Canter CE, Mahony L, et al. 
Carvedilol for children and adolescents with heart failure: a randomized
 controlled trial. <abbr class="cit-jnl-abbrev">JAMA</abbr><span class="cit-pub-date">2007</span>;<span class="cit-vol">298</span>:<span class="cit-fpage">1171</span>-9.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DJAMA%26rft.stitle%253DJAMA%26rft.issn%253D0002-9955%26rft.aulast%253DShaddy%26rft.auinit1%253DR.%2BE.%26rft.volume%253D298%26rft.issue%253D10%26rft.spage%253D1171%26rft.epage%253D1179%26rft.atitle%253DCarvedilol%2Bfor%2BChildren%2Band%2BAdolescents%2BWith%2BHeart%2BFailure%253A%2BA%2BRandomized%2BControlled%2BTrial%26rft_id%253Dinfo%253Adoi%252F10.1001%252Fjama.298.10.1171%26rft_id%253Dinfo%253Apmid%252F17848651%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=10.1001/jama.298.10.1171&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=17848651&amp;link_type=MED&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>Medline</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=000249374200022&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-297-1" title="View reference 297 in text" id="ref-297">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.297" data-doi="10.1136/bmj.326.7400.1167"><div class="cit-metadata"><cite>Lexchin
 J, Bero LA, Djulbegovic B, Clark O. Pharmaceutical industry sponsorship
 and research outcome and quality: systematic review. <abbr class="cit-jnl-abbrev">BMJ</abbr><span class="cit-pub-date">2003</span>;<span class="cit-vol">326</span>:<span class="cit-fpage">1167</span>-70.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DBMJ%26rft.stitle%253DBMJ%26rft.issn%253D0007-1447%26rft.aulast%253DLexchin%26rft.auinit1%253DJ.%26rft.volume%253D326%26rft.issue%253D7400%26rft.spage%253D1167%26rft.epage%253D1170%26rft.atitle%253DPharmaceutical%2Bindustry%2Bsponsorship%2Band%2Bresearch%2Boutcome%2Band%2Bquality%253A%2Bsystematic%2Breview%26rft_id%253Dinfo%253Adoi%252F10.1136%252Fbmj.326.7400.1167%26rft_id%253Dinfo%253Apmid%252F12775614%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/ijlink?linkType=ABST&amp;journalCode=bmj&amp;resid=326/7400/1167&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-ijlink"><span><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-298-1" title="View reference 298 in text" id="ref-298">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.298" data-doi="10.1136/bmj.325.7358.249"><div class="cit-metadata"><cite>Kjaergard
 LL, Als-Nielsen B. Association between competing interests and authors’
 conclusions: epidemiological study of randomised clinical trials 
published in the BMJ. <abbr class="cit-jnl-abbrev">BMJ</abbr><span class="cit-pub-date">2002</span>;<span class="cit-vol">325</span>:<span class="cit-fpage">249</span>.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DBMJ%26rft.stitle%253DBMJ%26rft.issn%253D0007-1447%26rft.aulast%253DKjaergard%26rft.auinit1%253DL.%2BL%26rft.volume%253D325%26rft.issue%253D7358%26rft.spage%253D249%26rft.epage%253D249%26rft.atitle%253DAssociation%2Bbetween%2Bcompeting%2Binterests%2Band%2Bauthors%2527%2Bconclusions%253A%2Bepidemiological%2Bstudy%2Bof%2Brandomised%2Bclinical%2Btrials%2Bpublished%2Bin%2Bthe%2BBMJ%26rft_id%253Dinfo%253Adoi%252F10.1136%252Fbmj.325.7358.249%26rft_id%253Dinfo%253Apmid%252F12153921%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/ijlink?linkType=ABST&amp;journalCode=bmj&amp;resid=325/7358/249&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-ijlink"><span><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-299-1" title="View reference 299 in text" id="ref-299">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.299" data-doi="10.1371/journal.pmed.0040184"><div class="cit-metadata"><cite>Bero
 L, Oostvogel F, Bacchetti P, Lee K. Factors associated with findings of
 published trials of drug-drug comparisons: why some statins appear more
 efficacious than others. <abbr class="cit-jnl-abbrev">PLoS Med</abbr><span class="cit-pub-date">2007</span>;<span class="cit-vol">4</span>:<span class="cit-fpage">e184</span>.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.stitle%253DPLoS%2BMed%26rft.aulast%253DBero%26rft.auinit1%253DL.%26rft.volume%253D4%26rft.issue%253D6%26rft.spage%253De184%26rft.epage%253De184%26rft.atitle%253DFactors%2Bassociated%2Bwith%2Bfindings%2Bof%2Bpublished%2Btrials%2Bof%2Bdrug-drug%2Bcomparisons%253A%2Bwhy%2Bsome%2Bstatins%2Bappear%2Bmore%2Befficacious%2Bthan%2Bothers.%26rft_id%253Dinfo%253Adoi%252F10.1371%252Fjournal.pmed.0040184%26rft_id%253Dinfo%253Apmid%252F17550302%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=10.1371/journal.pmed.0040184&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=17550302&amp;link_type=MED&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>Medline</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-300-1" title="View reference 300 in text" id="ref-300">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.300" data-doi="10.1016/j.cct.2007.08.001"><div class="cit-metadata"><cite>Sismondo S. Pharmaceutical company funding and its consequences: a qualitative systematic review. <abbr class="cit-jnl-abbrev">Contemp Clin Trials</abbr><span class="cit-pub-date">2008</span>;<span class="cit-vol">29</span>:<span class="cit-fpage">109</span>-13.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.stitle%253DContemp%2BClin%2BTrials%26rft.aulast%253DSismondo%26rft.auinit1%253DS.%26rft.volume%253D29%26rft.issue%253D2%26rft.spage%253D109%26rft.epage%253D113%26rft.atitle%253DPharmaceutical%2Bcompany%2Bfunding%2Band%2Bits%2Bconsequences%253A%2Ba%2Bqualitative%2Bsystematic%2Breview.%26rft_id%253Dinfo%253Adoi%252F10.1016%252Fj.cct.2007.08.001%26rft_id%253Dinfo%253Apmid%252F17919992%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=10.1016/j.cct.2007.08.001&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=17919992&amp;link_type=MED&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>Medline</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=000254117600003&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-301-1" title="View reference 301 in text" id="ref-301">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.301" data-doi="10.1001/jama.290.7.921"><div class="cit-metadata"><cite>Als-Nielsen
 B, Chen W, Gluud C, Kjaergard LL. Association of funding and 
conclusions in randomized drug trials: a reflection of treatment effect 
or adverse events? <abbr class="cit-jnl-abbrev">JAMA</abbr><span class="cit-pub-date">2003</span>;<span class="cit-vol">290</span>:<span class="cit-fpage">921</span>-8.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DJAMA%26rft.stitle%253DJAMA%26rft.issn%253D0002-9955%26rft.aulast%253DAls-Nielsen%26rft.auinit1%253DB.%26rft.volume%253D290%26rft.issue%253D7%26rft.spage%253D921%26rft.epage%253D928%26rft.atitle%253DAssociation%2Bof%2BFunding%2Band%2BConclusions%2Bin%2BRandomized%2BDrug%2BTrials%253A%2BA%2BReflection%2Bof%2BTreatment%2BEffect%2Bor%2BAdverse%2BEvents%253F%26rft_id%253Dinfo%253Adoi%252F10.1001%252Fjama.290.7.921%26rft_id%253Dinfo%253Apmid%252F12928469%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=10.1001/jama.290.7.921&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=12928469&amp;link_type=MED&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>Medline</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=000184828800029&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-302-1" title="View reference 302 in text" id="ref-302">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.302" data-doi="10.1001/jama.299.15.1800"><div class="cit-metadata"><cite>Ross
 JS, Hill KP, Egilman DS, Krumholz HM. Guest authorship and ghostwriting
 in publications related to rofecoxib: a case study of industry 
documents from rofecoxib litigation. <abbr class="cit-jnl-abbrev">JAMA</abbr><span class="cit-pub-date">2008</span>;<span class="cit-vol">299</span>:<span class="cit-fpage">1800</span>-12.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DJAMA%26rft.stitle%253DJAMA%26rft.issn%253D0002-9955%26rft.aulast%253DRoss%26rft.auinit1%253DJ.%2BS.%26rft.volume%253D299%26rft.issue%253D15%26rft.spage%253D1800%26rft.epage%253D1812%26rft.atitle%253DGuest%2BAuthorship%2Band%2BGhostwriting%2Bin%2BPublications%2BRelated%2Bto%2BRofecoxib%253A%2BA%2BCase%2BStudy%2Bof%2BIndustry%2BDocuments%2BFrom%2BRofecoxib%2BLitigation%26rft_id%253Dinfo%253Adoi%252F10.1001%252Fjama.299.15.1800%26rft_id%253Dinfo%253Apmid%252F18413874%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=10.1001/jama.299.15.1800&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=18413874&amp;link_type=MED&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>Medline</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=000254954800024&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-303-1" title="View reference 303 in text" id="ref-303">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.303" data-doi="10.1001/jama.289.19.2545"><div class="cit-metadata"><cite>McAlister FA, Straus SE, Sackett DL, Altman DG. Analysis and reporting of factorial trials: a systematic review. <abbr class="cit-jnl-abbrev">JAMA</abbr><span class="cit-pub-date">2003</span>;<span class="cit-vol">289</span>:<span class="cit-fpage">2545</span>-53.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DJAMA%26rft.stitle%253DJAMA%26rft.issn%253D0002-9955%26rft.aulast%253DMcAlister%26rft.auinit1%253DF.%2BA.%26rft.volume%253D289%26rft.issue%253D19%26rft.spage%253D2545%26rft.epage%253D2553%26rft.atitle%253DAnalysis%2Band%2BReporting%2Bof%2BFactorial%2BTrials%253A%2BA%2BSystematic%2BReview%26rft_id%253Dinfo%253Adoi%252F10.1001%252Fjama.289.19.2545%26rft_id%253Dinfo%253Apmid%252F12759326%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=10.1001/jama.289.19.2545&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=12759326&amp;link_type=MED&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>Medline</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=000182976500023&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-304-1" title="View reference 304 in text" id="ref-304">↵</a><div class="cit ref-cit ref-other" id="cit-340.mar23_1.c869.304"><div class="cit-metadata"><cite>Senn S. <span class="cit-source">Crossover trials in clinical research.</span> 2nd ed. Wiley, <span class="cit-pub-date">2002</span>.</cite></div><div class="cit-extra"></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-305-1" title="View reference 305 in text" id="ref-305">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.305"><div class="cit-metadata"><cite>Deeks JJ, Dinnes J, D’Amico R, Sowden AJ, Sakarovitch C, Song F, et al. Evaluating non-randomised intervention studies. <abbr class="cit-jnl-abbrev">Health Technol Assess</abbr><span class="cit-pub-date">2003</span>;<span class="cit-vol">7</span>:<span class="cit-fpage">iii</span>-173.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DHealth%2Btechnology%2Bassessment%2B%2528Winchester%252C%2BEngland%2529%26rft.stitle%253DHealth%2BTechnol%2BAssess%26rft.aulast%253DChilcott%26rft.auinit1%253DJ.%26rft.volume%253D7%26rft.issue%253D4%26rft.spage%253Diii%26rft.epage%253Di62%26rft.atitle%253DA%2Breview%2Bof%2Bthe%2Bclinical%2Beffectiveness%2Band%2Bcost-effectiveness%2Bof%2Broutine%2Banti-D%2Bprophylaxis%2Bfor%2Bpregnant%2Bwomen%2Bwho%2Bare%2Brhesus-negative.%26rft_id%253Dinfo%253Apmid%252F12633527%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=12633527&amp;link_type=MED&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>Medline</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-306-1" title="View reference 306 in text" id="ref-306">↵</a><div class="cit ref-cit ref-other" id="cit-340.mar23_1.c869.306"><div class="cit-metadata"><cite>Kunz R, Vist G, Oxman AD. Randomisation to protect against selection bias in healthcare trials. <span class="cit-source">Cochrane Database Syst Rev</span><span class="cit-pub-date">2007</span>;MR000012.</cite></div><div class="cit-extra"></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-307-1" title="View reference 307 in text" id="ref-307">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.307" data-doi="10.1016/S0140-6736(00)03651-5"><div class="cit-metadata"><cite>Collins R, MacMahon S. Reliable assessment of the effects of treatment on mortality and major morbidity, I: clinical trials. <abbr class="cit-jnl-abbrev">Lancet</abbr><span class="cit-pub-date">2001</span>;<span class="cit-vol">357</span>:<span class="cit-fpage">373</span>-80.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DLancet%26rft.stitle%253DLancet%26rft.aulast%253DCollins%26rft.auinit1%253DR.%26rft.volume%253D357%26rft.issue%253D9253%26rft.spage%253D373%26rft.epage%253D380%26rft.atitle%253DReliable%2Bassessment%2Bof%2Bthe%2Beffects%2Bof%2Btreatment%2Bon%2Bmortality%2Band%2Bmajor%2Bmorbidity%252C%2BI%253A%2Bclinical%2Btrials.%26rft_id%253Dinfo%253Adoi%252F10.1016%252FS0140-6736%252800%252903651-5%26rft_id%253Dinfo%253Apmid%252F11211013%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=10.1016/S0140-6736%2800%2903651-5&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=11211013&amp;link_type=MED&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>Medline</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=000166897900036&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-308-1" title="View reference 308 in text" id="ref-308">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.308" data-doi="10.1016/S0140-6736(96)01201-9"><div class="cit-metadata"><cite>Schulz KF. Randomised trials, human nature, and reporting guidelines. <abbr class="cit-jnl-abbrev">Lancet</abbr><span class="cit-pub-date">1996</span>;<span class="cit-vol">348</span>:<span class="cit-fpage">596</span>-8.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DLancet%26rft.stitle%253DLancet%26rft.aulast%253DSchulz%26rft.auinit1%253DK.%2BF.%26rft.volume%253D348%26rft.issue%253D9027%26rft.spage%253D596%26rft.epage%253D598%26rft.atitle%253DRandomised%2Btrials%252C%2Bhuman%2Bnature%252C%2Band%2Breporting%2Bguidelines.%26rft_id%253Dinfo%253Adoi%252F10.1016%252FS0140-6736%252896%252901201-9%26rft_id%253Dinfo%253Apmid%252F8774577%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=10.1016/S0140-6736%2896%2901201-9&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=8774577&amp;link_type=MED&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>Medline</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=A1996VF18600019&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-309-1" title="View reference 309 in text" id="ref-309">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.309" data-doi="10.1177/096228020000900103"><div class="cit-metadata"><cite>Murray GD. Promoting good research practice. <abbr class="cit-jnl-abbrev">Stat Methods Med Res</abbr><span class="cit-pub-date">2000</span>;<span class="cit-vol">9</span>:<span class="cit-fpage">17</span>-24.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DStatistical%2BMethods%2Bin%2BMedical%2BResearch%26rft.stitle%253DStat%2BMethods%2BMed%2BRes%26rft.issn%253D0962-2802%26rft.aulast%253DMurray%26rft.auinit1%253DG.%2BD%26rft.volume%253D9%26rft.issue%253D1%26rft.spage%253D17%26rft.epage%253D24%26rft.atitle%253DPromoting%2Bgood%2Bresearch%2Bpractice%26rft_id%253Dinfo%253Adoi%252F10.1177%252F096228020000900103%26rft_id%253Dinfo%253Apmid%252F10826155%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/ijlink?linkType=ABST&amp;journalCode=spsmm&amp;resid=9/1/17&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-ijlink"><span><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-310-1" title="View reference 310 in text" id="ref-310">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.310" data-doi="10.1089/acm.2007.0818"><div class="cit-metadata"><cite>Narahari
 SR, Ryan TJ, Aggithaya MG, Bose KS, Prasanna KS. Evidence-based 
approaches for the Ayurvedic traditional herbal formulations: toward an 
Ayurvedic CONSORT model. <abbr class="cit-jnl-abbrev">J Altern Complement Med</abbr><span class="cit-pub-date">2008</span>;<span class="cit-vol">14</span>:<span class="cit-fpage">769</span>-76.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DJournal%2Bof%2Balternative%2Band%2Bcomplementary%2Bmedicine%2B%2528New%2BYork%252C%2BN.Y.%2529%26rft.stitle%253DJ%2BAltern%2BComplement%2BMed%26rft.aulast%253DNarahari%26rft.auinit1%253DS.%2BR.%26rft.volume%253D14%26rft.issue%253D6%26rft.spage%253D769%26rft.epage%253D776%26rft.atitle%253DEvidence-based%2Bapproaches%2Bfor%2Bthe%2BAyurvedic%2Btraditional%2Bherbal%2Bformulations%253A%2Btoward%2Ban%2BAyurvedic%2BCONSORT%2Bmodel.%26rft_id%253Dinfo%253Adoi%252F10.1089%252Facm.2007.0818%26rft_id%253Dinfo%253Apmid%252F18684081%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=10.1089/acm.2007.0818&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=18684081&amp;link_type=MED&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>Medline</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=000258957400025&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-311-1" title="View reference 311 in text" id="ref-311">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.311" data-doi="10.7326/0003-4819-138-1-200301070-00010"><div class="cit-metadata"><cite>Bossuyt
 PM, Reitsma JB, Bruns DE, Gatsonis CA, Glasziou PP, Irwig LM, et al. 
Towards complete and accurate reporting of studies of diagnostic 
accuracy: The STARD Initiative. <abbr class="cit-jnl-abbrev">Ann Intern Med</abbr><span class="cit-pub-date">2003</span>;<span class="cit-vol">138</span>:<span class="cit-fpage">40</span>-4.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DAnnals%2Bof%2BInternal%2BMedicine%26rft.stitle%253DANN%2BINTERN%2BMED%26rft.issn%253D0003-4819%26rft.aulast%253DBossuyt%26rft.auinit1%253DP.%2BM.%26rft.volume%253D138%26rft.issue%253D1%26rft.spage%253D40%26rft.epage%253D44%26rft.atitle%253DTowards%2BComplete%2Band%2BAccurate%2BReporting%2Bof%2BStudies%2Bof%2BDiagnostic%2BAccuracy%253A%2BThe%2BSTARD%2BInitiative%26rft_id%253Dinfo%253Adoi%252F10.7326%252F0003-4819-138-1-200301070-00010%26rft_id%253Dinfo%253Apmid%252F12513043%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=10.7326/0003-4819-138-1-200301070-00010&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=12513043&amp;link_type=MED&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>Medline</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=000180996200006&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-312-1" title="View reference 312 in text" id="ref-312">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.312" data-doi="10.7326/0003-4819-147-8-200710160-00010"><div class="cit-metadata"><cite>von
 Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP. 
The Strengthening the Reporting of Observational Studies in Epidemiology
 (STROBE) statement: guidelines for reporting observational studies. <abbr class="cit-jnl-abbrev">Ann Intern Med</abbr><span class="cit-pub-date">2007</span>;<span class="cit-vol">147</span>:<span class="cit-fpage">573</span>-7.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DAnnals%2Bof%2BInternal%2BMedicine%26rft.stitle%253DANN%2BINTERN%2BMED%26rft.issn%253D0003-4819%26rft.aulast%253Dvon%2BElm%26rft.auinit1%253DE.%26rft.volume%253D147%26rft.issue%253D8%26rft.spage%253D573%26rft.epage%253D577%26rft.atitle%253DThe%2BStrengthening%2Bthe%2BReporting%2Bof%2BObservational%2BStudies%2Bin%2BEpidemiology%2B%2528STROBE%2529%2BStatement%253A%2BGuidelines%2Bfor%2BReporting%2BObservational%2BStudies%26rft_id%253Dinfo%253Adoi%252F10.7326%252F0003-4819-147-8-200710160-00010%26rft_id%253Dinfo%253Apmid%252F17938396%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=10.7326/0003-4819-147-8-200710160-00010&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=17938396&amp;link_type=MED&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>Medline</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=000250437100007&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-313-1" title="View reference 313 in text" id="ref-313">↵</a><div class="cit ref-cit ref-journal" id="cit-340.mar23_1.c869.313" data-doi="10.1056/NEJMoa0807611"><div class="cit-metadata"><cite>Tonino
 PA, De Bruyne B, Pijls NH, Siebert U, Ikeno F, van’t Veer M, et al. 
Fractional flow reserve versus angiography for guiding percutaneous 
coronary intervention. <abbr class="cit-jnl-abbrev">N Engl J Med</abbr><span class="cit-pub-date">2009</span>;<span class="cit-vol">360</span>:<span class="cit-fpage">213</span>-24.</cite></div><div class="cit-extra"><a style="display: none;" href="http://www.bmj.com/content/340/%7Bopenurl%7D?query=rft.jtitle%253DNew%2BEngland%2BJournal%2Bof%2BMedicine%26rft.stitle%253DNEJM%26rft.issn%253D0028-4793%26rft.aulast%253DTonino%26rft.auinit1%253DP.%2BA.L.%26rft.volume%253D360%26rft.issue%253D3%26rft.spage%253D213%26rft.epage%253D224%26rft.atitle%253DFractional%2BFlow%2BReserve%2Bversus%2BAngiography%2Bfor%2BGuiding%2BPercutaneous%2BCoronary%2BIntervention%26rft_id%253Dinfo%253Adoi%252F10.1056%252FNEJMoa0807611%26rft_id%253Dinfo%253Apmid%252F19144937%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url checkImage-processed"><span>OpenUrl</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=10.1056/NEJMoa0807611&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=19144937&amp;link_type=MED&amp;atom=%2Fbmj%2F340%2Fbmj.c869.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>Medline</span></a><a href="http://www.bmj.com/lookup/external-ref?access_num=000262434500004&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li></ol></div><span class="highwire-journal-article-marker-end"></span></div><span id="related-urls"></span></div></div>  </div>

  
  </div>
</div>
  </div>
</div>
</div></div>  </div>

  
  </div>
        </article>
      </div>
      <div class="right-nav col-xs-12 col-sm-4 col-md-4 col-lg-4">
        <aside>
          <div class="panel-pane pane-service-links">
  
      
  
  <div class="pane-content">
    <div class="service-links"><ul><li class="first"><iframe style="width: 107px; height: 20px;" data-twttr-rendered="true" title="Twitter Tweet Button" class="twitter-share-button service-links-twitter-widget twitter-tweet-button twitter-share-button twitter-count-horizontal" src="CONSORT%202010%20Explanation%20and%20Elaboration_%20updated%20guidelines%20for%20reporting%20parallel%20group%20randomised%20trials%20%7C%20The%20BMJ_files/tweet_button.html" allowtransparency="true" scrolling="no" id="twitter_widget" frameborder="0"></iframe></li>
<li><iframe class="service-links-facebook-like" style="border: medium none; overflow: hidden; width: 100px; height: 21px;" allowtransparency="true" scrolling="no" src="CONSORT%202010%20Explanation%20and%20Elaboration_%20updated%20guidelines%20for%20reporting%20parallel%20group%20randomised%20trials%20%7C%20The%20BMJ_files/like.html" frameborder="0"></iframe></li>
<li class="last"><div id="___plusone_0" style="text-indent: 0px; margin: 0px; padding: 0px; background: none repeat scroll 0% 0% transparent; border-style: none; float: none; line-height: normal; font-size: 1px; vertical-align: baseline; display: inline-block; width: 106px; height: 24px;"><iframe title="+1" data-gapiattached="true" src="CONSORT%202010%20Explanation%20and%20Elaboration_%20updated%20guidelines%20for%20reporting%20parallel%20group%20randomised%20trials%20%7C%20The%20BMJ_files/fastbutton.html" name="I0_1426066333151" id="I0_1426066333151" vspace="0" tabindex="0" style="position: static; top: 0px; width: 106px; margin: 0px; border-style: none; left: 0px; visibility: visible; height: 24px;" scrolling="no" marginwidth="0" marginheight="0" hspace="0" frameborder="0" width="100%"></iframe></div></li>
</ul></div>  </div>

  
  </div>
<div class="panel-separator"></div><div class="panel-pane pane-bmj-article-buttons">
  
        <h2 class="pane-title">Article tools</h2>
    
  
  <div class="pane-content">
    <a href="http://www.bmj.com/content/340/bmj.c869.full.pdf+html" title="PDF" class="pdf-link"><span class="icon"><i class="bmj-icon blue-icon fa fa-file-text"></i>PDF</span></a><a href="http://www.bmj.com/content/340/bmj.c869/rapid-responses" class="citation-rr-link"><i class="bmj-icon blue-icon fa fa-comment"></i>4 responses</a>  </div>

  
  </div>
<div class="panel-separator"></div><div class="panel-pane pane-panels-mini pane-jnl-bmj-art-tools">
  
      
  
  <div class="pane-content">
    <div class="panel-display panel-1col clearfix" id="mini-panel-jnl_bmj_art_tools">
  <div class="panel-panel panel-col">
    <div><ul><li class="first"><div class="panel-pane pane-custom pane-1">
  
      
  
  <div class="pane-content">
    <p><i class="bmj-icon fa fa-edit"></i><a href="http://www.bmj.com/content/340/bmj.c869/submit-a-rapid-response">Respond to this article</a></p>
  </div>

  
  </div>
</li>
<li><div class="panel-pane pane-bmj-variant-link">
  
      
  
  <div class="pane-content">
    <i class="bmj-icon fa fa-print"></i><a href="http://www.bmj.com/content/340/bmj.c869.full-text.print" data-font-icon="fa fa-print">Print</a>  </div>

  
  </div>
</li>
<li><div class="panel-pane pane-bmj-minipanel-model-link pane-jnl-bmj-article-page-alerts">
  
      
  
  <div class="pane-content">
    <div class="minipanel-model-wrapper"><div class="minipanel-model-link-link"><i class="bmj-icon fa fa-bullhorn"></i><a href="http://www.bmj.com/#mini-panel-jnl-bmj-article-page-alerts-1" data-toggle="collapse" role="button" data-font-icon="fa fa-bullhorn">Alerts &amp; updates</a></div><!-- Collapse --><div id="mini-panel-jnl-bmj-article-page-alerts-1" class="panel-collapse collapse"><div class="minipanel-header"><h4 class="minipanel-label">Article alerts</h4><div class="short-description"><div class="alerts-marketing">Please note: your email address is provided to the journal, which may use this information for marketing purposes.</div></div></div><div class="minipanel-body"><div class="panel-display row bootstrap-onecol" id="mini-panel-jnl_bmj_article_page_alerts">
  <div class="panel-panel col-xs-12 col-sm-12 col-md-12 col-lg-12">
    <div class="panel-pane pane-custom pane-2">
  
      
  
  <div class="pane-content">
    <h4 class="minipanel-label">Log in or register:</h4>
  </div>

  
  </div>
<div class="panel-separator"></div><div class="panel-pane pane-alerts-login-form">
  
      
  
  <div class="pane-content">
    <form action="/content/340/bmj.c869?tab=article-alert" method="post" id="user-login-form" accept-charset="UTF-8"><div><div class="form-type-textfield form-item-name form-item form-group">
  <label for="edit-name">Username <span class="form-required" title="This field is required.">*</span></label>
 <input class="form-control form-text required" id="edit-name" name="name" size="15" maxlength="60" type="text">
</div>
<div class="form-type-password form-item-pass form-item form-group">
  <label for="edit-pass">Password <span class="form-required" title="This field is required.">*</span></label>
 <input class="form-control form-text required" id="edit-pass" name="pass" size="15" maxlength="128" type="password">
</div>
<input name="form_build_id" value="form-MCgMU_YnvUpCTLjVMmHEAR6wwNqjdZSGSqucQ_5nohg" type="hidden">
<input name="form_id" value="highwire_alerts_user_login" type="hidden">
<input class="btn form-submit" id="edit-submit" name="op" value="Log in" type="submit"></div></form>  </div>

  
  </div>
<div class="panel-separator"></div><div class="panel-pane pane-custom pane-3" id="register-for-alerts">
  
      
  
  <div class="pane-content">
    <p><a class="btn register-button" href="http://myaccount.bmj.com/myaccount/registration.html?regService=bmj-registration&amp;fwdUrl=http://www.bmj.com/content/340/bmj.c869?tab=article-alert&amp;itemId=pr1906">Register for alerts</a><br>
</p><div class="alerts-email"><i class="fa fa-info-circle"></i> If you have registered for alerts, you should use your registered email address as your username</div>
  </div>

  
  </div>
  </div>
</div>
</div></div></div>  </div>

  
  </div>
</li>
<li><div class="panel-pane pane-bmj-minipanel-model-link pane-article-page-citation-download">
  
      
  
  <div class="pane-content">
    <div class="minipanel-model-wrapper"><div class="minipanel-model-link-link"><i class="bmj-icon fa fa-globe"></i><a href="http://www.bmj.com/#mini-panel-article-page-citation-download-1" data-toggle="collapse" role="button" data-font-icon="fa fa-globe">Citation tools</a></div><!-- Collapse --><div id="mini-panel-article-page-citation-download-1" class="panel-collapse collapse"><div class="minipanel-header"><h4 class="minipanel-label">Download this article to citation manager</h4></div><div class="minipanel-body"><div class="panel-display row bootstrap-onecol" id="mini-panel-article_page_citation_download">
  <div class="panel-panel col-xs-12 col-sm-12 col-md-12 col-lg-12">
    <div class="panel-pane pane-bmj-citation-export">
  
      
  
  <div class="pane-content">
    <div>
  <div class="highwire-citation-info">
      <div class="highwire-article-citation highwire-citation-type-highwire-article" data-node-nid="195507" id="node195507" data-pisa="bmj;340/mar23_1/c869" data-pisa-master="bmj;bmj.c869" data-apath="/bmj/340/bmj.c869.atom"><div class="highwire-cite highwire-cite-highwire-article highwire-citation-bmj-article-citation-export clearfix">
  
      <span class="highwire-cite-authors"><span data-delta="0"><span class="nlm-surname">Moher</span> <span class="nlm-given-names">David</span></span>, <span data-delta="1"><span class="nlm-surname">Hopewell</span> <span class="nlm-given-names">Sally</span></span>, <span data-delta="2"><span class="nlm-surname">Schulz</span> <span class="nlm-given-names">Kenneth F</span></span>, <span data-delta="3"><span class="nlm-surname">Montori</span> <span class="nlm-given-names">Victor</span></span>, <span data-delta="4"><span class="nlm-surname">Gøtzsche</span> <span class="nlm-given-names">Peter C</span></span>, <span data-delta="5"><span class="nlm-surname">Devereaux</span> <span class="nlm-given-names">P J</span></span> et al. </span>
  
      <span class="highwire-cite-title article-title">CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials</span>  
  
      <span class="highwire-cite-metadata"><span class="highwire-cite-metadata-journal">BMJ  </span><span class="highwire-cite-metadata-date">2010;  </span><span class="highwire-cite-metadata-volume">340 </span><span class="highwire-cite-metadata-volume">:c869 </span></span>
  
  
  </div>
</div>  </div>
  <div class="highwire-citation-formats">
  	    <div class="highwire-citation-formats-links">
      <span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.spage&amp;rft.epage&amp;rft.atitle=CONSORT%202010%20Explanation%20and%20Elaboration%3A%20updated%20guidelines%20for%20reporting%20parallel%20group%20randomised%20trials&amp;rft.volume=340&amp;rft.issue&amp;rft.date=2010-03-24%2000%3A06%3A15&amp;rft.stitle&amp;rft.jtitle=BMJ&amp;rft.au=Moher%2C+David&amp;rft.au=Hopewell%2C+Sally&amp;rft.au=Schulz%2C+Kenneth+F&amp;rft.au=Montori%2C+Victor&amp;rft.au=G%C3%B8tzsche%2C+Peter+C&amp;rft.au=Devereaux%2C+P+J&amp;rft.au=Elbourne%2C+Diana&amp;rft.au=Egger%2C+Matthias&amp;rft.au=Altman%2C+Douglas+G"></span><h3></h3><ul class="bmj-citation-links"><li class="first">BibTeX (win &amp; mac)<a href="http://www.bmj.com/highwire/citation/195507/bibtex" class="citation-link btn btn-primary pull-right">Download</a></li>
<li>EndNote (tagged)<a href="http://www.bmj.com/highwire/citation/195507/tagged" class="citation-link btn btn-primary pull-right">Download</a></li>
<li>EndNote 8 (xml)<a href="http://www.bmj.com/highwire/citation/195507/endnote8" class="citation-link btn btn-primary pull-right">Download</a></li>
<li>RefWorks Tagged (win &amp; mac)<a href="http://www.bmj.com/highwire/citation/195507/refworks" class="citation-link btn btn-primary pull-right">Download</a></li>
<li>RIS (win only)<a href="http://www.bmj.com/highwire/citation/195507/ris" class="citation-link btn btn-primary pull-right">Download</a></li>
<li class="last">Medlars<a href="http://www.bmj.com/highwire/citation/195507/medlars" class="citation-link btn btn-primary pull-right">Download</a></li>
</ul>    </div>
  </div>
</div>
  </div>

  
  </div>
<div class="panel-separator"></div><div class="panel-pane pane-snippet">
  
        <h2 class="pane-title">Help</h2>
    
  
  <div class="pane-content">
    <div class="jnl-bmj-citation-download-help" id="jnl-bmj-citation-download-help">
  
      
  <div class="snippet-content">
    <div class="citation-help">
  <p class="citation-manager">If you are unable to import citations, please contact
  technical support for your product directly (links go to external sites):</p>

  <ul>
    <li><a href="http://www.endnote.com/support/ensupport.asp">EndNote</a></li>

    <li><a href="http://www.procite.com/support/pcsupport.asp">ProCite</a></li>

    <li><a href="http://www.refman.com/support/rmsupport.asp">Reference
    Manager</a></li>

    <li><a href="http://www.refworks.com/content/products/content.asp">RefWorks</a></li>

    <li><a href="http://www.zotero.org/support">Zotero</a></li>
  </ul>
</div>  </div>

</div>
  </div>

  
  </div>
  </div>
</div>
</div></div></div>  </div>

  
  </div>
</li>
<li class="last"><div class="panel-pane pane-bmj-permission-link">
  
      
  
  <div class="pane-content">
    <i class="bmj-icon icon-copyright"></i><a href="https://s100.copyright.com/AppDispatchServlet?publisherName=BMJ&amp;publication=bmj&amp;title=CONSORT%202010%20Explanation%20and%20Elaboration%3A%20updated%20guidelines%20for%20reporting%20parallel%20group%20randomised%20trials&amp;publicationDate=03/24/2010&amp;author=David%20Moher%2C%20Sally%20Hopewell%2C%20Kenneth%20F%20Schulz%2C%20Victor%20Montori%2C%20Peter%20C%20G%C3%B8tzsche%2C%20P%20J%20Devereaux%2C%20Diana%20Elbourne%2C%20Matthias%20Egger%2C%20Douglas%20G%20Altman&amp;contentID=10.1136/bmj.c869&amp;volumeNum=340&amp;issueNum=&amp;startPage=&amp;endPage=&amp;copyright=British%20Medical%20Journal%20Publishing%20Group&amp;oa=y&amp;orderBeanReset=1&amp;link_type=PERMISSIONDIRECT&amp;atom=/bmj/340/bmj.c869.atom" rel="external" class="bmj-permission-link request-permissions" target="_blank" data-font-icon="icon-copyright">Request permissions</a>  </div>

  
  </div>
</li>
</ul></div>
  </div>
</div>
  </div>

  
  </div>
<div class="panel-separator"></div><div class="panel-pane pane-panels-mini pane-bmj-article-share-modal">
  
      
  
  <div class="pane-content">
    <div class="panel-display row bootstrap-onecol" id="mini-panel-bmj_article_share_modal">
  <div class="panel-panel col-xs-12 col-sm-12 col-md-12 col-lg-12">
    <div class="panel-pane pane-bmj-article-links">
  
      
  
  <div class="pane-content">
    <div class="bmj-article-links minipanel-model-wrapper"><ul class="links"><li><div class="minipanel-model-link-link"><i class="bmj-icon fa fa-user"></i><a data-font-icon="fa fa-bullhorn" role="button" data-toggle="collapse" href="http://www.bmj.com/#mini-panel-jnl-bmj-article-page-citation" class="collapsed">Author citation</a></div></li></ul><div style="height: 0px;" id="mini-panel-jnl-bmj-article-page-citation" class="panel-collapse collapse"><ul class="links"><li class="0 first"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=search&amp;db=pubmed&amp;term=Moher%20David%5Bau%5D&amp;dispmax=50" target="_blank">Articles by David Moher</a></li>
<li class="1"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=search&amp;db=pubmed&amp;term=Hopewell%20Sally%5Bau%5D&amp;dispmax=50" target="_blank">Articles by Sally Hopewell</a></li>
<li class="2"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=search&amp;db=pubmed&amp;term=Schulz%20Kenneth%20F%5Bau%5D&amp;dispmax=50" target="_blank">Articles by Kenneth F Schulz</a></li>
<li class="3"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=search&amp;db=pubmed&amp;term=Montori%20Victor%5Bau%5D&amp;dispmax=50" target="_blank">Articles by Victor Montori</a></li>
<li class="4"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=search&amp;db=pubmed&amp;term=G%C3%B8tzsche%20Peter%20C%5Bau%5D&amp;dispmax=50" target="_blank">Articles by Peter C Gøtzsche</a></li>
<li class="5"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=search&amp;db=pubmed&amp;term=Devereaux%20P%20J%5Bau%5D&amp;dispmax=50" target="_blank">Articles by P J Devereaux</a></li>
<li class="6"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=search&amp;db=pubmed&amp;term=Elbourne%20Diana%5Bau%5D&amp;dispmax=50" target="_blank">Articles by Diana Elbourne</a></li>
<li class="7"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=search&amp;db=pubmed&amp;term=Egger%20Matthias%5Bau%5D&amp;dispmax=50" target="_blank">Articles by Matthias Egger</a></li>
<li class="8 last"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=search&amp;db=pubmed&amp;term=Altman%20Douglas%20G%5Bau%5D&amp;dispmax=50" target="_blank">Articles by Douglas G Altman</a></li>
</ul></div></div><div class="bmj-article-links"><ul class="links"><li class="0 first last"><a href="http://portfolio.bmj.com/portfolio/add-to-portfolio.html?t=CONSORT%202010%20Explanation%20and%20Elaboration%3A%20updated%20guidelines%20for%20reporting%20parallel%20group%20randomised%20trials&amp;u=http%3A//www.bmj.com/content/340/bmj.c869" target="_blank" id="add-to-bmj-portfolio" class="bmj-portfolio" rel="nofollow">Add article to BMJ Portfolio</a></li>
</ul></div>  </div>

  
  </div>
<div class="panel-separator"></div><div class="panel-pane pane-bmj-minipanel-model-link pane-jnl-bmj-article-button-email-to">
  
      
  
  <div class="pane-content">
    <div class="minipanel-model-wrapper"><div class="minipanel-model-link-link"><i class="bmj-icon icon-email"></i><a href="http://www.bmj.com/#mini-panel-jnl-bmj-article-button-email-to-1" data-toggle="collapse" role="button" data-font-icon="icon-email">Email to a friend</a></div><!-- Collapse --><div id="mini-panel-jnl-bmj-article-button-email-to-1" class="panel-collapse collapse"><div class="minipanel-header"><h4 class="minipanel-label">Forward this page</h4></div><div class="minipanel-body"><div class="panel-display row bootstrap-onecol" id="mini-panel-jnl_bmj_article_button_email_to">
  <div class="panel-panel col-xs-12 col-sm-12 col-md-12 col-lg-12">
    <div class="panel-pane pane-block pane-forward-form">
  
      
  
  <div class="pane-content">
    <form action="/content/340/bmj.c869" method="post" id="forward-form" accept-charset="UTF-8"><div><div id="edit-instructions" class="form-type-item form-item form-group">
 <p>Thank you for your interest in spreading the word about The BMJ.</p><p>NOTE:
 We only request your email address so that the person you are 
recommending the page to knows that you wanted them to see it, and that 
it is not junk mail. We do not capture any email address.</p>
</div>
<div class="form-type-textfield form-item-name form-item form-group">
  <label for="edit-name--2">Username <span class="form-required" title="This field is required.">*</span></label>
 <input class="form-control form-text required" id="edit-name--2" name="name" size="58" maxlength="256" type="text">
</div>
<div class="form-type-textfield form-item-email form-item form-group">
  <label for="edit-email">Your Email <span class="form-required" title="This field is required.">*</span></label>
 <input class="form-control form-text required" id="edit-email" name="email" size="58" maxlength="256" type="text">
</div>
<div class="form-type-textarea form-item-recipients form-item form-group">
  <label for="edit-recipients">Send To <span class="form-required" title="This field is required.">*</span></label>
 <div class="form-textarea-wrapper"><textarea class="form-control form-textarea required" id="edit-recipients" name="recipients" cols="50" rows="3"></textarea></div>
</div>
<div id="edit-page" class="form-type-item form-item form-group">
  <label for="edit-page">You are going to email the following </label>
 <a href="http://www.bmj.com/content/340/bmj.c869" class="active">CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials</a>
</div>
<div class="form-type-textarea form-item-message form-item form-group">
  <label for="edit-message--2">Your Personal Message </label>
 <div class="form-textarea-wrapper"><textarea class="form-control form-textarea" id="edit-message--2" name="message" cols="50" rows="3"></textarea></div>
</div>
<input name="path" value="node/195507" type="hidden">
<input name="path_cid" value="" type="hidden">
<input name="forward_footer" value=" " type="hidden">
<input name="form_build_id" value="form-G3JakCPPI5dsfbfA8BJStokAMzfy60LjHtA5pVRLowY" type="hidden">
<input name="form_id" value="forward_form" type="hidden">
<input class="btn form-submit" id="edit-submit--2" name="op" value="Send" type="submit"></div></form>  </div>

  
  </div>
  </div>
</div>
</div></div></div>  </div>

  
  </div>
  </div>
</div>
  </div>

  
  </div>
<div class="panel-separator"></div><div class="panel-pane pane-bmj-article-specialities">
  
        <h2 class="pane-title">Topics</h2>
    
  
  <div class="pane-content">
    <div class="bmj-item-more-less-list bmj-item-list"><ul class="item-list-speciality"><li class="first"><a href="http://www.bmj.com/specialties/quantitative-research" class="article-speciality c-quantitative-research">Quantitative research</a></li>
<li><a href="http://www.bmj.com/specialties/clinical-trials-epidemiology" class="article-speciality c-clinical-trials-epidemiology">Clinical trials (epidemiology)</a></li>
<li class="last"><a href="http://www.bmj.com/specialties/internet" class="article-speciality c-internet">Internet</a></li>
</ul></div>  </div>

  
  </div>
<div class="panel-separator"></div><div class="panel-pane pane-snippet">
  
      
  
  <div class="pane-content">
    <div class="oas-ad-middle-1" id="oas-ad-middle-1">
  
      
  <div class="snippet-content">
    <script language="JavaScript">  
<!--  
OAS_AD('Middle1');  
//-->  
</script><a href="http://oas.services.bmj.com/RealMedia/ads/click_nx.ads/www.bmj.com/content/340/bmj.c869/1819545053@Middle1,Middle2,Top,Top2%21Middle1?" target="_top"><img class="uyhxjywpchhatgbxknae" src="CONSORT%202010%20Explanation%20and%20Elaboration_%20updated%20guidelines%20for%20reporting%20parallel%20group%20randomised%20trials%20%7C%20The%20BMJ_files/1819545053Middle1Middle2TopTop2Middle1.gif" border="0"></a>  </div>

</div>
  </div>

  
  </div>
<div class="panel-separator"></div><div class="panel-pane pane-snippet">
  
      
  
  <div class="pane-content">
    <div class="altmertrics" id="altmertrics">
  
      
  <div class="snippet-content">
    <!-- Widget start -->
<div id="altmetric"><div id="altmetric-header"><img src="CONSORT%202010%20Explanation%20and%20Elaboration_%20updated%20guidelines%20for%20reporting%20parallel%20group%20randomised%20trials%20%7C%20The%20BMJ_files/logo-altmetric.png"><p>Who is talking about this article?</p></div><div data-uuid="2636d928-7dfa-f8e1-05bb-0e52e994af0e" class="altmetric-embed" data-badge-type="medium-donut" data-badge-details="right" data-hide-no-mentions="true"><div style="overflow:hidden;">
  <div style="float:left; margin:0 20px 0 0;">
    <a target="_self" href="http://www.altmetric.com/details.php?domain=www.bmj.com&amp;citation_id=1205794" style="display:inline-block;">
      <img alt="Article has an altmetric score of 41" src="CONSORT%202010%20Explanation%20and%20Elaboration_%20updated%20guidelines%20for%20reporting%20parallel%20group%20randomised%20trials%20%7C%20The%20BMJ_files/a.png" style="border:0; margin: 0; max-width: none;" height="120px" width="120px">
    </a>
    <p style="padding-top: 10px; text-align: center;"><a target="_self" href="http://www.altmetric.com/details.php?domain=www.bmj.com&amp;citation_id=1205794">See more details</a></p>
  </div>
  <div id="_altmetric_popover_el" class="altmetric-embed right" style="margin:0; padding:0; display:inline-block; float:left; position:relative;">
    <div class="altmetric_container" id="_altmetric_container">
      <div class="altmetric-embed altmetric-popover-inner right" id="_altmetric_popover_inner">
        <div style="padding:0; margin: 0;" class="altmetric-embed altmetric-popover-content">
          
    <div style="padding-left: 10px; line-height:18px; border-left: 16px solid #FF0000;">Picked up by <b>1</b> news outlets</div>

    <div style="padding-left: 10px; line-height:18px; border-left: 16px solid #FFD140;">Blogged by <b>4</b></div>

    <div style="padding-left: 10px; line-height:18px; border-left: 16px solid #74CFED;">Tweeted by <b>3</b></div>

    <div style="padding-left: 10px; line-height:18px; border-left: 16px solid #2445BD;">On <b>1</b> Facebook pages</div>

    <div style="padding-left: 10px; line-height:18px; border-left: 16px solid #e7e7e7;">Mentioned in <b>1</b> Wikipedia entries</div>



    <div class="altmetric-embed readers" style="margin-top: 10px;">
      
          <div class="altmetric-embed tip_mendeley" style="padding-left: 10px; line-height:18px; border-left: 16px solid #A60000;">
              <b>1</b> readers on Mendeley
          </div>
      
      
          <div class="altmetric-embed tip_connotea" style="padding-left: 10px; line-height:18px; border-left: 16px solid #FF4040;">
              <b>1</b> readers on Connotea
          </div>
      
      
          <div class="altmetric-embed tip_citeulike" style="padding-left: 10px; line-height:18px; border-left: 16px solid #BCD2EF;">
              <b>4</b> readers on CiteULike
          </div>
      
    </div>



        </div>
      </div>
    </div>
  </div>
</div>
</div></div>
<!-- Widget end -->  </div>

</div>
  </div>

  
  </div>
<div class="panel-separator"></div><div class="panel-pane pane-custom pane-4">
  
      
  
  <div class="pane-content">
    <!-- Start CrossMark Snippet v1.4 --><script type="text/javascript" src="CONSORT%202010%20Explanation%20and%20Elaboration_%20updated%20guidelines%20for%20reporting%20parallel%20group%20randomised%20trials%20%7C%20The%20BMJ_files/jquery-ui.js"></script><script type="text/javascript" src="CONSORT%202010%20Explanation%20and%20Elaboration_%20updated%20guidelines%20for%20reporting%20parallel%20group%20randomised%20trials%20%7C%20The%20BMJ_files/crossmark.js"></script><p><link media="screen" rel="stylesheet" type="text/css" href="CONSORT%202010%20Explanation%20and%20Elaboration_%20updated%20guidelines%20for%20reporting%20parallel%20group%20randomised%20trials%20%7C%20The%20BMJ_files/crossmark_widget.css"><a id="open-crossmark" href="#" style="padding: 3px 0 13px 0;"><img alt="" title="" style="border: 0px none;" id="crossmark-icon" src="CONSORT%202010%20Explanation%20and%20Elaboration_%20updated%20guidelines%20for%20reporting%20parallel%20group%20randomised%20trials%20%7C%20The%20BMJ_files/crossmark_button.png"></a></p>

<!-- End CrossMark Snippet -->  </div>

  
  </div>
<div class="panel-separator"></div><div class="panel-pane pane-snippet">
  
      
  
  <div class="pane-content">
    <div class="oas-ad-middle-2" id="oas-ad-middle-2">
  
      
  <div class="snippet-content">
    <script language="JavaScript">  
<!--  
OAS_AD('Middle2');  
//-->  
</script><a href="http://oas.services.bmj.com/RealMedia/ads/click_nx.ads/www.bmj.com/content/340/bmj.c869/1819545053@Middle1,Middle2,Top,Top2%21Middle2?" target="_top"><img class="uyhxjywpchhatgbxknae" src="CONSORT%202010%20Explanation%20and%20Elaboration_%20updated%20guidelines%20for%20reporting%20parallel%20group%20randomised%20trials%20%7C%20The%20BMJ_files/1819545053Middle1Middle2TopTop2Middle2.gif" border="0"></a>    </div>

</div>
  </div>

  
  </div>
<div class="panel-separator"></div><div class="panel-pane pane-panels-ajax-tab-tabs">
  
      
  
  <div class="pane-content">
    <ul class="tabs inline panels-ajax-tab"><li class="first active"><a style="cursor: pointer;" href="http://www.bmj.com/content/340/bmj.c869" class="panels-ajax-tab-tab panels-ajax-tabs-once-processed panels-ajax-tabs-first-loaded panels-ajax-tabs-processed" data-panel-name="jnl_bmj_feeds_uk_jobs" data-target-id="panel_jobshome" data-entity-context="none" data-trigger="" data-url-enabled="0">UK jobs</a><a href="http://www.bmj.com/panels_ajax_tab/jnl_bmj_feeds_uk_jobs/none/0" rel="nofollow" style="display:none" class="js-crawler-link"></a></li>
<li class="last"><a style="cursor: pointer;" href="http://www.bmj.com/content/340/bmj.c869" class="panels-ajax-tab-tab panels-ajax-tabs-once-processed panels-ajax-tabs-processed" data-panel-name="jnl_bmj_feeds_international_jobs" data-target-id="panel_jobshome" data-entity-context="none" data-trigger="" data-url-enabled="0">International jobs</a><a href="http://www.bmj.com/panels_ajax_tab/jnl_bmj_feeds_international_jobs/none/0" rel="nofollow" style="display:none" class="js-crawler-link"></a></li>
</ul>  </div>

  
  </div>
<div class="panel-separator"></div><div class="panel-pane pane-panels-ajax-tab-container">
  
      
  
  <div class="pane-content">
    <div data-panels-ajax-tab-preloaded="jnl_bmj_feeds_uk_jobs" id="panels-ajax-tab-container-panel_jobshome" class="panels-ajax-tab-container"><div class="panels-ajax-tab-loading" style="display:none"><img class="loading" src="CONSORT%202010%20Explanation%20and%20Elaboration_%20updated%20guidelines%20for%20reporting%20parallel%20group%20randomised%20trials%20%7C%20The%20BMJ_files/loading.gif" alt="Loading" title="Loading"></div><div class="panels-ajax-tab-wrap-jnl_bmj_feeds_uk_jobs"><div class="panel-display row bootstrap-onecol">
  <div class="panel-panel col-xs-12 col-sm-12 col-md-12 col-lg-12">
    <div class="panel-pane pane-jnl-bmj-feed2widget">
  
      
  
  <div class="pane-content">
      <div class="feed2widget-item">
    <a href="http://jobs.bmj.com/job/21529/haematology-spr-wales-april-for-two-months/?TrackID=8&amp;g=w_bmj_bmj-com">Athona: Haematology SpR – Wales – April for two months</a>      </div>
  <div class="feed2widget-item">
    <a href="http://jobs.bmj.com/job/21412/general-medicine-spr-east-of-england-asap-until-january-2016/?TrackID=8&amp;g=w_bmj_bmj-com">Athona: General Medicine SpR – East of England– ASAP until January 2016</a>      </div>
  <div class="feed2widget-item">
    <a href="http://jobs.bmj.com/job/22764/are-you-an-rcgp1-doctor-lucrative-locums-available-london/?TrackID=8&amp;g=w_bmj_bmj-com">MERCO RECRUITMENT LTD: Are you an RCGP1 Doctor? Lucrative locums available - London</a>      </div>
  <div class="feed2widget-item">
    <a href="http://jobs.bmj.com/job/22763/gp-registrars-looking-to-gain-some-experience-/?TrackID=8&amp;g=w_bmj_bmj-com">MERCO RECRUITMENT LTD: GP Registrars, looking to gain some experience?</a>      </div>
  <div class="feed2widget-item">
    <a href="http://jobs.bmj.com/job/22759/consultant-radiologist/?TrackID=8&amp;g=w_bmj_bmj-com">Central Manchester University Hospitals NHS Foundation Trust: Consultant Radiologist</a>      </div>
  <div class="block-footer bmj_feed2widget">
    <a href="http://jobs.bmj.com/">View more</a>
  </div>
  </div>

  
  </div>
  </div>
</div>
</div></div>  </div>

  
  </div>
        </aside>
      </div>
  </div>
  <!-- /row -->

  <div class="row">
    <div class="panel-panel page-bottom col-md-12 col-lg-12"> <div class="panel-pane pane-highwire-back-to-top">
  
      
  
  <div class="pane-content">
    <a href="#page" class="back-to-top"><i class="icon-chevron-up"></i> Back to top</a>  </div>

  
  </div>
 </div>
  </div>
  <!-- /row -->
</div>
<!-- /container -->

</section> <!-- /.block -->
  </div>
        </section>
              </div><!-- /row -->
    </div><!-- /main-container -->
<!-- ______________________ FOOTER _______________________ -->
          <div class="footer-wrapper">
        <div class="container">
          <footer id="footer">
              <div class="region region-footer">
    <section id="block-panels-mini-bmj-footer" class="block block-panels-mini clearfix">

      
  <div class="panel-display bootstrap-footer" id="mini-panel-bmj_footer">
  <div class="footer-top-row">
    <div id="footer-social-media" class="footer-column panel-panel col-xs-12 col-sm-3 col-md-3 col-lg-3">
      <div class="panel-pane pane-block pane-menu-block-2">
  
        <h2 class="pane-title">Follow us on</h2>
    
  
  <div class="pane-content">
    <div class="menu-block-wrapper menu-block-2 menu-name-menu-footer parent-mlid-1298 menu-level-1">
  <ul class="menu nav"><li class="first leaf menu-mlid-1299"><a href="http://twitter.com/bmj_latest" target="_blank">Twitter</a></li>
<li class="leaf menu-mlid-1300"><a href="http://youtube.com/user/BMJmedia" target="_blank">YouTube</a></li>
<li class="leaf menu-mlid-1301"><a href="https://www.facebook.com/thebmjdotcom" target="_blank">Facebook</a></li>
<li class="last leaf menu-mlid-1302"><a href="http://www.bmj.com/rss">RSS</a></li>
</ul></div>
  </div>

  
  </div>
    </div>
    <div class="footer-content col-xs-12 col-sm-9 col-md-9 col-lg-9">
      <div id="footer-top-row" class="row">
        <div class="footer-column panel-panel col-xs-6 col-sm-4 col-md-4 col-lg-4">
          <div class="panel-pane pane-block pane-menu-block-3">
  
        <h2 class="pane-title">Content links</h2>
    
  
  <div class="pane-content">
    <div class="menu-block-wrapper menu-block-3 menu-name-menu-footer parent-mlid-1303 menu-level-1">
  <ul class="menu nav"><li class="first leaf menu-mlid-1305"><a href="http://www.bmj.com/us/research">Research</a></li>
<li class="leaf menu-mlid-1306"><a href="http://www.bmj.com/us/education">Education</a></li>
<li class="leaf menu-mlid-6506"><a href="http://www.bmj.com/us/news">News and views</a></li>
<li class="leaf menu-mlid-7612"><a href="http://www.bmj.com/rapid-responses">Rapid responses</a></li>
<li class="leaf menu-mlid-1309"><a href="http://www.bmj.com/archive">Archive</a></li>
<li class="leaf menu-mlid-1310"><a href="http://blogs.bmj.com/bmj/">Blogs</a></li>
<li class="leaf menu-mlid-7605"><a href="http://www.bmj.com/campaign/corruption-healthcare">Corruption in healthcare campaign</a></li>
<li class="leaf menu-mlid-17959"><a href="http://www.bmj.com/campaign/statins-open-data">Statins data campaign</a></li>
<li class="last leaf menu-mlid-7708"><a href="http://www.bmj.com/content/current">Print issue table of contents</a></li>
</ul></div>
  </div>

  
  </div>
        </div>
        <div class="footer-column panel-panel col-xs-6 col-sm-4 col-md-4 col-lg-4">
          <div class="panel-pane pane-block pane-menu-block-4">
  
        <h2 class="pane-title">About us</h2>
    
  
  <div class="pane-content">
    <div class="menu-block-wrapper menu-block-4 menu-name-menu-footer parent-mlid-1314 menu-level-1">
  <ul class="menu nav"><li class="first leaf menu-mlid-6487"><a href="http://www.bmj.com/about-bmj">About us</a></li>
<li class="leaf menu-mlid-1316"><a href="http://www.bmj.com/about-bmj/editorial-staff">Editorial staff</a></li>
<li class="leaf menu-mlid-1317"><a href="http://www.bmj.com/about-bmj/editorial-staff/bmj-united-states">BMJ in the USA</a></li>
<li class="leaf menu-mlid-1318"><a href="http://www.bmj.com/about-bmj/editorial-staff/bmj-india">BMJ in India</a></li>
<li class="leaf menu-mlid-1319"><a href="http://www.bmj.com/about-bmj/advisory-panels">Advisers</a></li>
<li class="leaf menu-mlid-1320"><a href="http://www.bmj.com/about-bmj/resources-authors/forms-policies-and-checklists">Policies</a></li>
<li class="leaf menu-mlid-1321"><a href="http://www.bmj.com/about-bmj/complaints-procedure">Complaints</a></li>
<li class="last leaf menu-mlid-1323"><a href="http://mc.manuscriptcentral.com/bmj">Submit your paper</a></li>
</ul></div>
  </div>

  
  </div>
        </div>
        <div class="footer-column panel-panel col-xs-6 col-sm-4 col-md-4 col-lg-4">
          <div class="panel-pane pane-block pane-menu-block-5">
  
        <h2 class="pane-title">Resources</h2>
    
  
  <div class="pane-content">
    <div class="menu-block-wrapper menu-block-5 menu-name-menu-footer parent-mlid-1324 menu-level-1">
  <ul class="menu nav"><li class="first leaf menu-mlid-1325"><a href="http://www.bmj.com/about-bmj/resources-authors">Authors</a></li>
<li class="leaf menu-mlid-1326"><a href="http://www.bmj.com/about-bmj/resources-reviewers">Reviewers</a></li>
<li class="leaf menu-mlid-1327"><a href="http://www.bmj.com/about-bmj/resources-bma-members">BMA members</a></li>
<li class="leaf menu-mlid-1329"><a href="http://www.bmj.com/about-bmj/resources-readers">Readers</a></li>
<li class="leaf menu-mlid-1328"><a href="http://www.bmj.com/about-bmj/resources-subscribers">Subscribers</a></li>
<li class="leaf menu-mlid-1330"><a href="http://www.bmj.com/about-bmj/resources-advertisers-and-sponsors">Advertisers and sponsors</a></li>
<li class="leaf menu-mlid-1331"><a href="http://www.bmj.com/about-bmj/resources-media">Media</a></li>
<li class="leaf menu-mlid-8069"><a href="http://www.bmj.com/campaign/patient-partnership">Patient partnership</a></li>
<li class="last leaf menu-mlid-7610"><a href="http://careers.bmj.com/careers/static/recruiters.html">Recruiters</a></li>
</ul></div>
  </div>

  
  </div>
        </div>
        <div class="footer-column panel-panel col-xs-6 col-sm-4 col-md-4 col-lg-4">
          <div class="panel-pane pane-block pane-menu-block-6">
  
        <h2 class="pane-title">Explore BMJ</h2>
    
  
  <div class="pane-content">
    <div class="menu-block-wrapper menu-block-6 menu-name-menu-footer parent-mlid-1332 menu-level-1">
  <ul class="menu nav"><li class="first leaf menu-mlid-7613"><a href="http://www.bmj.com/">BMJ Company</a></li>
<li class="leaf menu-mlid-7421"><a href="http://careers.bmj.com/">BMJ Careers</a></li>
<li class="leaf menu-mlid-7423"><a href="http://learning.bmj.com/">BMJ Learning</a></li>
<li class="leaf menu-mlid-7424"><a href="http://masterclasses.bmj.com/">BMJ Masterclasses</a></li>
<li class="leaf menu-mlid-7425"><a href="http://journals.bmj.com/">BMJ Journals</a></li>
<li class="leaf menu-mlid-7422"><a href="http://student.bmj.com/">Student BMJ</a></li>
<li class="leaf menu-mlid-7426"><a href="http://doc2doc.bmj.com/">doc2doc</a></li>
<li class="leaf menu-mlid-7427"><a href="http://bestpractice.bmj.com/best-practice/evidence.html">Best Practice</a></li>
<li class="leaf menu-mlid-17817"><a href="http://www.bmj.com/specialties">BMJ specialties</a></li>
<li class="last leaf menu-mlid-17958"><a href="http://thebmjawards.bmj.com/home">The BMJ Awards 2015</a></li>
</ul></div>
  </div>

  
  </div>
        </div>
        <div class="footer-column panel-panel col-xs-6 col-sm-4 col-md-4 col-lg-4">
          <div class="panel-pane pane-block pane-menu-block-7">
  
        <h2 class="pane-title">My account</h2>
    
  
  <div class="pane-content">
    <div class="menu-block-wrapper menu-block-7 menu-name-menu-footer parent-mlid-1343 menu-level-1">
  <ul class="menu nav"><li class="first leaf menu-mlid-1344"><a href="http://myaccount.bmj.com/myaccount/account/hw-registration.html">Email alerts</a></li>
<li class="last leaf menu-mlid-1345"><a href="http://journals.bmj.com/cgi/activate">Activate subscription</a></li>
</ul></div>
  </div>

  
  </div>
        </div>
        <div class="footer-column panel-panel col-xs-6 col-sm-4 col-md-4 col-lg-4">
          <div class="panel-pane pane-block pane-menu-block-8">
  
        <h2 class="pane-title">Information</h2>
    
  
  <div class="pane-content">
    <div class="menu-block-wrapper menu-block-8 menu-name-menu-footer parent-mlid-1346 menu-level-1">
  <ul class="menu nav"><li class="first leaf menu-mlid-1347"><a href="http://www.bmj.com/about-bmj/contact-us">Contact us</a></li>
<li class="last leaf menu-mlid-1348"><a href="http://myaccount.bmj.com/myaccount/customerservice/salesforce-form.html">Feedback</a></li>
</ul></div>
  </div>

  
  </div>
        </div>
      </div>
    </div>
  </div>

  <div id="footer-bottom-row" class="row">
    <div class="panel-panel col-xs-12 col-sm-12 col-md-12 col-lg-12">
      <div class="panel-pane pane-block pane-menu-block-9 hidden-phone">
  
      
  
  <div class="pane-content">
    <div class="menu-block-wrapper menu-block-9 menu-name-menu-footer parent-mlid-1349 menu-level-1">
  <ul class="menu nav"><li class="first leaf menu-mlid-1350"><a href="http://group.bmj.com/group/about/legal/privacy">Privacy and Cookie Policy</a></li>
<li class="leaf menu-mlid-1351"><a href="http://www.bmj.com/company/legal-information/">Website T&amp;Cs</a></li>
<li class="leaf menu-mlid-1352"><a href="http://group.bmj.com/group/about/revenue-sources">Revenue Sources</a></li>
<li class="leaf menu-mlid-1353"><a href="http://highwire.stanford.edu/">HighWire Press</a></li>
<li class="leaf menu-mlid-1354"><a href="http://myaccount.bmj.com/myaccount/customerservice/salesforce-form.html">Feedback</a></li>
<li class="leaf menu-mlid-8093"><a href="http://www.bmj.com/sitemap">Sitemap</a></li>
<li class="last leaf menu-mlid-1355"><a href="http://www.bmj.com/about-bmj/help-bmjcom-visitors">Help</a></li>
</ul></div>
  </div>

  
  </div>
    </div>
  </div>

</div>

</section> <!-- /.block -->
  </div>
          </footer> <!-- /footer -->
        </div><!-- /footer-wrapper:container -->
      </div><!-- /footer-wrapper -->
    
    
  </div> <!-- /wrapper -->
</div> <!-- /wrapper-outer -->
  <script>
setTimeout(function(){var a=document.createElement("script");
var b=document.getElementsByTagName("script")[0];
a.src=document.location.protocol+"//dnn506yrbagrg.cloudfront.net/pages/scripts/0014/4896.js?"+Math.floor(new Date().getTime()/3600000);
a.async=true;a.type="text/javascript";b.parentNode.insertBefore(a,b)}, 1);</script>
<script gapi_processed="true" src="CONSORT%202010%20Explanation%20and%20Elaboration_%20updated%20guidelines%20for%20reporting%20parallel%20group%20randomised%20trials%20%7C%20The%20BMJ_files/js_8D5n77GdFLPOdHV7WRso42GXVAUY9W3EmvZc7mm2E1g.js"></script>
    


<div style="display: none;" id="cboxOverlay"></div><div style="display: none; padding-bottom: 25px; padding-right: 30px;" class="" id="colorbox"><div id="cboxWrapper"><div><div style="float: left;" id="cboxTopLeft"></div><div style="float: left;" id="cboxTopCenter"></div><div style="float: left;" id="cboxTopRight"></div></div><div style="clear: left;"><div style="float: left;" id="cboxMiddleLeft"></div><div style="float: left;" id="cboxContent"><div style="width: 0px; height: 0px; overflow: hidden; float: left;" id="cboxLoadedContent"></div><div style="float: left;" id="cboxLoadingOverlay"></div><div style="float: left;" id="cboxLoadingGraphic"></div><div style="float: left;" id="cboxTitle"></div><div style="float: left;" id="cboxCurrent"></div><div style="float: left;" id="cboxNext"></div><div style="float: left;" id="cboxPrevious"></div><div style="float: left;" id="cboxSlideshow"></div><div style="float: left;" id="cboxClose"></div></div><div style="float: left;" id="cboxMiddleRight"></div></div><div style="clear: left;"><div style="float: left;" id="cboxBottomLeft"></div><div style="float: left;" id="cboxBottomCenter"></div><div style="float: left;" id="cboxBottomRight"></div></div></div><div style="position: absolute; width: 9999px; visibility: hidden; display: none;"></div></div><div style="position: absolute; display: none;" id="cluetip-waitimage"></div><div style="position: absolute; display: none;" id="cluetip"><div style="position: relative; z-index: 97;" class="cluetip-outer"><h3 class="cluetip-title ui-widget-header ui-cluetip-header"></h3><div class="cluetip-inner ui-widget-content ui-cluetip-content"></div></div><div class="cluetip-extra"></div></div><div aria-labelledby="ui-dialog-title-crossmark-dialog" role="dialog" tabindex="-1" class="ui-dialog ui-widget ui-widget-content ui-corner-all crossmark-ui-dialog" style="display: none; z-index: 3999; outline: 0px none;"><div class="ui-dialog-titlebar ui-widget-header ui-corner-all ui-helper-clearfix"><span id="ui-dialog-title-crossmark-dialog" class="ui-dialog-title">&nbsp;</span><a role="button" class="ui-dialog-titlebar-close ui-corner-all" href="#"><span class="ui-icon ui-icon-closethick">close</span></a></div><div class="ui-dialog-content ui-widget-content" id="crossmark-dialog" style="">
<!-- the external CrossMark data is loaded inside this iframe --><iframe id="crossmark-dialog-frame" frameborder="0"></iframe></div></div><div id="crossmark-tooltip-130" class="crossmark-tooltip" style="display: none;"><div class="cmtttop"></div><div class="cmttmid"><p>Click to get updates and verify authenticity.</p></div><div class="cmttbot"></div></div><iframe tabindex="-1" style="width: 1px; height: 1px; position: absolute; top: -100px;" src="CONSORT%202010%20Explanation%20and%20Elaboration_%20updated%20guidelines%20for%20reporting%20parallel%20group%20randomised%20trials%20%7C%20The%20BMJ_files/postmessageRelay.html" id="oauth2relay1776791810" name="oauth2relay1776791810"></iframe><script gapi_processed="true" src="CONSORT%202010%20Explanation%20and%20Elaboration_%20updated%20guidelines%20for%20reporting%20parallel%20group%20randomised%20trials%20%7C%20The%20BMJ_files/bmj.json" type="text/javascript"></script></body></html>